Title,Types,Diseases,Countries "´Multimodal motor symptoms quantification platform for individualized Parkinson´s disease treatments´ MuSyQ","Investments > €500k","Parkinson's disease & PD-related disorders",Sweden "‘D-activating Decline’: Exploring the combined effects of exercise and vitamin D3 supplementation on cognitive function in healthy older adults.","Investments < €500k",,Ireland "“Am I the right way up?” Investigating balance problems in posterior cortical atrophy","Investments < €500k",,"United Kingdom" "“Beauty and the brain” – A novel approach to anhedonia in dementia","Investments < €500k",,Australia "“EPSRC – NIHR HTC Partnership Award: Partnership with the MindTech HTC","Investments < €500k",,"United Kingdom" "1/2 Phenotype Predictors of Cognitive Outcomes in Geriatric Depression","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "100 kHz magic angle spinning for development of solid-state NMR methodology for probing protein dynamics","Investments < €500k",,"United Kingdom" "123I-MIBG Scintigraphy Utility as a biomarker for Prodromal DEmentia with Lewy Bodies (SUPErB)","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "1970 British Cohort Study","Population Cohorts","Neurodegenerative disease in general","United Kingdom" "1H and 31P MR Spectroscopy of Hippocampal Hyperactivity in Aging and MCI","Investments < €500k",,"United States of America" "2-Hydroxybenzylamine for the prevention of Alzheimers disease: Initial evaluation in humans","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "2/2 Phenotype Predictors of Cognitive Outcomes in Geriatric Depression","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "20,000 Volunteers for Medical Research","Population Cohorts","Neurodegenerative disease in general",France "2016 Parkinson Study Group Symposium and Training","Investments < €500k",,"United States of America" "2016-2018 Drug Discovery for Neurodegeneration Conferences","Investments < €500k",,"United States of America" "2017 Parkinsons Disease Gordon Research Conference and Seminar","Investments < €500k",,"United States of America" "201TlDDC-SPECT for early diagnosis of dementia","Investments > €500k","Alzheimer's disease & other dementias",Germany "20th SMA Researcher Meeting","Investments < €500k",,"United States of America" "21st Century EURODEM","Investments < €500k",,Sweden "2241 Co-Funded Brain Circulation Scheme",Fellowships,,Turkey "2nd Neurodegeneration Conference","Investments < €500k",,"United Kingdom" "3-Nitro-L-tyrosine in structures of neurodegenerative proteins","Investments < €500k",,"Czech Republic" "3’UTR -based regulation of neurotrophic factors as a novel tool to understand neuronal function and find treatment for Parkinson’s disease","Investments < €500k",,Finland "3C study","Population Cohorts","Alzheimer's disease & other dementias",France "3D in-line blood brain barrier pharmacology testing platform","Investments < €500k",,France "3D Memories promoting inhibited potential in design processes","Investments < €500k",,Sweden "3D two-photon fluorescence microscope","Capital Infrastructure",,Hungary "3DMiniBrain: High-Throughput, High-Content Screening of human neuroectodermal organoids for innovative drug discovery in neurodegenerative diseases","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders",France|Germany|Italy|JPND "3DPD: Advanced modelling of Parkinson’s disease with three-dimensional human midbrain organoids","Investments > €500k|JPND Projects","Parkinson's disease & PD-related disorders",Austria|Germany|Israel|JPND|Luxembourg|Netherlands "4D Software Tools for Longitudinal Prediction of Brain Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "A BBB-permeable neurotrophic polysaccharide, midi-GAGR","Investments < €500k",,"United States of America" "A biological resource for metagenomic studies of dementia","Investments < €500k",,"United Kingdom" "A biomarker-driven trial of angiotensin receptor blockers for prodromal Alzheimer","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "A cell surface, lipid raft-based signalling complex links amyloid-beta to tau via Fyn","Investments < €500k",,"United Kingdom" "A Collaborative International Knowledge Synthesis to Update Guidelines for Determining Medical Fitness to Operate Motor Vehicles with Dementia","Investments < €500k",,Canada "A common mitochondrial pathogenesis for Parkinson’s disease: elucidating disease mechanisms and designing treatments","Investments < €500k",,Norway "A Conserved Metalloprotease Required for Mitochondrial Maintenance and Protection","Investments > €500k","Motor neurone diseases","United States of America" "A CRISPR-Cas9 screen to identify genetic modifiers of APP/BACE-1 interactions","Investments < €500k",,"United States of America" "A Culturally-Relevant Approach to Reducing Dementia Caregiver Stress in an Underserved Population",Fellowships,"Alzheimer's disease & other dementias","United States of America" "A Defined Abeta Oligomer Epitope: Theranostic Applications","Investments < €500k",,Canada "A device to detect and measure the progression of dementia by quantifying the interactions between neuronal and cardiovascular oscillations","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "A Digital Brain Health Platform for improving dementia outcomes","Investments > €500k","Neurodegenerative disease in general","United Kingdom" "A double-blinded, randomized, controlled phase 2a safety, proof-of-concept and exploratory end point trial of the drug LM11A-31 in patients with mild to moderate Alzheimers disease.","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "A Drosophila model for studying mechanisms of Gauchers disease and synucleinopathies","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "A Drosophila model for studying mechanisms of Gauchers disease and synucleinopathies","Investments > €500k","Motor neurone diseases|Neurodegenerative disease in general|Parkinson's disease & PD-related disorders","United States of America" "A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "A feasibility study of facilitated reminiscence for people with dementia","Investments < €500k",,"United Kingdom" "A flavonoid gamma-secretase modulator (GSM) reduces beta-amyloid and tau pathologies in the AD mice","Investments < €500k",,"United States of America" "A Humanized Swine Model for Alzheimers Disease","Investments < €500k",,"United States of America" "A large randomised assessment of the relative cost-effectiveness of different classes of drugs for Parkinson’s disease (PD MED)","Investments > €500k","Parkinson's disease & PD-related disorders","United Kingdom" "A Longitudinal Analysis Stream for FreeSurfer","Investments > €500k","Neurodegenerative disease in general","United States of America" "A longitudinal study of mid-to late-life blood pressure profiles as risk factors for Alzheimer´s disease in Hispanics","Investments < €500k",,"United States of America" "A longitudinal study of the evolution of language changes in Motor Neuron Disease (MND): Neuropsychology and Neuroimaging correlates of Language performance in MND","Investments < €500k",,"United Kingdom" "A machine learning approach to identify Alzheimers disease therapeutic targets","Investments < €500k",,"United States of America" "A magnetoencephalographic study into the pathophysiological substrates of cognitive and motor symptoms and treatment effects in parkinsonian syndromes",Fellowships,"Parkinson's disease & PD-related disorders","United Kingdom" "A method for early and easy detection of Alzheimers disease","Investments < €500k",,"United States of America" "A microchip to analyze trafficking leukocytes in Alzheimer’s disease patients","Investments < €500k",,"United States of America" "A molecular anatomic imaging analysis of tau in progressive supranuclear palsy","Investments > €500k","Neurodegenerative disease in general","United States of America" "A Mouse Model of Tau Pathology in AD and Other Dementias","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "A multi-centre randomised controlled trial of Comprehensive Geriatric Assessment in an admission avoidance hospital at home setting","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "A multi-centre randomised controlled trial to compare the clinical and cost effectiveness of Lee Silverman Voice Treatment versus standard NHS speech and language therapy versus control in Parkinson’s disease (PD COMM)","Investments > €500k","Parkinson's disease & PD-related disorders","United Kingdom" "A multi-faceted intervention to enhance cognition in older people at risk of cognitive decline",Fellowships,"Alzheimer's disease & other dementias",Australia "A multi-hit model of Parkinson’s disease: LRRKing inflammatory mechanisms.","Investments < €500k",,Canada "A multi-scale data-driven model of the Abeta pore function and Ca2+ toxicity in Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "A multi-site evaluation of the Person, Interactions & Environment (PIE) tool to improve person-centred care for people with dementia admitted to acute hospital wards","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "A Multi-Target Approach to Alzheimer’s Disease: Novel Polyfunctional Therapeutics that Target Multiple Hallmarks","Investments < €500k",,Australia "A Multicentre Biomarker Resource Strategy in ALS: AMBRoSIA","Investments > €500k","Motor neurone diseases","United Kingdom" "A Multiobjective Evolutionary Approach to Understanding Parkinson’s Disease","Investments < €500k",,"United Kingdom" "A National Dementia Registry for Ireland: A feasbility analysis","Investments < €500k",,Ireland "A new antibody/RNAi combination therapy strategy for ALS","Investments < €500k",,"United States of America" "A new antibody/RNAi combination therapy strategy for ALS","Investments < €500k",,"United States of America" "A new approach to modeling ALS based on TBK1 mutation in mice","Investments < €500k",,"United States of America" "A new approach to modeling ALS based on TBK1 mutation in mice","Investments < €500k",,"United States of America" "A new approach to modeling ALS based on TBK1 mutation in mice","Investments < €500k",,"United States of America" "A new brain-dedicated Positron Emission Tomography (PET) system to identify Beta-amyloid biomarker for the early diagnosis of Alzheimer’s disease and other causes of cognitive decline","Investments < €500k",,"European Commission" "A new conditional BAC transgenic model of C9ORF72-linked Motoneuron Disease to allow direct visualisation and analysis of impaired RNA cellular pathways","Investments < €500k",,"United Kingdom" "A new form of deep brain stimulation to treat gait and balance disorders in Parkinson’s disease",Fellowships,"Parkinson's disease & PD-related disorders",Australia "A new Generation of Drugs for ALzheimer’s disease based on in vitro and in silico experiments of beta-amyloid oligomers and in vivo tests","Investments > €500k","Alzheimer's disease & other dementias",France "A next generation approach to drug development for Alzheimer’s Disease","Investments < €500k",,Finland "A next-generation MRI brain imaging platform for dementia research: from microstructure to function","Capital Infrastructure",,"United Kingdom" "A non-pharmacological intervention for patients with Alzheimer s disease and family caregivers","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "A novel APP processing pathway and its physiological function in modulation of synaptic activity","Investments < €500k",,France "A novel approach to enhance cognitive function and promote synaptic plasticity","Investments < €500k",,Australia "A novel biomarker platform for dementia research with single molecule sensitivity.","Investments < €500k",,"United Kingdom" "A novel diagnostic approach for Alzheimer´s disease based on the prion-like properties of tau","Investments < €500k",,Switzerland "A novel drug re-positioning strategy for Parkinson’s: Simultaneous, high content screening for translatable small molecules which are beneficial for mitochondrial and lysosomal dysfunction in primary fibroblasts from Parkinson’s patients",Fellowships,"Parkinson's disease & PD-related disorders","United Kingdom" "A novel dual hit model of environmental risk factors for Parkinsons Disease","Investments < €500k",,"United States of America" "A novel dual hit model of environmental risk factors for Parkinsons Disease","Investments < €500k",,"United States of America" "A Novel Image Guided System to Mount Micro Targeting Platform for Deep Brain Stimulation Surgery to treat Parkinsons Disease","Investments < €500k",,"United States of America" "A Novel Image Guided System to Mount Micro Targeting Platform for Deep Brain Stimulation Surgery to treat Parkinsons Disease","Investments < €500k",,"United States of America" "A Novel Mobile Health Exercise Intervention in Aging: Brain Perfusion and Cognition",Fellowships,"Alzheimer's disease & other dementias","United States of America" "A novel neuroprotective mechanism in Alzheimer’s disease","Investments < €500k",,Australia "A NOVEL NEUROPROTECTIVE THERAPY FOR ALZHEIMER’S DISEASE","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "A novel roadblock to vitamin B12 transport in the brain","Investments < €500k",,Australia "A Novel Small molecule TNF-alpha inhibitor as a disease-modifying AD drug treatment.","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "A novel two-step model for neurodegeneration in Parkinson’s disease","Investments > €500k","Parkinson's disease & PD-related disorders","European Commission" "A person-centred multidimensional interdisciplinary rehabilitation program for community dwelling older people with dementia and their informal primary caregivers: a randomised controlled trial","Investments < €500k",,Sweden "A pilot randomised controlled trial of a mindfulness based cognitive therapy delivered by Skype for people affected by Parkinson’s","Investments < €500k",,"United Kingdom" "A PK11195 PET Study of neuroinflammation in dementia with Lewy bodies","Investments < €500k",,"United Kingdom" "A potential biomarker for vascular dementia","Investments < €500k",,Canada "A Proinflammatory Endophenotype to Predict NSAID Treatment Response Alzheimers Disease Clinical Trials","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "A prospective cohort study on oral health and risks of dementia, cardiovascular diseases and inflammatory bowel diseases","Investments < €500k",,Sweden "A Prospective Study of Nicotine from Edible Solanaceae and Risk of Parkinson Disease","Investments < €500k",,"United States of America" "A Prospective Study of Nicotine from Edible Solanaceae and Risk of Parkinson Disease","Investments < €500k",,"United States of America" "A randomised control trial of rivastigmine versus placebo for improving gait stability in patients with Parkinson’s with a past history of a fall",Fellowships,"Parkinson's disease & PD-related disorders","United Kingdom" "A Randomised Controlled Trial of the Effectiveness of PDSAFE to prevent Falls among People with Parkinson’s Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United Kingdom" "‘A randomized controlled trial of calcium channel blockade (CCB) with amlodipine for the treatment of subcortical ischaemic vascular dementia (SIVD). (AFFECT clinical trial).","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "A randomized controlled trial of Theta Burst Stimulation for the treatment of cogntive impairment in mild to moderate Alzheimer’s disease","Investments < €500k",,Australia "A sleep electroencephalography biomarker predicting Alzheimers disease pathology","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "A Software Platform for Sensor-based Movement Disorder Recognition","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "A synthetic vesicle to carry modifier compounds to axonal blocks induced by pathogenic polyQ","Investments < €500k",,"United States of America" "A synthetic vesicle to carry modifier compounds to axonal blocks induced by pathogenic polyQ","Investments < €500k",,"United States of America" "A system approach to targeting innate immunity in AD","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "A system approach to targeting innate immunity in AD","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "A Systematic Programme to Develop and Evaluate the Best Candidate Treatments for Repositioning as Therapies for Alzheimer s Disease (SMART-AD).","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "A Systematic Review and Meta-Analysis of the Accuracy of Depression Rating Scales to Diagnose Depression in Older Adults with Alzheimer’s Disease and Other Dementias","Investments < €500k",,Canada "A systems approach to DNA methylation, gene expression, and cognitive dysfunction in Alzheimers disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "A systems pharmacology approach to the discovery of novel therapeutics in Alzheimer´s disease","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "A Tailored Technology Intervention for Diverse Family Caregivers of AD Patients","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "A targeted proteomic analysis for biomarkers discovery in ALS","Investments < €500k",,"United Kingdom" "A telehealth intervention to delay functional decline in community-dwelling people with dementia",Fellowships,"Alzheimer's disease & other dementias",Australia "A tissue-on-a-chip platform for systems-level studies of ALS pathology and drug screening",Fellowships,"Motor neurone diseases","European Commission" "A Translational Program of BDNF Gene Delivery in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "A trial to assess the safety and efficacy of intermittent putamenal GDNF infusions administered via Convection Enhanced Delivery (CED) in Parkinson’s","Investments > €500k","Parkinson's disease & PD-related disorders","United Kingdom" "A. Kenneth Snowman – MND Association Lectureship in Translational Neuroscience","Investments < €500k",,"United Kingdom" "A2A receptors and Tauopathy","Investments < €500k",,France "AAL-WELL Ambient Assistive Living Technologies for Wellness, Engagement and Long Life","Investments < €500k",,"United Kingdom" "Aalto NeuroImaging","Capital Infrastructure",,Finland "Aarhus Reseach Centre for Brain Aging and Dementia – ARCADIA","Investments > €500k","Alzheimer's disease & other dementias",Denmark "ABC-AD: ABC transporters as early diagnostics and treatment marker for neurodegenerative dementias – towards a personalised medicine in dementia","Investments < €500k",,Norway "ABCD study: Anticholinergics, Benzodiazepines, Cognition and Dementia","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Aberrant NMDA receptor and synaptic signaling in vulnerability to neurodegeneration: Focus on Huntington disease","Investments > €500k","Huntington's disease",Canada "Aberrant phospholipid and sphingolipid metabolism is a primary and targetable pathology in Alzheimer Disease","Investments > €500k","Alzheimer's disease & other dementias",Canada "Abeta Oligomers and Mechanisms of Neuronal Cell Death in Alzheimers Disease","Investments < €500k",,"United States of America" "Abeta-mediated toxicity in Alzheimer’s disease: delineating mechanisms of internalisation, cell-cell transmission and synaptic dysfunction","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Abeta-Targeted Fluorinated Liposomes for 19F MRI Detection of Abeta Pathologies in APP/PSEN1 Mice","Investments < €500k",,"United States of America" "ABIDE: Alzheimer’s Biomarkers in Daily Practice","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "Abnormal brain networks as novel biomarkers of neurodegeneration","Investments < €500k",,Sweden "Abnormal Mitochondrial Dynamics and Mitochondrial Dysfunction in Alzheimers Dise","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "ACA5: Action decisions in health and neurodegenerative disease","Investments > €500k","Parkinson's disease & PD-related disorders","United Kingdom" "ACAT inhibitors regulate palmitoylated APP and Abeta production","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Acceleration of Parkinson pathogenesis by chronic low-dose rate gamma exposure – OSTINATO","Investments < €500k",,Norway "ACED (Advanced Human-Based Concept for Efficient Drug Development)","Investments < €500k",,Finland "Achieving Quality and Effectiveness in Dementia Using Crisis Teams (AQUEDUCT)","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "ACTIFCare: Access to timely formal care","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias","Germany|Ireland|Italy|JPND|Netherlands|Norway|Portugal|Sweden|United Kingdom" "Actigraphic assessment of sleep quality in the A4 trial","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Actions of Nuclear Receptors on TREM2+ myeloid cells and microglia in AD brain","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Activated microglia regulate neuronal secretion of a-synuclein by exophagy through activation of neuronal JNK stress kinase","Investments < €500k",,Denmark "Activated microglia regulate neuronal secretion of α-synuclein by exophagy through activation of neuronal JNK stress kinase",Fellowships,"Alzheimer's disease & other dementias",Denmark "Activating the immune system to treat Alzheimer’s disease","Investments < €500k",,Australia "Activation of Neuronal JNK following Endogenous Stress or Inflammatory Signaling Regulates the Unconventional Secretion of Alpha-Synuclein","Investments < €500k",,Denmark "Activation of the 20S Proteasome to Normalize Tau Homeostasis","Investments < €500k",,"United States of America" "Activation of the GPCR Smoothened as a treatment of L-Dopa Induced dyskinesia","Investments < €500k",,"United States of America" "Activation of the GPCR Smoothened as a treatment of L-Dopa Induced dyskinesia","Investments < €500k",,"United States of America" "Activators of Nrf2 Translation in Alzheimers Disease","Investments < €500k",,"United States of America" "Active zone loss cause dying back neuropathy in amyotrophic lateral sclerosis","Investments > €500k","Motor neurone diseases","United States of America" "AD Gene Discovery: Exome Chip, New Endophenotypes & Functional Studies in CHARGE","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "AD Immunotherapy : Towards a disease modification therapy in Alzheimer disease via targeting Tau protein with monoclonal antibodies","Investments < €500k",,Belgium "AD ontological architecture for neuroimaging datawarehouse: merging and establishing anatomical normative data from 17 datasets","Investments < €500k",,Canada "AD Pilot Clinical Trials: Spatiotemporal Brain ERP Measures","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "ADAGE: Alzheimer’s Disease pathology within the ageing physiology.","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias","Italy|JPND|Sweden|United Kingdom" "ADAM10 nella Malattia di Huntington: studio molecolare e funzionale della sinapsi. ADAM10 in Huntington’s disease: molecular and functional study of the synapse","Investments < €500k",,Italy "Adaptieve neuromodulatie voor bewegingsstoornissen. Adaptive neuromodulation for movement disorders.",Fellowships,"Neurodegenerative disease in general",Netherlands "Adapting and testing an Alzheimer’s family caregiver intervention in Vietnam","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Adapting cognitive behavioural therapy for people with dementia",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Adaptive Implementation and Validation of the positively evaluated Meeting Centers Support Programme for people with dementia and their carers in Europe (Meetingdem)","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "Adding new cells to the mature central nervous system: investigating their normal function and potential for repair.",Fellowships,"Alzheimer's disease & other dementias",Australia "Addressing the contribution of JNK3 to axonal pathology in Huntingtons disease","Investments < €500k",,"United States of America" "Addressing the contribution of JNK3 to axonal pathology in Huntingtons disease","Investments < €500k",,"United States of America" "Adiposity, Inflammation and Neurocognitive Decline in African Americans","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Administration of VEGF (sNN0029) using an implanted drug delivery system for adose escalation study in patients with Amyotrophic Lateral Sclerosis.","Investments > €500k","Motor neurone diseases","United Kingdom" "Administrative Supplement: Neurobiological role of MicroRNA in Alzheimers","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp)","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Admixture mapping in late-onset Alzheimer’s disease","Investments < €500k",,"United States of America" "ADOPT BBMRI-ERIC (Horizon 2020)","Capital Infrastructure",,"European Commission" "ADSP Follow-up in Multi-Ethnic Cohorts via Endophenotypes, Omics & Model Systems","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Adult Determinants of Late Life Depression, Cognitive Decline and Physical Functioning – The Whitehall II Ageing Study","Investments > €500k","Neurodegenerative disease in general","United Kingdom" "Adult neural stem cells from post-mortem human brain: Towards an in vitro model for stimulating neurogenesis in neurodegenerative diseases.","Investments < €500k",,Netherlands "Adult stem cells as vehicles for delivery of neurotrophic factors to the degenerating brain","Investments < €500k",,Ireland "Advanced neural decoders for the restoration of communication","Investments > €500k","Motor neurone diseases","United States of America" "Advanced Regional Translation of Excellence into Medical Innovations for Delayed Aging","Investments < €500k",,"European Commission" "Advancing Antibody Technology for tau Immunotherapies and for Investigating tau Pathogenesis",Fellowships,"Alzheimer's disease & other dementias","United States of America" "ADVANCING DIAGNOSIS, PROGNOSIS AND THE THERAPY OF RARE NEURODEGENERATIVE DISEASES","Investments < €500k",,Spain "Advancing Geriatrics Infrastructure & Network Growth (Admin Supplement): Deprescribing Potential for Older Adults with Alzheimers Disease and Cognitive Impairment","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Advancing Our Understanding of Oligomer Toxicity in Age-Related Amyloid Disorders","Investments < €500k",,"United States of America" "Advancing the European Multidisciplinary Initiative on Neuroacanthocytosis – EMINA-2: Dissecting the molecular pathophysiology of Chorea-Acanthocytosis","Investments < €500k",,Netherlands "Aerobic Exercise in Alzheimers Disease: Cognition and Hippocampal Volume Effects","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Aetionomy: Organising Mechanistic Knowledge about Neurodegenerative Diseases for the Improvement of Drug Development and Therapy","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders","European Commission" "African AMERICANS Fighting Alzheimers In Midlife","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "African Ancestry and the Genomic Architecture of AD and Other Common Neurodegenerative Disease Neuropathologies","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "After the Liverpool Care Pathway – What next for people with dementia?","Investments < €500k",,"United Kingdom" "Age and genetic influence on fcMRI networks in autosomal dominant and sporadic AD",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Age-modified forms of Amyloid-β as initiator of Alzheimer Disease pathogenesis and mediator of Aβ-tau interaction: a study in a Drosophila model and Aβ immunized human Alzheimer patients",Fellowships,"Alzheimer's disease & other dementias", "AGE-RELATED BIOMARKET CHANGES IN CEREBROSPINAL FLUID","Investments < €500k",,"United States of America" "Age, Gene/Environment Susceptibility Study","Investments < €500k",,"United States of America" "AgeCoDe Cohort","Population Cohorts","Alzheimer's disease & other dementias",Germany "Aged Care Mental Health and Organizational Change","Investments > €500k","Alzheimer's disease & other dementias",Australia "Aged cells are damaged by clumps of protein",Fellowships,"Parkinson's disease & PD-related disorders",Sweden "Aged EFAD mice as a model for the effects of APOE and sex on AD pathology","Investments < €500k",,"United States of America" "Ageing and dementia in Aboriginal Australians: promoting vitality, identifying decline and supporting communities",Fellowships,"Alzheimer's disease & other dementias",Australia "Ageing: an innovative and TECHnology-enriched HOME care support for older patients with Alzheimer’s Disease. The TECH@HOME randomized trial","Investments < €500k",,Sweden "Ageing: Rethinking shared spaces in residential care facilities for persons with a dementia disease","Investments > €500k","Alzheimer's disease & other dementias",Sweden "Agents targeting iron in the brain in Parkinson’s disease","Investments < €500k",,Australia "Aggregation gatekeeper biology and its implications for recombinant protein production and misfolding disease",Fellowships,"Alzheimer's disease & other dementias",Belgium "Aggression Prevention Training for Caregivers of Persons with Dementia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Aging Brain, Cognition, and Dopamine","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Aging in the Brain: Role of the Fibrous Proteins","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Aging Rodents Platform (Quebec network for research on aging)","Experimental Models",,Canada "AGING, LIPIDIC HOMEOSTASIS AND INFLAMMATION IN EXPERIMENTAL PARKINSONISM. EFFECT OF TREATMENT WITH FASUDIL AND / OR WITH PIOGLITAZONE.","Investments < €500k",,Spain "AIBL Biobank",Biobanks,"Alzheimer's disease & other dementias|Neurodegenerative disease in general",Australia "AIBL III – Efficient identification of preclinical AD","Investments < €500k",,Australia "Air pollution nano-particulate matter, APP processing, and glutamate receptors","Investments < €500k",,"United States of America" "Airway protection deficits according to stimulus type in Parkinsons disease","Investments < €500k",,"United States of America" "Airway protection deficits according to stimulus type in Parkinsons disease","Investments < €500k",,"United States of America" "AKR1B1 Inhibitors in Diabetes, Inflammation and Age Dependent Neurodegeneration","Investments < €500k",,Turkey "Algorithms for Glyco-Proteoform Detection","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Allele-Selective Inhibitors for Expanded Trinucleotide Repeat Genes","Investments < €500k",,"United States of America" "Allele-Selective Inhibitors for Expanded Trinucleotide Repeat Genes","Investments < €500k",,"United States of America" "Allopregnanolone a Regenerative Therapy for Alzheimers: FDA-Required Toxicolog","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Alpha-Galactosidase A: a novel target for reducing alpha-synuclein toxicity","Investments < €500k",,"United States of America" "Alpha-Galactosidase A: a novel target for reducing alpha-synuclein toxicity","Investments < €500k",,"United States of America" "Alpha-synuclein and ER-mitochondria interactions in Parkinson’s","Investments < €500k",,"United Kingdom" "Alpha-synuclein and mitochondrial dysfunction: key links between Gaucher’s disease and Parkinson’s?",Fellowships,"Parkinson's disease & PD-related disorders","European Commission" "Alpha-synuclein biomarkers in Parkinson disease",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Alpha-synuclein Immunotherapy for Parkinson´s disease","Investments > €500k","Parkinson's disease & PD-related disorders",Sweden "alpha-Synuclein Inhibition of Mitochondrial Protein Import","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Alpha-synuclein is a key player in the pathogenic process of Parkinsons disease","Investments < €500k",,Sweden "Alpha-synuclein is crucial for neuronal function and survival-Characterization of a novel conditional alpha-synuclein knockout mouse model","Investments < €500k",,"United States of America" "Alpha-synuclein is crucial for neuronal function and survival-Characterization of a novel conditional alpha-synuclein knockout mouse model","Investments < €500k",,"United States of America" "Alpha1A-Adrenoceptors in Cognition","Investments < €500k",,"United States of America" "ALS as a Model System for Studying Degenerative Brain Diseases","Investments > €500k","Motor neurone diseases",Sweden "ALS behandelrichtlijn","Investments < €500k",,Netherlands "ALS CarE: A Programme for ALS Care in Europe","Investments > €500k|JPND Projects","Motor neurone diseases","Belgium|Germany|Ireland|Italy|JPND|Netherlands|United Kingdom" "ALS disease models and therapeutic drug screen","Investments < €500k",,"United Kingdom" "ALS is caused by strains of SOD1 prions","Investments < €500k",,Sweden "ALS Kennisplatform fase 3: ‘Kennis delen voor betere zorg’ ALS Knowledge Platform Phase 3: Sharing Knowledge for Better Care","Investments > €500k","Motor neurone diseases",Netherlands "ALS quality register","Disease Registers","Motor neurone diseases",Sweden "ALS register swabia","Disease Registers","Motor neurone diseases",Germany "ALS/FTD mutant C9orf72-induced genetic and nuclear pathology in iPS cell models","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "ALS/FTD mutant C9orf72-induced genetic and nuclear pathology in iPS cell models","Investments > €500k","Motor neurone diseases","United States of America" "ALSOD Biobank at UmU",Biobanks,"Alzheimer's disease & other dementias|Motor neurone diseases|Prion disease",Sweden "Alteration of Metabolism in Amyotrophic Lateral Sclerosis","Investments > €500k","Motor neurone diseases",Sweden "Alteration of tau splicing to identify and treat tauopathies",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Alterations in autophagy in frontotemporal lobar degeneration: identifying new targets for therapeutic intervention","Investments < €500k",,"United Kingdom" "ALTERATIONS OF THE METABOLIC PROFILE INDUCED BY LRRK2 PATHOGENIC MUTATIONS AS PARKINSON DISEASE BIOMARKERS","Investments < €500k",,Spain "Altered Amyloid Processing HIV","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Altered APP metabolism triggers changes in tau that cause dementia","Investments < €500k",,"United States of America" "Altered Heparan Sulfate in Ageing and Dementia: a Potential Axis for Dysregulation of BACE-1 in Alzheimers Disease","Investments < €500k",,"United Kingdom" "Altered monocyte function in relation to the CD33 Alzheimers disease locus","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "ALZHEIMER DISEASE Biomarkers AS PROGNOSTIC FACTORS IN NORMAL IDIOPATHIC PRESSURE HYDROCEPHALISM","Investments < €500k",,Spain "Alzheimer Disease Genetic Architecture in African Americans","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Alzheimer Disease Genetic Architecture in African Americans","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Alzheimer Disease Pathobiology and Mechanisms of Neurodegeneration","Investments < €500k",,Canada "Alzheimer neuroimaging-biomarkers in pre-clinical cognitive decline from a population-based study","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Alzheimer pathology: swimming against the current","Investments < €500k",,Netherlands "Alzheimer treatment based on the editing of the Amyloid Precursor Protein gene","Investments < €500k",,Canada "Alzheimer´s amyloid degradation by secreted lysosomal enzymes",Fellowships,"Alzheimer's disease & other dementias",Sweden "Alzheimer’s desease and implicit motor learning","Investments > €500k","Alzheimer's disease & other dementias",France "ALZHEIMER’S DISEASE AND DOWN SYNDROME. MULTIMODAL STUDIES OF CLEAR LIQUID, MAGNETIC RESONANCE AND PET OF AMYLOID.","Investments < €500k",,Spain "Alzheimer’s disease and posterior cortical atrophy: cognitive and neuroimaging studies of visual dysfunction",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Alzheimer’s disease and Zinc: the missing link ?","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "Alzheimer’s Disease Diagnosis by Spectroscopy. Accurate and Non-Invasive Medical Device for the Diagnosis of Early Stage Alzheimer’s Disease.","Investments < €500k",,"European Commission" "Alzheimer’s Research UK Bristol and Bath Network Centre Grant","Investments < €500k",,"United Kingdom" "Alzheimer’s Research UK Cambridge Network Centre Grant","Investments < €500k",,"United Kingdom" "Alzheimer’s Research UK Cardiff Network Centre Grant","Investments < €500k",,"United Kingdom" "Alzheimer’s Research UK Drug Discovery Institute 2015: University College London","Investments > €500k","Neurodegenerative disease in general","United Kingdom" "Alzheimer’s Research UK Drug Discovery Institute 2015: University of Cambridge","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Alzheimer’s Research UK Drug Discovery Institute 2015: University of Oxford","Investments > €500k","Neurodegenerative disease in general","United Kingdom" "Alzheimer’s Research UK Drug Discovery Institute 2016: University College London","Investments > €500k","Neurodegenerative disease in general","United Kingdom" "Alzheimer’s Research UK Drug Discovery Institute 2016: University of Cambridge","Investments > €500k","Neurodegenerative disease in general","United Kingdom" "Alzheimer’s Research UK Drug Discovery Institute 2016: University of Oxford","Investments > €500k","Neurodegenerative disease in general","United Kingdom" "Alzheimer’s Research UK Imperial College London Network Centre Grant","Investments < €500k",,"United Kingdom" "Alzheimer’s Research UK King’s College London Network Centre Grant","Investments < €500k",,"United Kingdom" "Alzheimer’s Research UK Manchester and North West Network Centre Grant","Investments < €500k",,"United Kingdom" "Alzheimer’s Research UK Midlands Network Centre Grant – Year 2","Investments < €500k",,"United Kingdom" "Alzheimer’s Research UK Newcastle Network Centre Grant","Investments < €500k",,"United Kingdom" "Alzheimer’s Research UK Northern Ireland Network Centre Grant","Investments < €500k",,"United Kingdom" "Alzheimer’s Research UK Oxford Network Centre Grant","Investments < €500k",,"United Kingdom" "Alzheimer’s Research UK Scotland Network Centre Grant","Investments < €500k",,"United Kingdom" "Alzheimer’s Research UK South Coast Network Centre Grant","Investments < €500k",,"United Kingdom" "Alzheimer’s Research UK South West Network Centre – Year 2","Investments < €500k",,"United Kingdom" "Alzheimer’s Research UK Stem Cell Research Centre","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Alzheimer’s Research UK University College London Network Centre Grant","Investments < €500k",,"United Kingdom" "Alzheimer’s Research UK Yorkshire Network Centre Grant","Investments < €500k",,"United Kingdom" "Alzheimer’s Society Doctoral Training Centre in Dementia Research at the University of Exeter","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Alzheimer3D: Trifunctional Conjugates for the Selective Drug Delivery in Alzheimer’s Disease","Investments < €500k",,Portugal "Alzheimers Abeta, apolipoproteins and blood-brain barrier","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Alzheimers BACE1 inhibition regulates neuronal contactin function","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Alzheimers Brain-Seeded Abeta Fibrils","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Alzheimers Disease & Related Dementias: Geography, Environments, and Mechanisms","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Alzheimers Disease Connectome Project","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Alzheimers Disease Cooperative Study","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Alzheimers Disease Genetics Consortium","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Alzheimers Disease Neuroimaging Initiative","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Alzheimers disease risk analyzed using population imaging genomics","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Alzheimers Disease Viewed as a Neurovascular Inflammatory Disorder","Investments < €500k",,"United States of America" "Alzheimers Disease, Genes, and Pesticide Use in the Agricultural Health Study","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Alzheimers Medical Advisor: A Symptom and Sign Management Toolkit for Caregivers","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Alzheimers sjukdom biomarkörer för molekylära mekanismer, diagnostik och theragnostik. Alzheimer’s disease – biomarkers for molecular mechanisms, diagnostics and theragnostics","Investments < €500k",,Sweden "Amélioration des addictions comportementales de patients parkinsoniens traités par stimulation subthalamique : suivi à long terme. Improvement of behavioral addictions of parkinsonian patients treated with subthalamic stimulation: long – term follow – up.","Investments < €500k",,France "AMP-activated protein kinase in the pathogenesis of Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias",France "AMPA- and GABA(A) receptor signalling and corticospinal motor neuron excitability in mouse models of ALS","Investments > €500k","Motor neurone diseases","United Kingdom" "AMPK in Alzheimers Disease-Associated Synaptic Failure and Memory Deficits","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "AMPK, metabolism and ALS","Investments > €500k","Motor neurone diseases","United States of America" "Amsterdam Dementia Cohort","Population Cohorts","Alzheimer's disease & other dementias",Netherlands "AMYGING Longitudinal Study of Brain Amyloid imaGing in MEMENTO (MEMENTOAmyGing)","Investments < €500k",,France "Amyloid and vessels: Imaging the role of cerebrovascular function","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "Amyloid Based Bioactive Membrane Production","Investments < €500k",,Turkey "Amyloid Beta Aggregation Inhibition of 1,3-benzoxazol-2(3H) Compounds","Investments < €500k",,Turkey "Amyloid Beta and sleep problems, a neurotoxic pas de deux during aging?","Investments < €500k",,Belgium "Amyloid Beta Postsynaptic Signaling through AKAP-anchored Calcineurin","Investments < €500k",,"United States of America" "Amyloid Beta-Protein: Wild Type and Familial Mutant Assembly and Inhibition","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Amyloid in the retina","Investments < €500k",,Netherlands "Amyloid ion channels to design therapeutics for neurodegenerative diseases","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Amyloid Neuropathology Underlying Sleep-dependent Memory Decline in Older Adults","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Amyloid Oligomers: Precursors, Competitors or Inhibitors of Mature Fibril Formation?","Investments < €500k",,"United States of America" "Amyloid Pathology and Cognition in Normal Elderly","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Amyloid Precursor Protein Signalosome: directing Abeta production in Alzheimer’s disease","Investments < €500k",,Australia "amyloid-Beta and Altered Cellular Metabolism in Alzheimers Disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Amyloid-beta regulation of hippocampal synaptic plasticity","Investments < €500k",,Canada "Amyotrophic Lateral Sclerosis and the DNA Damage Response","Investments < €500k",,"United Kingdom" "Amyotrophic Lateral Sclerosis from a cortical perspective: towards alternative therapeutic strategies","Investments > €500k","Motor neurone diseases","European Commission" "Amyotrophic Lateral Sclerosis Online Genetics Database (ALSOD )","Disease Registers","Motor neurone diseases|Prion disease",Sweden "Amyotrophic lateral sclerosis: disease or syndrome?",Fellowships,"Motor neurone diseases",Netherlands "An Australian Community Of practice in Research in Dementia (ACcORD) to improve health outcomes for people with dementia and their carers","Investments > €500k","Alzheimer's disease & other dementias",Australia "An H/F/X/Y Fast-MAS NMR Probe Particularly for Alzheimer’s and Cancer Research","Investments < €500k",,"United States of America" "An In Vitro Model of Stem Cell Innervation of Myotubes","Investments > €500k","Motor neurone diseases","United States of America" "An Innovative Approach to Study Alzheimer Disease Blood Biomarkers","Investments < €500k",,"United States of America" "An Integrated Genomic and Epigenomic Approach to Dissect the Aetiology of Motor Neuron Disease",Fellowships,"Motor neurone diseases",Australia "An integrated genomics approach to identify new ALS genes",Fellowships,"Motor neurone diseases","United Kingdom" "An integrated genomics approach to identify new ALS genes","Investments < €500k",,"United Kingdom" "An integrated research project between the Stockholm memory clinics to increase knowledge about prognostic information, cognitive and physiological mechanisms, and diagnostic accuracy",Fellowships,"Alzheimer's disease & other dementias",Sweden "An integrative analysis of DNA methylation, transcriptomic changes, and cognitive dysfunction in Alzheimers disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "An international perspective on dementia care: a Lancet Commission","Investments < €500k",,"United Kingdom" "An investigation into the neural substrates of cognitive deficits in Mild Cognitive Impairment, and the mechanisms of action of a novel treatment",Fellowships,"Alzheimer's disease & other dementias",Australia "An investigation into the neurocomputational role of brain oscillations in human motor control for health and disease.",Fellowships,"Parkinson's disease & PD-related disorders","United Kingdom" "An investigation of the mechanisms by which BDNF Val66Met protects against amyloid toxicity in healthy older adults: Implications for forestalling Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias",Australia "An Investigation of the role of the ageing process in Alzheimer’s Disease","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "An iPSC based platform for functionally assessing genetic and environmental risk","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "An olfactory ‘stress test’ for the early detection of Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias",Australia "An Optimized Person Centred Intervention to Improve Mental Health and Reduce Antipsychotics amongst People with Dementia in Care Homes","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "An Orally Bioavailable Drug Candidate for Spinal Muscular Atrophy","Investments > €500k","Spinal muscular atrophy (SMA)","United States of America" "An RCT of an Educational Video to Improve Nursing Home Care in End-Stage Dementia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "ANÁLISE DA PREDISPOSIÇÃO DA POPULAÇÃO PARA DOENÇAS NEURODEGENERATIVAS COM BASE NA AVALIAÇÃO DO POTENCIAL TOXICOLÓGICO DE SOLOS, ÁGUAS E VEGETAIS NA ENVOLVENTE DE DUAS MINAS DE MN.ANALYSIS OF PREDISPOSITION OF THE POPULATION FOR NEURODEGENERATIVE DISEASES BASED ON THE EVALUATION OF THE TOXICOLOGICAL POTENTIAL OF SOILS, WATERS AND VEGETABLES IN THE ENVOLVENT OF TWO MINES OF MN.",Fellowships,"Neurodegenerative disease in general",Portugal "Analyse juridique de la capacité des personnes atteintes de maladie d’Alzheimer. Legal analysis of the capacity of people with Alzheimer’s disease","Investments < €500k",,France "Analysing the cell biology of the Parkinson’s Disease-linked missense mutation in the retromer VPS35 subunit.","Investments < €500k",,"United Kingdom" "Analysis and characterization of a cohort of familial Parkinsons disease exomes","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Analysis of bradykinesia and speech in Parkinson’s disease","Investments < €500k",,"Czech Republic" "Analysis of genetic modulators for mitochondrial dysfunction in alpha-synuclein models for Parkinson`s disease","Investments < €500k",,Luxembourg "Analysis of Genome-Wide Data in the Health and Retirement Study","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Analysis of mitochondrial homeostasis in ageing and neurodegeneration","Investments > €500k","Motor neurone diseases|Neurodegenerative disease in general|Parkinson's disease & PD-related disorders","United Kingdom" "Analysis of mitophagy in neural stem cells carrying Parkinson’s disease associated mutations in LRRK2.","Investments < €500k",,Luxembourg "Analysis of the impact of ROS in networks describing neurodegenerative diseases","Investments < €500k",,Luxembourg "Analysis of the RNA-binding Protein FUS and Its Role in Neurodegenerative Disease","Investments > €500k","Motor neurone diseases","United States of America" "Analyzing Large-Scale Neuroimaging Data in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Anatomical Physiology of Semantic Associations in Primary Progressive Aphasia","Investments < €500k",,"United States of America" "ANATOMICAL-FUNCTIONAL CORRELATES OF DISORDERS OF THE CONTROL OF IMPULSES AND APATIA IN PARKINSON’S DISEASE","Investments < €500k",,Spain "Angiogenesis and Alzheimer’s Disease","Investments < €500k",,"United States of America" "Angiogenin as a therapeutic for the treatment of ALS","Investments < €500k",,Ireland "Animal model of impaired autoregulation for study of age related vascular cognitive impairment","Investments < €500k",,"United States of America" "Animal Models for Studying Human Frontotemporal Dementia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Animal Models for Studying Human Frontotemporal Dementia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Ank3-exon1e Mouse Luciferase Reporter (Royal College of Surgeons in Ireland)","Experimental Models",,Ireland "ANKK1 IN THE DOPAMINERGIC SYSTEM: IMPLICATION IN ETIOLOGY AND IMPULSIVE RISKS IN PARKINSON’S DISEASE","Investments < €500k",,Spain "Antecedent Biomarker Changes in AD: Ordering, Stages, and Implications for Trials","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Anti-inflammatory copper complexes for treatment of Alzheimer’s Disease",Fellowships,"Alzheimer's disease & other dementias",Australia "Anti-RPS23RG1 Nanoantibody as Novel Therapeutic and Research Reagents for Alzheimer’s Disease.","Investments < €500k",,"United States of America" "Antibodies as a tool to investigate prion protein toxicity","Investments < €500k",,Switzerland "Antisense oligonucleotide mediated exon skipping to remove the expanded polyQ repeat from the ataxin 3 protein in Spinocerebellar Ataxia 3","Investments < €500k",,Netherlands "Antwerp Biobank",Biobanks,"Alzheimer's disease & other dementias",Netherlands "Anxiety in Parkinsons: Use of quantitative methods to guide rational treatment",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Apathy in Alzheimers Disease Methyphenidate Trial II (ADMET II)","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "APGeM: Pre-clinical genotype-phenotype predictors of Alzheimer’s disease and other dementia","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias|Neurodegenerative disease in general","JPND|Norway|Sweden|United Kingdom" "Apnea and local sleep: Mechanism and intervention in preclinical Alzheimers","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "ApoE and LRP1 in brain insulin signaling and glucose metabolism (Competitive Renewal)","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "APOE genotype and diet influences on Alzheimers biomarkers",Fellowships,"Alzheimer's disease & other dementias","United States of America" "APOE genotype and sex dependent effects of 17-alpha-estradiol on AD pathology","Investments < €500k",,"United States of America" "ApoE isoform-specific therapy for Alzheimer disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "ApoE receptor pathways and abeta metabolism","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "ApoE4 and mechanisms of diffuse white matter injury","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "ApoE4-targeted therapeutics that normalize SirT1","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "APOEomic: Searching for APOE interacting risk factors using omics data","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Apolipoprotein E gene in the Metabolic Syndrome","Investments < €500k",,"European Commission" "Apolipoprotein E in Alzheimers Disease: Molecular Mechanism","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Apolipoprotein E/Lipoprotein Binding Mechanism","Investments < €500k",,"United States of America" "Apolipoprotein E4 as a Therapeutic Target for Alzheimer’s Disease: Identification of Small-Molecule Structure Correctors That Prevent Apolipoprotein E4 Associated Neuropathology","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Apoptotic neuronal cells serve as sources for spreading of human a-synuclein pathology in the brain","Investments < €500k",,"United States of America" "Apoptotic neuronal cells serve as sources for spreading of human a-synuclein pathology in the brain","Investments < €500k",,"United States of America" "APP as a common denominator for Alzheimers disease and osteoporosis","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "APP Regulates Brain and Adipose Changes in Obesity","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "APP ubiquitination and implications for AB generation",Fellowships,"Alzheimer's disease & other dementias","United States of America" "APP/APLP1/APLP2 in the brain","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Apports d’une thérapie sémantique sur tablette tactile dans la maladie d’Alzheimer, formes jeunes et tardives. IngentaConnect Alzheimer’s Disease and Alzheimer’s Disease","Investments < €500k",,France "Approaches to diagnosing dementia syndrome in general practice: Determining the value of gestalt judgment, clinical history and tests.",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "ArcAbeta Mouse (University of Zurich +ETH)","Experimental Models",,Switzerland "Archiving the Rancho Bernardo Study of Healthy Aging","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Are astrocytes required for optimal survival of ES cell-derived dopaminergic transplants?","Investments < €500k",,"United Kingdom" "Argumentation and linked-metadata services for reproducible target validation","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "ARIC Neurocognitive Study (ARIC-NCS)","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "ARIC Neurocognitive Study (ARIC-NCS) 1 of 5","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "ARIC Neurocognitive Study (ARIC-NCS) Renewal 2 of 5","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "ARIC Neurocognitive Study (ARIC-NCS) Renewal 4 of 5","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "ARIC Neurocognitive Study (ARIC-NCS) Renewal UNC 4 of 5","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "ASPirin in Reducing Events in the Elderly","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "ASPirin in reducing Events in the Elderly: an RCT of low dose aspirin","Case Control Studies","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders",Australia "Assessing interactions between cerebrovascular and tau pathologies",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Assessing Large-scale Brain Connectivities in Mild Cognitive Impairment","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Assessing the effectiveness of healthcare interventions with routinely collected data","Investments < €500k",,Finland "Assessing the effectiveness of healthcare interventions with routinely collected data",Fellowships,"Neurodegenerative disease in general",Finland "ASSESSMENT AND CHARACTERIZATION OF BIOMARCATORS OF THE PRECLINIC STADIUM OF ALZHEIMER’S DISEASE","Investments < €500k",,Spain "Assessment and satisfaction of services for Juvenile Huntington’s Disease and modelling alternative methods of service organisation","Investments > €500k","Huntington's disease","United Kingdom" "Assessment of brain degeneration in relationship to psychomotor and cognitive functions in MCI and mild Alzheimer’s disease","Investments < €500k",,Norway "Assessment of Brain Insulin Resistance in Alzheimers Disease with Insulin Clamp","Investments < €500k",,"United States of America" "Assessment of Genetic Risk Factors in Alzheimer’s Disease","Investments < €500k",,Turkey "Assessment of hyperphosphorylated tau PET binding in primary progressive aphasia","Investments < €500k",,"United States of America" "Assessment of neuropathological changes associated with vascular dementia: validation of a consensus approach","Investments < €500k",,"United Kingdom" "Assessment of Ultrsound-facilitated Neurotherapeutics in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Assistive Technology and Telecare to maintain Independent Living At home for people with dementia: The ATTILA Trial","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Association between vitamin D receptor gene polymorphism and Alzheimer’s disease","Investments < €500k",,Turkey "Association of ALS to gene-environment mediated changes in HDL proteins","Investments > €500k","Motor neurone diseases","United States of America" "Association of Disturbed Sleep with Cognitive Performance in the Baltimore Longitudinal Study of Aging","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Association of induced hyperhomocysteinemia with progression of neurodegenerative changes under the experimental conditions.","Investments < €500k",,Slovakia "Astrocyte dysfunction in Alzheimers disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Astrocytes influence interactions between Abeta and tau to cause synaptotoxicity in AD",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Astrocytic Calcineurin and Connexin43 Gap Junctions in Alzheimers Disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "aSYN minipig models of Parkinson’s disease for testing aSYN imaging agents and therapies","Investments < €500k",,Denmark "aSynProtec: Alpha-synuclein pathology propagation in Parkinson’s disease and quest for novel protective strategies","Investments > €500k|JPND Projects","Parkinson's disease & PD-related disorders","Belgium|Denmark|Germany|JPND|Sweden|Switzerland|United Kingdom" "Atlantic Philanthropies",Fellowships,"Alzheimer's disease & other dementias",Ireland "Atomic details of antimicrobial peptides at work in live cells","Investments > €500k","Alzheimer's disease & other dementias",Australia "Atrophy and resting state connectivity in primary progressive aphasia",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Att hindra forskridandet av Alzheimers och andra demenssjukdomar. To prevent the spread of Alzheimer’s and other dementia diseases","Investments < €500k",,Sweden "Attentional Network Dysfunction in Visual Hallucinations",Fellowships,"Alzheimer's disease & other dementias",Australia "Auditory Cognitive Training in Persons with Mild Cognitive Impairment","Investments < €500k",,"United States of America" "Augmenting Cognitive Training in Older Adults – The ACT Grant","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Australian National Creutzfeldt-Jakob Disease Registry","Disease Registers","Prion disease",Australia "AUTOMAC: AUTOmated Mouse behAviour reCognition","Investments < €500k",,"United Kingdom" "Automated Multimodality Image-based Classifiers for Early Detection of Alzheimer’s Disease","Investments < €500k",,Netherlands "Automated subcortical brain segmentation using multispectral MRI for improved AD diagnosis and disease tracking","Investments < €500k",,"United Kingdom" "Autophagy at synapses: proteopathic stress and neurodegeneration in Parkinson’s disease",Fellowships,"Parkinson's disease & PD-related disorders",Belgium "Autophagy dysfunction in Parkinsons Disease by VPS35 D620N","Investments < €500k",,"United States of America" "Autophagy dysfunction in Parkinsons Disease by VPS35 D620N","Investments < €500k",,"United States of America" "Autophagy in health and disease.",Fellowships,"Neurodegenerative disease in general","United Kingdom" "Axon degeneration and axon protection in CNS disease and injury","Investments < €500k",,Australia "BACE1 as a Therapeutic Target for Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "BACE1 in neurodegeneration and neuronal dysfunction","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Bacterial Amyloid Secretion: Structural Biology and Biotechnology.","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "BAFF/APRIL in the central nervous system","Investments < €500k",,France|Germany "Balancing Best Interests in Medical Ethics and Law (BABEL).","Investments < €500k",,"United Kingdom" "BALANCING ENDOCANNABINOID-MEDIATED PLASTICITY WITH NICOTINE","Investments < €500k",,Sweden "Banque d’ADN et de Cellules de l’ICM (DNA and Cell Bank)","Capital Infrastructure",,France "Barriers of the CNS, tight junctions and novel therapeutic targets in neural disease.","Investments > €500k","Alzheimer's disease & other dementias",Ireland "Basal Ganglia Cortical Coupling and Connectivity Changes in PD and DBS","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "BASES-MOLECULAR GENETIC spinocerebellar ataxias: IDENTIFICATION OF DEFICITS GROUNDS, BIOMARKERS AND THERAPEUTIC TARGETS","Investments < €500k",,Spain "Basic and Patient-Oriented Dementia Research: Linking Novel Methods for Early Stage Detection with Understanding Pathological Mechanisms in Dementia","Investments < €500k",,Canada "Batseson Centre – Zebrafish (University of Sheffield)","Experimental Models",,"United Kingdom" "Bayesian models of expression in the transcriptome for clinical RNA-seq","Investments > €500k","Motor neurone diseases","United Kingdom" "BBB : Development of a roadmap for assessment of blood-brain barrier drug transport – Translation from rodents to patients","Investments > €500k","Alzheimer's disease & other dementias",Belgium "BDNF rs6265 and Response to Dopaminergic Therapy in PD","Investments < €500k",,"United States of America" "BDNF rs6265 and Response to Dopaminergic Therapy in PD","Investments < €500k",,"United States of America" "Before Alzheimer’s Disease: novel mechanism of amyloid precursor protein signaling in adult healthy brain","Investments < €500k",,Romania "Behavioral and cell-based complementary screens to identify druggable targets modulating tau protein levels","Investments < €500k",,"United States of America" "Behavioural Changes in ALS : What Families and Healthcare Professionals Need to Know","Investments < €500k",,Ireland "Behavioural Tests – Cognition & Motor Function (National Univeristy of Ireland Galway)","Experimental Models",,Ireland "Being obliged, willing and prepared to care: A study on how to support current and prospective carers.",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Benfotiamine in Alzheimers Disease: A pilot study","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Beta-amyloid, hippocampal function and episodic memory in aging",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Beta-cell Function and Cognition in the Restoring Insulin Secretion (RISE) Study","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Beter Thuis met Dementie: doorontwikkeling en effectonderzoek van een innovatief programma voor mantelzorgers en hun naaste. Better Home with Dementia: development and impact research of an innovative program for caregivers and their neighbors.","Investments < €500k",,Netherlands "Better Conversations with Primary Progressive Aphasia (BCPPA): Communication training to keep families together.",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Bevorderen van plezierige fysieke activiteiten en kwaliteit van leven bij dementie: onderzoek naar de (kosten)effectiviteit van exergaming. Promoting enjoyable physical activities and quality of life in dementia: research into the (cost) effectiveness of exergaming","Investments < €500k",,Netherlands "Bewegen met Parkinson: de Park-in-Shape studie Moving with Parkinson’s: the Park-in-Shape study","Investments > €500k","Parkinson's disease & PD-related disorders",Netherlands "Beyond APOE: A Polygenic Approach to Risk for Alzheimers Disease in Humans",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Bilateral Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Patients","Investments < €500k",,Turkey "Bilingual Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "BILIVERDIN REDUCTASE-A IN BRAIN INSULIN SIGNALING AND OXIDATIVE STRESS- MEDIATED NEURODEGENERATION",Fellowships,"Alzheimer's disease & other dementias", "Biobank Alzheimer Center Limburg Cohort (BB-ACL)","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "Biochemical analysis of the PINK1-Parkin signalling pathway in Parkinson’s disease.",Fellowships,"Parkinson's disease & PD-related disorders","United Kingdom" "BIOCHEMICAL AND ELECTROPHYSIOLOGICAL CHANGES IN NST / SNR ECP IN PATIENTS WITH PARKINSON DISEASE AND ALTERATION OF THE MARCH","Investments < €500k",,Spain "BIOCHEMICAL AND NEUROIMAGEN STUDY OF PRE-AMYLOIDOGENIC CHANGES IN ALZHEIMER’S PRECLINIC DISEASE; ANALYSIS OF CEREBRAL LIPIDOMIC AND MICROSTRUCTURE OF NEUROCOGNITIVE NETWORKS","Investments < €500k",,Spain "Biochemical dissection of amyloid precursor protein transport from the Golgi",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Biodistribution, pharmacokinetic and toxicity studies on a novel retro-inverso peptide inhibitor of beta-amyloid oligomer formation","Investments < €500k",,"United Kingdom" "Bioenergetic deficit in neurodegeneration: studies in motor neuron disease (MND)","Investments < €500k",,Australia "Bioenergetic profiling of cellular models of motor neuron disease (MND) to identify new approaches for supporting motor neurone health.",Fellowships,"Motor neurone diseases","United Kingdom" "Bioenergetic profiling of cellular models of motor neuron disease (MND) to identify new approaches for supporting motor neurone health.","Investments < €500k",,"United Kingdom" "Biological and mathematical modelization of amyloid origin, spreading and impact on brain function","Investments < €500k",,France "Biological and Pathological Interactions between Tau and LRRK2","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders","United States of America" "Biological and Pathological Interactions between Tau and LRRK2","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Biological Determinants of Impulsivity in Parkinsons Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Biological predictors of brain aging trajectories","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "biological samples in patients with Alzheimer’s diseases and other dementia",Biobanks,"Alzheimer's disease & other dementias",Germany "Biological samples in patients with human prion diseases",Biobanks,"Prion disease",Germany "Biology and Mode of Action of Novel Neurotrophic Factors CDNF and MANF","Investments < €500k",,Finland "Biology and pathobiology of alpha-synuclein","Investments < €500k",,Canada "Biology of Down Syndrome: Impacts Across the Biomedical Spectrum","Investments < €500k",,"United States of America" "Biology of Native Alpha-Synuclein Tetramers in Parkinsons Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Biology of Native Alpha-Synuclein Tetramers in Parkinsons Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Biology of sleep disorders in patients with Parkinson’s disease","Investments < €500k",,Norway "BIOMARKAPD: Biomarkers for Alzheimer’s disease and Parkinson’s disease","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias",Ireland|JPND "Biomarker assay development to expedite ALS experimental therapeutic advancement","Investments < €500k",,"European Commission" "Biomarker based adaptive development in Alzheimer disease (BioAdaptAD)","Investments > €500k","Alzheimer's disease & other dementias",Belgium "Biomarker based adaptive development in Alzheimer disease (BioAdaptAD)","Investments > €500k","Alzheimer's disease & other dementias",Belgium "Biomarker based adaptive development in Alzheimer disease (BioAdaptAD)","Investments > €500k","Alzheimer's disease & other dementias",Belgium "Biomarker Development for Postoperative Cognitive Impairment in the Elderly","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "BIOMARKERS FOR EARLY DETECTION OF BRAIN AGING AND NEURODEGENERATIVE DISORDERS – ROLE OF SORTING NEXIS",Fellowships,"Neurodegenerative disease in general",Portugal "Biomarkers discovery in the progressive bulbar palsy/amyotrophic lateral sclerosis clinical spectrum: combined tissue and fluid-phase proteomics","Investments < €500k",,"United Kingdom" "Biomarkers for early intervention in Parkinson disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Biomarkers for synaptic and neurodegeneration in early Alzheimer’s disease.",Fellowships,"Alzheimer's disease & other dementias",Belgium "Biomarkers for White Matter Injury in Mixed and Vascular Cognitive Impairment","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Biomarkers in Mild Cognitive Disorder to Dementia in Parkinson’s Disease","Investments < €500k",,Turkey "Biomarkers of Alzheimers Disease in Adults with Down Syndrome","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Biomarkers of Alzheimers Disease in Adults with Down Syndrome","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Biomarkers of pain in Parkinson’s","Investments < €500k",,"United Kingdom" "Biomarkers of Parkinson Disease and Related Disorders","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders","United States of America" "Biomarkers of Vascular Function and Integrity in Cerebral Amyloid Angiopathy: A Prospective Longitudinal Cohort Study","Investments < €500k",,Canada "Biomarkers, environmental and lifestyle risk factors for amyotrophic lateral sclerosis","Case Control Studies","Motor neurone diseases",Sweden "Biomedical devices for easier and quicker screening procedures of the Alzheimer disease",Fellowships,"Parkinson's disease & PD-related disorders",Portugal "Biopharmaceutical Neurology: Blood Assay for the Predictive and Early Diagnosis of Alzheimer’s Disease","Investments < €500k",,Germany "Biophysical principles of intra- and inter-molecular recognition in protein folding and interactions involving disordered proteins","Investments > €500k","Neurodegenerative disease in general",Canada "Biophysical studies of the amyloid beta peptide – structure conversion, aggregation pathways and molecular interactions","Investments < €500k",,Sweden "BIOPHYSICALLY ADJUSTED STATE-INFORMED CORTEX STIMULATION (BaSiCs): SHAPING THE FUNCTIONAL ARCHITECTURE OF NEURAL NETWORKS TO IMPROVE HUMAN BRAIN FUNCTION","Investments > €500k","Neurodegenerative disease in general|Parkinson's disease & PD-related disorders",Denmark "Biophysics and structure of intrinsically disordered polypeptides studied on the N-terminal tail of tau protein: implications for neurodegenerative tauopathies","Investments < €500k",,Slovakia "BioSecrete – Bioreactors as Tools for Controlling Mesenchymal Stem Cells Secretome: A Focus on Parkinson’s Disease Regenerative Medicine",Fellowships,"Parkinson's disease & PD-related disorders",Portugal "BLOOD AND NEUROPHYSIOLOGICAL MARKERS OF THE PROGRESSION OF COGNITIVE DETERIORATION IN PARKINSON’S DISEASE","Investments < €500k",,Spain "Blood based early and predictive diagnostics of Alzheimer’s dementia","Investments < €500k",,Portugal "Blood RNA biomarkers of Parkinsons disease and progressive supranuclear palsy","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Blood RNA biomarkers of Parkinsons disease and progressive supranuclear palsy","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Blood-based diagnostics for Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Blood-based diagnostics for Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Blood-brain barriar clearance of aβ peptides in Alzheimer’s disease models","Investments < €500k",,Netherlands "Blood-brain barrier leakage in dementia","Investments < €500k",,Netherlands "BMP9 as a juvenile protective factor in cognitive aging","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "BNMDR (Belgian Neuromuscular Disease Registry)","Disease Registers","Motor neurone diseases|Spinal muscular atrophy (SMA)|Spinocerebellar ataxia (SCA)",Belgium "Body-Worn Sensors to Characterize & Treat Freezing of Gait in Parkinsons Disease",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Boosting lysosome function as a therapy for Alzheimer´s disease","Investments < €500k",,Switzerland "Botulinum toxin for sialorrhea in people with Parkinson’s disease","Investments < €500k",,Ireland "BPN14770 Safety and Cognitive Effect in Young and Elderly Subjects","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "BPSD-CARE: A person-centred approach to managing behavioural and psychological symptoms of dementia in residential care",Fellowships,"Alzheimer's disease & other dementias",Australia "Brain Activation and Pain Reports in People with Alzheimers Disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Brain aging and treatment response in geriatric depression","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Brain barriers: modulating iron availability to target diseases of the central nervous system",Fellowships,"Alzheimer's disease & other dementias",Portugal "Brain changes associated with dementia and mild cognitive impairment after stroke","Investments < €500k",,Norway "Brain connectivity: the missing link between amyloid and clinical symptoms","Case Control Studies","Alzheimer's disease & other dementias",Netherlands "Brain connectivity: the missing link between amyloid and clinical symptoms",Fellowships,"Alzheimer's disease & other dementias",Netherlands "Brain degeneration and regeneration in preclinical models of Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias",Canada "BRAIN e-novation: Innovation, Brain, e-Health","Investments < €500k",,France "Brain image processing with Alpha-Stable distributions. Applications to intensity normalization, segmentation and diagnosis of Parkinsonian syndrome and Alzheimer’s disease.",Fellowships,"Alzheimer's disease & other dementias", "Brain imaging and cognitive ageing in the Lothian Birth Cohort 1936: III","Investments > €500k","Neurodegenerative disease in general","United Kingdom" "Brain Imaging, APOE & the Preclinical Course of Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Brain Imaging, APOE & the Preclinical Course of Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Brain iron imaging for Alzheimer’s disease (AIBL-ADIRON study)","Investments > €500k","Alzheimer's disease & other dementias",Australia "Brain metal neurochemistry: mechanism-driven drug discovery for neurodegeneration",Fellowships,"Alzheimer's disease & other dementias",Australia "Brain Microcirculation : Numerical simulation for inter-species translation with applications in human health","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "Brain network connectivity and genetic risk for Alzheimers disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Brain Neurotropic Growth Factor Delivery to Prevent and Treat Alzheimer’s Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Brain Oscillations as a Biomarker in Alzheimer’s Disease","Investments < €500k",,Turkey "Brain Plasticity Measures in MCI","Investments < €500k",,"United States of America" "Brain Sleep Clearance of Amyloid-Beta Peptides Study (Brain SCRAPS)","Investments < €500k",,"United States of America" "Brain-Gut Communication in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" Brain-Net,Biobanks,"Neurodegenerative disease in general",Germany "BRAINet: Composite Network Modeling of Neurological/Psychiatric Disorders and Application to Alzheimer’s Disease","Investments < €500k",,Turkey BrainGainSweden,"Research Networks",,Sweden "Brains for Dementia Research","Capital Infrastructure",,"United Kingdom" "Brains for Dementia Research",Biobanks,"Alzheimer's disease & other dementias","United Kingdom" "Brains for Dementia Research","Population Cohorts","Alzheimer's disease & other dementias","United Kingdom" "BRI2 Familial British and Danish Dementias and Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "BRIDGET: BRain Imaging, cognition, Dementia and next generation GEnomics: a Transdisciplinary approach to search for risk and protective factors of neurodegenerative disease","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias","Austria|Canada|France|Germany|JPND|Netherlands|United Kingdom" "Bridging the world of fungi and dementia",Fellowships,"Alzheimer's disease & other dementias", "Brief psychometric instruments for early diagnosis of Alzheimer’s disease in senior population","Investments < €500k",,"Czech Republic" "Bringing palliative care for dementia patients into agreement with their wishes and needs: development and evaluation of Decidem","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "Building a Low Cost High Density Data Gathering Platform For Studying High-functioning Elders","Investments < €500k",,"United States of America" "Buildings at DZNE sites","Capital Infrastructure",,Germany "Burden, depression, and health in dementia caregivers: The role of emotion","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Búsqueada de bio-marcadores sinápticos en la enfermedad de Alzheimer",Fellowships,"Alzheimer's disease & other dementias",Spain "C / EBPS MICROGLIALES AS DOTH THERAPEUTIC POTENTIAL IN PARKINSON’S DISEASE","Investments < €500k",,Spain "C-DEMQOL – Measurement of quality of life in family carers of people with dementia: development of a new instrument for evaluation","Investments < €500k",,"United Kingdom" "C. elegans ND Models (CRCHUM – Universite de Montreal)","Experimental Models",,Canada "C9orf72 hexanucleotide repeat expansion caused neurodegeneration in ALS and FTD","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "C9orf72 hexanucleotide repeat expansion caused neurodegeneration in ALS and FTD","Investments > €500k","Motor neurone diseases","United States of America" "C9ORF72 in Motor System Biology and ALS","Investments > €500k","Motor neurone diseases","United States of America" "C9ORF72 in Motor System Biology and ALS","Investments > €500k","Motor neurone diseases","United States of America" "C9orf72 repeat expansion in FTD/ALS – from mechanisms to therapeutic approaches","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","European Commission" "C9orf72-mediated neurodegeneration: mechanisms and therapeutics","Investments > €500k","Neurodegenerative disease in general","European Commission" "Caffeine as a Therapeutic Agent in Parkinson’s disease","Investments < €500k",,Canada "Calcineurin and inflammatory signaling processes in aging and Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "CALPAIN-MEDIATED PROTEOLYSIS IN MACHADO-JOSEPH DISEASE: BIOMARKER AND THERAPEUTIC TARGET",Fellowships,"Spinocerebellar ataxia (SCA)",Portugal "Can brain training lead to short term and sustained improvements in cognitive function?","Investments < €500k",,"United Kingdom" "Can induced pluripotent stem cells from frontotemporal dementia be used to characterize mechanisms underlying progranulin haploinsufficiency mediated neurodegeneration?",Fellowships,"Alzheimer's disease & other dementias",Belgium "Can music mend minds? Investigating the mechanisms underlying the beneficial effects of music on persons with dementia",Fellowships,"Alzheimer's disease & other dementias",Australia "Can we protect neurons against mitochondrial dysfunction?",Fellowships,"Parkinson's disease & PD-related disorders","United Kingdom" "Can we safely treat and monitor people with Parkinson’s in Tanzania: A model for sub-Saharan Africa?","Investments < €500k",,"United Kingdom" "Canadian Centre for Aging and Brain Health Innovation","Investments > €500k","Alzheimer's disease & other dementias",Canada "Canadian Consortium on Neurodegeneration in Aging","Investments < €500k",,"United Kingdom" "Canadian Consortium on Neurodegeneration in Aging – Full Proposal","Investments > €500k","Alzheimer's disease & other dementias",Canada "Capacity building in sub-Saharan Africa to conduct cutting-edge genetics research in Parkinsons disease.","Investments < €500k",,"United States of America" "Capacity building in sub-Saharan Africa to conduct cutting-edge genetics research in Parkinsons disease.","Investments < €500k",,"United States of America" "Capillary electrophoresis based high-throughput system for beta-secretase inhibitor screening as a therapeutic target of Alzheimer’s disease","Investments < €500k",,"Czech Republic" "Capturing changes in cognition: developing a measure for progression in dementia","Investments < €500k",,Netherlands "Capturing initial molecular events in the pathogenesis of motor neuron disease: the roles of RNA metabolism and cellular autonomy.",Fellowships,"Motor neurone diseases","United Kingdom" "CARASIL – a window into Alzheimer’s disease?","Investments < €500k",,"United Kingdom" "Cardiac function as a mechanism for maladaptive brain aging","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Cardiac function as a mechanism for maladaptive brain aging","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Cardiac function as a mechanism for maladaptive brain aging","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Cardiff Fetal Tissue Bank: Quality assured tissue for biomedical research and clinical trial in neurodegenerative disease","Investments < €500k",,"United Kingdom" "Cardiovascular Health and Progression of Alzheimer´s disease (VAS-PAD)","Investments < €500k",,Norway "Care coaching for the optimal support of people with dementia","Investments > €500k","Alzheimer's disease & other dementias",Germany "Care transitions and delirium in nursing home residents","Investments < €500k",,Norway "Caregiver training app to maintain independence in persons with Alzheimers.","Investments < €500k",,"United States of America" "Caregivers Reactions and Experience: Imaging Dementia Evidence for Amyloid Scanning CARE IDEAS","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Caregiving for Alzheimers Disease and Related Dementias: Enhancing the National Study of Caregiving (NSOC)","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Carer and patient-led development of recommendations for people with dementia returning home from hospital: understanding what is important","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Caring for people who have dementia in Community Hospitals: A longtitudal ethographic study of healthcare workers everyday decision making","Investments < €500k",,"United Kingdom" "Carriers Break Barriers in Drug Delivery","Investments > €500k","Neurodegenerative disease in general",Netherlands "Case-Control Study on Parkinson’s Disease Among Mutualité Sociale Agricole Affliates in Five Départements","Case Control Studies","Parkinson's disease & PD-related disorders",France "Case-Control Study on Parkinson’s Disease Among Mutualité Sociale Agricole Affliates in Five Départements","Case Control Studies","Parkinson's disease & PD-related disorders",France "Case-Control Study on Tracking Nursing Home Patients with Dementia","Case Control Studies","Alzheimer's disease & other dementias|Neurodegenerative disease in general",France "Cathepsin D Activation: A Target to Reduce Alpha-Synuclein Pathology in a Parkinson’s Model","Investments > €500k","Parkinson's disease & PD-related disorders",Canada "CATI – Multicenter Neuroimaging Platform","Capital Infrastructure",,France "Causal relationship between a LC-omega-3-enriched diet and cognition","Investments < €500k",,Canada "Cause and consequences of Parkinson´s disease in the midbrain locomotor command center",Fellowships,"Parkinson's disease & PD-related disorders",Switzerland "Causes, consequences and costs of injury-related hospitalisations for people with dementia: identifying opportunities for prevention and enhanced management",Fellowships,"Alzheimer's disease & other dementias",Australia "CAVIA: Cerebral Amyloid Angiopathy: Vascular Imaging and fluid markers of Amyloid deposition.","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "CBRAIN: A national platform for neurodegenerative disease imaging data","Investments < €500k",,Canada "CBRAIN: Canadian Brain Research And Informatics Platform","Investments > €500k","Neurodegenerative disease in general",Canada "CD33 and Alzheimers Disease: from Biology to Therapy","Investments < €500k",,"United States of America" "CeBioND – Mitochondrial metabolism and dysfunction model","Bio/Neuroinformatic Resources","Alzheimer's disease & other dementias|Huntington's disease|Neurodegenerative disease in general|Parkinson's disease & PD-related disorders",Ireland "CeBioND: Cellular Bioenergetics in Neurodegenerative Diseases: A system based pathway and target analysis","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias|Huntington's disease|Parkinson's disease & PD-related disorders",Canada|Germany|Ireland|Italy|JPND|Sweden "CEDER – Center for dementia research","Capital Infrastructure",,Sweden "CELL AND MOLECULAR PATHOBIOLGY OF ALZHEIMERS DISEASE","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Cell autonomous and non-cell autonomous roles of the GWAS risk factor BIN1 in Alzheimers disease neuropathology","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Cell autonomous mechanisms of Apolipoprotein E isoform-dependent neurodegeneration",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Cell Biology: Cellular functions of the prion protein","Investments > €500k","Prion disease","United Kingdom" "Cell death regulation","Investments > €500k","Neurodegenerative disease in general","United Kingdom" "Cell type specific epigenetic analysis to understand complex mechanisms underlying Alzheimers disease phenotypes","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Cell-Cell Signaling in Development and Regeneration of Visual Connections","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Cell-targeted phenotyping: using optogenetics to study ALS patient-derived motor neurons","Investments < €500k",,"United Kingdom" "Cell-type specific changes in gene-networks in the human brain: towards a selective Alzheimer therapeutic target","Investments < €500k",,Netherlands "Cellular and Genetic Mechanisms of Dopamine Transporter-associated Parkinsonism",Fellowships,"Parkinson's disease & PD-related disorders",Denmark "Cellular and Genetic Mechanisms of Dopamine Transporter-associated Parkinsonism","Investments < €500k",,Denmark "Cellular and Molecular Mechanisms of FUS-related Amyotrophic Lateral Sclerosis","Investments > €500k","Motor neurone diseases","United States of America" "Cellular and Molecular Medial Temporal Lobe Pathology in Elderly PreMCI subjects","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Cellular And Molecular Pathogenesis Of Alzheimer","Investments < €500k",,"United States of America" "Cellular aspects of protein misfolding in neurodegenerative diseases","Investments > €500k","Neurodegenerative disease in general","United Kingdom" "CELLULAR CHANGES ALTERING SYNAPTIC CONNECTIVITY IN PRECLINICAL AD","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Cellular determinants of neuronal plasticity on the level of single synapses in vivo","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "Cellular lipids in Huntington’s disease","Investments > €500k","Huntington's disease",Canada "Cellular mechanisms of prion propagation","Investments > €500k","Prion disease","United Kingdom" "Cellular mechanisms underlying detoxification of mutant Huntingtin","Investments < €500k",,"United States of America" "Cellular mechanisms underlying detoxification of mutant Huntingtin","Investments < €500k",,"United States of America" "Cellular modelling of C9orf72 di-peptide repeat proteins","Investments < €500k",,"United Kingdom" "Cellular Mosaicism as a cause for Parkinson’s disease.","Investments < €500k",,Luxembourg "Cellular pathophysiology of prion-mediated neurodegeneration – a model for understanding protein misfolding disorders","Investments > €500k","Prion disease","United Kingdom" "Cellular responses to protein misfolding in aging cells","Investments < €500k",,Canada "Cellular transport dysfunction and motor neuron disease","Investments < €500k",,Australia "Cellular-level Signatures of Pre-Symptomatic Neurodegenerative Disease Progression: Hyperpolarized Magnetic Resonance and Correlated TEM/NanoSIMS Imaging","Investments < €500k",,Switzerland "Centre for Cognitive Ageing & Cognitive Epidemiology","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Centre for Neural Computation (CNC)","Capital Infrastructure",,Norway "Centre of Excellence in Research on Mitochondria, Metabolism and Disease (FinMIT)","Investments > €500k","Neurodegenerative disease in general|Parkinson's disease & PD-related disorders",Finland "Centre of Research Excellence in Cognitive Health: Evidence, intervention and population modelling","Investments > €500k","Alzheimer's disease & other dementias",Australia "Cerebral amyloid angioathy: vascular imaging and fluid biomarkers of amyloid deposition","Case Control Studies","Alzheimer's disease & other dementias",Netherlands "CEREBRAL AMYLOID ANGIOPATHY AND MECHANISMS OF BRAIN AMYLOID ACCUMULATION","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Cerebral Microbleeds in Young Adults: risk factors, biomarkers and genetics","Investments < €500k",,"United States of America" "Cerebral Protein Synthesis as a Measure of Degenerative Changes in a Transgenic Rat Model of Alzheimers Disease","Investments < €500k",,"United States of America" "Cerebral Small Vessels in Motor and Cognitive Decline","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "CEREBRAL STRUCTURE AND METABOLISM IN ALZHEIMER’S DISEASE PRECLINICA. INTERACTIONS BETWEEN “NEW AND OLD” BIOMARCADORES.","Investments < €500k",,Spain "Cerebrovascular beta-Amyloidosis: A-beta CNS Transport Pathways","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Cerebrovascular Contributions to Brain Aging and Dementia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Cerebrovascular pathophysiology in mouse models of Alzheimer’s disease","Investments < €500k",,Canada "Cerebrovascular Reactivity in the Presence of Cerebral Amyloid and Cerebrovascular Disease: A novel multi-modal imaging measure of vascular reserve in cognitively normal elderly",Fellowships,"Alzheimer's disease & other dementias","United States of America" "CERMEP – in vivo imaging","Capital Infrastructure",,France "CERVICAL-CEREBRAL ATEROSCLEROSIS, ICTUS AND COGNITIVE DETERIORATION INCIDENTS IN THE POPULATION COHORT ASIA","Investments < €500k",,Spain "Champalimaud Neuroscience Program","Research Networks",,Portugal "Changes in arterial stiffness, cognition and dementia risk in a diverse cohort","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Changes in Sleep and Cognition in Older Women","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Chaperone defenders against toxic clusters in Huntington’s disease","Investments < €500k",,Australia "CHAPERONE MEDIATED AUTOPHAGY, MACROAUTOPHAGY AND PARKIN UBIQUITINATION IN NEURODEGENERATION. NEW THERAPEUTICAL APPROACHES",Fellowships,"Neurodegenerative disease in general",Spain "Chaperonnes en de aggregatie van Tau. Chaperonnes and the aggregation of Tau","Investments < €500k",,Netherlands "Characterisation of a novel cell model for Huntington’s disease: insights into pathogenesis",Fellowships,"Huntington's disease","United Kingdom" "Characterisation of a novel in vivo model of human tauopathy","Investments < €500k",,"United Kingdom" "Characterisation of a TDP-43 knockin mouse model of motor neuron disease","Investments < €500k",,"United Kingdom" "Characterisation of enteric nervous system function of the intestine in Alzheimer’s disease","Investments < €500k",,"United Kingdom" "Characterisation of newly identified proteins that interact with the MND-causing expanded repeat in C9orf72","Investments < €500k",,"United Kingdom" "Characterisation of the long-term prognosis of Parkinson’s and development of statistical models to predict prognosis","Investments < €500k",,"United Kingdom" "Characterisation of the unfolded protein response, apoptosis and autophagy in human AD cases","Investments < €500k",,"United Kingdom" "Characterising Kynurenine 3-Monooxygenase (KMO) As A Therapeutic Target For Huntington’s Disease","Investments > €500k","Huntington's disease","United Kingdom" "Characterising protein oligomers and their role in neurodegenerative disease in humans","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders","European Commission" "Characterization of a caspase-cleavage resistant tau knock-in mouse","Investments < €500k",,"United States of America" "Characterization of a complex regulatory element of Spinal Muscular Atrophy genes","Investments > €500k","Spinal muscular atrophy (SMA)","United States of America" "Characterization of a Parkinson’s disease gene DJ-1 in regulatory T cells","Investments < €500k",,Luxembourg "Characterization of Alzheimers Mutations in ADAM10.","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Characterization of ApoE4 Induced Phospholipid Dysregulation in AD Pathogenesis","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Characterization of ATXN1 in APP processing and AD pathogenesis","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Characterization of genetic pathways mediating synapse dysfunction in a Drosophila Alzheimer´s disease model","Investments < €500k",,Switzerland "Characterization of modified amyloid peptides for the derivation of vaccine strategies and specific detection methods","Investments > €500k","Alzheimer's disease & other dementias",Germany "Characterization of the Fidelity to PD of a Unique Rat Model","Investments < €500k",,"United States of America" "Characterization of the Fidelity to PD of a Unique Rat Model","Investments < €500k",,"United States of America" "Characterizing and Targeting Pyk2 Kinase in Alzheimer’s Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Characterizing Cognitive Decline in Late Life Depression: The ADNI-D Project","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Characterizing Intrinsic Functional Cortical Networks in Parkinson Disease Dementia","Investments < €500k",,"United States of America" "Characterizing Intrinsic Functional Cortical Networks in Parkinson Disease Dementia","Investments < €500k",,"United States of America" "Characterizing Intrinsic Functional Cortical Networks in Parkinson Disease Dementia","Investments < €500k",,"United States of America" "Characterizing novel hippocampal drugs for Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Characterizing the Behavior Profile of Healthy Cognitive Aging","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Characterizing the glymphatic peri-vascular connectome and its disruption in AD","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Characterizing the glymphatic peri-vascular connectome and its disruption in Alzheimer’s disease","Investments < €500k",,Denmark "Characterizing the Role of the Endosomal/ Lysosomal system in beta-Amyloid Production and Secretion in Alzheimer’s disease","Investments < €500k",,Canada "CHARGE: Identifying Risk & Protective SNV for AD in ADSP Case-control Sample","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Chemical biological dissection of Ca2+ entry through Ca2+ channels","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Chemical Fingerprinting","Investments > €500k","Huntington's disease","United States of America" "Chemical-Genetic Approaches to Define Lrrk2 Kinase Function in Parkinson Disease",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Chemical-genetics approaches using in vivo models of age-dependent neurodegeneration","Investments < €500k",,Canada "Chemogenetic approaches to investigate astrocyte role in Alzheimer´s Disease and ALS",Fellowships,"Alzheimer's disease & other dementias",Switzerland "CHEVAL-in: neurophysiological determinants of conversion to psychosis and response to cholinesterase inhibitors in Parkinson’s disease","Investments < €500k",,Netherlands "ChinherbAD – The multitarget low molecular compounds from traditional Chinese herbs in treatment of Alzheimer´s disease","Investments < €500k",,Slovakia "Choir participation to improve wellbeing and relationship quality for community-dwelling people with dementia and their primary care-givers",Fellowships,"Alzheimer's disease & other dementias",Australia "Cholesterol and Sphingolipid Metabolism in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Cholesterol and the Amyloid Precursor Protein","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Cholesterol Metabolizing P450s; structure and function","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Cholinergic overload and resilience to attentional capacities in aging","Investments < €500k",,"United States of America" "CHolinEsterase inhibitors to slow progression of Visual hALlucinations in Parkinson’s disease: a multi-center placebo-controlled trial(CHEVAL)","Investments > €500k","Parkinson's disease & PD-related disorders",Netherlands "Chronic physiologic and behavior changes induced by novel STN DBS patterns for PD","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Chronic physiologic and behavior changes induced by novel STN DBS patterns for PD","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "CIC-CRB Lille – Biobank","Capital Infrastructure",,France "CIEN Foundation Tissue Bank for Neurological Research (BT-CIIN)",Biobanks,"Alzheimer's disease & other dementias|Neurodegenerative disease in general",Spain "CIRCADIAN CLOCK DYSFUNCTION AS A MEDIATOR OF NEURODEGENERATION",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Circadian dysfunction and GSK3 in neurodegenerative disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Circadian Regulation of Memory",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Circadian Rhythms and Sleep-Wake Cycles in Parkinsons Disease",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "CJD Research and Resource Centre","Investments > €500k","Prion disease","United Kingdom" "CLaSP: Care for Late Stage Parkinsonism","Investments > €500k|JPND Projects","Parkinson's disease & PD-related disorders","France|Germany|JPND|Netherlands|Portugal|Sweden|United Kingdom" "Clearance and In Vivo Detection of Tau Pathology","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Clem Jones Centre for Ageing Dementia Research focused the on prevention and treatment of dementia","Investments > €500k","Alzheimer's disease & other dementias",Australia CLEMENS,"Disease Registers","Neurodegenerative disease in general",Switzerland "Click strategies for multifunctional anti-Alzheimer agents","Investments < €500k",,France "Clinical and Informatics Research on Large Clinical Databases","Investments < €500k",,"United States of America" "CLINICAL AND RADIOLOGICAL QUANTITATIVE EVALUATION IN PATIENTS PMM2-CDG THROUGH A NATIONAL NETWORK OF PROFESSIONALS.","Investments < €500k",,Spain "Clinical Coordination Center for STEADY-PD3","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Clinical Evaluation of PET Radiotracers","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Clinical Evaluation of T3D-959 as a Potential Disease Remedial Therapeutic for the Treatment of Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Clinical follow-up on the development of impulse control disorders in Parkinson’s disease","Investments < €500k",,Netherlands "CLINICAL PHENOTYPES AND NEW PHYSIOPATHOLOGICAL, DIAGNOSTIC AND PROGNOSTIC BIOMARCATORS IN ALZHEIMER’S DISEASE OF PRECIOUS START AND BEHAVIORAL BEHAVIOR OF FRONTOTEMPORA DEMENTIA","Investments < €500k",,Spain "Clinical phenotypes and novel neurophysiological and immunological biomarkers in inflammatory neuropathy and neurodegeneration",Fellowships,"Motor neurone diseases",Australia "Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Tr","Investments > €500k","Spinal muscular atrophy (SMA)","United States of America" "Clinical Research Studies in the UK and PNG","Investments > €500k","Prion disease","United Kingdom" "Clinical trials network for preventing dementia and Alzheimer’s disease","Investments < €500k",,Finland "CLINICAL UTILITY OF 23 LOCI RELATED TO ALZHEIMER’S DISEASE IN SUBJECTS AT THE RISK OF CONVERSION TO DEMENTIA","Investments < €500k",,Spain "Clinical Utility of MicroRNAs as Diagnostic Biomarkers of Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "CLINICAL-GENETIC CORRELATIONS IN DEMENTIA AND FAMILY PRESERVED nonagenarian cognitively","Investments < €500k",,Spain "Clinical, imaging and biological investigations of frontotemporal dementia and related conditions","Case Control Studies","Alzheimer's disease & other dementias|Motor neurone diseases",Australia "Clinical, Imaging, and Pathological Studies in the Oldest Old: The 90+ Study","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Clinical, neuropsychological, neuroimaging, electrophysiological and biological makers for early diagnosis of neurodegenerative disorders with cognitive impairment","Investments < €500k",,Bulgaria "Clinical, Pathological, Genetic and Biomarker Studies of Frontotemporal Dementia","Investments > €500k","Neurodegenerative disease in general",Canada "Closed loop deep brain stimulation for Parkinsons disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Closed-loop deep brain stimulation: Optimising treatment of Parkinson’s disease using adaptive stimulation","Investments < €500k",,Australia "Closing the Loop between Understanding and Effective Treatment of the Basal Ganglia and their Disorders","Investments > €500k","Parkinson's disease & PD-related disorders","European Commission" "Clot formation as a potential diagnostic tool and therapeutic target for Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias", "CloudUPDRS: Big Data Analytics for Parkinson’s Disease patient stratification","Investments > €500k","Parkinson's disease & PD-related disorders","United Kingdom" "CNS and Plasma Amyloid–Beta Kinetics in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "CNS TAU KINETICS IN ALZHEIMERS DISEASE","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Co-LEsions dans la Maladie d’Alzheimer et les maladies apparentées. Co-lesions in Alzheimer’s Disease and Related Diseases","Investments > €500k","Alzheimer's disease & other dementias",France "Co-producing socio-technical solutions for people living with complex multi-morbidity: developing methodology and assessing pros and cons of a RCT","Investments < €500k",,"United Kingdom" "Cochrane Dementia and Cognitive Improvement Group","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders","United Kingdom" "Cocoa Supplement and Multivitamin Outcomes Study in the Mind (COSMOS-Mind)","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "CODE Z: Continuïteit van zorg bij Opname van mensen met Dementie in het Ziekenhuis (Continuity of care during and after unplanned hospital admissions of home-dwelling patients with dementia)","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "Coenzyme Q10 a potential therapeutic target for ataxia: Evaluation of therapeutic strategies","Investments < €500k",,"United Kingdom" "Cognition and Obstructive Sleep Apnea in Parkinson’s Disease, Effect of Positive Airway Pressure Therapy (COPE-PAP Trial)","Investments < €500k",,Canada "Cognitive and Aerobic Resilience for the Brain","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Cognitive and Neural Moderators of Longitudinal Decline in Frontotemporal Degeneration","Investments < €500k",,"United States of America" "Cognitive Complaints in Aging Adults",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Cognitive complications in Parkinson’s disease: the contribution of dopamine.","Investments < €500k",,Canada "Cognitive decline after hospitalization in older adults: predictors and pathogenesis",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Cognitive decline in diabetes","Investments < €500k",,Australia "Cognitive Enhancement Through Transcranial Laser Therapy","Investments < €500k",,"United States of America" "Cognitive Function, caregiver stress and cortisol: Mechanisms and implications for prevention of adverse health consequences in spouse dementia caregivers","Investments > €500k","Alzheimer's disease & other dementias",Ireland "Cognitive function, caregiver stress and cortisol: Mechanisms and implications for prevention of adverse health consequences in spouse dementia caregivers.","Investments > €500k","Alzheimer's disease & other dementias",Ireland "Cognitive impairment in Parkinson’s disease: histological correlation of hypometabolism and cerebral atrophy in an animal model and the effect of cogntive stimulation in patients","Investments < €500k",,Spain "Cognitive interventions for older adults at-risk of dementia and with early-stage neurodegenerative disease",Fellowships,"Alzheimer's disease & other dementias",Australia "Cognitive predictors of neurodegeneration","Investments < €500k",,"Czech Republic" "Cognitive rehabilitation for Parkinsons disease dementia: a pilot","Investments < €500k",,"United Kingdom" "Cognitive resilience to Alzheimer neuropathologic changes in the Honolulu-Asia Aging Study and the Nun Study","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Cognitive training and practice effects in MCI","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Cognitive, Motor, and Emotional Markers of Self-reported Cognitive Concerns",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Cohort of Consultants from Health Examination Clinics","Population Cohorts","Neurodegenerative disease in general",France "Cohort to illuminate Neurodegeneration, Genetics, Imaging Associations and Leukoaraiosis (CONGENIAL)","Investments > €500k","Neurodegenerative disease in general",Canada "Collection of Gene Edited Cell Lines (Neurobiology Laboratory for Brain Aging & Mental Health, Basal)","Experimental Models",,Switzerland "Colllaborative project Munich-Sofia in the field of Dementia","Investments < €500k",,Bulgaria "Colonic alpha-synuclein as a potential biomarker of the premotor stage of Parkinson’s disease","Investments < €500k",,Slovakia "Combined anti-inflammatory- and iron chelation therapy in a preclinical model of neurodegeneration with brain iron accumulation","Investments < €500k",,Denmark "Combined Multi-Pinhole and Fan-Beam Brain SPECT","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Combined TMS-EEG for early diagnosis of Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias",Australia "Combining AD Epitope Vaccine with Innate Immunity","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "COMBINING TRANSPLANTATION OF NEURAL STEM CELLS AND MUTANT ATAXIN-3 GENE SILENCING AS A NEW THERAPEUTIC STRATEGY FOR MACHADO-JOSEPH DISEASE",Fellowships,"Spinocerebellar ataxia (SCA)",Portugal "Comment proches et professionnels communiquent avec les personnes atteintes de la maladie d’Alzheimer. Apprentissage et diversité des compétences communicationnelles. How close and professional are communicating with people with Alzheimer’s disease. Learning and diversity of communication skills","Investments < €500k",,France "Commercialization of a serum diagnostic for detection of Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Common mechanisms and pathways in Stroke and Alzheimer’s disease.","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "Community based assessments regarding vascular contributions to Alzheimers Disease in M2OVE AD consortium","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Community-based End-of-life Intervention for African American Dementia Caregivers","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Comparing the nature and evolution of Mild Cognitive Impairment in individuals with and without Parkinson’s disease.","Investments < €500k",,Canada "Compatibility rules for glycosaminoglycan-amyloid interactions","Investments < €500k",,"United Kingdom" "Compatibility rules for glycosaminoglycan-amyloid interactions","Investments < €500k",,"United Kingdom" "Competence centers for deaf people in old age – Especially for people with dementia","Investments > €500k","Alzheimer's disease & other dementias",Germany "Competence Network – Parkinson disease","Investments > €500k","Parkinson's disease & PD-related disorders",Germany "Competence Network Dementia – Epidemiology","Investments > €500k","Alzheimer's disease & other dementias",Germany "Competence Network Dementia – FTLD","Investments > €500k","Alzheimer's disease & other dementias",Germany "Competence Network Dementia – rpAD","Investments > €500k","Alzheimer's disease & other dementias",Germany "Competition “Local alliances for people with dementia” 2014","Investments > €500k","Alzheimer's disease & other dementias",Germany "Competition “Local Alliances for People with Dementia” 2015","Investments > €500k","Alzheimer's disease & other dementias",Germany "Complement activation as a therapeutic target and clinical biomarker for Parkinson’s disease","Investments < €500k",,Australia "Complement and microglial activation in mouse models of dementia","Investments < €500k",,"United Kingdom" "Complement-Microglia Interaction in Synaptic Loss and Neurodegeneration in HD","Investments > €500k","Huntington's disease","United States of America" "Comprehensive approach to modelling outcome and cost impacts of interventions for dementia","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Comprehensive assessment of endophenotypes in neurodegenerative diseases – translating impaired molecular signalling pathways into novel therapeutic strategies for Parkinson’s disease – PEARL","Investments > €500k","Parkinson's disease & PD-related disorders",Luxembourg "Comprehensive Longitudinal Probabilistic Atlas of the Brain of Older Adults Without Dementia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Comprehensive Synaptome Proteomics Targeting Protein Expression and PTMs in HD","Investments > €500k","Huntington's disease","United States of America" "Computation and theory to predict structures and mechanisms for protein misfolding in amyotrophic lateral sclerosis","Investments < €500k",,Canada "Computational modeling of semantic decline in Alzheimers disease","Investments < €500k",,"United States of America" "Computational Models of Deep Brain Stimulation of the Cerebellothalamic and Subthalamopallidal Pathways",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Computational models of neurodegenerative disease progression","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Computational neurobiology of hippocampal dendrites",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Computational PLatform for Assessment of Cognition In Dementia (C-PLACID)","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Computational prediction of biochemical compensatory mechanisms in subjects at risk of developing Parkinson’s disease.","Investments < €500k",,Luxembourg "Computational studies of the structural and chemical biology of A2A adenosine and D2 dopamine receptor signaling","Investments < €500k",,Sweden "Computer simulation of metal-amyloid interaction and its role in plaque formation","Investments < €500k",,"United Kingdom" "Concordance of TDP-43 Inclusions with Cortical Atrophy and Clinical Phenotype","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Concurrent Aerobic Exercise and Cognitive Training to Prevent Alzheimer’s in at-risk Older Adults","Investments < €500k",,"United States of America" "Conditional deletion of Mapt in the adult mouse brain","Investments < €500k",,"United States of America" "CONGENTO – Consortium for Genetically Tractable Organisms","Research Networks",,Portugal "CONGENTO – Consortium for Genetically-Tractable Organisms","Capital Infrastructure",,Portugal "ConnectAD: connecting brain injury to cognitive outcome in Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias",Netherlands "Connectomic imaging in familial and sporadic frontotemporal degeneration","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Connectomics of Brain Aging and Dementia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Consequences of impaired insulin signalling in astrocytes: A role in Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone","Investments > €500k","Parkinson's disease & PD-related disorders","European Commission" "Consortium of Neuroimmunology of Mood Disorders and Alzheimer’s Disease.","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Construction of Amyloid Protein Based Bacterial Biofilms via Synthetic Biology","Investments < €500k",,Turkey "Consumer Directed Care: Understanding and promoting participation and care outcomes for people living with dementia in receipt of a Home Care Package",Fellowships,"Alzheimer's disease & other dementias",Australia "Contribution of age-related-circulatory factors to late-onset Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias",Netherlands "Contribution of DNA Repair Deficits to Alzheimer Pathogenesis","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "CONTRIBUTION OF THE INTERPLAY BETWEEN PARAQUAT EXPOSURE, NOX1-DERIVED ROS AND A-SYNUCLEIN PATHOGENIC CHANGES, FOR THE DEVELOPMENT OF PARKINSON’S DISEASE: ARE EPIGENETIC MECHANISMS IMPLICATED?",Fellowships,"Parkinson's disease & PD-related disorders",Portugal "Contribution of TREM2 and neuroinflammation to neurodegeneration and cognitive dysfunction in response to chronic cerebral hypoperfusion","Investments < €500k",,"United Kingdom" "Contributions of amino- and dipeptidyl-peptidases-mediated truncations of amyloid peptides to Alzheimer’s disease: a combined cellular and in vivo approach","Investments < €500k",,France "Contributions of mitochondrial fission proteins to mitophagy","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Contributions to the basic understanding of pathological protein processing and toxicity in Machado-Joseph disease","Investments > €500k","Spinocerebellar ataxia (SCA)",Germany "CONTROL AND MODULATION OF HIPPOCAMPAL OLM INTERNEURONS IN MEMORY FORMATION","Investments < €500k",,Sweden "Control theory for neural synchrony: modeling based on optogenetics data, anda closed-loop alteration of pathological brain oscillations",Fellowships,"Parkinson's disease & PD-related disorders",France "Convergence of Abeta and tau pathogenic mechanisms on axonal transport","Investments < €500k",,"United Kingdom" "CONVERGING MECHANISMS BETWEEN AUTOPHAGIA AND AXONAL FUNCTION AND METABOLIC INFLUENCE IN THE REGULATION OF NEURODEGENERATIVE DISEASES","Investments < €500k",,Spain "Conversational engagement as a means to delay onset AD: Phase II","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Converting Alzheimers reactive astrocytes into functional neurons","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Cooperative Health Research in the Augsburg Region","Population Cohorts","Alzheimer's disease & other dementias|Neurodegenerative disease in general|Parkinson's disease & PD-related disorders",Germany "Coordinating Center for Genetics and Genomics of Alzheimers Disease (CGAD)","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Coordinating Center for Genetics and Genomics of Alzheimers Disease (CGAD)","Capital Infrastructure",,"United States of America" "Coordination and electrochemical background of role of metal ions in neurodegenerative disorders","Investments < €500k",,Hungary "Cortical connectivity in neurodevelopment and neurodegeneration","Investments < €500k",,Canada "Cortical Pathophysiology in Mouse Models of Huntingtons Disease","Investments < €500k",,"United States of America" "Cortical-Subcortical Interaction in PD and Normal Speech","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Cortico-basal ganglia connectivity in a non-human primate model of Huntingtons disease","Investments > €500k","Huntington's disease","United States of America" "Cortico-Spinal Motor Neurons in Amyotrophic Lateral Sclerosis : Contribution, Mechanisms and Therapy",Fellowships,"Motor neurone diseases","European Commission" "Cortico-striatal contributions to symptomology in dementia: new targets for therapy","Investments < €500k",,"United Kingdom" "Corticospinal motor neuron developmental control genes as candidates for human ALS susceptibility","Investments < €500k",,"United Kingdom" "Coupling factor 6, a circulating vasoactive peptide, in Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias|Neurodegenerative disease in general",Finland "COURAGE-PD: COmprehensive Unbiased Risk factor Assessment for Genetics and Environment in Parkinson‘s Disease","Investments > €500k|JPND Projects","Parkinson's disease & PD-related disorders","France|Germany|Israel|Italy|JPND|Luxembourg|Netherlands|Norway|Spain|United Kingdom" "CRACK IT – UnTangle Challenge","Investments < €500k",,"United Kingdom" "CRB – CHU Montpellier – Biobank","Capital Infrastructure",,France "CRB HUEP-UPMC",Biobanks,,France "CRB HUEP-UPMC – Biobank","Capital Infrastructure",,France "CRB-CHU Montpellier",Biobanks,,France "CRB-HCL : CardioBioTec – Tissue Bank",Biobanks,"Alzheimer's disease & other dementias|Neurodegenerative disease in general|Prion disease",France "CRB-HCL : NeuroBiotec",Biobanks,"Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders",France "CRCNS: Propagation of beta oscillations in cortico-basal ganglia-thalamic loop","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Creating a novel ‘protein only’ knock-in mouse model of C9orf72 neurodegeneration","Investments < €500k",,"United Kingdom" "Creating new Drosophila models to study Tau loss and gain-off functions","Investments < €500k",,"United States of America" "Creative Conversations: An exploratory study of an arts in health apporach to embedding person-centered care and improving communication between care staff and people living with dementia","Investments < €500k",,"United Kingdom" "CRISPR-Cas9 genetic screens for genes conferring survival to oxidative stress in dopamine neurons","Investments < €500k",,"United Kingdom" "Critical analysis of glycosphingolipid pathways in aging and Parkinsons disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Critical hypothalamic circuitries controlling depression and anxiety in Huntington disease.","Investments > €500k","Huntington's disease",Sweden "CRMBM/CEMEREM – MRI 4,7T / 7T/11,75T","Capital Infrastructure",,France "Cross-talk between amyloid and neuroinflammatory cascades in neurodegenerative diseases.","Investments < €500k",,Sweden "CrossSeeds: Mechanisms of pathogenic protein cross-seeding in neurodegenerative disorders","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias|Huntington's disease|Parkinson's disease & PD-related disorders",France|Germany|JPND|Norway "CSF predictors of postoperative delirium in non-demented hip fracture patients",Fellowships,"Alzheimer's disease & other dementias","United States of America" "CSF YKL-40 as a potential biomarker of Alzheimer’s disease.","Investments < €500k",,Poland "CSF, MRI, and PET biomarkers of neuroinflammation in Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "CSF/ISF highways for tau brain clearance","Investments < €500k",,"United States of America" "Cue-shoe for Parkinson’s disease: a single step from freezing to freedom",Fellowships,"Parkinson's disease & PD-related disorders",Netherlands "CureALS: Stress granules and proteostasis in motor neurons: towards a mechanistic understanding of ALS","Investments > €500k|JPND Projects","Motor neurone diseases",Germany|Israel|Italy|JPND|Sweden|Switzerland "Current and Future Costs of Alzheimers and Dementia Care","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Cyclic EphA4 peptide antagonists for neuroprotection in ALS","Investments > €500k","Motor neurone diseases","United States of America" "Cyclin-dependent kinase 5 (Cdk5 physiology and pathology)","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Cytohesins, ARF GTPases and Neurodegeneration","Investments > €500k","Motor neurone diseases","United States of America" "Cytosolic Phospholipase A2 in Amyloid-beta Peptide-stimulated Cerebral Endothelial cells","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "DACAPO-AD: Deciphering Interactions of Acquired Risk Factors and ApoE-mediated Pathways in Alzheimer’s Disease","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias",Denmark|France|Germany|JPND|Sweden "Damage of the blood-brain barrier of transgenic rat models for tauopathies","Investments < €500k",,Slovakia "DAMNDPATHS: Elucidation of common transcriptional targets in vulnerable DopAmine, MotorNeuron and frontotemporal Dementia disease PATHwayS","Investments > €500k|JPND Projects","Motor neurone diseases|Neurodegenerative disease in general|Spinal muscular atrophy (SMA)",Italy|JPND|Spain|Sweden "Danubian Network for Dementia education and care- Phase 2","Investments < €500k",,Bulgaria "Data Coordination Center for STEADY-PD3","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "DBS-Expert: Automated Deep Brain Stimulation Programming Using Functional Mapping","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "DDI- dementia disease initiation",Fellowships,"Alzheimer's disease & other dementias",Norway "De ERAD-C eiwitafbraak-route bij de ziekte van Alzheimer. The ERAD-C protein degradation pathway in Alzheimer’s disease","Investments < €500k",,Netherlands "De invloed van verouderingsprocessen op het regeneratief potentieel van de zebravisretina. The influence of aging processes on the regenerative potential of the zebrafish retina",Fellowships,"Alzheimer's disease & other dementias",Belgium "De mond niet vergeten! Implementatieproject voor goede mondzorg voor thuiswonende ouderen met dementie. Do not forget the mouth! Implementation project for good oral care for home-grown elderly people with dementia","Investments < €500k",,Netherlands "De ontwikkeling van een ALS therapie gericht op Ataxine-2. The development of an ALS therapy focused on Ataxin-2","Investments < €500k",,Netherlands "De rol van een verhoogde stofwisseling bij ALS","Investments < €500k",,Netherlands "De rol van het ceramide transporter proteine (CERT) bij de ziekte van Alzheimer. The role of the ceramide transporter protein (CERT) in Alzheimer’s disease","Investments < €500k",,Netherlands "De rol van SPPL2b bij pathogenese van de ziekte van Alzheimer. The role of SPPL2b in Alzheimer’s disease pathogenesis","Investments < €500k",,Netherlands "De stem van ons (The Voice of Our Memory)","Investments < €500k",,Belgium "De ziekte van Alzheimer en de epigenetische programmering van neurale stamcellen door stress. Alzheimer’s disease and epigenetic programming of neural stem cells by stress","Investments < €500k",,Netherlands "Deaf people with Dementia: next steps","Investments < €500k",,"United Kingdom" "DECIDE: DElirium and Cognitive Impact in DEmentia",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Deciphering mechanisms underlying the dysfunction of motoneurons derived from ALS patient iPSCs","Investments < €500k",,"United Kingdom" "Deciphering Protein Quality Control Pathways Targeting Cytosolic Proteins for Proteasome Degradation","Investments > €500k","Neurodegenerative disease in general",Canada "Deciphering stress-induced immune alterations and their contribution to physiopathological mechanisms in Parkinson’s disease.","Investments < €500k",,France "Deciphering the fundamental roles of two proteins involved in neurodegenerative disease.",Fellowships,"Neurodegenerative disease in general","United Kingdom" "Deciphering the mechanisms of TDP-43 and FUS/TLS mediated neurotoxicity",Fellowships,"Motor neurone diseases",Switzerland "DECIPHERING THE MECHANISMS UNDERLYING THE LOST OF BDNF NEUROPROTECTION IN ALZHEIMER’S DISEASE",Fellowships,"Alzheimer's disease & other dementias",Portugal "Deciphering the molecular landscape of Early Onset Parkinson Disease using an integrated approach of exome and transcriptome sequencing",Fellowships,"Parkinson's disease & PD-related disorders",Belgium "Deciphering the role and importance of altered glycosylations in neurodegenerative and neurometabolic diseases","Investments < €500k",,Sweden "Decision Making for Cardiovascular Therapy in Adults with Mild Cognitive Impairment","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Decision Support System for Patient-Driven Monitoring Of Cognitive Decline through Computer Aided Personal Support for Cognitive Resources","Investments < €500k",,Norway "Decoding Presymptomatic white matter changes in Huntington Disease (WIN-HD)","Investments > €500k","Huntington's disease","France|United Kingdom" "Decoding the role of diverse astrocyte populations in aging and AD","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Deconstructing the cellular and molecular basis of SBMA motor neuron disease: From mechanism to therapy","Investments > €500k","Spinal muscular atrophy (SMA)","United States of America" "Deconstructing the function of APP as a Wnt signaling receptor and its relevance to Alzheimer’s disease","Investments < €500k",,Belgium "Deconstructing the pathogenic effect of APP in memory circuits","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Dedicated Brain PET Device Optimized for Brain Imaging","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Deep Brain Stimulation – Novel Technical Concepts and Clinical Indications","Investments < €500k",,Sweden "Deep Brain Stimulation and MR Analysis in Parkinson’s Patients","Investments < €500k",,Turkey "Deep Brain Stimulation for Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Deep brain stimulation for disabling action tremor: a controlled comparison of two different targets","Investments < €500k",,Norway "Deep Brain Stimulation induced changes in monoaminergic neurotransmission and regional cerebral blood flow","Investments < €500k",,Denmark "Deep brain stimulation surgery under local versus general anesthesia in Parkinson’s disease","Investments < €500k",,Netherlands "Deep brain stimulation: a new way of understanding the human brain","Investments < €500k",,Hungary "Deep Brain Stimulation: Effects on brain circuits and neurotransmission.","Investments < €500k",,Denmark "Deep Phenotyping and Complex Genetics of ALS: A multidisciplinary population based approach","Investments > €500k","Motor neurone diseases",Ireland "Deep Resequencing of Candidate Gene Regions in Late-onset Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Default Mode Short Term Memory Retention in Mild Cognitive Disorder in Early Alzheimer Patients","Investments < €500k",,Turkey "Deficient Wnt signalling in synapse degeneration and its contribution to Parkinson’s Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United Kingdom" "Defining an Electrophysiological Phenotype of ALS Patient-Derived Motor Neurons",Fellowships,"Motor neurone diseases","United States of America" "Defining disease progression in ALS: A novel analytic approach using existing clinical and imaging datasets","Investments < €500k",,"United Kingdom" "Defining Genetic Polygenic and Environmental Risk for Alzheimer’s disease using multiple powerful cohorts,focussed Epigenetics and Stem cell metabolomics","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "Defining mechanisms of RNA-binding protein assembly linked to Alzheimer disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Defining systems that clear dangerous misfolded proteins from body fluids","Investments < €500k",,Australia "Defining the changes in cell biology caused by PRESENILIN truncations associated with different diseases","Investments < €500k",,Australia "Defining the Cohort, Outcomes and Predictors for a Prognostic Index for Older Patients with Alzheimers Disease or Related Dementias","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Defining the disease mechanism(s) in ALS/FTLD with SQSTM1 mutations","Investments < €500k",,"United Kingdom" "Defining the genetic etiology of Alzheimer’s disease in the Faroe Islands",Fellowships,"Alzheimer's disease & other dementias",Denmark "Defining the machinery for mitochondrial turnover governed by the Parkinson’s Disease proteins PINK1 and Parkin","Investments < €500k",,Australia "Defining the mechanisms by which ABCA7 and apoE control Alzheimer’s disease risk. Functional characterisation of new therapeutic targets for dementia prevention and treatment.",Fellowships,"Alzheimer's disease & other dementias",Australia "Defining the mechanisms of dipeptide repeat protein toxicity in C9orf72 ALS/FTD","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "Defining the mechanisms of dipeptide repeat protein toxicity in C9orf72 ALS/FTD","Investments < €500k",,"United States of America" "Defining the mechanisms of dipeptide repeat protein toxicity in C9orf72 ALS/FTD","Investments < €500k",,"United States of America" "Defining the mechanistic basis of a prion disaggregase","Investments < €500k",,"United States of America" "Defining the mechanistic basis of a prion disaggregase","Investments < €500k",,"United States of America" "Defining the pathways and mechanism of misfolded protein triage and quality control in eukaryotic cells","Investments < €500k",,"European Commission" "Defining the role of FUS phosphorylation in neurodegeneration","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "DEFINING THE ROLE OF NMDA RECEPTORS ON HIPPOCAMPAL NEUROGENESIS IN A TRANSGENIC MICE MODEL OF ALZHEIMER’S DISEASE UNDER HYPERGLYCEMIA",Fellowships,"Alzheimer's disease & other dementias",Portugal "Defining the role of retromer in endosomal sorting in health and disease.",Fellowships,"Neurodegenerative disease in general","United Kingdom" "Delaying institutionalization, sustaining families: Comparative case studies of care at home for persons with dementia","Investments < €500k",,Canada "Delineating protein-protein interaction network of hyperphosphorylated tau in tauopathies","Investments < €500k",,"United States of America" "DElineation of Striato-CoRtical contrIbutions to BEhavioral symptoms in FrontoTemporal Dementia",Fellowships,"Alzheimer's disease & other dementias", "Delivering personalised synthetic voices for patients with MND","Investments < €500k",,"United Kingdom" "Démence en EHPAD: Télémédecine pour la prise en Charge des Troubles psycho-comportementaux. Dementia in EHPAD: Telemedicine for the Management of Psycho-Behavioral Disorders","Investments < €500k",,France "Dementia and Cognitive Impairment in the Prison Population of England and Wales: Identifying Individual Need and Developing a skilled, Multi-Agency Workforce to Deliver Targeted and Responsive Services","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Dementia and interaction – intersections between research and communication training",Fellowships,"Neurodegenerative disease in general",Finland "Dementia and interaction – intersections between research and communication training","Investments < €500k",,Finland "Dementia and Neurodegeneration Network Ireland (DNNI)","Investments < €500k",,Ireland "Dementia and Neurodegeneration Network Ireland (DNNI)","Research Networks",,Ireland "Dementia biobank",Biobanks,"Alzheimer's disease & other dementias|Neurodegenerative disease in general",Sweden "Dementia Care Tool","Investments < €500k",,Australia "Dementia Collaborative Research Centres – Assessment & Better Care","Investments > €500k","Alzheimer's disease & other dementias",Australia "Dementia Collaborative Research Centres – Carers & Consumers","Investments > €500k","Alzheimer's disease & other dementias",Australia "Dementia Collaborative Research Centres – Diagnosis & Prevention","Investments > €500k","Alzheimer's disease & other dementias",Australia "Dementia Disease Initiation",Fellowships,"Alzheimer's disease & other dementias",Norway "Dementia Disease Initiation","Investments < €500k",,Norway "Dementia for people with learning difficulties","Investments < €500k",,Germany "Dementia Friendly Irish Hospitals: Opportunities, Barriers, Costs and Solutions","Investments > €500k","Alzheimer's disease & other dementias",Ireland "Dementia in people with Intellectual Disability: A longitudinal study with focus on translatable outcomes.",Fellowships,"Alzheimer's disease & other dementias",Australia "Dementia in the population: Trajectories of disease, health care use, and places of care","Investments > €500k","Alzheimer's disease & other dementias",Canada "Dementia in Type 2 Diabetes – studying causal mechanisms",Fellowships,"Alzheimer's disease & other dementias",Australia "Dementia Innovation Hub","Investments > €500k","Alzheimer's disease & other dementias",Ireland "Dementia Prevalence over Time: Proximate Causes and Consequences","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Dementia related deficits in striatal cholinergic function and decision-making","Investments < €500k",,Australia "Dementia Specialist","Investments < €500k",,Australia "Dementia undetected or undiagnosed in primary care: the prevalence, causes and consequences","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Dementia with Lewy bodies and Alzheimer’s disease: an unfortunate couple?",Fellowships,"Alzheimer's disease & other dementias",Netherlands "Dementia with Lewy Bodies Consortium","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Dementia with Lewy Bodies Consortium","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders","United States of America" "Dementia-friendly architecture: Reducing Spatial Disorientation in Dementia Care Homes","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Democracy, autonomy and justice – citizenship practice for people with dementia","Investments > €500k","Alzheimer's disease & other dementias",Sweden "Demystifying Microglia in Aging and Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Dendrites and memory/Momentum grant",Fellowships,"Neurodegenerative disease in general",Hungary "DeNDRoN MND Co-ordinator","Investments < €500k",,"United Kingdom" "Dénervation dopaminergique et polymorphisme de la COMT chez les patients parkinsoniens de novo. Plasma tau protein and biomarkers of amyloid precursor protein (APP) for the diagnosis and prognosis of Alzheimer’s disease. Ancillary study under study BALTAZAR (Biomarker of AmyLoïd pepTide and AlZheimer’s diseAse Risk).","Investments < €500k",,France "Depletion of interfering antibodies for biomarker-based monitoring of clinical trials for immunotherapy of Alzheimer’s disease","Investments < €500k",,Germany "Depolarization-induced tau and exosome release from synapses in AD","Investments < €500k",,"United States of America" "Depression in Dementia",Fellowships,"Alzheimer's disease & other dementias",Australia "Deranged calcium signaling and polyglutamine expansion disorders","Investments > €500k","Huntington's disease","United States of America" "Description of causes of neurodegenerative disease mechanisms by producing amyloid beta aggregates from synthetic and patient material","Investments < €500k",,Germany "Design and development of a mixed reality system for skilled locomotor training in individuals with Parkinsons disease","Investments < €500k",,"United States of America" "Design and development of a mixed reality system for skilled locomotor training in individuals with Parkinsons disease","Investments < €500k",,"United States of America" "Design And Development Of Experimental Therapeutics","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Design and Optimisation of New Chemical Entities that Prevent the Neurotoxic Oligomerization and Misfolding of both beta-amyloid and tau Proteins: A Disease Modifying Therapeutics Approach for Alzheimer’s Dementia","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Design and synthesis of molecular probes to study the role of microglia in pathologies related to neuroinflammation. Progettazione e sintesi di sonde molecolari per lo studio del ruolo della microglia in patologie correlate alla neuroinfiammazione.","Investments > €500k","Alzheimer's disease & other dementias|Huntington's disease|Parkinson's disease & PD-related disorders",Italy "Design of antibody fragments specific for amyloidogenic aggregates","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Design, synthesis and pharmacological evaluation of Multi-Target Directed Ligands as potential procognitive drugs in Alzheimer’s disease treatment","Investments < €500k",,France "Detecting early dementia in mice: The contribution of amyloid vs tau","Investments < €500k",,"United Kingdom" "Detecting, tracking & modelling structural and functional brain imaging changes in Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Detection and Clearance of AD Lesions","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Detection of Post-Translationally Modified Proteins as a Biomarker Panel for Parkinsons Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Determinants of healthy ageing in the Whitehall II study",Fellowships,"Neurodegenerative disease in general","United Kingdom" "Determinants of mental capacity: Individual differences, age-related changes, and neurodegenerative decline","Investments < €500k",,Denmark "Determinants of Midlife & Longitudinal Change in Cognitive Function: CARDIA Study","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Determinants of Neurodegenerative Decline in Primary Progressive Aphasia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Determination of the Change in Mitochondria Numbers in Lymphocytes of Alzheimer’s Patients via Quantitative in situ Mitochondrial Analysis","Investments < €500k",,Turkey "Determining Factors and The Progression of The Onset of Alzheimer’s Disease and Cognitive Impairment","Population Cohorts","Alzheimer's disease & other dementias",France "Determining how neural activity impairs bioenergetics in PD pathogenesis","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Determining if Reduced Insulin Response in the Brain is Linked to Cognitive Loss","Investments < €500k",,"United States of America" "Determining neuronal connections involved in Parkinson’s disease and cocaine addiction",Fellowships,"Parkinson's disease & PD-related disorders",Australia "Determining the causes and consequences of brain amyloidosis, atrophy and cerebrovascular disease","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Determining the contribution of peripheral immune complement signalling in the progression of motor neuron disease","Investments > €500k","Motor neurone diseases",Australia "Determining the impact of a designated multidisciplinary care centre in Cambridge on the natural history of Motor Neurone Disease","Investments < €500k",,"United Kingdom" "Determining the role and mechanism of action of ether-phospholipids in nervous tissue",Fellowships,"Neurodegenerative disease in general",Portugal "Determining the role of lysosomal Ca2+ signalling in the pathogenesis of Alzheimer’s disease","Investments < €500k",,"United Kingdom" "Determining the role of M cells in TSE agent neuroinvasion from the intestine","Investments < €500k",,"United Kingdom" "Determining the role of striatal cell types, regions and compartments in the generation of Parkinson’s akinesia and dyskinesia.",Fellowships,"Parkinson's disease & PD-related disorders",Sweden "Developin in-vitro models of A beta toxicity: Complementary yeast and human stem cell approaches",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Developing a methodological framework for trials in presymptomatic neurodegenerative disease – the Presymptomatic Neurodegeneration Initiative (PreNI)","Investments < €500k",,"United Kingdom" "DEVELOPING A MICRORNA-TARGETED THERAPY FOR ALS","Investments < €500k",,"United States of America" "DEVELOPING A MICRORNA-TARGETED THERAPY FOR ALS","Investments < €500k",,"United States of America" "Developing a new biomarker for the early diagnosis of dementia; a novel nonlinear signal processing approach using resting state EEG.","Investments < €500k",,"United Kingdom" "Developing a Novel Neuroprotective Drug Target for Alzheimer’s Disease","Investments < €500k",,Australia "Developing a SCA1 therapy targeting the ataxin-1 protein in a patient-specific neuronal cell model","Investments < €500k",,Netherlands "Developing a sustainable research programme to prevent falls and promote physical activity among older people with dementia.",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Developing an early reliable blood-derived biomarker of cognitive deterioration","Investments < €500k",,Ireland "Developing an intervention to enhance social connectedness and improve quality of life for people with dementia in long-term care",Fellowships,"Alzheimer's disease & other dementias",Canada "Developing and evaluating an online psychoeducation package for adolescent depression",Fellowships,"Huntington's disease","United Kingdom" "Developing ASO Therapy for Repeat Expanded C9orf72 ALS-FTD","Investments > €500k","Motor neurone diseases","United States of America" "Developing ASO Therapy for Repeat Expanded C9orf72 ALS-FTD","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "DEVELOPING BETTER MODELS FOR LONG-TERM SURVIVAL OF HUMAN EMBRYONIC STEM CELLS IN IMMUNE-COMPETENT HOSTS","Investments < €500k",,Sweden "Developing IMS-SID/MAD-MS Instrumentation for Characterizing Intrinsically Disordered Protein Structure","Investments > €500k","Huntington's disease","United States of America" "Developing insight into the molecular origins of familial and sporadic frontotemporal dementia and amyotrophic lateral sclerosis","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases",Australia "Developing neuroprotective strategies for proteinopathy","Investments > €500k","Motor neurone diseases","United States of America" "Developing quantitative biomarkers for monitoring longitudinal changes in brain microvascular health",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Developing smart glasses with light therapy and visual cueing to improve health and behaviour in Parkinson’s disease","Investments > €500k","Parkinson's disease & PD-related disorders",Netherlands "Developing the Oxford study for biomarkers in Motor Neurone Disease (BioMOx2): Capturing pre-symptomatic events and advancing clinical translation",Fellowships,"Motor neurone diseases","United Kingdom" "Developing the Oxford study for biomarkers in Motor Neurone Disease (BioMOx2): Capturing pre-symptomatic events and advancing clinical translation","Investments < €500k",,"United Kingdom" "Developing, evaluating, and disseminating new methods and technologies to advance Parkinson disease research","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Development and application of global lipidomic arrays to inflammatory vascular disease.","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "Development and characterization of a novel Clusterin mouse model","Investments < €500k",,"United States of America" "Development and dissemination of a web-based support for people with dementing dementia and their loved ones","Investments > €500k","Alzheimer's disease & other dementias",Germany "Development and implementation of evidence-based deprescribing guidelines to guide person-centred care for people with dementia",Fellowships,"Alzheimer's disease & other dementias",Australia "Development and Implementation of Neuroimaging Analysis in Dementia",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Development and Use of a Context-Rich Virtual Learning Environment for Practicing Interpersonal Communication Skills","Investments < €500k",,Australia "Development and validation of a human three-dimensional in vitro midbrain model","Investments < €500k",,Luxembourg "Development and Validation of an Instrument to Assess Cognitive Function Regulati",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Development and validation of the first culturally based quality of life tool for Aboriginal Australians living with dementia or cognitive impairment",Fellowships,"Alzheimer's disease & other dementias",Australia "Development of a blood-based early diagnosis of Alzheimer’s dementia","Investments < €500k",,Germany "Development of a C9orf72 transgenic zebrafish model of ALS","Investments < €500k",,"United Kingdom" "Development of a composite imaging/ gait-behaviour biomarker for early detection of cognitive impairment in ageing","Investments < €500k",,Switzerland "Development of a comprehensive specialist support service to enhance the experiences of younger people with Huntington’s disease in residential care","Investments < €500k",,Australia "Development of a diamond waveguide sensor for ultra sensitive chemical analysis using tunable mid-IR quantum cascade lasers","Investments < €500k",,Sweden "Development of a high throughput gene, environment and epigenetics database and analysis system for international ALS research","Investments < €500k",,"United Kingdom" "Development of a high-throughput screen to identify disease-modifying agents using primary neurons from a novel TDP-43-associated mouse model of motor neurone disease","Investments < €500k",,"United Kingdom" "Development of a late-onset-Alzheimer’s disease (LOAD) profile for accurate diagnosis and identification of potential therapeutic approaches",Fellowships,"Alzheimer's disease & other dementias", "Development of a multiplex nanofluidic assay for selective detection and monitoring of Alzheimer’s disease biomarkers",Fellowships,"Alzheimer's disease & other dementias", "Development of a New ALS Mouse Model that Targets Profilin1 and Actin Filaments","Investments < €500k",,"United States of America" "Development of a New ALS Mouse Model that Targets Profilin1 and Actin Filaments","Investments < €500k",,"United States of America" "Development of a new blood test for the diagnosis of Alzheimer’s disease","Investments < €500k",,Germany "DEVELOPMENT OF A NEW MODEL OF PARKINSON DISEASE BY nonhuman primates PLK2 overexpression of dopaminergic neurons","Investments < €500k",,Spain "Development of a non-fibrillic amyloid-beta oligomer selective positron emission tomography imaging diagnostic for Alzheimer.","Investments < €500k",,"United States of America" "Development of a novel Alzheimers test based on a microfluidic chip for the analysis of erythrocyte markers","Investments > €500k","Alzheimer's disease & other dementias",Germany "Development of a Novel F18-PET tracer for early diagnosis of Alzheimers Dementia","Investments > €500k","Alzheimer's disease & other dementias",Norway "Development of a PET Tracer Selective for Cerebral Amyloid Angiopathy","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Development of a small molecule therapeutic for the treatment of prion infection of humans","Investments > €500k","Prion disease","United Kingdom" "Development of a Telehealth Platform for Treatment with the SpeechVive Device","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Development of an Automated System for Pain Detection and Monitoring in Older Adults with Dementia","Investments < €500k",,Canada "Development of an in vivo microPET imaging platform for the non-invasive investigation of novel therapeutics in Alzheimer’s disease.",Fellowships,"Alzheimer's disease & other dementias",Belgium "Development of an information-rich assay for C9ORF72 as a test for ALS and FTD","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "Development of an information-rich assay for C9ORF72 as a test for ALS and FTD","Investments > €500k","Motor neurone diseases","United States of America" "Development of an ophthalmic diagnostic probe for neurodegenerativedisorders","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Development of Analog Sensitive PINK1 Animal Model and iPS Cells","Investments < €500k",,"United States of America" "Development of Analog Sensitive PINK1 Animal Model and iPS Cells","Investments < €500k",,"United States of America" "Development of Biomaterial-based Delivery Systems for Parkinson’s disease – an Integrated Pan-European Approach",Fellowships,"Parkinson's disease & PD-related disorders","European Commission" "Development of confocal endomicroscopy for MND research","Investments < €500k",,"United Kingdom" "Development of DNAzyme Gene Therapy for Huntingtons Disease","Investments < €500k",,"United States of America" "Development of DNAzyme Gene Therapy for Huntingtons Disease","Investments < €500k",,"United States of America" "Development of EP2 receptor antagonists for suppression of Alzheimers neuropathology","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Development of Florescent Probes for Detection of Amyloid Fibrilles","Investments < €500k",,Turkey "Development of in vivo gene therapy methods to treat Parkinson’s disease.","Investments < €500k",,Sweden "Development of in vivo gene therapy methods to treat Parkinson’s disease.","Investments < €500k",,Sweden "Development of mouse models for ALS5 and SPG11","Investments < €500k",,"United States of America" "Development of mouse models for ALS5 and SPG11","Investments < €500k",,"United States of America" "Development of MRI microvascular biomarkers in cognitive impairment and dementia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Development of new biomarkers and brain imaging techniques for Dementia and Parkinsonian disorders: key tools for exploring etiology to improve diagnosis and advance drug development","Investments < €500k",,Sweden "Development of new pharmaceutical drugs to treat dementia","Investments > €500k","Alzheimer's disease & other dementias|Neurodegenerative disease in general",Hungary "DEVELOPMENT OF NEW THERAPEUTIC STRATEGIES FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY: REGULATION OF AUTOPHAGIA AND INTRACELLULAR SIGNALING WAYS.","Investments < €500k",,Spain "Development of new therapeutics for Alzheimer´s disease","Investments < €500k",,Sweden "Development of new therapies for the treatment of Alzheimer’s disease and / or multiple sclerosis by modulation of oxidative stress in combination with new selective inhibitors","Investments > €500k","Alzheimer's disease & other dementias",Germany "Development of novel food concepts for prevention of lifestyle-related neurodegenerative diseases using malted barley waste-products","Investments > €500k","Alzheimer's disease & other dementias",Sweden "Development of novel inhibitors of C1q for the treatment of Neurodegenerative diseases","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Development of Novel Machine Learning methodologies for early Parkinson’s disease diagnosis from multi-modal MRI","Investments < €500k",,Luxembourg "Development of novel strategies for treating Alzheimer’s disease by understanding glial mechanisms for brain waste removal","Investments < €500k",,Norway "Development of novel strategy for Alzheimer disease therapy based on modulation of molecular chaperone networks","Investments < €500k",,Sweden "DEVELOPMENT OF NOVEL THERAPEUTIC ANTI-TAU ANTIBODIES","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "DEVELOPMENT OF NOVEL THERAPEUTIC ANTI-TAU ANTIBODIES","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Development of peptide inhibitors for neuroinflammation and neurodegeneration","Investments < €500k",,"United States of America" "DEVELOPMENT OF PET TRACERS TO IMAGE THE PARASYMPATHETIC NERVOUS SYSTEM – WITH SPECIAL EMPHASIS ON PARKINSON’S DISEASE","Investments < €500k",,Denmark "Development of prognostic epigenetic biomarkers for ALS","Investments > €500k","Motor neurone diseases","United Kingdom" "Development of protein molecular probes for detection of alpha synuclein oligomeric assemblies","Investments < €500k",,"United States of America" "Development of protein molecular probes for detection of alpha synuclein oligomeric assemblies","Investments < €500k",,"United States of America" "Development of SLIC, a methodology for synthetic lethal screening in the CNS","Investments > €500k","Huntington's disease","United States of America" "Development of small molecule Usp8 inhibitors as therapeutics in Lewy body dementia","Investments < €500k",,"United Kingdom" "Development of staging criteria to distinguish preclinical tauopathies from primary age-related tauopathy (PART)","Investments < €500k",,Australia "Development of VU0652957 for the treatment of Parkinsons disease (PD)","Investments < €500k",,"United States of America" "Development of VU0652957 for the treatment of Parkinsons disease (PD)","Investments < €500k",,"United States of America" "Development, Validation, and Application of an Imaging based CVD Scale","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Developmental Factors for Reducing Dopamine Loss in Primate Models of PD & Aging","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Diabetes Status and Brain Amyloid in Middle Aged Hispanics","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Diabetes Status and Brain Amyloid in Middle Aged Hispanics","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Diabetes, Defective Nutrient Signalling and Dementia: an Epidemiological Neuropathology Approach","Investments < €500k",,"United Kingdom" "Diagnosis of Alzheimers Disease Using Dynamic High-Order Brain Networks","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Diagnosis of Parkinsons Disease using Diffusion Tensor Imaging",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Diagnostic and Drug Discovery Initiative for Alzheimer’s Disease",Fellowships,"Alzheimer's disease & other dementias","European Commission" "Diagnostic and prognostic biomarkers for Parkinsons disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Diagnostic Biomarkers for pre-dementia Alzheimer Disease",,"Alzheimer's disease & other dementias",Canada "Diagnostic Biomarkers for pre-dementia Alzheimer Disease","Investments > €500k","Alzheimer's disease & other dementias",Canada "Diagnostic markers and pathophysiological mechanisms of atypical parkinsonian syndromes","Investments < €500k",,"Czech Republic" "Diagnostic tools for neurodegenerative disease biomarkers based on robust optically signaling capture phases","Investments > €500k","Alzheimer's disease & other dementias",Sweden "Diagnostik av Alzheimers sjukdom: lösligt amyloid-beta med PET-kamera. Diagnosis of Alzheimer’s Disease: Soluble Amyloid Beta with PET Camera","Investments < €500k",,Sweden "DIAN-TU: Next Generation Prevention Trial","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Diet and Exercise Trial to Improve Insulin Resistance, Increase Cerebral Blood Flow, Alter Metabolomic Biomarkers, and Decrease Alzheimers Disease Risk","Investments < €500k",,"United States of America" "Dietary patterns, cognitive performance and cardiovascular risk",Fellowships,"Alzheimer's disease & other dementias",Australia "Diets rich in palmitate increase Alzheimers disease risk by activating CHOP gene","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Differences in Pain Between Alzheimers Disease and Vascular Dementia in Older Females","Investments < €500k",,"United States of America" "Differentiation of GMP-grade human embryonic stem cells to midbrain dopaminergic neurons for transplantation","Investments > €500k","Parkinson's disease & PD-related disorders","United Kingdom" "Direct current stimulation and rehabilitation of comprehension deficits in stroke aphasia","Investments < €500k",,"United Kingdom" "Directional proteome analysis of extracellular vesicles in AD models","Investments < €500k",,"United States of America" "Discovery of antibody biomarkers for Alzheimer’s Disease","Investments < €500k",,"United States of America" "Discovery of druggable pathways that prevent cell death caused by proteotoxic stress",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Discovery of drugs for the treatment and prevention of Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias", "DISCOVERY OF GENES THAT PROTECT AGAINST DEMENTIA","Investments > €500k","Alzheimer's disease & other dementias",Australia "Discovery of LXR Agonists via Pharmacophore Space Mining","Investments < €500k",,"United States of America" "Discovery of New Chemical Entities for Alzheimers Disease Tauopathy","Investments < €500k",,"United States of America" "Discovery of Novel Proteomic Targets for Treatment of Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Discovery of Novel Proteomic Targets for Treatment of Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Discovery of probes that enhance expression of the neuroprotective protein Klotho","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Discovery of Therapeutic Targets for FUS- and TDP43-Dependent Forms of ALS","Investments > €500k","Motor neurone diseases",Canada "DISCRIMINATION AND MARKERS FOR REGIONAL VULNERABILITY FACTORS IN NEURONAL AGING neurodegeneration associated normal and pathological CNS","Investments < €500k",,Spain "Disease Mechanisms in Human Ubiquilinopathy","Investments < €500k",,"United States of America" "Disease progression in Parkinson’s disease (PD) – a-Synuclein and Sirtuin 2 as biomarker and biological aspects of their interaction","Investments < €500k",,Norway "Disease-Modifying Genes in Huntingtons Diseae","Investments > €500k","Huntington's disease","United States of America" "Disentangling aphasic syndromes in Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias",Australia "Disentangling clinical heterogeneity in Parkinson´s disease – moving towards individualized therapy",Fellowships,"Parkinson's disease & PD-related disorders",Norway "Disentangling network dysfunction in Alzheimer’s disease pathology: cause, consequence and rescue","Investments < €500k",,"United Kingdom" "Disentangling the contribution of tau to aging and AD","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Disentangling the contributions of dopamine and amyloid burden to age-related changes in cognition and brain network connectivity in healthy older adults",Fellowships,"Alzheimer's disease & other dementias", "Disentangling the genetic, pathophysiological and classification complexities of vascular dementia","Investments < €500k",,"United Kingdom" "Disorders of sacacia refixation in people with neurodegenerative disease","Investments < €500k",,Poland "Disruption to intracellular trafficking as a central pathogenic mechanism in amyotrophic lateral sclerosis (ALS)","Investments < €500k",,Australia "Dissecting molecular mechanisms involved in resilience of Alzheimers pathology","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Dissecting Neuronal Specificity in Hereditary Neuropathy.",Fellowships,"Neurodegenerative disease in general","United Kingdom" "Dissecting the cellular mechanisms driving disease progression in CHMP2B activated Frontotemporal Dementia: Identifying Innate immune activation and the co-regulation of membrane traffic in neurons","Investments < €500k",,"United Kingdom" "DISSECTING THE MECHANISMS OF MICROGLIA RESPONSE, DETERMINANTS AND BIOMARKERS IN AMYOTROPHIC LATERAL SCLEROSIS",Fellowships,"Motor neurone diseases",Portugal "Dissecting the neuroprotective role of neurosteroids in Alzheimer’s disease: Modulation of bioenergetics and amyloid-ß/tau toxicity","Investments < €500k",,Switzerland "Dissecting the role of 5LO in neurodegeneration associated with homocysteine","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Dissecting the role of alpha-synuclein phosphorylation in Parkinson’s disease",Fellowships,"Parkinson's disease & PD-related disorders",Portugal "Dissecting the role of Parkinson’s Disease related genes in the regulation of clock neurons and circadian rhythms.","Investments < €500k",,Belgium "Dissecting the role of RNA processing and long gene regulation in the aetiology of ALS","Investments < €500k",,"United Kingdom" "Dissecting the Toxicity of Glial and Neuronal Expression of APP in the Brain","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Disseminating the START (STrAtegies for RelaTives) coping intervention for family carers of people with dementia","Investments < €500k",,"United Kingdom" "Dissemination and implementation in dementia care: a systematic review","Investments < €500k",,"United Kingdom" "Dissociating Intrinsic and Extrinsic Motor Learning in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Distinct nicotinic acetylcholine receptors in dorsal and ventral striatum: Basis for novel therapies of Parkinson’s disease","Investments < €500k",,Finland "DJ-1 and neurodegeneration: its roles in mitochondria and in protein misfolding","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders","United Kingdom" "DJ-1 Linked Neurodegeneration Pathways in New Mouse Models of Parkinson’s Disease","Investments < €500k",,Luxembourg "Dkk1-Wnt signalling pathway in synapse degeneration: implication for early stages of Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "DNA and cell bank-ICM",Biobanks,"Neurodegenerative disease in general",France "DNA Bank (University of Ostrava)",Biobanks,"Alzheimer's disease & other dementias","Czech Republic" "DNA repair dysfunction in neurodegeneration","Investments < €500k",,"United States of America" "DNA rEpair impaired Mice with accElerated Neurodegeneration as Tool to Improve Alzheimer therapeutics","Investments < €500k",,"European Commission" "DNA-isolaties LEAP-study","Investments < €500k",,Netherlands "DnaJ co-chaperones which modify tau aggregation and neurodegeneration","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "DNMT3a: een epigenetische regelaar van cognitieve achteruitgang? DNMT3a: An epigenetic controller of cognitive decline?","Investments < €500k",,Netherlands "Do Executive Skills and Musical Sophistication Preserve Function in Older Adults with Mild Cognitive Impairment?",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Do inflammatory mechanisms cause Alzheimer’s disease following brain injury?",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Do strokes cause dementia?",Fellowships,"Alzheimer's disease & other dementias",Australia "Do strokes cause dementia? Brain size changes and cognition following stroke","Investments > €500k","Alzheimer's disease & other dementias",Australia "Do we live longer healthy or with disease? A comparison of 85-90 year olds today and 2 decades ago.","Investments < €500k",,Sweden "Doctoral Training Centre for Dementia Care and Services Research","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Does a monitoring deficit underly the real world/laboratory prospective memory paradox in healthy and pathological aging?","Investments < €500k",,France "Does air pollution increase risk of AD in a genetically susceptible animal model?","Investments < €500k",,"United States of America" "Does IGF-1 signalling impact Alzheimer Disease","Investments < €500k",,France "Does Microglial Activation Influence Propagation of Alpha-synuclein Pathology","Investments < €500k",,"United States of America" "Does Microglial Activation Influence Propagation of Alpha-synuclein Pathology","Investments < €500k",,"United States of America" "Does prompt delivery of medication to in-patients with Parkinson’s decrease length of stay in hospital?","Investments < €500k",,"United Kingdom" "Does sleep deprivation increase Alzheimer’s disease risk by disruption of amyloid-bBeta clearance","Investments < €500k",,Netherlands "Does social competence impact quality of life for people with a diagnosis of dementia?","Investments < €500k",,Australia "Does subcutaneous interleukin-1 receptor antagonist reduce inflammation after ischaemic stroke compared to placebo?","Investments < €500k",,"United Kingdom" "Does TDP-43 dysfunction in astrocytes trigger motor neuron degeneration?","Investments < €500k",,"United States of America" "Does TDP-43 dysfunction in astrocytes trigger motor neuron degeneration?","Investments < €500k",,"United States of America" "DOGS+CELLS Trial","Investments < €500k",,Australia "Dominantly Inherited Alzheimer Network","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "DOMINANTLY INHERITED ALZHEIMER NETWORK TRIAL: AN OPPORTUNITY TO PREVENT DEMENTIA","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Dominantly Inherited Alzheimers Network Trials Unit – Adaptive Prevention Trial","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Dopamine Effects on Mesocorticolimbic Function in Parkinson Disease",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Dopamine Gene therapy for the treatment of Motor and Non-motor symptoms of Parkinson disease. A translational program from Non-Human primate models to patients","Investments > €500k","Parkinson's disease & PD-related disorders",France "Dopamine modulation of synaptic plasticity and integration in the striatum","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "’Dopamine Transporter Deficiency Syndrome’: a new cause of parkinsonism and neuropsychiatric disease","Investments < €500k",,Denmark "Dopamine-Induced Striatal Synaptic Plasticity","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Dopaminergic and Muscarinic Signaling in the Striatum","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Dopaminergic encoding of counterfactual information in human striatum","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Dopaminergic Neuronal Survival During Aging and Neurodegenerative Stress","Investments < €500k",,Canada "Double-blind randomised crossover placebo-controlled pilot trial with intra-nasal Oxytocin to increase social cognitive function and reduce carer burden in frontotemporal dementia.","Investments < €500k",,"United Kingdom" "Double-blocking Anti-crosslinking Strategy for AD Drug Development","Investments < €500k",,"United States of America" "Drainage van Amyloid ß via de perivasculaire ruimte. Drainage of Amyloid ß via the perivascular space","Investments < €500k",,Netherlands "DREAMS (Dementia Related Manual for Sleep) START (Strategies for Relatives)","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "DRIVING PERFORMANCE IN PRECLINICAL ALZHEIMERS DISEASE","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Drosophila models for Huntington’s and Parkinson’s disease (University of Lisbon)","Experimental Models",,Portugal "Drug Delivery across the Human Blood-Brain Barrier","Investments > €500k","Neurodegenerative disease in general",Canada "Drug Discovery against the Early, Secreted and Toxic Tau in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Drug discovery and regeneration for Parkinson’s disease","Investments > €500k","Parkinson's disease & PD-related disorders",Sweden "DUAL AND MULTIPLE PROTEINOPATHIES IN NEURODEGENERATIVE DEMENTIAS – RISK FACTORS, PROGNOSTIC INDICATORS AND CLINICAL RAMIFICATIONS",Fellowships,"Alzheimer's disease & other dementias",Australia "Dublin Brain Bank",Biobanks,"Neurodegenerative disease in general",Ireland "Dynamic combinatorial synthesis of optical molecular markers of the aggregated Aβ peptide","Investments < €500k",,France "Dynamic Ocular Imaging: New tools to study Neurodegenerative Disease",Fellowships,"Neurodegenerative disease in general",Australia "Dynamin-Related Protein 1 and Mitochondrial Fragmentation in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Dynamin-related protein 1, neurodegeneration and Huntingtons disease","Investments > €500k","Huntington's disease","United States of America" "Dynamique et recomposition professionnelles au tour de la maladie d’Alzheimer. Analyse qualitative du rôle des professionnels du soin, des nouveaux professionnels et des dispositifs créés par la Plan Alzheimer. Professional dynamics and recomposition in the turn of Alzheimer’s disease. Qualitative analysis of the role of care professionals, new professionals and devices created by the Alzheimer’s Plan","Investments < €500k",,France "Dysarthria in Parkinson’s disease: Lusophony vs. Francophony","Investments < €500k",,France "Dysarthria in Parkinson’s disease: Lusophony vs. Francophony comparison","Investments < €500k",,Portugal "Dysfunction of cortical networks in Alzheimer’s disease","Investments < €500k",,Canada "Dysfunctional synaptic and neuronal network encoding in tauopathy-associated dementia",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Dyskinesia induced by L-dopa in Parkinson’s disease: New mechanisms and molecular targets. Discinesia indotta dalla L-DOPA nella malattia di Parkinson: nuovi meccanismi e targets molecolari.","Investments > €500k","Parkinson's disease & PD-related disorders",Italy "Dysregulation of TDP-43 expression in amyotrophic lateral sclerosis and frontotemporal lobar degeneration","Investments < €500k",,Slovenia "DZNE Alzheimer Disease Family Study","Case Control Studies","Alzheimer's disease & other dementias",Germany "DZNE Cognitive Impairment Longitudinal Study","Case Control Studies","Alzheimer's disease & other dementias",Germany "EADB: A European DNA bank for deciphering the missing heritability of Alzheimer’s disease","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias","Australia|Finland|France|Germany|Italy|JPND|Netherlands|Sweden|United Kingdom" "Early Age-of-Onset AD: Clinical Heterogeneity and Network Degeneration","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Early and late-life metal exposures and Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Early and preclinical diagnosis of Parkinson’s disease using olfactory testing and Diffusion Tensor Imaging of olfactory bulb and substantia nigra.","Investments < €500k",,Canada "Early biomarker changes in frontotemporal dementia","Case Control Studies","Alzheimer's disease & other dementias|Motor neurone diseases",Netherlands "Early Cortical Network Markers of AD Risk: a Transcranial Magnetic Stimulation Intervention Trial in Aged Rats","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Early CSF detection of FTLD",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Early Detection and Prevention of Mild Cognitive Impairment due to Cerebrovascular Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Early detection of Alzheimer’s disease using ocular biomarkers",Fellowships,"Alzheimer's disease & other dementias",Australia "Early detection of Alzheimers (MCI stage): Analysis of plasma cell-free miRNA","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Early detection of asymptomatic middle-age adults at risk for AD",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Early detection of asymptomatic middle-age adults at risk for AD",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Early detection of cognitive decline and dementia in Parkinson’s disease","Investments < €500k",,Norway "Early detection of dementia: finding the best combination of cognitive and non-cognitive markers of preclinical dementia","Investments < €500k",,Sweden "Early detection of Huntingtons Disease: Longitudinal analysis of basal ganglia and cortical thickness","Investments > €500k","Huntington's disease","United States of America" "EARLY DETECTION OF TAU ACETYLATION USING ULTRA-HIGH AFFINITY ANTIBODIES","Investments < €500k",,"United States of America" "Early diagnosis of Alzheimer’s disease: conceptual considerations and ethical guidance","Investments < €500k",,Netherlands "Early identification of Alzheimer’s disease: dynamic biomarkers for enrichment of trials",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Early imaging markers for elderly individuals with high risk to develop Alzheimers disease","Investments < €500k",,"United States of America" "Early life brain inflammation and vulnerability to neurodegeneration in late life","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Early life environment and later life dementia, cognition, neuropathology, and reserve",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Early macrostructural and microstructural cortical changes in Alzheimer’s disease: longitudinal and cross-sectional studies of early change",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Early Markers of Alzheimer Disease","Investments < €500k",,"United States of America" "Early neuronal circuitry dysfunction as a target for treatment of amyotrophic lateral sclerosis","Investments < €500k",,"United Kingdom" "Early Onset Dementia in Parkinson’s Disease: Molecular Mechanisms and Biomarker Discovery","Investments < €500k",,Norway "Early synaptic dysfunctions in HD model: role of GluN3A","Investments < €500k",,Switzerland "Early-Onset Alzheimers Disease Phenotypes: Neuropsychology and Neural Networks","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "EEG Neurofeedback as a treatment method for Parkinson Disease.","Investments < €500k",,"United Kingdom" "Een super-resolutie raamwerk voor de bepaling van kwantitatieve hersenperfusiemaps met Arterial Spin Labeling. A super-resolution framework for the quantitative determination of brain perfusion maps with Arterial Spin Labeling",Fellowships,"Neurodegenerative disease in general",Belgium "Effect of Aerobic Exercise on Alzheimers Pathophysiology in Preclinical AD","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Effect of Aging on Efficacy of Alzheimer-focused Therapeutic Strategies","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Effect of an interactive therapeutic robotic animal on engagement, mood states, agitation and antispychotic drug use","Investments > €500k","Alzheimer's disease & other dementias",Australia "Effect of APOE on CNS Neurons: Role of LRP","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Effect of bright light on mood and sleep in Parkinson’s disease, a randomized controlled trial",Fellowships,"Parkinson's disease & PD-related disorders",Netherlands "Effect of catechol-O-methyltransferase inhibitor tolcapone on levodopa induced hyperhomocysteinaemia among patients with Parkinson’s disease treated with levodopa/carbidopa intestinal gel","Investments < €500k",,Slovakia "Effect of GLP1 analogue, Liraglutide on cerebral glucose metabolism and microglial activation in Alzheimer’s disease","Investments < €500k",,"United Kingdom" "Effect of Kynurenic Acid in Beta Amyloid Neurotoxicity","Investments < €500k",,Turkey "Effect of Tat-N-Dimer in Neural Protection and Memory in Amyloid Beta Peptide 1-42 Based Alzheimer’s Model","Investments < €500k",,Turkey "Effect of tau pathology on memory consolidation in cognitively normal aging",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Effect of Unilateral and Bilateral STN Stimulation on Eye-Hand Coordination","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Effect of Vitamin D and miRNA125b in Alzheimer’s Disease Pathogenesis","Investments < €500k",,Turkey "Effecten van Aß op synapses die inhibitie aansturen. Effects of Aβ on synapses that control inhibition","Investments < €500k",,Netherlands "EFFECTIVE HOME SUPPORT IN DEMENTIA CARE: COMPONENTS, IMPACT AND COSTS OF TERTIARY PREVENTION","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "EFFECTIVENESS AND SAFETY OF A FRAGMENT OF BAPINEUZUMAB AS A THERAPY OF ALZHEIMER’S DISEASE IN A MURINO MODEL. IMPLICATION OF APOLIPOPROTEINS IN CLARIFICATION","Investments < €500k",,Spain "Effectivity of a mixed-reality dementia simulator: does it enhance empathy and reduce burden in informal caregivers","Investments < €500k",,Netherlands "Effects and costs of a day centre care program, designed for people with dementia – a 24 month controlled study (ECOD)","Investments > €500k","Alzheimer's disease & other dementias",Norway "Effects and costs of a day centre care program, designed for people with dementia – a 24 month controlled study (ECOD)",Fellowships,"Alzheimer's disease & other dementias",Norway "Effects of 6-hydroxy-nicotine on chlorisondamine-induced oxidative stress and neurotoxicity: relevance for Alzheimer’s disease","Investments < €500k",,Romania "Effects of acute and regular exercise on myokines and microRNAs in circulation and cerebrospinal fluid in relation to cognitive functions and metabolism of patients with neurodegenerative disease.","Investments < €500k",,Slovakia "Effects of aerobic exercise on cognition and brain health in older adults at increased risk of Alzheimer disease and dementia: probing the biological mechanisms using translational physiology.","Investments > €500k","Alzheimer's disease & other dementias",Canada "Effects of Aging on Visual Memory: Neuroimaging Studies","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Effects of an exercise program for nursing home patients with dementia","Investments < €500k",,Norway "Effects of chronic inflammation on brain structure and function","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Effects of Hyperglycemia on Neuronal Activity, Cerebral Metabolism, and Amyloid-beta Levels",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Effects of intracranial rAAV.Neu3 on dementia and neuropathology","Investments < €500k",,"United States of America" "Effects of modified erythropoietin on cognition and neuropathology","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Effects of Oxidative / Nitrosative Stress and Aging on Cholinergic Neuron Function","Investments < €500k",,Canada "Effects of physical activity on brain function and network connectivity in MCI","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Effects of tDCS on spoken and written production in Primary Progressive Aphasia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Effects on quality of life and family caregiving experiences by the Namaste Care Family program for advanced dementia","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "Effektmekanismen ved dyb hjernestimulation for Parkinsons sygdom belyst med magnetoencephalografi. Effect mechanism of deep brain stimulation for Parkinson’s disease illuminated with magnetoencephalography","Investments < €500k",,Denmark "Effet de la buspirone sur les dyskinésies iatrogènes de la maladie de Parkinson avancée. Essai multicentrique de phase II, international, randomisé double insu, contrôlé, contre placebo, en deux groupes parallèles. Effect of buspirone on iatrogenic dyskinesias of advanced Parkinson’s disease. Phase II, international, double-blind, controlled, placebo-controlled, multicentre trial in two parallel groups.","Investments < €500k",,France "Efficacies and Pharmacodynamic Assays for LRRK2 Small-Molecule Inhibitors","Investments < €500k",,"United States of America" "Efficacies and Pharmacodynamic Assays for LRRK2 Small-Molecule Inhibitors","Investments < €500k",,"United States of America" "Efficacy and safety of low-dose IL-2 (Id-IL-2) as a Treg enhancer for controlling neuro-inflammation in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients (MIROCALS)","Investments < €500k",,"United Kingdom" "Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients","Investments > €500k","Motor neurone diseases","European Commission" "Efficacy of Pain Treatment on Depression in Patients with Dementia. A Randomized Clinical Trial of Efficacy",Fellowships,"Alzheimer's disease & other dementias",Norway "Efficacy of Pain Treatment on Depression in Patients with Dementia. A Randomized Clinical Trial of Efficacy",Fellowships,"Alzheimer's disease & other dementias",Norway "Efficacy of Pain Treatment on Depression in Patients with Dementia. A Randomized Clinical Trial of Efficacy","Investments < €500k",,Norway "EFFICIENT PREVENTION OF DEMENTIA IN SUBJECTS WITH HIGH RISK.","Investments < €500k",,Spain "Efficient Statistical Methods for Association Studies with Dense Genotypes and Family History of Disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "EID on the advanced science and technology of rat models for neurodegenerative diseases",Fellowships,"Neurodegenerative disease in general", "eIF2alpha Phosphorylation in Synaptic Plasticity, Memory, and Brain Disorders","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Einstein Aging Study","Investments < €500k",,"United States of America" "Electrophysiological and neuroimaging evaluation of C9ORF72 related Amyotrophic lateral sclerosis",Fellowships,"Motor neurone diseases",Australia "Electrophysiological mapping of networks dynamics in basal ganglia in normal and Parkinsonian conditions using optogenetic control of specific neuronal pathway.","Investments < €500k",,France "Electrophysiological markers of cognitive processes and neuroplasticity in healthy ageing and Alzheimer`s disease",Fellowships,"Alzheimer's disease & other dementias","European Commission" "Elucidating early pathogenic mechanisms of neurodegeneration in Parkinson’s disease through a humanized dynamic in vitro model","Investments > €500k","Parkinson's disease & PD-related disorders","European Commission" "Elucidating pathways from hereditary Alzheimer mutations to pathological tau phenotypes",Fellowships,"Alzheimer's disease & other dementias", "Elucidating the mechanism linking Protein Aggregation Disease to DNA Damage Response","Investments < €500k",,Israel "Elucidating the mechanism of mitochondrial quality control in Drosophila","Investments < €500k",,"United States of America" "Elucidating the mechanism of mitochondrial quality control in Drosophila","Investments < €500k",,"United States of America" "Elucidating the mechanisms of protein aggregation and clearance in heavy metal/metalloid toxicity and tolerance.","Investments < €500k",,Sweden "Elucidating the Protective Mechanism of Phospho-N17 Huntingtin in Huntington’s disease","Investments > €500k","Huntington's disease",Canada "Elucidation of the molecular effects of inhibition of LRRK2, a kinase involved in Parkinson’s disease",Fellowships,"Parkinson's disease & PD-related disorders",Belgium "Elucidation of the role of Sirt6 in neural function, aging, and neurodegeneration",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Embedding a Human Rights Based Approach to Dementia Care","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Emergence and evolution of social self-management of Parkinsons disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Emergence of cognitive impairment in an Alzheimer’s Disease mouse model: the role of NMDA receptor currents.","Investments < €500k",,"United Kingdom" "EmoRobot – Emotions stimulating assisting robots in the care and support of people suffering from dementia in long-term care","Investments > €500k","Alzheimer's disease & other dementias",Germany "Employing Familial AD Induced Pluripotent Stem Cells to Study Neurodegeneration",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Empowering Diffusion MRI Measures by Integrating White and Grey Matter Morphology","Investments < €500k",,"United States of America" "Empowering people with dementia: green care farms as an alternative to traditional dementia care environments.","Investments < €500k",,Netherlands "Enabling high-throughput genomic approaches in Alzheimer’s disease.","Investments < €500k",,"United Kingdom" "End-of-life care in institutionalized people with Young Onset Dementia (YOD): the Care4Youngdem-study","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "Endocannabinoids in Neurodegenerative Diseases","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Endogenous GABAergic Activity in the Mammalian Brain","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Endogenous petides as markers of abnormal SOD-1 protein in familial and sporadic ALS","Investments < €500k",,"United States of America" "Endogenous petides as markers of abnormal SOD-1 protein in familial and sporadic ALS","Investments < €500k",,"United States of America" "Endogenous prototoxins to ameliorate cognitive deficits in Alzheimer’s disease","Investments < €500k",,Denmark "Endoplasmic Reticulum Mitochondrial membranes in Alzheimers disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Endoplasmic reticulum stress modulation by S-glutathionylation in Parkinson’s disease",Fellowships,"Parkinson's disease & PD-related disorders",Portugal "Endoplasmic reticulum-mitochondria interactions and Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Endothelial Dysfunction In The Cerebral Circulation","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Endothelial eNOS-deficient mice as chronic cerebral hypoperfusion model","Investments < €500k",,"United States of America" "Endothelial function of amyloid precursor protein","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Energy Metabolism of Dopaminergic Neurons in Microfluidic Cell Culture","Investments < €500k",,Luxembourg "Engineering Protein Stability Through Phage-Assisted Continuous Evolution",Fellowships,"Huntington's disease","United States of America" "English Longitudinal Studies of Ageing","Population Cohorts","Neurodegenerative disease in general","United Kingdom" "English Longitudinal Study of Ageing (ELSA)","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "English Longitudinal Study of Ageing: renewal 2014","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Enhanced Creutzfeldt-Jakob Disease Surveillance in the Older Population","Investments > €500k","Prion disease","United Kingdom" "Enhanced deep brain stimulation electrodes for improved efficacy in Parkinson’s disease therapy","Investments > €500k","Parkinson's disease & PD-related disorders",Australia "Enhanced respiratory plasticity in models of respiratory motor neuron death","Investments > €500k","Motor neurone diseases","United States of America" "Enhancing capacity of neuroimaging and biomarkers- application in early stage Alzheimer’s disease with co-morbidities","Investments < €500k",,Bulgaria "Enhancing Glutamate Transport in Age-related Cognitive Decline and Alzheimers Disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Enhancing siRNA delivery and efficacy in the brain through conjugation of bioactive, polyunsaturated fatty acids",Fellowships,"Huntington's disease","United States of America" "Enhancing vascular remodeling in Alzheimer’s disease following covert stroke","Investments > €500k","Alzheimer's disease & other dementias",Canada "Enhancing vascular remodeling in Alzheimer’s disease following covert stroke",,"Alzheimer's disease & other dementias",Canada "Ensuring High Quality DNA and RNA isolation from the Brains for Dementia Research (BDR) Resource using the Agilent 2200 TapeStation Nucleic Acid System.","Investments < €500k",,"United Kingdom" "Entorhinal-hippocampal circuit dysfunction in AD mice","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Environment and cognitive decline in older Hispanics","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Environmental copper exposure and its impact on microglial Abeta clearance","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Environmental Determinants of Pathological Brain Aging in WHI Memory Studies","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Environmental Epidemiology of Essential Tremor","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Environmental Metals, Excitotoxicity and ALS","Investments > €500k","Motor neurone diseases","United States of America" "EPAD:GRF Informationists Administrative Supplement","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "EPIC: A Group-based Intervention for Early-stage AD Dyads in Diverse Communities","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Epidemilogical study of the prevalence of neurodegenerative parkinsonism","Investments < €500k",,"Czech Republic" "Epidemiologic Study of Decision Making in Preclinical Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Epidemiologic Study of Neural Reserve and Neurobiology of Aging","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Epidemiologic Study of TDP-43 Pathology in Aging and Dementia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Epidemiology and Biomarkers of Parkinsonism in Welders",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Epidemiology and Genetics of Alzheimer’s Disease","Case Control Studies","Alzheimer's disease & other dementias","Czech Republic" "Epidemiology of Alzheimers Disease and Cognition: Innovative Approaches to Global Harmonization","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Epidemiology of Alzheimer’s disease resilience and risk pedigrees","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Epidemiology of Familial Late-Onset Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "EPIGENETIC ANALYSIS OF IPSC-DERIVED DOPAMINERGIC NEURONS AND BLOOD CELLS IN PARKINSON DISEASE.","Investments < €500k",,Spain "EPIGENETIC AND ENVIRONMENTAL FACTORS BRACING COGNITIVE IMPAIRMENT AND LATE-ONSET DEPRESSION IN ELDERLY AND EARLY STAGES OF ALZHEIMER DISEASE","Investments > €500k","Alzheimer's disease & other dementias",Spain "EPIGENETIC AND MRNA PROFILING OF STRIATOPALLIDAL NEURONS IN HUNTINGTONS DISEASE","Investments < €500k",,"United States of America" "EPIGENETIC AND MRNA PROFILING OF STRIATOPALLIDAL NEURONS IN HUNTINGTONS DISEASE","Investments < €500k",,"United States of America" "Epigenetic and phenotypic effects of arsenic: impacts on cognition and AD","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Epigenetic changes in synaptic and inflammatory genes involved in the age-dependent development of Alzheimers disease pathologies andcognitive decline","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Epigenetic Editing of Mutant C9orf72","Investments > €500k","Motor neurone diseases","United States of America" "Epigenetic Editing of Mutant C9orf72","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "Epigenetic Mechanisms in human memory quantified by non-invasive PET imaging","Investments < €500k",,"United States of America" "Epigenetic modification of mitochondrial genes in Alzheimer’s disease (AD)","Investments < €500k",,"United Kingdom" "Epigenetic pathology and therapy in Huntingtons disease","Investments > €500k","Huntington's disease","United States of America" "Epigenetics In Neurodegenerative Disease: Targeting Histone Modifications in ALS",Fellowships,"Motor neurone diseases","United States of America" "Epigenomics of Parkinson’s Disease – Functional Analysis","Investments > €500k","Parkinson's disease & PD-related disorders",Germany "Episodic memory protection in apolipoprotein E (APOE) knockout rats","Investments < €500k",,"United States of America" "Epitope-Specific Targeting of Tau Aggregates.","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "EPSRC Centre for Predictive Modelling in Healthcare","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Escitalopram for Agitation in Alzheimer Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "ESMI: European Spinocerebellar Ataxia Type 3/Machado-Joseph Disease Initiative","Investments > €500k|JPND Projects","Spinocerebellar ataxia (SCA)","Germany|JPND|Netherlands|Portugal|United Kingdom" "Establishing an Approach for the Selection and Design of Secondary Structure Mimetics to Antagonise Protein-protein Interactions.","Investments < €500k",,"United Kingdom" "ESTABLISHING AN ASSAY FOR DETECTING SINGLE TAU FIBRILS","Investments < €500k",,"United States of America" "Establishing Sustainable Knowledge Mobilisation Communities in Dementia Care",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Establishment of a laboratory for biomarker research of the central nervous system","Investments < €500k",,Hungary "ESTABLISHMENT OF A MITOCHONDRIAL ALGORITHM TO PREDICT THE RISK OF PROGRESSION TO ALZHEIMER’S DISEASE IN PATIENTS WITH LOW COGNITIVE IMPAIRMENT","Investments < €500k",,Spain "Establishment of a primate model that exhibits Alzheimer’s-like features to explore new preventative and therapeutic strategies.","Investments < €500k",,Canada "Establishment of demented dogs as a superior model for Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias",Denmark "Establishment of Prion-like Parkinson model and testing of neuroprotective strategies","Investments < €500k",,Denmark "Establishment of Sil1 as a novel drug target for Alzheimer’s disease","Investments < €500k",,Australia "Estimating And Alleviating The Impacts Of Age-Related Sensory Decline",Fellowships,"Alzheimer's disease & other dementias",Australia "Estimating Long-Term Disease Trajectories from Short-Term Data","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Estimating the benefits and harms of Z-drugs for people with dementia and sleep disorders","Investments < €500k",,"United Kingdom" "ET-1-mediated reduction of cerebral blood flow in Alzheimer’s disease: therapeutic potential of zibotentan","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Etanercept in Alzheimer’s Disease: a randomised, placebo controlled, double-blind phase 2 trial","Investments < €500k",,"United Kingdom" "ETHICAL AND LEGAL FRAMEWORK FOR PREDICTIVE DIAGNOSIS OF ALZHEIMER’S DISEASE: QUALITY OF LIFE OF INDIVIDUALS AT RISK AND THEIR CLOSE OTHERS","Investments < €500k",,Spain "Etiological and pathophysiological contributions of impulsivity trait and anhedonia to impulse control disorders in Parkinson’s disease","Investments < €500k",,France "Etiological Linkage of DNA Damage/Repair Deficiency in Neurodegenerative Diseases","Investments > €500k","Motor neurone diseases","United States of America" "Etiologie et physiopathologie des syndromes parkinsoniens en région Caraïbe. Etiology and physiopathology of parkinsonian syndromes in the Caribbean region.","Investments < €500k",,France "Etiopathogenesis of neurodegenerative diseases: focus on RNA processing regulation in development and progression of sporadic tauopathies and Alzheimer´s disease","Investments < €500k",,Slovakia "Etude de l’effet de la stimulation électrique du noyau basal de Meynert sur les troubles cognitivo-comportementaux des patients atteints de la démence à corps de Lewy. Etude DEMENSTIM. Study of the effect of electrical stimulation of the Meynert basal nucleus on cognitive-behavioral disorders in patients with Lewy body dementia. DEMENSTIM study","Investments < €500k",,France "Etude de la composante vasculaire dans la survenue de la maladie d’Alzheimer et des maladies apparentées. Study of the vascular component in the onset of Alzheimer’s disease and related diseases","Investments > €500k","Alzheimer's disease & other dementias",France "Etude de l’activité électrophysiologique du noyau subthalamique lors du traitement d’informations émotionnelles chez des patients atteints de maladie de Parkinson. Study of the electrophysiological activity of the subthalamic nucleus during the treatment of emotional information in patients with Parkinson’s disease","Investments < €500k",,France "Etude de l’efficacité de la pimavaserin sur les troubles du contrôle des impulsions dans la maladie de Parkinson. Study of the efficacy of pimavaserin on impulse control disorders in Parkinson’s disease.","Investments > €500k","Parkinson's disease & PD-related disorders",France "Étude de l’efficacité de la Pompe à Apomorphine dans la maladie de Parkinson au stade précoce de la maladie. Study of the efficacy of the Apomorphine Pump in Parkinson’s Disease Early Stage","Investments > €500k","Parkinson's disease & PD-related disorders",France "Etude de phase IIa dans la maladie de Huntington visant à évaluer le potentiel thérapeutique du resvératrol. Phase IIa study in Huntington disease to evaluate the therapeutic potential of resveratrol","Investments > €500k","Huntington's disease",France "Etude des facteurs prédictifs de la réponse thérapeutique sur la qualité de vie de la stimulation subthalamique dans la Maladie de Parkinson. Study of predictive factors of therapeutic response on the quality of life of subthalamic stimulation in Parkinson’s disease","Investments > €500k","Parkinson's disease & PD-related disorders",France "Etude longitudinale en imagerie multimodale de la maladie d’Alzheimer à un stade précoce : biomarqueurs de détection et de progression et mécanismes physiopathologiques. Longitudinal study in multimodal imaging of Alzheimer’s disease at an early stage: biomarkers of detection and progression and physiopathological mechanisms.","Investments > €500k","Alzheimer's disease & other dementias",France "Etude longitudinale en imagerie multimodale de la maladie d’Alzheimer à un stade précoce : biomarqueurs de détection et de progression et mécanismes physiopathologiques. Longitudinal study in multimodal imaging of Alzheimer’s disease at an early stage: biomarkers for detection and progression and pathophysiological mechanisms","Investments > €500k","Alzheimer's disease & other dementias",France "EURO-SCD: Subjective cognitive decline in preclinical Alzheimer’s Disease: European initiative on harmonization and on a lifestyle-based prevention strategy","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias",Germany|JPND|Netherlands|Spain "European DNA bank to decipher the Alzheimer disease missing heritability","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "European Medical Information Framework (EMIF)","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "European multidisciplinary ALS network identification to cure motor neuron degeneration","Investments > €500k","Motor neurone diseases","European Commission" "European network to optimize the care of patients with amyotrophic lateral sclerosis (ALS) and their relatives","Investments > €500k","Motor neurone diseases",Germany "European Prevention of Alzheimer’s Dementia Consortium (EPAD)","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "European Spinocerebellar Ataxia Natural History Study","Population Cohorts","Spinocerebellar ataxia (SCA)",Germany "European stem cell consortium for neural cell replacement, reprogramming and functional brain repair","Investments > €500k","Huntington's disease|Parkinson's disease & PD-related disorders","European Commission" "Evaluating AAV-mediated gene replacement for Spinal Muscular Atrophy with Respiratory Distress 1","Investments < €500k",,"United States of America" "Evaluating AAV-mediated gene replacement for Spinal Muscular Atrophy with Respiratory Distress 1","Investments < €500k",,"United States of America" "Evaluating and Extending Our Hypothetical Model of Alzheimers Biomarkers","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "EVALUATING MICROGLIAL AND ASTROGLIAL DYSFUNCTION AS A BASIS OF THE NEURODEGENERATIVE PROCESS IN ALZHEIMER’S DISEASE: NEW THERAPEUTIC APPROACHES","Investments < €500k",,Spain "EVALUATING MICROGLIAL AND ASTROGLIAL DYSFUNCTION AS THE BASIS OF NEURODEGENERATIVE PROCESS AND DEMENTIA IN ALZHEIMER’S DISEASE: NEW THERAPEUTIC APPROACHES.","Investments < €500k",,Spain "Evaluating the Adverse Cognitive Effects of Medications",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Evaluating the effectiveness and cost effectiveness of Dementia Care Mapping (DCM) to enable person-centred Care for people with dementia and their carers: A UK cluster randomised controlled trial in care homes (DCM EPIC trial)","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Evaluating the effects of a virtual communication environment for people with aphasia","Investments < €500k",,"United Kingdom" "Evaluating the impact of therapeutic alliance between the rehabilitation clinician and stroke survivor",Fellowships,,"United Kingdom" "Evaluating the impact of therapeutic alliance between the rehabilitation clinician and stroke survivor",Fellowships,,"United Kingdom" "Evaluating the implementation fidelity of self-managed computer therapy for aphasia post-stroke and exploring the factors associated with adherence",Fellowships,,"United Kingdom" "Evaluating the relationship between ischaemia and neurodegeneration in post-mortem brain tissue","Investments < €500k",,"United Kingdom" Evaluation,"Investments > €500k","Alzheimer's disease & other dementias",Ireland "Evaluation de l’impact d’un suivi PHARMaceutique intégré à un accompagnement psychosocial sur le fardeau des AIDants naturels de patients âgés atteints de maladie d’Alzheimer et maladies apparentées. Assessment of the impact of an integrated PHARMaceutical follow-up on psychosocial support on the burden of natural AIDs in elderly patients with Alzheimer’s disease and related diseases","Investments < €500k",,France "Évaluation des capacités de conduite automobile en situation écologique chez les sujets âgés atteints de maladie d’Alzheimer au stade léger et modéré. Assessment of driving capabilities in an eco-friendly environment in elderly patients with mild to moderate Alzheimer’s disease.","Investments < €500k",,France "Evaluation des effets antalgiques de l’OXYcodone LP et de la L-Dopa, versus placebo, dans les DOuleurs neuropathiques centrales du patient PArkinsonien : Essai OXYDOPA. Evaluation of the analgesic effects of OXYcodone LP and L-Dopa, versus placebo, in the central neuropathic patients of the Parkinsonian patient: OXYDOPA trial","Investments > €500k","Parkinson's disease & PD-related disorders",France "Evaluation du traitement par stimulation du nerf tibial postérieur par neurostimulation électrique transcutanée (TENS) des troubles vésico-sphinctériens (TVS) secondaires à un syndrome parkinsonien. Evaluation of treatment by stimulation of the posterior tibial nerve by transcutaneous electrical neurostimulation (TENS) of vesico-sphincteric disorders (TVS) secondary to a parkinsonian syndrome","Investments < €500k",,France "Evaluation of a 12-week combined psychoeducation and home-based exercise program on mood and wellbeing in older adults with early Alzheimer’s disease.","Investments < €500k",,Australia "Evaluation of glucocerebrosidase pathway biomarkers in Parkinson Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Evaluation of microglial activation in Alzheimer’s disease and mild cognitive impairment subjects using a novel TSPO marker, GE180",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Evaluation of non-explosive symptoms in people with Parkinson’s disease treated with deep stimulation of the hypothalamic nucleus","Investments < €500k",,Poland "Evaluation of Oxidative Capacity and Exercise Tolerance in Ambulatory Patients with Spinal Muscular Atrophy",Fellowships,"Spinal muscular atrophy (SMA)","United States of America" "EVALUATION OF OXIDATIVE STRESS AND MITOCHONDRIAL DYSFUNCTION IN ANIMAL MODELS AND PATIENTS OF HUNTINGTON’S DISEASE USING CU(II)-ATSM PET.",Fellowships,"Huntington's disease",Portugal "Evaluation of patients with Motor Neuron Disease who have a specific genetic mutation",Fellowships,"Motor neurone diseases",Australia "Evaluation of specialist nursing support for carers of people with dementia","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Evaluation of tau aggregation detected by novel tau tracer, [18F]T807 PET in mild cognitive impairment subjects: a preliminary collaborative PET study.","Investments < €500k",,"United Kingdom" "Evaluation of the clinical and cost-effectiveness of Short-term Integrated Palliative Care Services (SIPC) to OPTimise CARE for people with advanced longterm Neurological conditions (OPTCARE Neuro)","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases|Parkinson's disease & PD-related disorders","United Kingdom" "EVALUATION OF THE DIAGNOSTIC CAPACITY OF OPTICAL COHERENCE TOMOGRAPHY OF SPECTRAL DOMINION TO DIFFERENTIATE BETWEEN PARKINSON’S DISEASE AND ATIPIC PARKINSONISMS","Investments < €500k",,Spain "EVALUATION OF THE IMPACT OF IMAGE PET amyloid-BETA IN THE DIAGNOSIS AND CONTROL CLINIC OF patients with cognitive impairment EVALUATED BY SUSPECTED Alzheimer’s disease (AD).","Investments < €500k",,Spain "Evaluation of the impact of the AlzheimerNet programme: a Comparative Effectiveness Research on the transit from fragmented care to a collaborative dementia networks of multidisciplinary care","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "Evaluation of the profile and disorders of emotional processes in patients with atrial fibrillation, Alzheimer’s disease and frontal-temporal dementia","Investments < €500k",,Poland "EVALUATION OF THE PROGRESSION AND PROGNOSIS OF PARKINSON’S DISEASE USING THE ANALYSIS OF RETINE AND NERVE RETARDIAL FIBER LAYERS AS AXONAL DEGENERATION MARKERS","Investments < €500k",,Spain "Evaluation of vascular determinant for cognitive decline in old age: Coordinated analysis of within-person associations using data from four longitudinal aging studies","Investments < €500k",,Sweden "EVERYDAY MEMORY IN AGING AND EARLY ALZHEIMERS DISEASE","Investments < €500k",,"United States of America" "Evidence synthesis of trajectories of cognitive change due to chronological age, death and preclinical dementia.",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Evolution of Alzheimer’s Disease: From dynamics of single synapses to memory loss","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "Evolution of memory related fMRI activation over the course of MCI and AD","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Evolution of Pathologic RNA-Protein Aggregates in Motor Neuron Disease",Fellowships,"Motor neurone diseases","United States of America" "Examination of the earliest symptoms and biomarkers of FTLD MAPT carriers","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Examining the effects of S1P receptor drugs in Alzheimer’s disease","Investments < €500k",,Ireland "Exceptional Cognitive Aging: Neuropsychologic, Anatomic and Pathologic Correlates","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Excessive Lysosomal Exocytosis Triggers Pathogenic Mechanisms in Sialidosis Mice","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "EXECUTIVE DYSFUNCTIONING REHABILITATION IN PARKINSON DISEASE: AN INTENSIVE TDCS PARALLEL, DOUBLE BLIND, PLACEBO CONTROLLED RANDOMIZED INTERVENTION",Fellowships,"Parkinson's disease & PD-related disorders",Portugal "Exercise and Intensive Vascular Risk Reduction in Preventing Dementia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "EXERCISE AND PARKINSONS: COMPARING INTERVENTIONS AND EXPLORING NEURAL MECHANISMS","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Exercise Intervention for Slowing HD Progression","Investments < €500k",,"United States of America" "Exercise Intervention for Slowing HD Progression","Investments < €500k",,"United States of America" "Exome sequencing in dementias – more than a family business",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Exome sequencing in motor neuron disease: bioinformatic analyses and biological validation of novel variants","Investments < €500k",,"United Kingdom" "Exome sequencing pipeline and analysis in Frontotemporal dementia","Bio/Neuroinformatic Resources","Alzheimer's disease & other dementias",Netherlands "Exosome based therapeutics in Huntingtons disease","Investments > €500k","Huntington's disease","United States of America" "Exosome LRRK2 in Predicting Parkinson Disease Phenotypes","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Exosome-mediated propagation of pathogenic tau protein","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Exosomes and Neuroinflammation in Parkinsons Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Experiences and understandings of dementia among Black, Asian and Minority Ethnic (BAME) Groupsmin Wales: community individual and intergenerational perspectives.",Fellowships,"Neurodegenerative disease in general","United Kingdom" "Exploiting homomers to reveal new principles of protein interaction, polymerization and aggregation","Investments < €500k",,"European Commission" "Exploiting PrP for the diagnosis and treatment of protein aggregation diseases","Investments < €500k",,"United States of America" "Exploration of the gamma-secretase substrate binding site",Fellowships,"Alzheimer's disease & other dementias",Belgium "Exploring and enhancing Karyopherin beta-2 disaggregate activity","Investments < €500k",,"United States of America" "Exploring and enhancing Karyopherin beta-2 disaggregate activity","Investments < €500k",,"United States of America" "Exploring cholinergic mechanisms to understand behavioral deficits in dementia.",,"Alzheimer's disease & other dementias",Canada "Exploring cholinergic mechanisms to understand behavioral deficits in dementia.","Investments > €500k","Alzheimer's disease & other dementias",Canada "Exploring Cognitive Aging Using Refernce Ability Neural Networks","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Exploring novel neurostimulation based therapies for swallowing impairments in Parkinson’s","Investments < €500k",,"United Kingdom" "Exploring Parkinson’s Disease Inhibitor Efficacy on a Non-dopaminergic Target","Investments < €500k",,Luxembourg "Exploring personhood in dementia and its importance for care relationships, service delivery and regulatory instruments.","Investments < €500k",,Ireland "Exploring practice in NHS inpatient dementia wards: developing an integrated assessment document and decision-making tool",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Exploring the basis of hippocampal dysfunction in ageing and Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias",Portugal "Exploring the contribution of astrocytes to Huntington disease","Investments > €500k","Huntington's disease","United States of America" "Exploring the economics of hospital care for people with dementia","Investments < €500k",,"United Kingdom" "Exploring the experience of diagnostic imaging for people with dementia",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Exploring the involvement of Na pump inhibitor marinobufagenin in the interactions between age-associated vascular and neurodegenerative processes in cognitive impairment and Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Exploring the links between Alzheimer´s Disease, Diabetes and Obesity – Is there Genetic Evidence of Inflammation and Insulin Resistance the Human Brain?","Investments < €500k",,Denmark "EXPLORING THE MECHANISM BEHIND METABOLIC RISK FACTORS FOR ALZHEIMER DISEASE. AN INTEGRATIVE APPROACH TO TYPIFY DISEASE PATHWAYS, OPTMISE DIAGNOSIS AND TREATMENT.","Investments < €500k",,Sweden "Exploring the potential of multi-target treatment for Alzheimer’s disease: towards an integrated and transdisciplinary approach","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "Exploring the Role of Aging in Cerebral Ischemic Small Vessel Disease Using Notch3 Mutant Mice","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Exploring the Role of the Brain Epigenome: Cognitive Decline and Life Experiences","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Exploring the toxicity of aggregates associated with protein-misfolding diseases","Investments > €500k","Huntington's disease|Motor neurone diseases","United States of America" "EXPRESSION PROFILES OF GLUCOCEREBROSIDASA MRNA AND ITS REGULATORY GENES IN BRAIN AND PERIPHERAL BLOOD: IDENTIFICATION OF BIOLOGICAL SIGNALS FOR DEMENTIA WITH LEWY BODIES.","Investments < €500k",,Spain "Extracellular Mechanisms of TFEB-mediated Clearance of pTau in Tauopathies",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Extracellular tau oligomers and Alzheimer disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Extraction and modelling of Alzheimer’s disease data for patient stratification: integrative, multiplex network approach","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Extrasynaptic glutamate signalling and synapoptosis in brain development and degeneration","Investments < €500k",,Sweden "Eye Determinants of Cognition (EyeDOC) Study","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Factors for disease progression in Alzheimer´s disease","Population Cohorts","Alzheimer's disease & other dementias",Germany "Factors that influence the effectiveness of conversation training for people with aphasia",Fellowships,,"United Kingdom" "Failure of metabolite clearance in a model of multi-lacunar infarcts","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Families At Risk: Long-term Impact of Huntingtons Presymptomatic Genetic Testi","Investments > €500k","Huntington's disease","United States of America" "Family traits of chronic disease and the missing heritability link. The Malmö Offspring Study (MOS)","Investments > €500k","Alzheimer's disease & other dementias",Sweden "Fast transformation between episodic and semantic memories: Interactions between the hippocampal formation and related regions and their breakdown in Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "Fbw7 as a therapeutic target for treating Parkinsons disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Fe65/APP signalling and brain-derived neurotrophic factor in Alzheimer’s disease","Investments < €500k",,"United Kingdom" "FEZ1 Gene Expression in Rat Model of Alzheimer Pathogenesis","Investments < €500k",,Turkey "FFAR4 and nigrostriatal function: A novel target for treatment of PD?","Investments < €500k",,"United States of America" "FFAR4 and nigrostriatal function: A novel target for treatment of PD?","Investments < €500k",,"United States of America" "Financial Decision making in Late Adulthood","Investments < €500k",,Australia "Finding the right words in neurogenic communication disorders: Naming of objects and actions, communicative strategies in conversation and effects of training.","Investments < €500k",,Sweden "Fingerprinting the risk of dementia and likelihood of intervention response to facilitate prevention-related decision-making","Investments < €500k",,Finland "Fingerprinting the risk of dementia and likelihood of intervention response to facilitate prevention-related decision-making",Fellowships,"Alzheimer's disease & other dementias",Finland "Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability","Investments < €500k",,Finland "First-time biotechnological production and reconstitution of olive polyphenols and investigation of their potential for the prevention of neurodegenerative diseases","Investments > €500k","Neurodegenerative disease in general",Germany "FishMed (FP7-Seventh Framework Programme)","Capital Infrastructure",,"European Commission" FIT,"Investments < €500k",,Netherlands "Fluorescence microscopy and therapy monitoring of Alzheimer’s disease and other tauopathies in the olfactory mucosa","Investments > €500k","Alzheimer's disease & other dementias",Germany "Fly-SMALS: Common RNA-dependent pathways for motor neuron degeneration in spinal muscular atrophy and amyotrophic lateral sclerosis","Investments > €500k|JPND Projects","Motor neurone diseases|Spinal muscular atrophy (SMA)",France|Germany|JPND|Portugal|Spain "Focus on the locus network with 7Tesla MRI: from normal to impaired memory","Investments < €500k",,Netherlands Follow.Me,"Investments < €500k",,Belgium "Forging a new understanding of iron in neurodegenerative disease.",Fellowships,"Alzheimer's disease & other dementias",Australia "Formation and Propagation of Tau Oligomeric Strains in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Forte-centre Ageing and health: Center for capability in aging (AGECAP) from genes to society","Investments > €500k","Alzheimer's disease & other dementias|Neurodegenerative disease in general",Sweden "Forte-centre: Centre for Ageing and Supportive Environments, CASE","Investments > €500k","Alzheimer's disease & other dementias",Sweden "Forte-centre: FAS center KI-SU ARC (Karolinska Institutet – Stockholm University Aging Research Center)","Investments > €500k","Alzheimer's disease & other dementias",Sweden "Fractalkine agonists to treat neurodegenerative disease","Investments < €500k",,"United Kingdom" "FRAlim : Registry on Amyotrophic Lateral Sclerosis (ALS) in Limousin","Disease Registers","Motor neurone diseases",France "Framtagning och karaktärisering av en ny typ av kognitionsförstärkare. 69/5000 Did you mean: Framtagning och karaktärisering av en ny typ av kognition förstärkare Development and characterization of a new type of cognition enhancer","Investments < €500k",,Sweden "France Life Imaging (FLI)","Research Networks",,France "France-BioImaging, CNRS","Capital Infrastructure",,France "Freezing of Gait in Parkinson’s Disease","Investments < €500k",,Australia "Friska äldre med plackpatologi – individer med risk för Alzheimers sjukdom? Healthy Elderly With Plaque Pathology – Individuals At Risk Of Alzheimer’s Disease?","Investments < €500k",,Sweden "From assistant to associate professor: Career development by research into apolipoprotein E and neurodegeneration",Fellowships,"Alzheimer's disease & other dementias",Sweden "From Brain Gene Transfer Towards Gene Therapy: Pharmacological Assessment of AAV, CAV and LVV",Fellowships,"Parkinson's disease & PD-related disorders", "From brain maps to mechanisms: Modelling the pathophysiology of dementia",Fellowships,"Alzheimer's disease & other dementias",Australia "From Cells to Organs on Chips: Development of an Integrative Microfluidic Platform","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "From Evidence-Base to Practice: Implementing RDAD in AAA Community-Based Services","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "From knowledge base of the pathogenic astrocyte-motoneuron communication in amyotrophic lateral sclerosis to therapeutic approaches","Investments < €500k",,Switzerland "From microstructure to clinical practice in early Huntington disease: a multimodal magnetic resonance study",Fellowships,"Huntington's disease",Spain "From Patient Data to Clinical Diagnosis in Neurodegenerative Diseases","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "From test-tubes, to mice, to human ALS","Investments < €500k",,Sweden "From zebrafish to man Modifying amyotrophic lateral sclerosis (ALS): translation of biology into therapy","Investments > €500k","Motor neurone diseases","European Commission" "Frontotemporal dementia and motor neurodegenerative syndromes","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases",Australia "Frontotemporal Dementia Induced Pluripotent Stem Cell Consortium","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "FTLD Cohort","Case Control Studies","Alzheimer's disease & other dementias",Germany "Function and activation mechanism of LRRK2 and the understanding of Parkinson’s disease","Investments > €500k","Parkinson's disease & PD-related disorders",Netherlands "Function and Behavior Focused Care for Nursing Home Residents with Dementia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Function and malfunction of the prion protein","Investments > €500k","Prion disease","European Commission" "Function and mechanism of a novel SUMO protease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Function and pathology of spatacsin/ALS5 using a novel Drosophila model","Investments < €500k",,"United Kingdom" "Function of ceramide in neurodegenerative disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Function of Parkinson Disease Genes in Mitochondrial Quality Control","Investments < €500k",,Canada "Function of the TREM2 R47H variant associated with risk of Alzheimers disease","Investments < €500k",,"United States of America" "Function of TMEM106B in neurodegeneration","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Functional ability assessment in early dementia and mild brain injury using cognitive-motor integration.","Investments < €500k",,Canada "Functional Amyloid in Melansome Biogenesis","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Functional analysis of neuronal circuits in health and disease","Investments < €500k",,Sweden "Functional Analysis of O-GlcNAc Modifications Using Synthetic Protein Chemistry","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "FUNCTIONAL ANALYSIS OF SLEEP HOMEOSTASIS IN DROSOPHILA","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Functional Analysis of Sleep Promoting Neurons in Health and Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Functional and pathological correlates of memory self-awareness in aging and AD",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Functional annotation of the oxidized lipid hydrolase PLA2G7 in neurodegeneration",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Functional Assessment using a Virtual Environment","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Functional brain connectivity: a new imaging marker for preclinical","Investments < €500k",,Netherlands "Functional brain connectivity: a new imaging marker for preclinical dementia?","Investments < €500k",,Netherlands "Functional Brain Networks: Individual Integrity in Aging and Dementia",Fellowships,"Alzheimer's disease & other dementias",Netherlands "Functional circuitry analysis of the subthalamic nucleus in mice: Relevance for Deep Brain Simulation in Parkinson´s disease.","Investments < €500k",,Sweden "Functional deficits in a novel murine model of frontotemporal lobar degeneration","Investments < €500k",,"United Kingdom" "Functional dissection of therapeutic deep brain stimulation circuitry","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Functional genomics approach to extend lifespan while preventing age-related cognitive decline","Investments > €500k","Alzheimer's disease & other dementias",Australia "Functional impact of Alzheimer’s disease on cortical neurons","Investments < €500k",,Slovakia "FUNCTIONAL IN VITRO MODELS OF HUMAN NEURONAL AND ASTROCYTE INTERACTIONS",Fellowships,"Alzheimer's disease & other dementias",Sweden "Functional markers for cognitive disorders","Investments < €500k",,Netherlands "Functional Neuroanatomy Underlying Excessive Sleepiness",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Functional Neuroimaging of dopamine systems: application to Parkinson’s Disease, addiction and obesity.","Investments > €500k","Parkinson's disease & PD-related disorders",Canada "Functional neuroproteomic changes associated with L-Dopa-induced dyskinesia in Parkinson´s disease","Investments < €500k",,Sweden "Functional parameters that depend on prefrontal cortex and hippocampus in mouse Alzheimer’s disease models and their use to evaluate experimental therapies","Investments < €500k",,Belgium "Functional Roles of Nurr1 in AD Related Pathophysiology","Investments < €500k",,"United States of America" "Functional significance of amyloid dynamics and deposition in the AD brain","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Functional Validation of the CD2AP Susceptibility Network in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Functions of alpha-Synuclein in Neurotransmitter Release","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Functions of alpha-Synuclein in Neurotransmitter Release","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Functions of human and mouse Trem2 in vivo","Investments < €500k",,"United States of America" "Functions of Metabotropic Glutamate Receptor Subtypes","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Fundamental membrane interactions of copper generated oligomers, profibrils and amyloid fibres","Investments < €500k",,"United Kingdom" "Funding for Cognitive Imaging","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Further defining the genetic architecture of Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Further development of a systemic gene therapy treatment for Parkinson’s",Fellowships,"Parkinson's disease & PD-related disorders","United Kingdom" "Future workplace dementia","Investments < €500k",,Germany "Fyn Inhibition by AZD0530 for Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "G-quadruplex Structures as Targets and Tools in ALS","Investments < €500k",,"United States of America" "G-quadruplex Structures as Targets and Tools in ALS","Investments < €500k",,"United States of America" "G-quadruplex Structures as Targets and Tools in ALS","Investments < €500k",,"United States of America" "G51D SNCA rat (MRC Centre for Regenerative Medicine)","Experimental Models",,"United Kingdom" "GABA-A alpha-5 agonists for the treatment of amnestic Mild Cognitive Impairment","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Gait in elderly with Parkinson´s disease – Long term effects of highly challenging balance training program","Investments < €500k",,Norway "Gamma-Secretase and Myelin: A Paradigm Shift in Brain Disorders","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Gamma-secretase cleavage of the p75 receptor","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "GBA pathway markers for Lewy body dementias","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "GBA pathway markers for Lewy body dementias","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders","United States of America" "GBA-PARK: GBA1 mutations in Parkinson disease: clinical and biochemical prodrome, risk profile and pathogenetic modelling for therapeutic intervention","Investments > €500k|JPND Projects","Parkinson's disease & PD-related disorders","Canada|Germany|Italy|JPND|United Kingdom" "GDE and Neurodegenerative Diseases","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Gebruik van Oud-Mantelzorgervaring voor betere dementiezorg thuis. Use of Early Care Care for better dementia care at home","Investments < €500k",,Netherlands "Genbank Parkinson’s Disease Germany – GEPARD",Biobanks,"Parkinson's disease & PD-related disorders",Germany "Gene discovery in motor neuron disease through systems genomics","Investments > €500k","Motor neurone diseases",Australia "Gene discovery in PSP by transcriptome, neuropathology and sequence analysis","Investments > €500k","Neurodegenerative disease in general","United States of America" "Gene Expression Biomarkers for Early Identification of Mild Cognitive Impairment: A Twin Study","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Gene therapy and nanotechnology based CNS targeted vectors","Investments > €500k","Motor neurone diseases|Spinal muscular atrophy (SMA)","European Commission" "Gene Therapy for Upper Airway and Respiratory Insufficiency in an ALS Mouse Model","Investments < €500k",,"United States of America" "Gene Therapy for Upper Airway and Respiratory Insufficiency in an ALS Mouse Model","Investments < €500k",,"United States of America" "Gene Therapy Targeting Striatal cGMP signaling in experimental parkinsonism","Investments < €500k",,"United States of America" "Gene Therapy Targeting Striatal cGMP signaling in experimental parkinsonism","Investments < €500k",,"United States of America" "Gene-environment interactions as an approach to modelling Parkinson’s disease","Investments < €500k",,Ireland "Gene-Environment Interactions in Brain Disorders",Fellowships,"Alzheimer's disease & other dementias",Australia "Gene-Environment Interactions in Neurodegeneration: Role of Efflux Transporters","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Gene-Environment Interactions in the Etiopathogenesis of Parkinson’s Disease: Role of Inflammation",Fellowships,"Parkinson's disease & PD-related disorders", "Gene-environment interactions modulating cognition and dementia in Huntington’s disease","Investments < €500k",,Australia "Gene-Neurotoxicant Interactions in Huntington Disease","Investments > €500k","Huntington's disease","United States of America" "General Anesthesia and Alzheimers Disease Neuropathogenesis","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "GENERAL VARIABLES ASSOCIATED RISK AND MORTALITY AFTER diagnosis of dementia in general population","Investments < €500k",,Spain "Generation and characterisation of induced pluripotent stem cells from ALS lymphoblasts to model disease pathogenesis and advanced drug discovery","Investments > €500k","Motor neurone diseases","United Kingdom" "Generation and characterization of a human dopamine producing cell system","Investments < €500k",,Luxembourg "Generation of effective carbohydrate-based inhibitors of a glycosidase implicated in Alzheimer disease and their molecular mechanism of action.","Investments < €500k",,Canada "Generation of human authentic striatal neurons from pluripotent stem cells for transplantation in Huntington’s disease. Generazione di neuroni umani striatali autentici da cellule staminali pluripotenti per il trapianto nell’Huntington.","Investments > €500k","Huntington's disease",Italy "Generation of induced pluripotent stem cells from people with Parkinson’s / Modelling Parkinson’s with rat embryonic stem cells and transgenesis (extension)","Investments > €500k","Parkinson's disease & PD-related disorders","United Kingdom" "Genes, environments, interactions, and cognitive decline in the HRS","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Genes, Exercise, Neurocognitive and Neurodegeneration: Community-Based Approach","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Genetic Analyses of Lipids in Cerebral Hemorrhage and Small Vessel Disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Genetic Analysis Of Alzheimer s Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Genetic Analysis Of Non-alzheimer Dementias","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Genetic Analysis of the Abeta tau Interaction",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Genetic Analysis of the PINK1-Parkin Pathway","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Genetic and Functional Analysis of Nested AD Risk Genes CTNNA3 and LRRTM3","Investments < €500k",,"United States of America" "Genetic and Lifestyle Determinants of Cognitive Resilience in Midlife","Investments < €500k",,"United States of America" "GENETIC AND NEUROPATHOLOGICAL CHARACTERIZATION OF NEURODEGENERATIVE DISEASES",Fellowships,"Neurodegenerative disease in general",Finland "Genetic and Neuropsychological Heterogeneity in Alzheimers Disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Genetic architecture of memory and executive functioning in Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Genetic characterization of atypical parkinsonism","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Genetic Correction of Mutant Huntingtin in Vivo","Investments > €500k","Huntington's disease","United States of America" "GENETIC DISRUPTION OF TAU METABOLISM IN TAUOPATHIES",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Genetic Epidemiology of Caffeine and Cognitive Decline",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Genetic Epidemiology of Cerebrovascular Factors in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Genetic Epidemiology of Cognitive Decline in an Aging Population Sample","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Genetic Epidemiology of Early-Onset Alzheimers disease in Caribbean Hispanics and non-Hispanic Whites","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Genetic etiology of Amyotrophic Lateral Sclerosis","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "Genetic etiology of Fronto-Temporal Dementia","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "Genetic factors causing sporadic and familial amyotrophic lateral sclerosis (ALS/MND) with or without frontotemporal dementia.","Investments > €500k","Motor neurone diseases",Sweden "Genetic Frontotemporal Dementia Initiative (GENFI) in Canada","Investments > €500k","Alzheimer's disease & other dementias",Canada "Genetic mechanisms that moderate effects of Aß accumulation in preclinical Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias",Australia "Genetic Modifiers of Alzheimer Disease in PSEN1 Mutation Carriers in Puerto Rico","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Genetic mosaicism in the brain as a cause of Alzheimer’s Disease","Investments < €500k",,Belgium "Genetic pleiotropy in neurodegeneration",Fellowships,"Alzheimer's disease & other dementias",Netherlands "Genetic Resilience to the Clinical Manifestation of Dementia",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Genetic Susceptibility and Epigenetic Modulation in Levodopa Induced Dyskinesia",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Genetic Susceptibility to Manganese Neurotoxicity","Investments < €500k",,"United States of America" "Genetic Susceptibility to Manganese Neurotoxicity","Investments < €500k",,"United States of America" "Genetic variability and efficacy of drugs used to treat Parkinson’s disease (NGS sequencing)","Investments < €500k",,Poland "GENETIC-MOLECULAR BASES OF SPINOCEREBELOSE ATAXIES: IDENTIFICATION AND CHARACTERIZATION OF THE CAUSE OF DEFINITION OF SPINOCEREBELOSA ATAXIA 37 (SCA37).","Investments < €500k",,Spain "GENETICALLY DETERMINED PARKINSON DISEASE NEUROIMAGEN MARKERS","Investments < €500k",,Spain "Genetische risicofactoren en proteostasis bij de ziekte van Alzheimer. Genetic risk factors and proteostasis in Alzheimer’s disease","Investments < €500k",,Netherlands "Genetiske forhold ved demens med lewylegemer -Genetic conditions in dementia with lewy bodies","Investments < €500k",,Norway "Genome editing in HD iPS cells to reduce mutant and total Huntington expression","Investments < €500k",,"United States of America" "Genome editing in HD iPS cells to reduce mutant and total Huntington expression","Investments < €500k",,"United States of America" "Genome Wide Analysis LXR Binding-Metabolic and Epigenetic Regulation in AD","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Genome wide analysis of LXR binding – metabolic and epigenetic regulation in AD","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Genome-scale exploration of flux distributions for dopaminergic neurons in Parkinson’s disease","Investments < €500k",,Luxembourg "Genome-wide analysis of tau neurotoxicity","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Genome-wide Profiling of Brain DNA Hydroxymethylome in Alzheimer’s Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Genomic and functional analysis of transcriptome changes in Huntingtons Disease","Investments > €500k","Huntington's disease","United States of America" "Genomic and Metabolomic Data Integration in a Longitudinal Cohort at Risk for Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Genomic Characterization of Alzheimers Disease Risk in the Puerto Rican Population","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Genomic profiling of pathological R-loop formation in human diseases.","Investments > €500k","Motor neurone diseases","United States of America" "Geographic Gerontology and Dementia Friendly Environments: Illuminating perspectives of people with dementia and carers","Investments < €500k",,Australia "German National Cohort","Population Cohorts","Alzheimer's disease & other dementias|Neurodegenerative disease in general|Parkinson's disease & PD-related disorders",Germany "GGGGCC hexanucleotide repeat expansions in neurodegenerative disease","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "GGGGCC hexanucleotide repeat expansions in neurodegenerative disease","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "GIE-Neuro-CEB, Paris – Biobank","Capital Infrastructure",,France "Gigaxonin E3 ligase in neurodegeneration and cytoskeleton architecture: pathological mechanisms and therapeutic approaches",Fellowships,"Neurodegenerative disease in general",France "Glial huntingtin and neurodegeneration","Investments > €500k","Huntington's disease","United States of America" "Glial uptake of dopamine after L-DOPA medication","Investments < €500k",,"United States of America" "Glial uptake of dopamine after L-DOPA medication","Investments < €500k",,"United States of America" "Global Brain Health Initiative","Investments > €500k","Alzheimer's disease & other dementias|Neurodegenerative disease in general",Ireland "Global Brain Health Initiative – Partnerships","Investments > €500k","Neurodegenerative disease in general",Ireland "Global RNA Interference Therapy for Huntingtons Disease","Investments < €500k",,"United States of America" "Global RNA Interference Therapy for Huntingtons Disease","Investments < €500k",,"United States of America" "Glucocerebrosidase Biology and Its Role in Parkinsons Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Glucocerebrosidase chaperones in Parkinson’s","Investments < €500k",,"United Kingdom" "Glucocerebrosidase deficiency, alpha-synuclein and Parkinson’s: A zebrafish study","Investments < €500k",,"United Kingdom" "Glucocerebrosidase mutations in Parkinson disease:molecular pathogenesis,and the basis for personalised therapy with small molecule chaperones","Investments > €500k","Parkinson's disease & PD-related disorders","United Kingdom" "Glycosaminoglycan-Interacting Small Molecule (GISMO) as Parkinsons Therapeutic","Investments < €500k",,"United States of America" "Glycosaminoglycan-Interacting Small Molecule (GISMO) as Parkinsons Therapeutic","Investments < €500k",,"United States of America" "Glycosphingolipid dysregulation and lysosomal dysfunction in amyotrophic lateral sclerosis","Investments < €500k",,"United Kingdom" "Glymphatic function in a transgenic rat model of Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Goal-oriented cognitive rehabilitation in early-stage Alzheimer’s disease: multi-centre single-blind randomised controlled trial (GREAT)","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Graduate school: CASE Graduate School and a National Platform for Graduate Studies in Ageing Research",Fellowships,"Neurodegenerative disease in general",Sweden "Graduate school. Graduate School for Aging Research at ARC – a collaborative project to form a new generation of researchers with a strong multidisciplinary background",Fellowships,"Alzheimer's disease & other dementias",Sweden "GRIFOLS (Loan under the European Fund for Strategic Investments)","Capital Infrastructure",,"European Commission" "GRIP on neuropsychiatric symptoms in young-onset dementia: The BEYOND-II study","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "Groene initiatieven in de stad voor thuiswonende ouderen met dementie en hun mantelzorgers. Green initiatives in the city for home-living elderly people with dementia and their caregivers","Investments < €500k",,Netherlands "Growth and Development of the Striatum in Huntingtons Disease","Investments > €500k","Huntington's disease","United States of America" "Growth hormone ameliorates ageing dementia","Investments < €500k",,Australia "Guardianship and Medical Decision Making for the Unbefriended Elderly","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Guidepost dementia","Investments < €500k",,Germany "GWAS in AD: focus on microRNA","Investments > €500k","Alzheimer's disease & other dementias",Canada|France "H2020 Catalyst Award: Targeting glial plasticity to alleviate age-related loss of neuronal function in Alzheimer’s disease","Investments < €500k",,Ireland "H2O2-MEDIATED SRC SIGNALING PATHWAYS IN GLUTAMATERGIC SYNAPSES IN ALZHEIMER’S DISEASE MODELS",Fellowships,"Alzheimer's disease & other dementias",Portugal H70,"Population Cohorts","Neurodegenerative disease in general",Sweden "Haalbaarheidsstudie van de eerste pijplijnproducten van Thera Neuropharma NV voor de behandeling van amytrofe laterale sclerose en traumatische hersenletsels (Feasibility study of the first pipeline products Thera Neuro Pharma NV for the treatment of amyotrophic lateral sclerosis and traumatic brain injuries)","Investments < €500k",,Belgium "Happy or Sad? The Influence of Emotional Body Cues on Facial Expression Perception in Huntington’s Disease",Fellowships,"Huntington's disease", "HARC (FP7-Seventh Framework Programme)","Capital Infrastructure",,"European Commission" "Harmonized Cognitive and Dementia Assessment in China","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Study of India (LASI)","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Harnessing Adult Stem Cells for Neurotrophin Delivery to the Degenerating Brain","Investments < €500k",,Ireland "Harnessing the anti-inflammatory potential of cannabinoid CB2 receptors for disease modification in Parkinson’s disease","Investments < €500k",,Ireland "Harnessing the consequences of impaired mitochondrial energy metabolism to treat the symptoms of age-related neuronal decline","Investments < €500k",,Australia "Harnessing the consequences of impaired mitochondrial function to treat and image motor neuron disease",Fellowships,"Motor neurone diseases",Australia "Harnessing the Ubiquitin-Proteasome System in the Brain: Implications for Dementia","Investments < €500k",,"United Kingdom" "HBP (FP7-Seventh Framework Programme)","Capital Infrastructure",,"European Commission" "HCL- NeuroBioTec – Groupement Hospitalier Est, Lyon","Capital Infrastructure",,France "HDAC3 neurophysiology and drug targeting in neurodegeneration",Fellowships,"Neurodegenerative disease in general",Portugal "Head up: The development of a novel cervical orthosis to support neck weakness due to neurological disease.","Investments > €500k","Motor neurone diseases","United Kingdom" "Health and Wellness on the Beat","Investments > €500k","Parkinson's disease & PD-related disorders","European Commission" "Health Disparities in Alzheimers Disease Among Mexican Americans","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Health Research Board",Fellowships,"Motor neurone diseases",Ireland "Health Research Board",Fellowships,"Motor neurone diseases",Ireland "Healthcare interventions and Alzheimer’s Disease (AHEAD)","Investments < €500k",,Australia "Healthy ageing","Investments < €500k",,Sweden "Healthy Aging and Senile Dementia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Healthy Aging with Nitrate – (Attacking late onset Alzheimer’s Disease from the vascular side)","Investments < €500k",,Denmark "Hemodynamic Biomarkers of Healthy and Diseased Aging",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Hemorheological Factors in Cerebral Ischemia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Hereditary ataxias, an integrated study: genomic approach to the pathogenetic mechanisms by animal and cellular models. Atassie ereditarie, uno studio integrato: dall’approccio genomico ai meccanismi patogenetici mediante modelli animali e cellulari.","Investments > €500k","Motor neurone diseases|Neurodegenerative disease in general|Spinocerebellar ataxia (SCA)",Italy "HERMOSTON RAPPEUMASAIRAUKSIEN IMMUNOLOGISEEN SÄÄTELYYN PERUSTUVAT PIENMOLEKYYLIT. Nerve degeneration diseases immunologically BASED ON REGULATORY small molecules","Investments < €500k",,Finland "Hexanucleotide repeat translation in ALS and Frontotemporal Dementia","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "Hexanucleotide repeat translation in ALS and Frontotemporal Dementia","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "High intesity focused Ultrasounds – CENIR, Université Pierre et Marie Curie","Capital Infrastructure",,France "High Throughput Screening to Discover Chemical Probes and Pharmacological Agents for Modulating Parkin Activity","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "High-Intensity Functional Exercise for Older People with Dementia: A Randomized Controlled Trial","Investments < €500k",,Sweden "High-resolution imaging of hippocampal mechanisms in age-related memory decline.","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "High-Resolution Structural and Functional Brain Imaging of Medial Temporal Lobe i","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "High-throughput and high-resolution digital slide scanner Nanozoomer-XR for studies in dementia","Investments < €500k",,"United Kingdom" "High-throughput genotyping of rare variants identified through next-generation sequencing of Alzheimer’s disease candidate genes",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Higher Order Chromatin and Genetic Risk for Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Highly evolved brain circuits in primates: molecular vulnerabilities for disease","Investments > €500k","Neurodegenerative disease in general","United States of America" "Hijacking cell signalling pathways with magnetic nanoactuators for remote-controlled stemcell therapies of neurodegenerative disorders","Investments > €500k","Parkinson's disease & PD-related disorders","European Commission" "Hip Fracture Caregiver Intervention Function Focused Care Hip Care at Home","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Hippocampal Neurovascular Plasticity in CVN-AD Mouse: Fornix-Septal Stimulation","Investments < €500k",,"United States of America" "Hippocampal sclerosis – a poorly understood cause of dementia among the older old","Investments < €500k",,"United Kingdom" "Hippocampal Synaptic Structure","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "HOME 4 CARE–the Hearthstone Optimized Multimedia Environment for Care-planning, Activities, Recreation, and Education","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "HOME-based ICT solutions FOR the independent living of people with DEMentia and their caregivers","Investments > €500k","Alzheimer's disease & other dementias",Norway "HOME-based ICT solutions FOR the independent living of people with DEMentia and their caregivers","Investments > €500k","Alzheimer's disease & other dementias",Sweden "Home, Health and Disability along the Process of Ageing: A Mixed Methods Project","Investments > €500k","Parkinson's disease & PD-related disorders",Sweden "Homogeneous Heparan Sulfate Glycopeptides: Synthetic and Functional Studies","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Hospital At Home care program for patients with dementia and an acute medical crisis","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "HOT-ROXS: An integrated platform for identifying activators of non-druggable targets using biophysical screening, x-ray solution scattering and high-throughput co-crystallization","Investments < €500k",,"United States of America" "Hotspots of dementia risk in Australian communities: an approach to better targeting preventive interventions","Investments < €500k",,Australia "How can people with obesity combat dementia? A lifespan approach","Investments < €500k",,Sweden "How do individual differences in midlife adiposity and APOE genotype as risk factors for dementia affect brain structure and cognition? A cross-sectional MRI study.",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "How do mutations in autophagy receptors cause FTD and ALS?",Fellowships,"Alzheimer's disease & other dementias",Australia "How do people with and without dementia use anticoagulants? Systematic literature review and analyses of PBS data","Investments < €500k",,Australia "How do small extracellular vesicles contribute to the development of prion disease","Investments < €500k",,Australia "How Does APP Modulate Ferroportin? Developing Strategies to Determine Mechanism","Investments < €500k",,"United States of America" "How noradrenaline modulates memory and the brain in Alzheimer’s disease","Investments < €500k",,Netherlands "How road blocks form in nerve cells, impair trafficking and contribute to Alzheimers disease","Investments < €500k",,Australia "How to design dementia-friendly outdoor areas in cities?","Investments > €500k","Alzheimer's disease & other dementias",Sweden "HPA-axis dysfunction in Huntingtons disease",Fellowships,"Huntington's disease","United States of America" "HQLC Dementia Carers Instrument Development: DECIDE","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "HTA-SYMBAD – StudY of Mirtazapine or carBamazepine for Agitation in Dementia","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "HTS – Maximising the value of MRC Brain Banks","Investments > €500k","Neurodegenerative disease in general","United Kingdom" "HTS to Identify Inhibitors of c-Abl kinase for the Potential Treatment of Alzheimers Disease","Investments < €500k",,"United States of America" "HTS to identify small molecules to disrupt abnormal huntingtin interactions in HD","Investments > €500k","Huntington's disease","United States of America" "Human genetic studies of Alzheimer disease and other dementias","Investments < €500k",,Sweden "Human induced neuronal stem cell models of familial Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Human iPSC-based personalized cell therapy of PD","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Human iPSCs-derived neuron-astrocyte co-culture as an innovative strategy to study the role of astrocytes in Alzheimer’s disease","Investments < €500k",,France "Human molecular genetics and bioinformatics","Investments > €500k","Prion disease","United Kingdom" "Human Monoclonal Antibodies for the Therapy of Transthyretin Amyloidosis Diseases","Investments < €500k",,Sweden "Human pluripotent stem cell differentiation, safety and preparation for therapeutic transplantation in Huntington’s disease","Investments > €500k","Huntington's disease|Parkinson's disease & PD-related disorders","European Commission" "Human prion diseases: molecular characteristics","Population Cohorts","Prion disease",Germany "Human stem cell models of Alzheimer’s disease.",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Humanizing Regulators of the Complement Cascade to Improve Research Relevance","Investments < €500k",,"United States of America" "Humanizing the Tardbp (TDP43) locus in the mouse","Investments < €500k",,"United Kingdom" "HUNT Biobank",Biobanks,"Alzheimer's disease & other dementias|Neurodegenerative disease in general|Parkinson's disease & PD-related disorders",Norway "HUNT Data center","Bio/Neuroinformatic Resources","Alzheimer's disease & other dementias|Neurodegenerative disease in general|Parkinson's disease & PD-related disorders",Norway "Huntingtin proline-rich region modulation of Huntingtons disease pathogenesis","Investments > €500k","Huntington's disease","United States of America" "Huntington’s disease: deciphering the key molecular level processes of toxic amyloid aggregates","Investments < €500k",,Denmark "Huntingtons disease","Disease Registers","Huntington's disease|Neurodegenerative disease in general|Parkinson's disease & PD-related disorders","Czech Republic" "Huntingtons disease biomarkers and therapeutics","Investments > €500k","Huntington's disease","United States of America" "Huntingtons disease repeat instability and pathogenesis","Investments > €500k","Huntington's disease","United States of America" "Huntingtons disease: a novel developmental oligodendrogliopathy","Investments > €500k","Huntington's disease","United States of America" "Hydrogen sulphide-mediated sulfhydration of the K+ channel Kv2.1: A new signalling pathway to target in the treatment of Alzheimer’s disease.","Investments < €500k",,"United Kingdom" "Hyperbaric oxygen therapy for cognition in diabetic elderly at high dementia risk","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Hypertension angiotensin receptor blockers and cognition: effects and mechanism","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Hypertension in Dementia – Feasibility Study","Investments < €500k",,"United Kingdom" "Hypertension, hypoperfusion and neurodegeneration in Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "ICT services for Life Improvement For the Elderly","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders","European Commission" "IDEA Intervention to prevent Depressive symptoms and promote well-being in EArly stage dementia development and feasibility",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "IDEA Project – Inclusion in the Digital Economy for Aphasia",Fellowships,,"United Kingdom" "Identificatie en functionele analyse van extracellulaire Tau varianten betrokken in de spreiding van Tau pathologie. Identification and functional analysis of extracellular Tau variants involved in the spread of tau pathology",Fellowships,"Alzheimer's disease & other dementias",Belgium "Identification and Care of Patients at Risk of Post-Stroke Dementia",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Identification and characterisation of mismatch repair associated factors involved in genomic instability associated with Huntington’s disease","Investments < €500k",,Denmark "Identification and characterization of AD risk networks using multi-dimensional omics data","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Identification and characterization of diagnostic biomarkers in Alzheimer’s disease and in prodormal stadium","Investments < €500k",,Hungary "Identification and characterization of Novel drug targets in neurodegenerative diseases by RNAi screening","Investments > €500k","Neurodegenerative disease in general",Germany "Identification and functional analysis of novel human-specific small vessel disease proteins","Investments < €500k",,"United States of America" "Identification and modulation of pathogenic Amyloid beta-peptide species","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "Identification and validation of cerebral KCa3.1/KCa2.3 potassium channels a drug tragets for the prevention and treatment of cerebral ischemia associated with diabetes and Alzheimers disease",Fellowships,"Alzheimer's disease & other dementias", "Identification of ALS associated genes using whole genome sequencing","Investments > €500k","Motor neurone diseases","United States of America" "Identification of Cellular Targets for Amyloid Beta Toxicity in Alzheimers Disease",Fellowships,"Alzheimer's disease & other dementias",Sweden "Identification of dementia and motor neuron disease genes","Investments < €500k",,Australia "IDENTIFICATION OF DIAGNOSTIC BIOMARKERS IN PATIENTS WITH AMIOTROPHIC LATERAL SCLEROSIS","Investments < €500k",,Spain "Identification of Endophenotypes in the Behavioral-Variant of Frontotemporal Deme",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Identification of Functional Genomic Variants in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Identification of Gait and Imaging Markers for Freezing of Gait in Parkinsons Disease",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Identification of genetic modifiers of Machado Joseph disease (MJD) using a Caernohabditis elegans transgenic model",Fellowships,"Spinocerebellar ataxia (SCA)",Portugal "Identification of Genetic Modifiers of Neuronal Deficits and Memory Failure in Alzheimers Disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Identification of genetic modifiers of onset age in frontotemporal lobar degeneration: a family-based integrative approach",Fellowships,"Alzheimer's disease & other dementias",Belgium "Identification of molecular and genetic mechanisms in familial Lewy Body Dementia: a novel approach","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "Identification of molecular mechanisms underlying dysregulated proteostasis in neurodegenerative proteinopathy","Investments < €500k",,Slovakia "Identification of new causative genes in spinocerebellar degenerations by combination of whole genome scan, next-generation sequencing and biological validation in vitro and in vivo","Investments < €500k",,France "Identification of non-coding RNA biomarkers from serum and cerebrospinal fluid for use as biomarkers in Amyotrophic Lateral Sclerosis","Investments < €500k",,"United Kingdom" "Identification of novel aβ-associated proteins","Investments < €500k",,Netherlands "Identification of Old-Age-Associated Alzheimers Disease Drug Targets","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Identification of Parkinson’s disease genes in Queensland families showing patterns of Mendelian inheritance.","Investments < €500k",,Australia "IDENTIFICATION OF PARKINSON’S DISEASE EFFECTIVE DRUGS INTEGRATING COMPUTATIONAL SYSTEM CHEMICAL BIOLOGY AND EXPERIMENTAL APPROACHES",Fellowships,"Parkinson's disease & PD-related disorders",Portugal "Identification of pathogenic mechanisms important in multiple system atrophy","Investments < €500k",,"United States of America" "Identification of prediction and progression biomarkers in the earliest stages of Parkinson’s disease","Investments > €500k","Parkinson's disease & PD-related disorders",Germany "Identification of unfolded protein response, apoptosis and autophagy markers in human AD","Investments < €500k",,"United Kingdom" "Identifications of druggable pathways that influence tau toxicity","Investments < €500k",,"United Kingdom" "Identifying Alzheimers disease genes using genomic and family data","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Identifying best practices in care trajectories of communitydwelling persons with dementia. A comparison of care trajectories, quality indicators and costs extracted from routine care registrations and health insurance data","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "Identifying common points of neuronal dysfunction in the Motoneuron Disease – Frontotemporal Dementia spectrum using Drosophila and iPSC models.","Investments < €500k",,"United Kingdom" "Identifying effectors of mutant C9Orf72 ALS/FTD to combat neurodegeneration","Investments < €500k",,"France|United Kingdom" "Identifying Factors Regulating Medium Spiny Neuron Differentiation or Maintenance as Therapeutic Targets for Huntingtons Disease using Induced Pluripotent Stem Cells","Investments > €500k","Huntington's disease","United States of America" "Identifying functional molecular pathways that underlie the earliest changes associated with Alzheimer’s Disease",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Identifying genetic risk of dementia: from gene discovery to clinical implications","Investments > €500k","Alzheimer's disease & other dementias",Norway "Identifying Huntingtons disease markers by modern statistical learning methods.","Investments > €500k","Huntington's disease","United States of America" "Identifying key steps in the processing of proteins involved in Alzheimer’s and prion diseases",Fellowships,"Alzheimer's disease & other dementias",Australia "Identifying neurophysiological markers of early cognitive decline in Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias",Australia "Identifying novel anti-amyloid targets in psychogeriatric disorders","Investments < €500k",,Sweden "Identifying novel markers to differentiate frontotemporal dementia from Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias",Australia "IDENTIFYING RARE VARIANTS THAT INCREASE RISK FOR ALZHEIMERS DISEASE","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Identifying sleep targets for intervention and detection of preclinical AD",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Identifying the functional link between cell adhesion and the cytoskeleton at synapses in Alzheimer’s disease","Investments < €500k",,Australia "Identifying the mechanisms of neuronal fate commitment during direct conversion",Fellowships,"Motor neurone diseases","United States of America" "Identifying the Neural Basis and Functional Role of Emotional Empathy in Dementia",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Identifying the role and mechanisms of selective vulnerability of a novel projection neuron in frontotemporal dementia and other cognitive disorders",Fellowships,"Alzheimer's disease & other dementias",Netherlands "Identifying therapeutic targets and causes of dopaminergic neuronal degeneration using C. elegans high-throughput genetic approaches",Fellowships,"Parkinson's disease & PD-related disorders",Norway "Identifying therapeutic targets and causes of dopaminergic neuronal degeneration using C. elegans high-throughput genetic approaches","Investments < €500k",,Norway "Identifying, validating and targeting AD susceptibility networks in monocytes","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Illettrisme et vulnérabilité de développement de la maladie d’Alzheimer : apport de l’imagerie par Tomographie d’émission de Positons. Illiteracy and Vulnerability of Alzheimer’s Disease: Positron emission tomography imaging.","Investments < €500k",,France "Imaging agents for synucleinopathy drug discovery","Investments < €500k",,"United States of America" "Imaging agents for synucleinopathy drug discovery","Investments < €500k",,"United States of America" "Imaging agents for synucleinopathy drug discovery","Investments < €500k",,"United States of America" "Imaging amyloid and neuroinflammation in subjects “at risk” for Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Imaging and genetic biomarkers for Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Imaging Cerebral and Retinal Microvasculature in Cerebral Small Vessel Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Imaging cerebral neuroinflammation in acute and chronic cerebrovascular disease: a predictor of outcome and biomarker for guiding treatment","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Imaging cerebral vascular alterations and their modulation in experimental models: a translational approach","Investments < €500k",,"United Kingdom" "Imaging copper trafficking in Alzheimer’s disease with PET: potential clinical applications","Investments < €500k",,"United Kingdom" "Imaging corticostriatal loop dysfunction during skilled locomotion of Parkinsonian mice","Investments < €500k",,Switzerland "Imaging Dementia: Brain Matters","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "Imaging epigenetics of Alzheimers Disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Imaging Genomics Based Brain Disease Prediction","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Imaging inflammation and tau in elders with different clinical and biomarker profiles of Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Imaging Innate Immune Responsiveness of Microglia in Alzheimers Disease Brain","Investments < €500k",,"United States of America" "Imaging Neurodegenerative Disease",Fellowships,"Alzheimer's disease & other dementias",Australia "Imaging neuronal and capillary dysfunction deep in the rodent brain in vivo using 1700 nm Optical Coherence Microscopy and tracer-based kinetics","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Imaging of Cognition, Learning and Memory in Aging","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Imaging of Neurodegeneration",Fellowships,"Alzheimer's disease & other dementias",Australia "Imaging of Neuroinflammation in Neurodegenerative Diseases","Investments > €500k","Neurodegenerative disease in general","European Commission" "Imaging tau, amyloid, and neurodegeneration in PPA","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Imaging the eye to diagnose pre-clinical Alzheimer’s Disease","Investments < €500k",,Australia "Imaging the origins of dementia: vascular, grey and white matters","Investments < €500k",,Norway "Imaging the Retina for Early Alzheimer Diagnosis (I-READ)","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "Imaging-genetics biomarkers for disease risk in Alzheimer’s Disease.","Investments < €500k",,Canada "Immediate-early intra-axonal signaling in neurodegeneration","Investments < €500k",,"United States of America" "Immune genes impact on development of a-synucleinopathy","Investments < €500k",,Denmark "Immune regulated amino acid pathways in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Immune Regulation of Neuronal Injury and Repair","Investments > €500k","Motor neurone diseases","United States of America" "IMMUNE RESPONSE ADAPTATIVE IN PARKINSON DISEASE INDUCED BY ALPHA-SINUCLEINE PROTEOFINS PRESENT IN THE LEWY BODIES: DIAGNOSTIC AND THERAPEUTIC APPLICATION","Investments < €500k",,Spain "Immune responses in neurodegenerative diseases: Protection or progression?",Fellowships,"Alzheimer's disease & other dementias", "Immune-based nutrient deprivation and neurodegenerative disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Immune-Mediated Mechanisms underlying CNS Abeta Clearance","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Immunogenetic markers in Slovak patients with Alzheimer´s disease.","Investments < €500k",,Slovakia "Immunological and histochemical assessment of an Alzheimer´s vaccine","Investments < €500k",,Sweden "Immunology of aging and immunotherapy of aging-associated diseases","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Immunosuppression in humans with AD","Investments < €500k",,"United States of America" "Immunotherapy of familial prion diseases","Investments < €500k",,Germany "Impact d’un traitement précoce par amantadine sur les complications motrices induites par la L-DOPA dans la maladie de Parkinson : étude comparative randomisée versus placebo. Impact of early amantadine treatment on motor complications induced by L-DOPA in Parkinson’s disease: a randomized, placebo-controlled comparative study","Investments > €500k","Parkinson's disease & PD-related disorders",France "Impact neuroprotecteur, moteur et cognitif du travail aérobie prolongé à haute intensité dans la maladie de Parkinson. Comparaison de deux programmes de réentraînement à l’effort d’intensités différentes et d’un programme de kinésithérapie conventionnelle appliqués pendant 9 mois. Neuroprotective, motor and cognitive impact of prolonged high intensity aerobic work in Parkinson’s disease. Comparison of two exercise intensity training programs with a different intensity and a conventional physiotherapy program for 9 months","Investments > €500k","Parkinson's disease & PD-related disorders",France "IMPACT OF ALPHA-SYNUCLEIN UPON miRNAS: ROLE IN PARKINSON’S DISEASE PATHOLOGY AND PROGRESSION",Fellowships,"Parkinson's disease & PD-related disorders",Spain "Impact of Ambient Ultrafine Particle Exposures on Alzheimers Disease Progression","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Impact of base excision repair on epigenetics in brain; Implications for neurodegeneration","Investments < €500k",,Norway "IMPACT OF COENZYME Q10 (UBIQUINOL) IN THE COMMITMENT OF VASCULAR BRAIN ENDOTHELIUM IN THE COGNITIVE DETERIORATION: FUNCTIONAL AND METABOLIC VALUATION IN VIVO AND IN VITRO.","Investments < €500k",,Spain "Impact of estrogen loss and replacement on GluN2B containing NMDARs, synaptic plasticity, and learning and memory in females using a novel transgenic rat model of Alzheimer’s Disease","Investments < €500k",,"United States of America" "Impact of genetics on the effect that modifiable lifestyle factors have on rates of change in Alzheimer’s Disease","Investments < €500k",,Australia "Impaired Axonal transport in Alzheimer’s disease","Investments < €500k",,Netherlands "Impaired Decision-Making and the Role of Dopamine in Modulating Executive Function in Parkinson’s Disease",Fellowships,"Parkinson's disease & PD-related disorders",Australia "Impaired immune surveillance in Alzheimer’s disease: studies on pre-clinical transgenic models and patient-derived samples",Fellowships,"Alzheimer's disease & other dementias",Switzerland "Impairment of Synaptic Vesicles function in Alzheimer Disease","Investments < €500k",,France "Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised Diagnosis","Investments < €500k",,Ireland "Implementation and evaluation of a multi-component online resource for caregivers of persons with dementia","Investments < €500k",,Canada "Implementation of a work aid for the recognition and satisfaction of the needs of people with severe dementia in the care outpatient and inpatient care of elderly people with the aim of a needs-oriented care","Investments > €500k","Alzheimer's disease & other dementias",Germany "Implementing delirium prevention in hospitalised older patients using Normalisation Process Theory",Fellowships,"Alzheimer's disease & other dementias",Australia "Implicating Novel Genes in Familial Parkinsonism","Investments > €500k","Parkinson's disease & PD-related disorders",Canada "Implications of retinal neurodegeneration in Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias",Australia "Implicit Memory in Cerebellar Ataxia Patients","Investments < €500k",,Turkey "Importance of low-grade inflammation in patients with cognitive impairment due to AD and stroke","Investments < €500k",,Norway "Improve the health and wellbeing of older people and the quality of community care they receive, especially for people living with dementia.",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Improving a new form of deep brain stimulation to treat gait and balance disturbance in Parkinson’s disease","Investments < €500k",,Australia "Improving access to UK dementia services for the South Asian minority ethnic population: development and pilot of an intervention.",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Improving balance and physical activity in elderly with Parkinson’s disease – long-term efficacy and effectiveness in a clinical practise of the HiBalance program","Investments < €500k",,Sweden "Improving clinical diagnosis of mild neurocogntive disorders",Fellowships,"Alzheimer's disease & other dementias",Australia "Improving cognitive functioning in Parkinson’s Disease with transcranial Direct Current Stimulation.","Investments < €500k",,Netherlands "Improving Dementia Education Access (the IDEA study) for clinical hospital staff in regional and district hospitals: a cluster randomised study to improve knowledge and patient outcomes.",Fellowships,"Alzheimer's disease & other dementias",Australia "Improving diagnosis and prognosis of early-onset dementia",Fellowships,"Alzheimer's disease & other dementias",Australia "Improving diagnostic and care pathways in progressive supranuclear palsy and corticobasal degeneration.",Fellowships,"Neurodegenerative disease in general","United Kingdom" "Improving function in Huntington’s disease through neurofeedback: using real-time fMRI to enhance cortical plasticity in early stages of the disease","Investments > €500k","Huntington's disease","United Kingdom" "Improving Outcomes for Family Caregivers and Older Adults with Complex Conditions: The Adult Day Service Plus Program","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Improving Performance in Drivers with Mild Cognitive Impairment: An RCT of Cognitive Training","Investments < €500k",,Canada "Improving postural stability in people with Parkinson’s disease using textured insoles.","Investments > €500k","Parkinson's disease & PD-related disorders",Australia "Improving prevention trials in Alzheimer’s disease through imaging","Investments < €500k",,"United Kingdom" "Improving Quality of Life for People with Dementia: Development and Evaluation of a 3D Virtual World","Investments < €500k",,Australia "Improving quality use of medicines in residential aged care",Fellowships,"Alzheimer's disease & other dementias",Australia "Improving the acute hospital care experience from admission through to discharge for older patients with cognitive impairment and their carers / families.",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Improving the diagnosis and management of neurodegenerative dementia of Lewy body type in the NHS (DIAMOND-Lewy)","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders","United Kingdom" "Improving the lives of Parkinson’s Disease patients while reducing side-effects through tailored deep brain stimulation","Investments > €500k","Parkinson's disease & PD-related disorders","European Commission" "Improving Translational Research Potential at the Institute of Biomedicine of Seville","Investments > €500k","Neurodegenerative disease in general","European Commission" "Impulse Control Disorders in Parkinson’s Disease","Investments < €500k",,Norway "In search for endothelial mechanisms of TPO-induced neuroprotection",Fellowships,"Alzheimer's disease & other dementias","European Commission" "In vivo Amyloid-Beta Imaging in Mouse Brain Using Stochastic Object Models","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "In vivo analysis of neuromuscular junction stability in zebrafish models of amyotrophic lateral sclerosis",Fellowships,"Motor neurone diseases","European Commission" "In vivo and in vitro Drosophila models to study the role of heparan sulfate in Alzheimer´s disease pathogenesis","Investments < €500k",,Sweden "In vivo assessment of brain neurotransmitter dysfunction and microglial activation in patients with REM sleep behavior disorder as early markers of parkinsonian disorders","Investments > €500k","Parkinson's disease & PD-related disorders",Denmark "In vivo assessment of the role of aggregated tau in preclinical and prodromal Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias",Australia "In vivo characterization of the PET pharmacokinetic properties of T807 in humans","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "In Vivo Imaging Alzheimers Disease Pathology with 2-Photon/Lifetime Microscopy","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "In vivo imaging of levodopa-induced angiogenesis and its relevance to tardive dyskinesia in a parkinsonian rat model","Investments < €500k",,Canada "In vivo models of disease and toxicity in the nervous system","Investments > €500k","Neurodegenerative disease in general|Prion disease","United Kingdom" "In vivo models of small RNP biogenesis and Spinal Muscular Atrophy","Investments > €500k","Spinal muscular atrophy (SMA)","United States of America" "In vivo optische detectie van Amyloid Beta plaques in de menselijke retina. In vivo optical detection of Amyloid Beta plaques in the human retina","Investments < €500k",,Netherlands "In vivo permeability of the human blood-cerbrospinal fluid barrier in dementia","Investments < €500k",,"United States of America" "In vivo study of the metabotropic glutamate receptor type 5 (mGluR5) in relation to adenosine signaling and neuroinflammation in experimental Parkinson’s disease",Fellowships,"Parkinson's disease & PD-related disorders",Belgium "In Vivo Visualization of TAU and Amyloid-Beta Networks for Early AD Detection",Fellowships,"Alzheimer's disease & other dementias","United States of America" "In-cell NMR monitoring of alpha-Synuclein aggregation in neuronal cells","Investments > €500k","Neurodegenerative disease in general","European Commission" "Incidence of Cognitive Impairment in Cohorts with Longitudinal Evaluation-PD (ICICLE-PD) Study Extension","Investments < €500k",,"United Kingdom" "Incidence of Cognitive Impairments in Cohorts with Longitudinal Evaluation in Parkinson’s disease","Case Control Studies","Parkinson's disease & PD-related disorders","United Kingdom" "Inciting dialogue and disruption – developing participatory analysis of the experience of living with dementia and dementia care","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "InCure: Innate Immune Activation in Neurodegenerative Disease","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders",France|Germany|Italy|JPND|Netherlands|Sweden "IND- and NDA-enabling toxicology studies for PTI-125, a novel small molecule for Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "INdependent LIving support Functions for the Elderly","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "Indiana University Dementia Screening Trial: The IU CHOICE Study","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Indices of Motor Synergies as Early Biomarkers of Parkinsons Disease","Investments < €500k",,"United States of America" "Indices of Motor Synergies as Early Biomarkers of Parkinsons Disease","Investments < €500k",,"United States of America" "Individual activation of people with dementia","Investments > €500k","Alzheimer's disease & other dementias",Germany "Individual Differences in Coping with a Diagnosis of ALS: Psychosocial Adjustment and Implications for Psychological Treatment Planning",Fellowships,"Motor neurone diseases",Australia "INDIVIDUAL DIFFERENCES IN LONGITUDINAL CHANGES IN FUNCTIONAL AND STRUCTURAL CONNECTIVITY IN PRE-SYMPTOMATIC PATIENTS OF HUNTINGTON DISEASE","Investments < €500k",,Spain "Individualized Cell Therapy for Parkinsons Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Induced Adult Neurogenesis for Parkinsons Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Induced neuronal progenitor cells derived from patient fibroblasts (University of Sheffield)","Experimental Models",,"United Kingdom" "Induced pluripotent stem cells as a model system for motoneuron diseases","Investments > €500k","Motor neurone diseases",Germany "Industrial Academic Initial Training Network towards focused treatment of age-related motor symptoms.",Fellowships,"Parkinson's disease & PD-related disorders", "Infantile parkinsonism due to dopamine transporter deficiency: functional characterisation and therapeutic approaches .",Fellowships,"Parkinson's disease & PD-related disorders","United Kingdom" "Inflammation and delayed cognitive dysfunction after stroke","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Inflammation, Amyloid and Atrophy in The Aging Brain: The Borders between Healthy Brain Aging and Neurodegeneration","Investments > €500k","Alzheimer's disease & other dementias",Norway "Inflammation, Amyloid and Atrophy in The Aging Brain: The Borders between Healthy Brain Aging and Neurodegeneration",Fellowships,"Alzheimer's disease & other dementias",Norway "Influence of Age-related Neuropathology on Functional Brain Networks",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Influence of apoE on LRP1 function and Beta-Amyloid Transport Across the BBB","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Influence of genetic risk factors on biomarkers and cognitive decline in preclinical AD",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Influence of Genetic Variation on Manganese Neurotoxicity and Parkinsons disease",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Influence of genotype on microglia phenotype and function in PD","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Influence of neuromuscular pathology on parkinsonian communication deficits","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Influence of systemic immune inflammation upon the tauopathy phenotype in mouse models","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Influenza, Inflammation, and Parkinsons Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Information and Analysis Management (Part of France Life Imaging)","Bio/Neuroinformatic Resources",,France "Inhaleerbare levodopa voor gebruik tijdens een off periode bij patiënten met de ziekte van Parkinson. Inhalable levodopa for use during an off period in patients with Parkinson’s disease","Investments < €500k",,Netherlands "Inherited Disease, Caregiving, and Social Networks","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Inhibition of BACE1 for benefiting Alzheimers patients","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Inhibtion of expression of natively unfolded proteins and its consequence for progression of neurodegeneration","Investments < €500k",,Slovakia "Innovating Tablet-Based Cognitive Assessment for CNS Disorders of Aging","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Innovating technology to characterize balance loss in Ecological setting of daily life: application to Parkinson’s disease","Investments > €500k","Parkinson's disease & PD-related disorders",France "Innovative bioassay concepts for Alzheimer’s Disease diagnostics",Fellowships,"Alzheimer's disease & other dementias",Belgium "Innovative interventions to improve quality of life in dementia",Fellowships,"Alzheimer's disease & other dementias",Australia "INNOVERSUM – reimbursement models promoting innovation in elderly care","Investments > €500k","Alzheimer's disease & other dementias",Sweden "Insight into the synergistic interactions between Aβ amyloid, α-synuclein and Tau",Fellowships,"Neurodegenerative disease in general", "Insights into Parkinson’s disease, Crohn’s disease, and leprosy: a common role for LRRK2","Investments > €500k","Parkinson's disease & PD-related disorders",Canada "Insights into the Brain Clearance Mechanisms of Oligomeric Beta-Amyloid Species","Investments < €500k",,"United States of America" "INSTALZ: Genomic Instability in Alzheimer’s Disease and Related Disorders: a Single-Cell Approach","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias","Belgium|Denmark|France|JPND|Sweden|United Kingdom" "Institute of Biomedical Imaging (I2BM)","Capital Infrastructure",,France "Institutional Funding through Helmholtz Programme Oriented Funding (POF)","Investments > €500k","Alzheimer's disease & other dementias|Neurodegenerative disease in general|Parkinson's disease & PD-related disorders",Germany "Institutional Funding through Helmholtz Programme Oriented Funding (POF)","Investments > €500k","Alzheimer's disease & other dementias|Neurodegenerative disease in general|Parkinson's disease & PD-related disorders",Germany "Insulin and SREBP-2 in brain cholesterol regulation",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Insulin Resistance and Accelerated Cognitive Aging","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Insulin Resistance in Late-Life Depression",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Insulin Resistance, Biomarkers of Brain Function, and Intermittent Calorie Restriction",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Intact Circuit Assessment of Aging Dopamine Neurons vis Optogenetics and CLARITY","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Integrated European –omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases","Investments > €500k","Neurodegenerative disease in general","European Commission" "Integrated functional and structural neuroimaging in movement disorders","Investments < €500k",,Norway "Integrated genomic and biochemical studies to understand the molecular mechanisms of neurodegenerative disease and the development of new therapeutics","Investments > €500k","Neurodegenerative disease in general|Parkinson's disease & PD-related disorders",Hungary "Integrated multidisciplinary approach/Agrica MSA IFR Public Health 99","Population Cohorts","Neurodegenerative disease in general",France "Integrated Neurocognitive and Sleep-Behavior Profiler for the Endophenotypic Classification of Dementia Subtypes (INSPECDS)","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Integrated Software for the Assessment of Diffusion Tensor Imaging of Brain Wiring in Alzheimer’s Disease and Dementia","Investments < €500k",,Canada "Integrating Neurophysiological Views of the Aging Visual System","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Integrating Quality Control: Studies of UBQLN2 in Age-Related Neurodegeneration","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "Integrating Quality Control: Studies of UBQLN2 in Age-Related Neurodegeneration","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "Integrative analysis of genomic and epigenomic architecture in cognitive decline",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Integrative Biology Approach to Complexity of Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Integrative Biology Approach to Complexity of Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Integrative Biology Approach to Complexity of Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Integrative translational discovery of vascular risk factors in aging and dementia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Intelligence led drug discovery for the amyloid cascade","Investments < €500k",,"United Kingdom" "Intelligent Parkinson eaRly detectiOn Guiding NOvel Supportive InterventionS","Investments > €500k","Parkinson's disease & PD-related disorders","European Commission" "INTERACTION BETWEEN ADENOSINE A2A RECEPTORS AND GROWTH FACTORS IN THE CONTROL OF NEURODEGENERATION AND BRAIN REPAIR",Fellowships,"Neurodegenerative disease in general",Portugal "Interaction of BIN1 and Tau: physiological functions and pathological consequences in Alzheimer’s disease.","Investments > €500k","Alzheimer's disease & other dementias",France "Interaction of intrinsic and extrinsic factors underpinning functional disability in dementia",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Interaction of systemic and central apolipoproteins in the pathogenesis and treatment of cerebral amyloid angiopathy",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Interaction-based Human Motion Analysis","Investments < €500k",,"United Kingdom" "Interactions between testosterone and oxidative stress in dopamine neurons","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Interactions of Centella asiatica, mitochondrial function and oxidative stress during aging",Fellowships,"Alzheimer's disease & other dementias","United States of America" "INTERACTIONS OF REELINE / APOE AND ALTERNATIVE LIGANDS WITH ß-AMYLOID, ITS DISFUNCTION IN ALZHEIMER’S DISEASE","Investments < €500k",,Spain "Interactions within and between the basal ganglia and thalamocortical circuits in function and dysfunction","Investments > €500k","Parkinson's disease & PD-related disorders","United Kingdom" "Interactive safety and assistance system to increase the safety and participation of persons with dementia","Investments > €500k","Alzheimer's disease & other dementias",Germany "INTERACTOMES AND MARKERS TO DISCRIMINATE REGIONAL NEURONAL VULNERABILITY FACTORS IN NEURODEGENERATION ASSOCIATED WITH NORMAL AND PATHOLOGICAL AGING IN THE CNS.","Investments < €500k",,Spain "Interdisciplinary Research to Understand the Interplay of Diabetes, Cerebrovascular disease and Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Interferometric Microscopy and Nanoscopy in Live Biological Cells and Tissues",Fellowships,"Alzheimer's disease & other dementias", "International Cerebral Amyloid Angiopathy Conference in Boston","Investments < €500k",,"United States of America" "Interoperable Cognitive Wellness in Aging Screen-iCogWell","Investments < €500k",,"United States of America" "Interplay between cArt, HIV, and amyloid at the blood-brain barrier.","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "INTERPLAY OF AMYLOID AND ISCHEMIA AND THEIR INFLUENCE ON BLOOD-BRAIN BARRIER, AMYLOID TRANSPORTATION SYSTEMS AND NEURODEGENERATION IN CEREBRAL AMYLOID ANGIOPATHY (CAA)","Investments < €500k",,Spain "Interrogating the link between aging and AD with temporally-controlled transgenes","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Intersection of alpha synuclein and tau contributions to neurotoxicity","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders","United States of America" "Intersection of alpha synuclein and tau contributions to neurotoxicity","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Intersection of Physiologic Frailty and Cognitive Performance in Older Adults: An Integrative Data Analysis",Fellowships,"Alzheimer's disease & other dementias","United States of America" "INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer’s Symptomatic Expression: The INCREASE study","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Intranasal Delivery of Peptide Drugs to the Brain","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Intranasal Insulin in a Mouse Model of Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Intrathecal and intramuscular application of mesenchymal stem cells and their secretome in the treatment of amyotrophic lateral sclerosis","Investments < €500k",,"Czech Republic" "Intravenous Enzyme Replacement Therapy for CNS Disorders","Investments < €500k",,"United States of America" "Intrinsic Activity and Cognition in Parkinson Disease Assessed by Simultaneous fMRI/EEG","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Intrinsic Cortical Networks and Cognitive Dysfunction in Parkinsons Disease",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Intrinsic Cortical Networks and Cognitive Dysfunction in Parkinsons Disease",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Intrinsic Modeling and Tracking of Neuroanatomy in Alzheimers Disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Invasive Approach to Model Human Cortex-Basal Ganglia Action-Regulating Networks","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Investigating a neuronal subcellular transcriptome by the novel technique of RNA TU-tagging, in a normal and ALS-related mouse model.","Investments > €500k","Motor neurone diseases","United Kingdom" "Investigating a Toxic Gain-of-Interaction Between FUS/TLS & Stress Granules","Investments > €500k","Motor neurone diseases","United States of America" "Investigating a-synuclein dependent neurodegeneration in two novel transgenic mouse lines modeling increased aggregation and lack of age-dependent trophic a-synuclein signalling","Investments < €500k",,Denmark "Investigating a2-chimaerin-dependent motor neuron protection in ALS","Investments > €500k","Motor neurone diseases","United States of America" "Investigating alpha-synuclein aggregate toxicity in cellula","Investments < €500k",,Denmark "Investigating biometal dyshomeostasis in dementia with Lewy bodies",Fellowships,"Alzheimer's disease & other dementias",Australia "Investigating CD47-SIRPa as novel protective signals during CNS synaptic pruning","Investments > €500k","Huntington's disease","United States of America" "Investigating cerebellar glutathione in SCA14 by MR spectroscopy in order to identify a new treatment option","Investments < €500k",,"United Kingdom" "Investigating deficits of axonal RNA metabolism and axonal signalling in amyotrophic lateral sclerosis","Investments < €500k",,"United Kingdom" "Investigating deficits of axonal RNA metabolism and axonal signalling in amyotrophic lateral sclerosis",Fellowships,"Motor neurone diseases","United Kingdom" "Investigating deficits of axonal RNA metabolism and axonal signalling in amyotrophic lateral sclerosis",Fellowships,"Motor neurone diseases","United Kingdom" "Investigating dementia worry and its impact on older adults","Investments < €500k",,"United States of America" "Investigating disease Mechanisms in C9orf72-linked ALS/FTD","Investments > €500k","Motor neurone diseases","United States of America" "Investigating disease Mechanisms in C9orf72-linked ALS/FTD","Investments > €500k","Alzheimer's disease & other dementias|Huntington's disease|Motor neurone diseases","United States of America" "Investigating fornix integrity as a sensitive biomarker in individuals who show the earliest signs of Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias",Canada "Investigating Gains in Neurocognition in an Intervention Trial of Exercise","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Investigating Golgi Fragmentation in Alzheimers Disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Investigating mechanisms of dementia and motor neuron disease",Fellowships,"Alzheimer's disease & other dementias",Australia "Investigating mechanisms of UBQLN2-mediated neurodegenerative disease","Investments < €500k",,"United States of America" "Investigating mechanisms of UBQLN2-mediated neurodegenerative disease","Investments < €500k",,"United States of America" "Investigating mechanistic causes of C9ORF72-related amyotrophic lateral sclerosis (ALS).","Investments > €500k","Motor neurone diseases","United Kingdom" "Investigating molecular mechanisms of cross-species prion transmission",Fellowships,"Prion disease","United States of America" "Investigating novel protective mechanisms in motor neurons","Investments < €500k",,"United Kingdom" "Investigating peripheral biochemical changes during familial Alzheimer’s disease progression","Investments < €500k",,Australia "Investigating RNA splicing factor aggregations in Alzheimers disease and CTE",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Investigating secondary effects of a promising therapeutic strategy for Alzheimer’s disease","Investments < €500k",,Australia "Investigating the cause and consequences of iron deposition in Parkinson’s disease","Investments < €500k",,Australia "Investigating the clinical and research applications of whole-genome sequencing in Parkinson disease and other movement disorders",Fellowships,"Parkinson's disease & PD-related disorders",Australia "Investigating the contributions of astrocyte gap junctions to ALS disease progression","Investments < €500k",,"United States of America" "Investigating the contributions of astrocyte gap junctions to ALS disease progression","Investments < €500k",,"United States of America" "Investigating the effect of ApoE genotype on synaptic dysfunction using sporadic Alzheimer’s disease patient iPSC-derived cells","Investments < €500k",,"United Kingdom" "Investigating the efficacy of an online intervention aiming to increase respite use amongst carers of people with dementia: Roles of motivational enhancement and professional delivery","Investments < €500k",,Australia "Investigating the impact of meditation training on mental health and wellbeing in the ageing population","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "Investigating the iron proteome in Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias",Australia "Investigating the LRRK2-melanin connection through phosphoproteomics of isogenic melanoma cells",Fellowships,"Parkinson's disease & PD-related disorders","European Commission" "Investigating the Mechanism and Effect of Disease-Associated Increases in the Huntingtin Long 3UTR Isoform",Fellowships,"Huntington's disease","United States of America" "Investigating the mechanism of Amyloid-beta GxxxG-motif-targeting agents","Investments > €500k","Alzheimer's disease & other dementias",Canada "Investigating the mechanisms of axonal degeneration in amyotrophic lateral sclerosis using Drosophila and mouse transgenics",Fellowships,"Motor neurone diseases","United Kingdom" "Investigating the mechanisms of axonal degeneration in amyotrophic lateral sclerosis using Drosophila and mouse transgenics","Investments < €500k",,"United Kingdom" "Investigating the modifying effect of cognitive reserve on subjective memory complaining in pathologically at risk older adults",Fellowships,"Alzheimer's disease & other dementias",Australia "Investigating the neuroinflammatory role of RIP1 kinase","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Investigating the Propagation and Pattern of Spread of Unique Tau Strains",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Investigating the response of FUS/TLS to excitotoxic insult","Investments < €500k",,"United States of America" "Investigating the response of FUS/TLS to excitotoxic insult","Investments < €500k",,"United States of America" "Investigating the RhoA/ROCK pathway for the treatment of Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Investigating the role of autophagy and the UPS in TDP-ALS","Investments < €500k",,"United Kingdom" "Investigating the role of bvFTD-affected networks in socioemotional behavior","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Investigating the role of DJ-1/LRRK2 and RhoT1 in microglial polarization","Investments < €500k",,Luxembourg "Investigating the role of kinesin motor proteins in a human neuronal cell model of Alzheimer’s Disease: a new drug discovery target?","Investments < €500k",,"United Kingdom" "Investigating the role of Myosin VI in quality control of mitochondria linked to Parkinson’s disease pathology","Investments > €500k","Parkinson's disease & PD-related disorders","United Kingdom" "Investigating the Role of the Histone Demethylase LSD1/KDMI in Neurodegeneration","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "INVESTIGATING THE ROLE OF THE LET-7 MICRORNA IN MACHADO-JOSEPH DISEASE",Fellowships,"Spinocerebellar ataxia (SCA)",Portugal "Investigating the role of the microglial receptor TREM2 in Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Investigating the toxic particles formed by the Alzheimer’s disease protein amyloid-beta",Fellowships,"Alzheimer's disease & other dementias",Australia "Investigating the utility of oxidative stress as a biomarker for cognitive decline and dementia: a longitudinal magnetic resonance imaging study in ‘at risk’ older adults and Alzheimer’s disease.","Investments < €500k",,Australia "Investigating underlying mechanisms linking Type 2 diabetes with Alzheimer’s disease pathology","Investments < €500k",,Australia "Investigating V1 interneuron subtype diversity using embryonic stem cells",Fellowships,"Motor neurone diseases","United States of America" "Investigation into LRRK2 vesicular trafficking pathways to provide further insight into Parkinson’s disease pathogenesis.","Investments < €500k",,"United Kingdom" "Investigation into the impact of systemic inflammation due to infection on microglial phenotype and its contribution to Alzheimer’s disease neuropathology","Investments < €500k",,"United Kingdom" "Investigation of ALS caused by mutant CHCHD10","Investments > €500k","Motor neurone diseases","United States of America" "Investigation of mechanisms by which PINK1 protects against Parkinson’s disease: to develop better biomarkers and treatment targets for the disease.","Investments < €500k",,Ireland "Investigation of postnatal neurogenesis in relation to neurodegeneration","Investments < €500k",,Slovakia "INVESTIGATION OF PROGRESSIVE BEHAVIORAL DEFICITS AND CIRCUIT DYSFUNCTION IN THE STRIATUM DURING GRADUAL DOPAMINE DEPLETION",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Investigation of reduced penetrance in ALS using ATXN2 and C9orf72 repeat genotypes","Investments < €500k",,"United Kingdom" "Investigation of the bioeffects of blood-brain barrier disruption by focused ultrasound: A multifaceted imaging approach","Investments > €500k","Alzheimer's disease & other dementias",Canada "Investigation of the dynamic structure and inhibition of aggregation of TAR DNA binding protein-43","Investments < €500k",,"United Kingdom" "Investigation of the gamma-secretase heterogeneity",Fellowships,"Alzheimer's disease & other dementias",Belgium "Investigation of the mechanism by which huntingtin fragments are produced and their pathogenic relevance to Huntington’s disease","Investments < €500k",,"United Kingdom" "Investigation of the molecular mechanisms underlying alpha synuclein function at the presynapse",Fellowships,"Parkinson's disease & PD-related disorders",Australia "Investigation of the relationship between the material properties of insoluble, protein aggregates known as amyloids and common forms of age-related dementia such as Alzheimer’s and Parkinson’s.",Fellowships,"Alzheimer's disease & other dementias", "Investigation of the roles of GSK-3 isoforms in mediating Abeta, tau and insulin related Alzheimer-like synaptic, cholinergic impairments",,"Alzheimer's disease & other dementias",Canada "Investigation of the roles of GSK-3 isoforms in mediating Abeta, tau and insulin related Alzheimer-like synaptic, cholinergic impairments","Investments > €500k","Alzheimer's disease & other dementias",Canada "Investigation of the Tau Gene Network and Quantitative Alzheimers Disease Biomarker Phenotypes","Investments < €500k",,"United States of America" "Investigation of zinc dyshomeostasis associated with aging and dementia-related disorders using novel nanodiamond-based markers",Fellowships,"Alzheimer's disease & other dementias",Australia "INVESTIGATIONS OF DEMENTIA IN PARKINSON DISEASE","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "INVESTIGATIONS OF DEMENTIA IN PARKINSON DISEASE","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Involvement of AMPA receptor endocytosis in Alzheimers disease: Examining memory and structural plasticity deficits in mouse models","Investments < €500k",,Canada "Involvement of myelin integrity in Alzheimers disease pathogenesis","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "INVOLVEMENT OF TUBULIN POLYMERIZATION PROMOTING PROTEIN (TPPP/p25) IN NEUROPROTECTION ACHIEVED BY AUTOPHAGY, PROTEASOME AND AGGRESOME SYSTEMS Dissection of peptidomimetic foldamer for potential anti-synucleinopathy drugs","Investments < €500k",,Hungary "Involving Family to Improve Primary Care Visits for Cognitively Impaired Patients","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "iRhom2 in neuroinflammation and pathogenesis of Alzheimer’s Disease",Fellowships,"Alzheimer's disease & other dementias","European Commission" "Irish ALS DNA BANK",Biobanks,"Motor neurone diseases",Ireland "Irish ALS Register","Disease Registers","Motor neurone diseases",Ireland "Irish ALS Research Group","Bio/Neuroinformatic Resources","Motor neurone diseases",Ireland "Irish Network for Biomarkers in Neurodegeneration (IN-BIND)",Biobanks,"Alzheimer's disease & other dementias",Ireland "IRMAGE – MRI 3T/ 4,7T / 7T / 9,4T & cryoprobe","Capital Infrastructure",,France "IRON EXPORT PROTEIN FAILURE IN PARKINSONISM AND DEMENTIA","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders",Australia "Is ALS/FTD neuropsychologically distinct from FTD?","Investments < €500k",,"United Kingdom" "Is Chronic Arsenic Poisoning Associated With Protein Aggregate Pathology?","Investments < €500k",,Sweden "Is HSF1 the key in mediating Hsp90 inhibitor effect in AD?","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Is it possible to develop a complex intervention to improve the outcome of fall-related injuries in people with dementia? (DIFRID)","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Is it possible to stop the spreading of neurofibrillary degeneration by active stimulation of the brain?","Investments < €500k",,Slovakia "ISD Biobank",Biobanks,"Alzheimer's disease & other dementias|Neurodegenerative disease in general",Germany "Isoform-dependent apoE processing by human induced pluripotent stem cells. A novel pathway linking APOE genotype and Alzheimer’s disease risk.","Investments < €500k",,Australia "ITRIBIS – (FP7-Seventh Framework Programme)","Capital Infrastructure",,"European Commission" "Jamboxx: Interactive Respiratory Therapy through Music and Gaming","Investments > €500k","Motor neurone diseases","United States of America" "Jargon Busting: The cognitive and neurobiological mechanisms underpinning Jargon Aphasia and Perseveration",Fellowships,,"United Kingdom" "JNK1, A THERAPEUTIC DIAL POTENTIAL IN ALZHEIMER’S DISEASE","Investments < €500k",,Spain "Johns Hopkins Medicine Biomarker Discovery in Parkinsons Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Johns Hopkins-Tufts Trial Innovation Center","Capital Infrastructure",,"United States of America" "Joining Familial Amyloid Polyneuropathy (FAP) and Alzheimer’s Disease (AD): research in therapies for amyloidosis and role of Transthyretin in AD",Fellowships,"Alzheimer's disease & other dementias",Portugal "Journeying through dementia; randomised controlled trial of clinical and cost effectiveness","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Klaarheid in het benevelde brein, spatiotemporele vingerafdrukken van neurodegeneratie door middel van whole-brain microscopische beeldvorming. Clarity to the muddled brain, spatiotemporal fingerprints of neurodegeneration through whole-brain microscopic imaging.",Fellowships,"Alzheimer's disease & other dementias",Belgium "Klotho and Neurodegenerative Disease","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders","United States of America" "Klotho and Neurodegenerative Disease","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders","United States of America" "Klothos potential to counteract Alzheimers disease-related neuronal dysfunction",Fellowships,"Alzheimer's disease & other dementias","United States of America" "KND (DCN), E1, Competence network dementia, Early- and differential diagnosis, genetics",Biobanks,"Alzheimer's disease & other dementias",Germany "KND (DCN), E3, competence networt dementia, epidemiology",Biobanks,"Alzheimer's disease & other dementias",Germany KNDD-FTLDc,"Disease Registers","Alzheimer's disease & other dementias|Motor neurone diseases|Neurodegenerative disease in general",Germany KNDD-LANDSCAPE,"Population Cohorts","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders",Germany "Knockin Mouse Models of Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Knowledge transfer in the field of redox biology for development of advanced molecular instruments in neurodegenerative diseases – the signature of transcription factor Nrf2 for diagnostic and treatment, REDBRAIN","Investments > €500k","Alzheimer's disease & other dementias|Neurodegenerative disease in general",Romania "Knowledge-based person centered activity for people with dementia living at home","Investments > €500k","Alzheimer's disease & other dementias",Norway "L1 retrotransposition: the missing link between genetics and environmental factors in Parkinson’s disease ?",Fellowships,"Alzheimer's disease & other dementias",Australia "La caféine est-elle un modificateur environnemental dans la maladie de Huntington? Is caffeine an environmental modifier in Huntington’s disease?","Investments < €500k",,France "La décision médicale et ses enjeux éthiques dans la relation de soin avec des malades d’Alzheimer et apparentés. The medical decision and its ethical stakes in the care relationship with Alzheimer’s and related patients","Investments < €500k",,France "Lake Cyanobacterial Harmful Algal Bloom Mapping and Analysis Platform (CHAB-MAP)","Investments < €500k",,"United States of America" "Lake Cyanobacterial Harmful Algal Bloom Mapping and Analysis Platform (CHAB-MAP)","Investments < €500k",,"United States of America" "Language Deficits And Cognitive Dysfunction In Motor Neuron Disease",Fellowships,"Alzheimer's disease & other dementias",Australia "Language in Primary Progressive Aphasia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Large Scale Biomarker Discovery and Validation for Parkinsons Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Lead Optimization of CRAC Channel Inhibitors for the Treatment of Alzheimers Disease","Investments < €500k",,"United States of America" "Lead Optimization of receptor antagonist CT0093 for disease-modifying Alzheimers","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Lead Optimization of receptor antagonist CT0093 for disease-modifying Alzheimers","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Lead optimization of somatostatin-based therapeutic for Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Learning and Memory Impairments in Transgenic AD Models","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Learning to resist Alzheimer’s disease: Novel molecular mechanisms that protect neurons against amyloid-beta","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "Legal, philosophical and social issues in neurosciences: the deep brain stimulation case","Investments < €500k",,France "Les dispositifs électroniques de géolocalisation destinés aux malades d’Alzheimer et maladies apparentées : production, usages et régulation. Electronic geolocation devices for Alzheimer’s and related diseases: production, use and regulation.","Investments < €500k",,France "Lessen van patiënten – dementie. Lessons from patients – dementia","Investments < €500k",,Netherlands "Lets talk about dementia","Investments < €500k",,"United Kingdom" "Lewy bodies in patients with dementia – Determining common and unique mechanisms in relation to Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias",Australia "Lewy Body Dementia Biomarkers","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders","United States of America" "Lewy Body Dementia Biomarkers","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Lewy body neuropathologies and SNCA gene: variants expression and splicing","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Lewy body neuropathologies and SNCA gene: variants expression and splicing","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "LIFE Biobank",Biobanks,"Alzheimer's disease & other dementias",Germany "Life Enhancing Activities for Family Caregivers of People with Dementia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Lifecourse health, cerebral pathology and ethnic disparities in dementia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Light-based regulation of autophagy processing to target pathological forms of tau","Investments < €500k",,"United States of America" "Lighting up the aging brain","Investments < €500k",,Canada "Linkage-specific ubiquitylation patterns as highly sensitive markers for neurodegenerative disease","Investments < €500k",,"United States of America" "Linking Olfactory deficits to Neurodegenerative Disorders","Investments < €500k",,"United States of America" "Linking Olfactory deficits to Neurodegenerative Disorders","Investments < €500k",,"United States of America" "Linking Olfactory deficits to Neurodegenerative Disorders","Investments < €500k",,"United States of America" "Linking Tau Structure to Its Functions and Mechanisms in Alzheimer’s Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Lipocalin 2 and its receptor, megalin, as diagnostic and drug targets in early stages of Alzheimer’s disease.",Fellowships,"Alzheimer's disease & other dementias",Netherlands "Lipocalin-2 vergroot de gevoeligheid van zenuwcellen voor Aβ. Lipocalin-2 increases the sensitivity of nerve cells to Aβ","Investments < €500k",,Netherlands "Liquor Bank Ulm (KNDD-FTLD, BMBF/DFG-ALS, EU-NeuroTAS, EU-Nadine, EU-cNeupro, LS-BW-PARK/BONDY)",Biobanks,"Neurodegenerative disease in general",Germany "LISPRO, an ionic cocrystal of lithium, as a potential novel treatment for Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Live cell tracking of amyloidogenic species related to Alzheimer’s disease","Investments < €500k",,"United Kingdom" "Living Alone in Older Age with Cognitive Impairment",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Living and dying with Amyotrophic Lateral Sclerosis: A Population based Analysis of Palliative Needs, Services and Outcomes in non-malignant terminal illness","Investments > €500k","Motor neurone diseases",Ireland "Living arrangements for people with dementia (monitor woonvormen dementie)","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "Living well with dementia","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Local alliances for people with dementia “committed locally and sustainably”","Investments < €500k",,Germany "Locally produced brain insulin in memory and Alzheimer’s disease: A multi-disciplinary approach to a key question","Investments > €500k","Alzheimer's disease & other dementias",Canada "Long-Term Nicotine Treatment of Mild Cognitive Impairment","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Long-term stability of local field potentials recorded from the subthalamic nucleus and effects of deep brain stimulation","Investments < €500k",,Canada "Long-term survival of new brain cells – a stereological study","Investments < €500k",,Denmark "Longitudinal Analysis for Early Diagnosis of Alzheimers Disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Longitudinal Cognitive ERP studies: Advancement for AD Clinical Trials","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Longitudinal DLB Cohort","Investments < €500k",,Netherlands "Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (LEFFTDS)","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (LEFFTDS)","Investments > €500k","Motor neurone diseases","United States of America" "Longitudinal interactive vascular exposure and Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Longitudinal transcriptome profiles for people with dementia",Fellowships,"Alzheimer's disease & other dementias",Australia "Longitudinal Urban Cohort Ageing Study","Population Cohorts","Alzheimer's disease & other dementias|Neurodegenerative disease in general",Germany "Loss of a cohort of axonal mRNAs as a result of reduced SMN levels.","Investments < €500k",,"United States of America" "Loss of a cohort of axonal mRNAs as a result of reduced SMN levels.","Investments < €500k",,"United States of America" "LRRK in Autophagy Function and Dopaminergic Neuron Survival","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Lrrk Interacts with Tau through the Actin Cytoskeleton",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "LRRK2 Cell Biology and Parkinson’s Disease","Investments > €500k","Parkinson's disease & PD-related disorders",Switzerland "LRRK2-mediated molecular and synaptic events in the striatum","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "LRRK2, KIF5A and Parkinson disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Lung Volume Recruitment in Neuromuscular Disease: Can “breath-stacking” improve lung function, respiratory symptoms and quality of life in people with neuromuscular disorders?",Fellowships,"Motor neurone diseases",Australia "LYLO « Les Yeux L Ont » : anomalies des saccades oculaires à la phase prodromale de la maladie d’Alzheimer. LYLO “Les Eyes L’Ont”: anomalies of ocular saccades in the prodromal phase of Alzheimer’s disease","Investments < €500k",,France "Lysosomal stress triggers exosome release and transfer of proteins","Investments < €500k",,"United States of America" "Lysosomal stress triggers exosome release and transfer of proteins","Investments < €500k",,"United States of America" "Maastricht Aging Study","Population Cohorts","Alzheimer's disease & other dementias",Netherlands "Maastricht Aging Study","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "Machine Learning Methods in Parkinson’s Disease Examination","Investments < €500k",,Turkey "Machinery and Mechanisms of Endosomal Protein Sorting – A key Pathway Associated with Alzheimer Disease","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "MADGIC: Generation of Improved Cellular and Animal Models for Identification of Disease Phenotype and New Therapeutic Targets of Alzheimer’s Disease","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias",Finland|France|Germany|JPND|Portugal|Sweden "Magnetic Resonance Elastography of the Brain","Investments < €500k",,"United States of America" "Magnetic resonance imaging biomarkers in ALS","Investments > €500k","Motor neurone diseases",Canada "Magnetic resonance imaging biomarkers in Alzheimer’s disease: investigating capillary dysfunction and neurodegeneration for diagnosis and prediction","Investments < €500k",,Denmark "Maintain Your Brain","Investments > €500k","Alzheimer's disease & other dementias",Australia "Maintaining function and well-being in later life: A longitudinal cohort study","Investments > €500k","Neurodegenerative disease in general","United Kingdom" "Maintaining independence in everyday life among seniors with subjective cognitive complaints.","Investments < €500k",,Canada "Maintaining Mitochondria Healthy: The Molecular Checkpoints involved in Mitochondrial Quality Control in Neurons",Fellowships,"Parkinson's disease & PD-related disorders",Portugal "Maintaining mitochondrial health in Parkinson’s disease: The role of PINK1 and Parkin","Investments < €500k",,Australia "Maintaining Neuronal Identity – Transcriptional control of the aging brain","Investments > €500k","Parkinson's disease & PD-related disorders",Sweden "Maintaining self-sufficiency, functional independence and social inclusion of community dwelling people with dementia and their informal caregivers","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "Maintaining synaptic function for a healthy brain: Membrane trafficking and autophagy in neurodegeneration","Investments > €500k","Neurodegenerative disease in general","European Commission" "Make-believe Matters. The Moral Role Things Play in Dementia Care.","Investments < €500k",,Netherlands "Maladaptive plasticity in the basal ganglia: focus on Parkinson´s disease and its treatment","Investments > €500k","Parkinson's disease & PD-related disorders",Sweden "MALDI-MS Imaging of Proteins in Neurodegenerative Brain Tissue","Investments < €500k",,Turkey "Malmö Diet and Cancer Study","Population Cohorts","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders",Sweden "Malmö Preventive Project","Population Cohorts","Alzheimer's disease & other dementias",Sweden "Management of pain in people with dementia living in care homes: Programme and intervention development","Investments < €500k",,"United Kingdom" "Managing active and healthy aging with use of caring service robots","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "Managing Dementia through a Multisensory Smart Phone Application to Support Aging in Place",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Managing diabetes in people with dementia: a realist synthesis (DIaMonD)","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Manifold-valued statistical models for longitudinal morphometic analysis in preclinical Alzheimers disease (AD)","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Manipulating mitochondrial dynamics as a potential therapeutic strategy for Parkinson’s disease","Investments > €500k","Parkinson's disease & PD-related disorders","United Kingdom" "Manipulation of C9orf72 dipeptide repeat proteins","Investments < €500k",,"United Kingdom" "Manipulation of the Direct/Indirect-Pathway Neurons in Striatum by Use of Genetically Reengineered Receptors to Restore Motor Function in Parkinsonian Mice","Investments < €500k",,Denmark "Mannose 6 Phosphate Receptor as a Target for Disease-modifying Therapies in Parkinson’s Disease","Investments < €500k",,Denmark "Mapping AD Memory Failure: Molecules to Connectivity of Brain Network","Investments < €500k",,"United States of America" "Mapping Brain Network Interactions in Neurodegenerative Disorders of the Subcortex",Fellowships,"Huntington's disease",Australia "Mapping interindividual variation in the aging connectome","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Mapping Social and Emotional Function of the Parkinsonian Face in Older Adults",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Mapping the epigenetics of Lewy body dementias","Investments < €500k",,Norway "Mapping the late-life health promoting mechanisms in worms and mammals","Investments > €500k","Neurodegenerative disease in general","European Commission" "Markers of neurodegeneration in differential diagnosis of parkinsonian syndrome","Investments < €500k",,"Czech Republic" "Marqueurs précoces de la maladie de Parkinson liés aux dérèglements des voies de la survie cellulaire. Early markers of Parkinson’s disease related to disorders of cell survival pathways","Investments > €500k","Parkinson's disease & PD-related disorders",France "Mass Spectrometry Imaging with Nano-DESI: New Methods and Application to Neurodegenerative Diseases","Investments < €500k",,Sweden "Master regulators in Parkinson’s Disease: PLA2G6 in lipid metabolism, mitochondria and synaptic transmission.",Fellowships,"Parkinson's disease & PD-related disorders",Belgium "Matrix Metalloproteinases: Therapeutic Targets For Huntingtons Disease","Investments > €500k","Huntington's disease","United States of America" "Measuring Recollection and Familiarity in Ageing and Mild Cognitive Impairment","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Measuring, Tracking and Disentangling the Impact of White Matter Disease in AD and Mixed Disease: A Longitudinal MRI and CSF Study",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Mechanism and Synergy of gamma-Secretase Modulators","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Mechanism of amyloid formation during melanosome biogenesis","Investments < €500k",,"United States of America" "Mechanism of DNA strand-break repair deficiency in Huntingtons disease","Investments > €500k","Huntington's disease","United States of America" "Mechanism of energy transduction by bacteriorhodopsin","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Mechanism of Gene Environment Interactions in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Mechanism of IL-1 Dependent A-beta Plaque Clearance in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Mechanism of modulation of huntingtin exon 1 aggregation by profilin","Investments > €500k","Huntington's disease","United States of America" "Mechanismen van Amyloid ß eiwit-klaring in Cerebrale Amyloid Angiopathie. Mechanisms of Amyloid β protein clearance in cerebral amyloid angiopathy","Investments < €500k",,Netherlands "Mechanisms and active compounds in the cognitive effects of Centella asiatica","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Mechanisms and Consequences of Heterochromatin Loss in Tauopathies","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Mechanisms and effects of GABAbR dephosphorylation during ischemic excitotoxicity",Fellowships,"Huntington's disease","United States of America" "Mechanisms and functions of subcellular motility","Investments > €500k","Motor neurone diseases","United States of America" "Mechanisms and treatment in Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias",Australia "Mechanisms by which Afferents Regulate Striatal Neuronal Loss and Motor Activity in Movement Disorders","Investments < €500k",,Canada "Mechanisms controlling sequestration and detoxification of Huntingtin proteins in yeast (Saccharomyces cerevisiae)","Investments < €500k",,Sweden "Mechanisms controlling skeletal muscle mitochondrial function and metabolic health","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "MECHANISMS FOR SELECTIVE REGULATION OF GAMMA-SECRETASE (AG09464-21A1 PROJ 2","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Mechanisms in C9orf72 LAS/FTLD and the search for therapeutic targets",Fellowships,"Motor neurone diseases",Belgium "Mechanisms Mediating NMJ Dennervation","Investments < €500k",,"United States of America" "Mechanisms Mediating NMJ Dennervation","Investments < €500k",,"United States of America" "Mechanisms of A-Beta Oligomer Induced Synapse Dysfunction in Alzheimer’s Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Mechanisms of abeta induced dysfunction in hippocampal neuronal circuitry","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Mechanisms of age-dependent nigral neuron loss in PINK1 knockout rats","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Mechanisms of age-related tauopathy","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Mechanisms of Aggregated Alpha-Synuclein Induction and Progression","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Mechanisms of alpha-synuclein accumulation in traumatic brain injury (R21 NS094908 Resubmission)","Investments < €500k",,"United States of America" "Mechanisms of amyloid-beta clearance in models of vascular cognitive impairment and mixed dementia","Investments < €500k",,Canada "Mechanisms of Apolipoprotein E Isoform Conferred Susceptibility and Resistance to Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Mechanisms of APP and APLP2 function at synapses","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Mechanisms of brain phenotypes caused by FAD-linked Presenilin-1 Mutations","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Mechanisms of brain rejuvenation","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Mechanisms of C9orf72 hexanucleotide repeat expansion caused neurodegeneration in ALS and FTD",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Mechanisms of C9orf72 hexanucleotide repeat expansion caused neurodegeneration in ALS and FTD",Fellowships,"Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "Mechanisms of C9orf72-associated dipeptide toxicity","Investments < €500k",,"United States of America" "Mechanisms of C9orf72-associated dipeptide toxicity","Investments < €500k",,"United States of America" "Mechanisms of C9orf72-associated dipeptide toxicity","Investments < €500k",,"United States of America" "Mechanisms of cell dysfunction by aggregation dynamics of polyQ-containing proteins",Fellowships,"Neurodegenerative disease in general", "Mechanisms of Central Synaptic Dysfunction in SMA","Investments > €500k","Spinal muscular atrophy (SMA)","United States of America" "Mechanisms of cortical and respiratory degenerations in Amyotrophic Lateral Sclerosis",Fellowships,"Motor neurone diseases",Australia "Mechanisms of DJ-1 in an aging model of PD","Investments > €500k","Parkinson's disease & PD-related disorders",Canada "Mechanisms of G4C2-derived dipeptide repeat protein toxicity in ALS","Investments < €500k",,"United Kingdom" "Mechanisms of HIPK2 in neurodegeneration","Investments > €500k","Motor neurone diseases","United States of America" "Mechanisms of Huntingtin-induced Neurodegeneration","Investments > €500k","Huntington's disease","United States of America" "Mechanisms of inherited neurodegenerative diseases","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Mechanisms of LRRK2 Mediated Dopaminergic Axonal Degeneration and Synaptic Transmission Deficits","Investments < €500k",,"United States of America" "Mechanisms of LRRK2 Mediated Dopaminergic Axonal Degeneration and Synaptic Transmission Deficits","Investments < €500k",,"United States of America" "Mechanisms of Metabolic Hormone Amylin Action on Alzheimers Disease Pathogenesis","Investments < €500k",,"United States of America" "Mechanisms of neurodegeneration caused by peroxisomal beta-oxidation deficiency","Investments < €500k",,Belgium "Mechanisms of Neurodegeneration in ALS","Investments > €500k","Motor neurone diseases","United States of America" "Mechanisms of neurodegeneration in an animal model of cerebral hypofusion","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Mechanisms of neuronal cell death in synucleinopathies",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Mechanisms of neuronal cell death in synucleinopathies",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Mechanisms of neurotoxicity of amyloid aggregates.","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Mechanisms of PhIP-induced dopaminergic neurotoxicity","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Mechanisms of postural instability in Parkinson’s disease: behavioral and neural correlates.","Investments < €500k",,Belgium "Mechanisms of Prion Protein Toxicity","Investments > €500k","Prion disease","United States of America" "Mechanisms of regulation of amyloid-beta metabolism by CALHM1","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Mechanisms of resistance to cognitive decline in AD","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Mechanisms of rotenone-induced neuroinflammation and Parkinsonism in aging mice","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Mechanisms of synapse damage in Alzheimer disease","Investments < €500k",,Sweden "Mechanisms of synaptic dysfunction in Parkinsons and other synuclein-linked dise","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Mechanisms of T-regulatory cell protection in MND","Investments < €500k",,Australia "Mechanisms of therapeutic efficacy of deep brain stimulation in Parkinson’s disease","Investments < €500k",,Canada "Mechanisms transducing insulin and insulin resistance in the hippocampus","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Mechanisms Underlying Excitability Regulation of Motoneuron Types in ALS","Investments > €500k","Motor neurone diseases","United States of America" "Mechanisms Underlying Tau45-230-Induced Neuronal Degeneration","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Mechanisms underlying the tau protein-mediated effects of amyloid beta on synaptic plasticity","Investments < €500k",,"United Kingdom" "Mechanistic analysis of axonal transport defects in neurodegenerative disease","Investments > €500k","Motor neurone diseases","United States of America" "Mechanistic insights into development of prion induced spongiform phenotype and neurotoxicity",Fellowships,"Prion disease",Switzerland "Mechanistic studies of anti-tau antibodies effects on tau biochemistry","Investments < €500k",,"United States of America" "Mediator as a transducer of amyloid precursor protein-dependent nuclear signaling","Investments < €500k",,"United States of America" "Medical Intelligence for Assistive Management Interface – Mild Dementia","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "Medicinal Chemistry of Drugs Acting on CRH Receptors","Investments < €500k",,"United States of America" "Medicine-associated dementia and cognitive impairment: identifying the problem, reducing the harm",Fellowships,"Alzheimer's disease & other dementias",Australia "Meeting the support needs of family carers of people living with dementia in the community: Potential translation into practice","Investments < €500k",,Australia "MEETINGDEM: Adaptive Implementation and Validation of the positively evaluated Meeting Centers Support Programme for people with dementia and their carers in Europe","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias","Italy|JPND|Netherlands|Poland|United Kingdom" "MEG – CENIR, Université Pierre et Marie Curie","Capital Infrastructure",,France "MEG/EEG – Institut de Neurosciences des systèmes","Capital Infrastructure",,France "Membrane interaction and disruption by the Alzheimers amyloid-beta peptide","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Membrane remodeling by alpha-synuclein: implications for function and disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Membrane trafficking in Alzheimer’s disease","Investments < €500k",,Australia "Membrane trafficking of BACE1 and amyloid precursor protein in primary neurons and the production of Abeta amyloid peptides","Investments < €500k",,Australia "Membrane-anchored amyloid peptides in Alzheimers disease","Investments < €500k",,"United States of America" "Memory Care Partner","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Memory Clinic, KBFZ, University of Bonn",Biobanks,"Alzheimer's disease & other dementias",Germany "Memory Lane: A neuro-exergame to mitigate cognitive decline in later life","Investments < €500k",,"United States of America" "Memory Matters: A Mobile Aid to Stimulate Reminiscing in Persons with Memory Loss","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Memory network dysfunction as an early marker of preclinical Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Memory processing after neuron loss in the entorhinal cortex and hippocampus","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Memory training for persons with Parkinson’s diesease","Investments < €500k",,Sweden "Memory training in older diabetic persons at risk of dementia",Fellowships,"Alzheimer's disease & other dementias",Australia "Memory training in people at risk for dementia",Fellowships,"Alzheimer's disease & other dementias",Australia "Memory-Related Protein Synthesis in Alzheimers Disease Mouse Models","Investments < €500k",,"United States of America" "MemoryCare: Investigating the management of refusal of care in people with dementia admitted to hospital with an acute condition","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Menopausal Vasomotor Symptoms and Brain Aging in Women","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Mental Ageing","Investments > €500k","Alzheimer's disease & other dementias|Neurodegenerative disease in general","United Kingdom" "Mental and cognitive health in relation to functional ability and somatic health in the elderly. The influence of age, sex, birth cohort, genetic, psychological, social and neurobiological factors.","Investments > €500k","Alzheimer's disease & other dementias",Sweden "Mentoring and Research on Neurobiological Markers of Clinical Outcomes in Depression",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Mentoring Imaging Research in Early AD",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Mercers Institute for Successful Ageing","Capital Infrastructure",,Ireland "MESENCHYMAL STEM CELLS FOR MACHADO-JOSEPH DISEASE THERAPY",Fellowships,"Spinocerebellar ataxia (SCA)",Portugal "Metabolic and Genetic Regulation of Ageing","Investments > €500k","Neurodegenerative disease in general","European Commission" "Metabolic and vascular contributors to dementia’","Investments < €500k",,"United Kingdom" "METABOLIC BASIS OF NEURODEGENERATIVE DISEASE","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "Metabolic dysregulation in astrocytes derived from Parkin-mutant patients","Investments < €500k",,"United Kingdom" "Metabolic hormones, aging, and Alzheimers Disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Metabolic imaging in neurodegenerative diseases","Investments > €500k","Neurodegenerative disease in general",Germany "Metabolic Networks and Pathways in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Metabolic Networks and Pathways in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Metabolic profiling of sporadic ALS patients: from fibroblasts to neurons and back","Investments > €500k","Motor neurone diseases","United States of America" "Metabolic Regulation of Neurodegeneration in Tauopathy","Investments < €500k",,"United States of America" "Metabolic Signatures Underlying Vascular Risk Factors for Alzheimer-type Dementias","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Metabolic Syndrome and Alzheimer’s Disease","Investments < €500k",,Turkey "Metabolomic/lipidomic analysis of apoE isoform effects in AD-linked brain regions",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Metabolomics and risk of Parkinsons Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Metagenomic Analysis of the Relationship Between Alzheimer’s Disease and Intestinal Microbiome","Investments < €500k",,Turkey "Metal complexes for the treatment of age-related diseases of the brain",Fellowships,"Alzheimer's disease & other dementias",Australia "Metal ions in disorders of aging: Interplay between Metallostasis and Proteostasis in Neurodegeneration. Ioni Metallici nelle Patologie da Invecchiamento: Interplay tra Metallostasi e Proteostasi nella Neurodegenerazione.","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders|Prion disease",Italy "Metal- and pH-induced conformational changes of peptides associated with neurodegenerative pathologies (METADIS)","Investments < €500k",,Romania "Metal-ion-based neurodegeneration: enabling techniques for understanding, detection, and treatment","Investments < €500k",,"United Kingdom" "Methamphetamine and Parkinsons disease: converging mechanisms of pathogenesis",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Methodology Issues in a Tailored Light Treatment for Persons with Dementia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Methods for Dynamic Causal Interactions in Human Brain Function and Dysfunction","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "mGlu Allosteric Modulation in Neurodegenerative Diseases","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "mhealth platform for Parkinson’s disease management","Investments > €500k","Parkinson's disease & PD-related disorders","European Commission" "MICA- Evaluation of AZD1080 (GSK-3 inhibitor) in a preclinical mouse model of motor neuron disease (MND)","Investments < €500k",,"United Kingdom" "MICA: HD-CSF: Studying cerebrospinal fluid to understand key CNS pathobiological targets in Huntington’s disease",Fellowships,"Huntington's disease","United Kingdom" "Microfluidic technology to help understand physical damage to brain cells","Investments < €500k",,Australia "Microglia Cell Model (VU University Medical Center)","Experimental Models",,Netherlands "MICROGLIA DYSREGULATION AS TRIGGER FOR CHRONIC NEUROINFLAMMATION: IMPACT FOR AGING AND NEURODEGENERATIVE DISEASES",Fellowships,"Neurodegenerative disease in general",Portugal "Microglia function in Alzheimer’s disease: studying human primary cells",Fellowships,"Alzheimer's disease & other dementias",Netherlands "Microglia, RAGE, and Alzheimers Disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Microglial and macrophage potassium channels as regulators of neuroinflammation in Alzheimers Disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Microglial modulation, a potential therapeutic approach in neurodegenerative diseases","Investments < €500k",,Canada "microRNA (miRNA) signaling in Alzheimers disease(AD)","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "MicroRNA as a biomarker in Parkinson’s Disease and Multiple System Atrophy","Investments < €500k",,Denmark "microRNA as novel therapeutic targets and disease biomarkers in Alzheimer’s Disease, Frontotemporal dementia and Anyotrophic lateral sclerosis (NEURO-MIR)","Investments < €500k",,Ireland "MicroRNA modulation of tau expression and phosphorylation in tauopathy","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "MicroRNA-15 dysregulation in sporadic Alzheimer’s disease: testing the “multiple hit” hypothesis in neurodegenerative disorders","Investments < €500k",,Canada "microRNA-758-3p in cognition and Alzheimers disease","Investments < €500k",,"United States of America" "Microrobotic nasal endoscopy by OCT: impact of smell deficiency on neurodegenerative diseases","Investments > €500k","Neurodegenerative disease in general",France "Microscopic image analysis of the relationship between electrophysiological energy cost and dopaminergic neuronal degeneration in vitro.","Investments < €500k",,Luxembourg "Microvascular breakdown: At the core of plaque formation and neuronal pathology in Alzheimer’s disease","Investments < €500k",,Australia "Microvascular function and brain networks: Keys to understanding the vascular burden in dementia",Fellowships,"Alzheimer's disease & other dementias",Netherlands "Midcareer Award for Research in Dementia Risk Factors and Prevention",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Midcareer Investigator Award in Amylin, Cognition, and Alzheimers Disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Midcareer Mentoring Award for Patient-Oriented Research in Aging",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Midlife Brain Plasticity: Exercise and Vascular Function",Fellowships,"Alzheimer's disease & other dementias","United States of America" "MIDLIFE COGNITIVE CHANGE AND RISK OF COGNITIVE DECLINE","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Mild Cognitive Impairment in Older Rural Dwelling Adults",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Mild Cognitive Impairment: a Prospective Community Study","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Million Women Study","Investments > €500k","Alzheimer's disease & other dementias|Neurodegenerative disease in general","United Kingdom" "Mimicry of Amyloid Oligomers","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "MIND Diet Intervention to Prevent Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "MIND-AD: Multimodal preventive trials for Alzheimer’s Disease: towards multinational strategies","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias",Finland|France|Germany|JPND|Netherlands|Sweden "MIND: An RCT of care coordination for community-living persons with dementia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Mindfulness and guided imagery for depressed family caregivers of patients with Alzheimer’s disease and related dementias: clinical outcomes and neural mechanisms","Investments < €500k",,"United States of America" "Minocycline in Alzheimer’s Disease Efficacy Trial: The MADE Trial","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Minocycline in Alzheimer’s Disease Efficacy Trial: The MADE Trial","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Mint Adaptor Proteins in APP Binding and Processing","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "MIRIAD : Molecular Imaging Research Initiative for Application in Drug Development","Investments > €500k","Parkinson's disease & PD-related disorders",Belgium "miRNAs as a Neurodegeneration Risk Factor in Boxers","Investments < €500k",,Turkey "Mise en évidence de BIOmarqueurs dans les syndromes PARKinsoniens – BIOPARK. Demonstration of BIO markers in PARKinsonian syndromes – BIOPARK","Investments < €500k",,France "Misfolded ALS-linked Profilin-1: a novel therapeutic target","Investments > €500k","Motor neurone diseases","United States of America" "Misfolded protein clearance enhancers for Alzheimers therapy","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Misfolded protein-clearance enhancers for Alzheimers therapy","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Misfolded SOD1 Toxicity in Amyotrophic Lateral Sclerosis",Fellowships,"Motor neurone diseases", "MisingLink: Identification and structural characterization of the primordial cytotoxic conformers of the amyloidogenic cascade: Ideal prevention/diagnostic/therapeutic targets in neurodegeneration","Investments < €500k|JPND Projects",,Ireland|JPND|Poland|Spain "Mito-ND: Mitochondrial Neurodegeneration","Investments < €500k",,"Germany|United Kingdom" "Mitochondrial ATP Synthase Dysfunction and Synaptic Stress in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Mitochondrial degrading enzyme, synaptic mitochondrial function in AD mouse model","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Mitochondrial DNA and Ape1 in Huntingtons Disease","Investments > €500k","Huntington's disease","United States of America" "Mitochondrial DNA Quality Control and Neurodegeneration","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Mitochondrial dysfunction in the pathogenesis of Parkinsons disease: elucidating disease mechanisms and identifying therapeutic targets","Investments > €500k","Parkinson's disease & PD-related disorders",Norway "Mitochondrial dysfunction in the pathogenesis of Parkinson’s disease: elucidating disease mechanisms and identifying therapeutic targets","Investments < €500k",,Norway "Mitochondrial dysfunction in the pathogenesis of Parkinson’s disease: identifying novel disease mechanisms and designing treatments","Investments > €500k","Parkinson's disease & PD-related disorders",Norway "Mitochondrial endophanotypes of Parkinson ‘s disease","Investments > €500k","Parkinson's disease & PD-related disorders",Germany "Mitochondrial endophenotypes of PD","Investments < €500k",,Luxembourg "Mitochondrial fission in Huntingtons Disease","Investments > €500k","Huntington's disease","United States of America" "Mitochondrial function in sporadic Parkinson’s","Investments < €500k",,"United Kingdom" "Mitochondrial imaging in live neurons from Parkinson’s disease patients","Investments < €500k",,Belgium "Mitochondrial imaging in live neurons from Parkinson’s disease patients","Investments < €500k",,Belgium "MITOCHONDRIAL PHARMACOGENOMIC IN ALZHEIMER’S DISEASE","Investments < €500k",,Spain "Mitochondrial SIRT3 in Huntingtons disease","Investments < €500k",,"United States of America" "Mitochondrial SIRT3 in Huntingtons disease","Investments < €500k",,"United States of America" "MITOCHONDRIAL TRAFFICKING IN ALZHEIMER’S DISEASE AND HYPOXIC PRECONDITIONING: UNVEILING THE ROLE OF THE HYPOXIA UP-REGULATED MITOCHONDRIAL MOVEMENT REGULATOR",Fellowships,"Alzheimer's disease & other dementias",Portugal "Mitochondrial ubiquitin dynamics and apoptotic cell death.","Investments > €500k","Parkinson's disease & PD-related disorders","United Kingdom" "Mitophagy upregulation as a therapeutic strategy for Alzheimers disease","Investments < €500k",,"United States of America" "Mnemic neglect in people affected with Mild Alzheimer’s disease: replicating and extending findings from Experimental Social Psychology","Investments < €500k",,"United Kingdom" "Mobile Application to Deliver Personalized Nutrition for the Prevention of Alzheimers Disease","Investments < €500k",,"United States of America" "Mobile Decision Support System for Nurse Management of Neuromodulation Therapy","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Mobilization assistant for patients with dementia and their relatives","Investments > €500k","Alzheimer's disease & other dementias",Germany "Mobilizing the healthcare community towards an integrated approach to improving outcomes of patients with sleep disorders – Canadian Sleep and Circadian Network (CSCN)","Investments > €500k","Neurodegenerative disease in general",Canada "Model of cellular communication between neural and immune system in Alzheimer’s disease","Investments < €500k",,Slovakia "Modeling aerobic exercise regimens: prevention and amelioration of amyloid pathologies and cognitive impairment","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Modeling and correcting Huntington’s disease-associated myelin deficiency in human glial chimeras","Investments < €500k",,Denmark "Modeling Axonal Density and Inflammation-Associated Cellularity in Alzheimer’s Disease Using Hybrid Diffusion Imaging","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Modeling DNA methylation changes in Alzheimers disease using induced human pluripotent stem cells.",Fellowships,"Alzheimer's disease & other dementias","United States of America" "MODELING HUNTINGTONS DISEASE WITH STRIATAL NEURONS DIRECTLY CONVERTED FROM PATIENT FIBROBLASTS","Investments < €500k",,"United States of America" "MODELING HUNTINGTONS DISEASE WITH STRIATAL NEURONS DIRECTLY CONVERTED FROM PATIENT FIBROBLASTS","Investments < €500k",,"United States of America" "Modeling Parkinsons Disease with Isogenic hiPSC-Derived Dopaminergic Neurons","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Modeling synaptic vesicles: how does alpha-Synuclein inhibit fusion?","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Modeling Synaptic Vulnerability of a Brainstem Sensorimotor Circuit in a Mouse Model for Amyotrophic Lateral Sclerosis","Investments < €500k",,"United States of America" "Modeling Synaptic Vulnerability of a Brainstem Sensorimotor Circuit in a Mouse Model for Amyotrophic Lateral Sclerosis","Investments < €500k",,"United States of America" "Modeling the effects of reducing huntingtin and Hdh alternative splicing in mice","Investments > €500k","Huntington's disease","United States of America" "Modeling the progression of SOD1-linked motor neuron disease","Investments > €500k","Motor neurone diseases","United States of America" "Modelling idiopathic Parkinson’s disease-associated somatic variation in dopaminergic neurons – ATTRACT","Investments > €500k","Parkinson's disease & PD-related disorders",Luxembourg "Modelling multi-factorial neurodegeneration in Parkinson’s disease: removing roadblocks towards the clinic","Investments > €500k","Neurodegenerative disease in general|Parkinson's disease & PD-related disorders",France "Modelling sub-clinical vCJD infection in the UK population","Investments > €500k","Prion disease","United Kingdom" "MODEM – Monitoring Of Dementia using Eye Movements","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Modifiable risk factors for cognitive impairment in ageing",Fellowships,"Alzheimer's disease & other dementias",Australia "Modifiable risks and interventions for older people ‘at risk’ of dementia",Fellowships,"Alzheimer's disease & other dementias",Australia "Modified intrinsic excitability in transgenic mouse models of progressive beta-amyloidopathy","Investments < €500k",,"United Kingdom" "Modifier Genes that Influence Age at Onset or Protect Against Development of Alzheimers Disease (AD)","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Modifiers of C9orf72 associated dipeptide protein toxicity in a C. elegans model","Investments < €500k",,"United States of America" "Modifiers of C9orf72 associated dipeptide protein toxicity in a C. elegans model","Investments < €500k",,"United States of America" "Modifiers of C9orf72 associated dipeptide protein toxicity in a C. elegans model","Investments < €500k",,"United States of America" "Modifiers of Machado-Joseph disease: study of ataxin3-like and Josephin domain containing proteins",Fellowships,"Spinocerebellar ataxia (SCA)",Portugal "Modifing the exosomal release of alpha synuclein as a potential target to prevent disease progression in Parkinson’s","Investments < €500k",,"United Kingdom" "Modifying the Trajectory of Insidious Late Life Cognitive Decline using Computerised Cognitive Training","Investments < €500k",,Australia "Modulating Blood Vessel Growth in Alzheimer’s Disease","Investments < €500k",,Canada "Modulating Ire1 to prevent Parkinson’ Disease","Investments < €500k",,Portugal "Modulating Ire1 to treat Parkinson’s Disease","Investments < €500k",,France "Modulating memory circuits: focal DBS treatments to improve medial temporal lobe function","Investments > €500k","Alzheimer's disease & other dementias",Canada "Modulating microglial function and its impact on neuronal function","Investments > €500k","Alzheimer's disease & other dementias",Ireland "Modulating the Nucleopathy caused by FUS Mutants of ALS","Investments < €500k",,"United States of America" "Modulating the Nucleopathy caused by FUS Mutants of ALS","Investments < €500k",,"United States of America" "MODULATION OF ALPHA-SYNUCLEIN AGGREGATION AND TOXICITY: PROTECTIVE STRATEGIES FOR PARKINSON’S DISEASE",Fellowships,"Parkinson's disease & PD-related disorders",Portugal "Modulation of microRNA pathways by gemfibrozil in predementia Alzheimer disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Modulation of Perceived Duration by Contextual (Motion) and Dopaminergic Factors: An Integrated Psychophysical, Functional Imaging, Electrophysiological, and Psychopharmacological Approach","Investments < €500k",,France "Modulation of tau pathogenesis by high dietary fat, gender and ApoE isoform","Investments < €500k",,"United States of America" "Modulation of the Innate Immune Response by Fisetin Derivatives for the Treatment of AD","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Modulation of tyrosine hydroxylase activity to control catecholamine synthesis and its effect on cellular metabolism – CORE","Investments > €500k","Parkinson's disease & PD-related disorders",Luxembourg "Modulatory Effects of Fitness on Hippocampal Dependent Memory Across the Lifespan",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Molecular analysis of neurodegeneration and muscular atrophy in amyotrophic lateral sclerosis","Investments < €500k",,Germany "Molecular and Biological Characterisation of Novel Genetic Markers Associated to the Common of Alzheimer’s Disease in a Population Isolate from Eastern Canada","Investments > €500k","Alzheimer's disease & other dementias",Canada "Molecular and cellular determinants of dopamine-related brain diseases","Investments < €500k",,Sweden "Molecular and cellular mechanisms of protein aggregation and toxicity in models of neurodegeneration.",Fellowships,"Neurodegenerative disease in general","United Kingdom" "Molecular and phenotypic analysis of human prion strains","Investments > €500k","Prion disease","United Kingdom" "Molecular and structural imaging in atypical Alzheimers disease: a longitudinal study","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Molecular approaches for understanding and advancing tau immunotherapies",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Molecular aspects of copper and zinc binding to the prion protein","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Molecular basis of Parkinson’s Disease: the fate of cytotoxic oligomers under cell-like conditions","Investments < €500k",,Denmark "Molecular basis of Parkinson’s Disease: the fate of cytotoxic oligomers under cell-like conditions","Investments < €500k",,Denmark "Molecular Basis of Protein Misfolding Disorders.","Investments > €500k","Neurodegenerative disease in general","United Kingdom" "Molecular Basis of Synaptic Suppression by ApoE","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Molecular Basis of TDP-43 Proteinopathies: Disease Models and Mechanisms","Investments < €500k",,"United States of America" "Molecular Basis of TDP-43 Proteinopathies: Disease Models and Mechanisms","Investments < €500k",,"United States of America" "Molecular Chaperones and Small Molecules","Investments > €500k","Huntington's disease","United States of America" "Molecular characterisation of mitochondrial disease, using Drosophila melanogaster as model system","Investments > €500k","Parkinson's disease & PD-related disorders",Sweden "Molecular Characterization and Validation of Gender Differences in Alzheimers Disease Pathogenesis","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Molecular Characterization of ALS/FTD in a novel C9orf72 BAC mouse model.","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "Molecular Characterization of ALS/FTD in a novel C9orf72 BAC mouse model.","Investments > €500k","Motor neurone diseases","United States of America" "Molecular determinants of CAG repeat expansions in Huntington’s disease","Investments < €500k",,Ireland "Molecular diagnostic strategies in prion disease","Investments > €500k","Prion disease","United Kingdom" "Molecular function of human senataxin protein, mutated in ataxia oculomotor apraxia type 2 (AOA2) and amyotrophic lateral sclerosis type 4 (ALS4), in the pathology of these diseases.","Investments < €500k",,"United Kingdom" "Molecular Genetic Characterization of SCA8","Investments > €500k","Spinocerebellar ataxia (SCA)","United States of America" "Molecular Genetic Characterization of SCA8","Investments > €500k","Spinocerebellar ataxia (SCA)","United States of America" "Molecular genetic studies of progranulin regulators in FTLD and ALS","Investments < €500k",,"United States of America" "Molecular genetic studies of progranulin regulators in FTLD and ALS","Investments < €500k",,"United States of America" "Molecular genetic studies of progranulin regulators in FTLD and ALS","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Molecular heterogeneity in brain disorders; studies in Huntington’s disease, Rubinstein-Taybi syndrome and glioblastomas",Fellowships,"Huntington's disease",Spain "Molecular imaging at the synaptic level: the role of synaptic zinc in traumatic brain injury and neurodegenerative disease","Investments < €500k",,Sweden "Molecular imaging in neuropathology","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders",Sweden "Molecular Imaging of Biomaterials – Single Cells","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Molecular Imaging of Inflammation in Amyotrophic Lateral Sclerosis (ALS)",Fellowships,"Motor neurone diseases","United States of America" "Molecular Imaging Radiochemistry Research Infrastructure (MIRRI)","Capital Infrastructure",,Finland "Molecular insights in inherited dementia disorders – Cerebrospinal fluid biomarkers and stem cell derived neuron pathology","Investments < €500k",,Denmark "Molecular interplay between A?, tau and mTOR: Mechanisms of neurodegeneration","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "MOLECULAR LINKS BETWEEN DIABETES AND NEURODEGENERATIVE DISORDERS","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders",Spain "Molecular mechanism of amyloid beta aggregation","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "Molecular mechanism of innate signalling in the immune and nervous system.",Fellowships,"Parkinson's disease & PD-related disorders","United Kingdom" "Molecular Mechanism of LRRK2 Biology and Pathology in Parkinsons Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Molecular mechanisms and cellular implications of tau dysfunction","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "MOLECULAR MECHANISMS IN DELIRIUM AND DEMENTIA: IDENTIFICATION OF POTENTIAL THERAPEUTIC TARGETS","Investments > €500k","Alzheimer's disease & other dementias",Norway "Molecular mechanisms in progranulin deficient frontotemporal dementia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Molecular mechanisms of Abeta aggregation in Alzheimer Disease","Investments < €500k",,Sweden "Molecular mechanisms of ADAMTSL3 and other brain-derived target genes in the cellular processes relevant for Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias",Finland "MOLECULAR MECHANISMS OF AGING-RELATED RETROTRANSPOSON DEREPRESSION: INSIGHTS INTO NEURODEGENERATIVE DISEASES AND NEW PROPHYLACTIC STRATEGIES",Fellowships,"Neurodegenerative disease in general",Portugal "Molecular mechanisms of C9ORF72 repeat expansion toxicity in frontotemporal dementia","Investments < €500k",,"United Kingdom" "Molecular mechanisms of C9ORF72 repeat expansion toxicity in motor neurone disease","Investments < €500k",,"United Kingdom" "Molecular mechanisms of diabetes-induced neurodegenerative changes in CNS","Investments < €500k",,Slovakia "Molecular mechanisms of ganglion cell loss in Alzheimers disease","Investments < €500k",,"United States of America" "Molecular mechanisms of huntingtin misfolding","Investments > €500k","Huntington's disease","United States of America" "Molecular mechanisms of mitochondrial dysfunction in ATP13A2-associated neurodege",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Molecular mechanisms of neurodegeneration","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders","United Kingdom" "Molecular mechanisms of neurodegeneration caused by mitochondrial disfunction",Fellowships,"Neurodegenerative disease in general",Finland "Molecular mechanisms of Parkin-directed mitochondrial quality control","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Molecular mechanisms of Parkinson pathology spread and potential therapeutic interventions","Investments > €500k","Parkinson's disease & PD-related disorders",Sweden "Molecular mechanisms of TDP-43 mediated neurodegeneration","Investments < €500k",,"United Kingdom" "Molecular Mechanisms Underlying Mitochondrial Dynamics Abnormalities in Alzheimer Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Molecular mediators of physical exercise and carnosine-induced effects in patients with preclinical and early stage neurodegenerative disease.","Investments < €500k",,Slovakia "Molecular Modeling and Synthesis of 2-Pyrazoline Derivatives for Alzheimer’s Disease Theraphy","Investments < €500k",,Turkey "MOLECULAR MODULATION OF EXTRASINAPTIC COMPLEXES OF NMDA RECEPTORS AS A THERAPEUTIC STRATEGY FOR ALZHEIMER’S DISEASE","Investments < €500k",,Spain "Molecular Neuroimaging of Disease Mechanisms in Cerebral Amyloid Angiopathy",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Molecular Neuropathology and Mechanisms of BACE1 Elevation in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Molecular neuropathology of TDP-43 proteinopathies","Investments < €500k",,"United States of America" "Molecular neuropathology of TDP-43 proteinopathies","Investments < €500k",,"United States of America" "Molecular neuropathology of TDP-43 proteinopathies","Investments < €500k",,"United States of America" "Molecular neuroscience of Parkinson’s Disease: Retromer (VPS35) dysfunction","Investments > €500k","Parkinson's disease & PD-related disorders",Canada "MOLECULAR ORCHESTRATION OF MITOCHONDRIAL FITNESS VIA REPLACEMENT OR REPAIR","Investments < €500k",,"United States of America" "MOLECULAR ORCHESTRATION OF MITOCHONDRIAL FITNESS VIA REPLACEMENT OR REPAIR","Investments < €500k",,"United States of America" "Molecular pathways leading to neurodegeneration in vivo","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Molecular PET imaging of Tau in comparison with AD and non-AD dementia pathology","Investments < €500k",,Sweden "Molecular Phenotyping in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Molecular phenotyping of cortical cell types in multiple rodent models of ALS","Investments > €500k","Motor neurone diseases","United States of America" "Molecular profiling of familial and sporadic Alzheimers disease","Investments < €500k",,"United States of America" "Molecular profiling of miRNA and gene expression changes in a model of human tauopathy","Investments < €500k",,Slovakia "Molecular Regulation of AEP during Ageing","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "MOLECULAR STUDY AND GENE THERAPY FOR MUCOPOLISACARIDOSIS TYPE VII.","Investments < €500k",,Spain "Mondgezondheid van mensen met de ziekte van Parkinson in Nederland. Oral health of people with Parkinson’s disease in the Netherlands","Investments < €500k",,Netherlands "Monitoring and evaluation of local alliances for people with dementia","Investments < €500k",,Germany "MONITORING THE MOBILITY OF PARKINSON ILLNESSES WITH THERAPEUTIC PURPOSES – 3 (MOMOPA-3)","Investments < €500k",,Spain "Mood Regulation Using Music: A Community Health Strategy for Improving Quality of Life in People With Mild Dementia",Fellowships,"Alzheimer's disease & other dementias",Australia "More than a Movement Disorder: Applying Palliative Care to Parkinsons Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Motor and Cognitive Health Outcomes in a Mn-Exposed African Community","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Motor axon stabilisation in zebrafish and models of motor neuron disease","Investments < €500k",,"United Kingdom" "Motor Neuron Disease Diagnosis: The utility of standard frame rate B-mode ultrasound imaging","Investments < €500k",,"United Kingdom" "Mouse Cell Type-Specific Brain Mapping in Health and Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Mouse model studies of TMEM230-linked Parkinsons disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Mouse models of C9orf72 di-peptide repeat proteins","Investments < €500k",,"United Kingdom" "Moving Behavioural Neuroscience & Neuroeconomics into Dementia Prevention: Spatial tracking and economic decision-making as new sensitive measures of daily function",Fellowships,"Alzheimer's disease & other dementias",Australia "MPP+ Parkinson’s Disease Model","Investments < €500k",,Turkey "MR Imaging Based Biomarkers in Mild Cognitive Disorders in Parkinson’s Disease","Investments < €500k",,Turkey "MRC Brain Banks: Joint Application to Underpin Neuroscience Research","Capital Infrastructure",,"United Kingdom" "MRC Centre for Neuropsychiatric Genetics and Genomics","Investments > €500k","Alzheimer's disease & other dementias|Neurodegenerative disease in general|Parkinson's disease & PD-related disorders","United Kingdom" "MRI 0,2T / 1,5T / 3T – Institut de Bio-Imaging (IBIO)","Capital Infrastructure",,France "MRI 1,5T / 4,7T/ Microscopy/ Microendoscopy – CLINATEC","Capital Infrastructure",,France "MRI 3T /Photonic imaging – Institut des Neurosciences de la Timone","Capital Infrastructure",,France "MRI 3T/11,7T, MRI-TMS 3T, PET-MRI 3T – CENIR, Université Pierre et Marie Curie","Capital Infrastructure",,France "MRI 4,7T / 7T / 9,4T – Institut de Bio-Imaging (IBIO)","Capital Infrastructure",,France "MRI 4,7T/Optic/Optoaccoustic/US – CREATIS","Capital Infrastructure",,France "MRI and CSF Biomarkers of White Matter Injury in VCID","Investments > €500k","Alzheimer's disease & other dementias","United States of America" MRI-APP,"Bio/Neuroinformatic Resources","Alzheimer's disease & other dementias",Switzerland "MRI, Cognitive, Genetic and Biomarker Precursors of AD & Dementia in Young Adults","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "MRI, Genetics & Cognitive Precursors of AD and Dementia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "mTOR signalling pathway in the risk stratification for future cognitive decline in Mild Cognitive Impairment (MCI).","Investments > €500k","Neurodegenerative disease in general","United Kingdom" "MULIDIDIAN CHIRAL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES: NICOTYL RECEPTOR LIGANDS, NRF2 AND ANTI-INFLAMMATORY INDUCTORS","Investments < €500k",,Spain "Multi-level Integrative Proteomics to Alzheimers Disease Pathways","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Multi-modal Prediction of Future Clinical Dementia","Investments < €500k",,"United States of America" "Multi-modal retinal biomarkers for vascular dementia: developing enabling image analysis tools","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Multi-Modality Image Data Fusion and Machine Learning Approaches for Personalized Diagnostics and Prognostics of MCI due to AD","Investments < €500k",,"United States of America" "Multi-parametric and super-resolution imaging of amyloidogenic proteins","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Multi-Source Sparse Learning to Identify MCI and Predict Decline","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Multicenter neuroimaging platform","Bio/Neuroinformatic Resources","Alzheimer's disease & other dementias|Huntington's disease|Motor neurone diseases|Neurodegenerative disease in general|Parkinson's disease & PD-related disorders",France "Multicentre evaluation of the Sheffield Support Snood","Investments < €500k",,"United Kingdom" "Multidisciplinary approach in the diagnosis of frontotemporal lobar degenerations and tauopathies: new insights into pathogenetic mechanisms","Investments < €500k",,"Czech Republic" "Multidisciplinary Fellowship in Dementia Research",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Multidomäna interventioner för att förebygga Alzheimers sjukdom: MIND-AD. Multidomain interventions to prevent Alzheimer’s disease: MIND-AD","Investments < €500k",,Sweden "Multifunctional brain pericytes: Implications for Brain Disease","Investments < €500k",,Sweden "Multimarker Parkinson’s Diagnotic test kit for monitoring disease progression based on electroanalytical detection of protein changes in blood.","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Multimedia Authoring and Management using your Eyes and Mind","Investments > €500k","Parkinson's disease & PD-related disorders","European Commission" "Multimodal analysis of Imaging and Biomarkers in Alzheimer’s disease","Investments < €500k",,Finland "Multimodal Assessment For Predicting Specific Pathological Substrate in Frontotemporal Lobar Degeneration","Investments < €500k",,Canada "Multimodal biomarkers for the longer-term prediction and staging of a probable Alzheimer’s disease in pre-dementia conditions","Investments < €500k",,Germany "Multimodal Biomarkers in Frontotemporal Lobar Degeneration",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Multimodal imaging in frontotemporal degeneration",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Multimodal modeling framework for fusing structural and functional connectome data","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Multimodal MRI biomarkers of small vessel disease for older persons with and without dementia.","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Multimodal MRI markers of nigrostriatal pathology in Parkinsons disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Multiple Approaches to Abeta Vaccination in Animal Models","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders","United States of America" "Multiple Approaches to Abeta Vaccination in Animal Models","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Multiple Sclerosis Society & Parkinson’s UK Tissue Bank",Biobanks,"Parkinson's disease & PD-related disorders","United Kingdom" "MULTISCALE ANALYSIS OF SENSORY-MOTOR CORTICAL GATING IN BEHAVING MICE","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Multiscale Modelling of the Neuromuscular System for Closed Loop Deep Brain Stimulation","Investments > €500k","Parkinson's disease & PD-related disorders","European Commission" "Multitarget compounds with therapeutic potential against Alzheimer disease: Design and in vitro studies",Fellowships,"Alzheimer's disease & other dementias","European Commission" "Muscle stem cells: New ALS growth factor therapy and disease model","Investments > €500k","Motor neurone diseases","United States of America" "Music systems for the therapy and activation of dementia patients","Investments > €500k","Alzheimer's disease & other dementias",Germany "Mutant protein spread in Huntington’s disease and its implications for other neurodegenerative disorders of the CNS.","Investments < €500k",,Canada "Mutational and Functional Analysis of Genes Identified by GWAS Studies of Alzheimer’s Disease","Investments > €500k","Neurodegenerative disease in general",Canada "Mutational and Functional Analysis of Genes Identified by GWAS Studies of Alzheimer’s Disease",,"Neurodegenerative disease in general",Canada "Myelin lipid breakdown affected by Apolipoprotein E genotype: implications for Alzheimer’s Disease pathogenesis",Fellowships,"Alzheimer's disease & other dementias",Australia "Myelinating oligodendrocytes as a therapeutic target for Alzheimer’s Disease","Investments < €500k",,Norway "MySearch: Purposeful Individual and Independent Activities for Persons with Early to Moderate Stage Alzheimer’s Disease and Related Dementias","Investments < €500k",,"United States of America" "NAB3: Development of a Novel Multicellular In Vitro Model of Alzheimer’s disease-like Blood-Brain Barrier","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias",France|Germany|Italy|JPND|Netherlands|Portugal "NAD metabolsim and mitochondrial dysfunction in ALS models","Investments > €500k","Motor neurone diseases","United States of America" "NAD, PGC-1alpha and SIRT3 as Therapeutics Targets for Huntingtons Disease","Investments > €500k","Huntington's disease","United States of America" "Nanobodies to cross the blood brain barrier",Fellowships,"Alzheimer's disease & other dementias",Belgium "Nanocarriers Designed to Deliver Nucleic Acids to Brain","Investments > €500k","Huntington's disease","United States of America" "Nanocatalytic drugs towards Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias", "Nanofibrous Scaffolds for Transplantation of Human Dopaminergic Neurons","Investments < €500k",,"United States of America" "Nanofibrous Scaffolds for Transplantation of Human Dopaminergic Neurons","Investments < €500k",,"United States of America" "Nanomaterials for treatment of neurodegenerative disorders",Fellowships,"Neurodegenerative disease in general", "Nanomodified antioxidants for the prevention and treatment of neurodegenerative diseases","Investments < €500k",,Germany "NANOPARTICLE ACCESS FACILITATION SYSTEMS IN NEURODEGENERATIVE DISORDERS (NANOPARTICLE DELIVERY SYSTEM FOR NEURODEGENERATIVE DISORDERS)","Investments < €500k",,Spain "Nanoparticle Assisted Brain in vivo Imaging","Investments > €500k","Alzheimer's disease & other dementias|Neurodegenerative disease in general",Finland "Nanotubes to overcome the blood-brain barrier for the therapy of neurodegenerative diseases and to construct a microfluidic barrier model","Investments > €500k","Neurodegenerative disease in general",Germany "Nanowire Sensor Array-based Assay for Early Diagnosis of Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Narratives of diseased brains and failing minds: Dementia in science, medicine and literature in the twentieth century.","Investments < €500k",,"United Kingdom" "National Cell Repository for Alzheimers Disease (NCRAD)","Capital Infrastructure",,"United States of America" "National Centre for Social Research on Dementia (NCSRD)","Investments > €500k","Alzheimer's disease & other dementias",Ireland "National Child Development Study","Population Cohorts","Neurodegenerative disease in general","United Kingdom" "National CJD Research and Surveillance Unit","Investments > €500k","Prion disease","United Kingdom" "National Data Bank for Alzheimer’s Disease","Disease Registers","Neurodegenerative disease in general",France "National research infrastructure for biological and medical imaging (Czech-BioImaging)","Capital Infrastructure",,"Czech Republic" "Natural and designed inhibitors of amyloid formation","Investments < €500k",,Sweden "Natural history and biomarker discovery in C9orf72 Amyotrophic lateral sclerosis and frontotemporal dementia","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "Natural History of Amyloid Deposition in adults with Down Syndrome","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Navarra Neurological Tissue Bank",Biobanks,, "Near-infrared molecular imaging for monitoring therapy in AD mouse models","Investments < €500k",,"United States of America" "NECTAR – Genetic Screening Component of AMBRoSIA (Biomarkers Study)","Investments > €500k","Motor neurone diseases","United Kingdom" "NEEDS in ALS: Network for determining existential decisions in Amyotrophic Lateral Sclerosis","Investments > €500k|JPND Projects","Motor neurone diseases",Germany|JPND|Poland|Sweden "Neighbourhoods and Dementia: A mixed methods study","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Netherlands Brain Bank (NIN)",Biobanks,"Neurodegenerative disease in general",Netherlands "Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED)","Research Networks",,Spain "Network Modeling of Myelin Dysregulation in Alzheimers Disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Network Neurodegeneration in Alzheimer’s Disease",Fellowships,"Alzheimer's disease & other dementias", "Neural and Biochemical Mechanisms of Cognitive Aging","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Neural and Kinematic Features of Freezing of Gait for Adaptive Neurostimulation","Investments < €500k",,"United States of America" "Neural and Kinematic Features of Freezing of Gait for Adaptive Neurostimulation","Investments < €500k",,"United States of America" "Neural Correlates of Discrimination and Generalization in Recognition Memory",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Neural mechanisms of balance deficits, falls, and freezing of gait in Parkinsons disease",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Neural Oscillations in Health and Disease",Fellowships,"Parkinson's disease & PD-related disorders","United Kingdom" "NEURAL RESPONSE TO INSULIN RESISTANCE TREATMENTS",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Neural stem cells and the promotion of healthy brain aging","Investments < €500k",,Canada "Neural stem cells and the promotion of healthy brain aging","Investments < €500k",,Canada "Neural Substrates of Deterministic Decision Making","Investments < €500k",,"United States of America" "Neural Substrates of Deterministic Decision Making","Investments < €500k",,"United States of America" "Neural Toxicity of Paraquat is Related to Iron Regulation in the Midbrain","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "NEURAL TRANSPLANTATION IN THE TREATMENT OF PATIENTS WITH PARKINSON’S DISEASE","Investments > €500k","Parkinson's disease & PD-related disorders","European Commission" NEURATRIS,"Capital Infrastructure",,France Neuratris,"Research Networks",,France "Neurite Orientation Dispersion and Density Imaging (‘NODDI’) – a new approach to understanding cellular pathology in MND.","Investments < €500k",,"United Kingdom" "Neuro Image-guided decoding of mechanisms involved in healthy, accelerated and pathological aging","Investments < €500k",,Belgium "NEURO-MIR (microRNA as novel therapeutic targets and disease biomarkers in Alzheimer’s Disease, Frontotemporal dementia and Amyotrophic lateral sclerosis)","Bio/Neuroinformatic Resources","Alzheimer's disease & other dementias|Motor neurone diseases",Ireland NEURO-MUC,Biobanks,"Alzheimer's disease & other dementias|Neurodegenerative disease in general",Germany "NEUROACT: A collaborative training program to develop multi-electrode array (MEA) platforms to understand synaptic function and treat diseases of the nervous system","Investments > €500k","Neurodegenerative disease in general","European Commission" "Neurobehavior, Neuropathology, and Risk Factors in Alzheimers Disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Neurobiological Role of MicroRNA in Alzheimers","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Neurobiology and Therapeutic Potential of Klotho","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Neurochemical Actions of Psychotropic Drugs","Investments > €500k","Huntington's disease","United States of America" "Neurochemical changes associated with Parkinson´s disease and L-Dopainduced dyskinesia","Investments < €500k",,Sweden "Neurochemical closed-loop controller for smart DBS","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Neurocognitive disorders of the frontostriatal system","Investments < €500k",,Hungary Neurodegeneration,"Investments > €500k","Huntington's disease|Motor neurone diseases","United Kingdom" "Neurodegeneration and Brain Diseases: A new instrumental approach of analysis and development of pharmaceutical formulations","Investments < €500k",,Romania "Neurodegeneration and Brain Function in Aging with HIV and Parkinsons Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Neurodegeneration and Neuroprotection: the role you neuroglobin expression induced by estrogen hormones. Neurodegenerazione e Neuroprotezione: Ruole dell’espressione della neuroglobina indotta dagli ormoni estrogeni.","Investments > €500k","Alzheimer's disease & other dementias|Huntington's disease|Parkinson's disease & PD-related disorders",Italy "Neurodegeneration and Proteotoxicity Dissected in C. elegans and Mammals","Investments > €500k","Motor neurone diseases","United States of America" "Neurodegeneration in Aging Down Syndrome (NiAD): A Longitudinal Study of Cognition and Biomarkers of Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Neurodegeneration triggered by dysfunction of FUS protein – studies of the mechanism using in vivo models","Investments < €500k",,"United Kingdom" "Neurodegenerative disease biomarkers based on high quality wireless EEG.","Investments < €500k",,"European Commission" "NEURODEGENERATIVE DISEASES CAUSED BY MUTATIONS IN P150/GLUED: GENERATION OF NOVEL ANIMAL MODELS AND IDENTIFICATION OF DISEASE MODIFIERS",Fellowships,"Neurodegenerative disease in general",Portugal "Neurodegenerative diseases: immunotherapy, biomarkers, clinical and epidemiological investigations","Investments < €500k",,Sweden "Neurodegenerative Effect of Fe3O4 and Graphene Based Peptides in in vitro and in vivo Parkinson’s Models","Investments < €500k",,Turkey "Neurodevelopmental Trajectories Towards Neurodegenerative Disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Neuroeconomics of Framing Effects and Risk Attitudes in Early Dementia",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Neuroepidemiology of the vascular contribution to cognitive impairment and Alzheimers disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "NEUROEXERCISE: The effects of an extensive exercise program on the progression of mild cognitive impairment (MCI)","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias",Germany|Ireland|JPND|Netherlands "Neurofibrillary pathology and amyloidogenesis in Alzheimer’s disease: mechanistic insights","Investments < €500k",,Canada "Neurofilaments, SOD1 and Motor Neuron Diseases","Investments > €500k","Motor neurone diseases","United States of America" "Neurofysiologische visualisatie van brein netwerk-activiteit betrokken bij cognitief herstel in neurodegeneratie. Neurophysiological visualization of brain network activity associated with cognitive rehabilitation in neurodegeneration.",Fellowships,"Alzheimer's disease & other dementias",Belgium "NeuroGeM: Identification of genes that commonly modulate the severity of neurodegenerative diseases","Fellowships|JPND Projects","Alzheimer's disease & other dementias",JPND|Norway "NeuroGeM: Identification of genes that modulate the severity of all neurodegenerative diseases","Investments > €500k|JPND Projects","Neurodegenerative disease in general",Canada|Germany|JPND|Netherlands|Norway "Neuroimaging and Risk Factor Correlates in Aging and MCI",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Neuroimaging insights into sleep-wake dysfunction in older adults ‘at risk’ of developing dementia",Fellowships,"Alzheimer's disease & other dementias",Australia "Neuroimaging Predictors of Cognitive Decline and Impairment","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "NeuroInflammation and Cognitive decline in Alzheimer’s Disease : a pilot study of PET imaging of the translocator proteine ligands (TSPO) with [18 F] DPA-714 (NICAD)","Investments < €500k",,France "Neuroinflammation in frontotemporal dementia: The role of microglia in TDP-43-related disease","Investments < €500k",,Australia "Neuroinflammatory and cognitive consequences of losing cholinergic anti-inflammatory tone in the forebrain","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Neuroleptiques et Maladie de Huntington – Comparaison de l’olanzapine, la tétrabénazine et du tiapride – Un essai multicentrique contrôlé, randomisé. Neuroleptics and Huntington’s Disease – Comparison of olanzapine, tetrabenazine and tiapride – A controlled, randomized, multicentre trial","Investments < €500k",,France "Neurological Tissue Bank (BTN)",Biobanks,, "Neurological Tissue Bank and Biological Samples",Biobanks,, Neurology,"Investments > €500k","Alzheimer's disease & other dementias|Huntington's disease|Parkinson's disease & PD-related disorders","United Kingdom" "Neuron death in Parkinsons disease: The role of Trib3","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Neuron- and Circuit-Specific Mechanisms and Adaptations Regulating Motor Function in Parkinson Disease Models","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Neuronal Activity in MC and SMA during STN and GPi DBS in the Parkinsonian Monkey","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Neuronal allocation mechanisms of recent and remote memories in the normal and pathological brain","Investments > €500k","Alzheimer's disease & other dementias",France "Neuronal diversity in globus pallidus: from molecular profiling to function in voluntary movement","Investments > €500k","Parkinson's disease & PD-related disorders",France "Neuronal function of huntingtin associated protein","Investments < €500k",,"United States of America" "Neuronal function of huntingtin associated protein","Investments < €500k",,"United States of America" "Neuronal hyperactivity and neurotrophic factors in motor neuron disease","Investments < €500k",,Australia "Neuronal model systems and neurotoxicity","Investments > €500k","Neurodegenerative disease in general","United Kingdom" "Neuronal network disruptions in a model of tauopathy",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Neuronal Oscillations and Dysregulated Motor Learning in Parkinsonian Rats",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "NEURONAL PLASTICITY IN LEKODOPA-INDUCED DISEASES IN PARKINSON’S DISEASE","Investments < €500k",,Spain "Neuronal regulation of mitochondrial dynamics in models of Parkinsons disease.","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Neuronal toll-like 2 receptors contribute to the spread of Parkinson’s disease","Investments > €500k","Parkinson's disease & PD-related disorders",Australia "Neuronal- and systems-level understanding of spatial and episodic memory.","Investments > €500k","Alzheimer's disease & other dementias|Neurodegenerative disease in general","United Kingdom" "Neurons and biological timing","Investments > €500k","Neurodegenerative disease in general","United Kingdom" "Neuropathologic-Epidemiological Study of Metallomics and Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Neuropathological basis of brain network dysfunction",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Neuropathological changes underlying clinical heterogeneity in Alzheimer disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Neuropathology for disrupted multiscale activity control in Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Neuropeptide signaling in health and disease","Investments < €500k",,Sweden "Neuropeptiden in veroudering en neurodegeneratie. Neuropeptides in aging and neurodegeneration",Fellowships,"Alzheimer's disease & other dementias",Belgium "Neurophysiological Aspects of Vision-based Speed of Processing Cognitive Training in Older Adults with Mild Cognitive Impairment","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Neurophysiological mechanisms underlying parkinsonian motor signs","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Neurophysiology of response inhibition in PD",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Neuroprogressive and Dementia Disease Research Network","Research Networks",,"United Kingdom" "Neuroprotection and immunomodulation in the enteric nervous system for the treatment of Parkinson’s disease","Investments < €500k",,Canada "Neuroprotection by MC1R as the basis for the melanoma-Parkinsons disease link","Investments < €500k",,"United States of America" "Neuroprotection by MC1R as the basis for the melanoma-Parkinsons disease link","Investments < €500k",,"United States of America" "NEUROPROTECTION MECHANISMS THROUGH THE MODULATION OF CANNINOIN ENDOGENES IN PARKINSON’S DISEASE","Investments < €500k",,Spain "Neuroprotective effects of novel analogs of anorexigenic prolactin-releasing peptide (PrRP) in mouse models of neurodegeneration and obesity","Investments < €500k",,"Czech Republic" "Neuroprotective functions of autophagy regulators in Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias",Australia "Neuroprotective Immunity and HIV Dementia","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Neuroprotective mechanisms of non-classical estrogen-like signaling activators in basal forebrain cholinergic neurons: testing of novel compounds","Investments < €500k",,Hungary "Neuroprotective microRNAs, trophic factors and ER stress in adult dopaminergic neurons: significance for Parkinson’s disease","Investments < €500k",,Finland "Neuroprotective microRNAs, trophic factors and ER stress in adult dopaminergic neurons: significance for Parkinson’s disease",Fellowships,"Parkinson's disease & PD-related disorders",Finland "Neuroprotective role of GLP-1 receptor agonists","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Neuropsychological Functioning of Women with Prophylactic Oophorectomy","Investments < €500k",,Canada "Neuroregulatory Mechanisms of PIAS1 and Implications for Huntingtons Disease","Investments > €500k","Huntington's disease","United States of America" "NEUROSPIN – NMR imaging 3T/ 7T/11,7T/ 17,2T","Capital Infrastructure",,France "NeuroTraffic: Orientated neuronal networks for investigating mechanisms of tau propagation","Investments < €500k",,"United Kingdom" "Neurotropic Viral Infection in CNS Aging and Alzheimers Disease","Investments < €500k",,"United States of America" "Neurovascular Adaptation","Investments > €500k","Alzheimer's disease & other dementias",Canada "Neurovascular dysfunction in Alzheimer’s disease: the search for early biomarkers","Investments < €500k",,"United Kingdom" "NeuTARGETs: Targeting the propagation of pathogenic protein assemblies in neurodegenerative disease","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders",France|Germany|JPND|Sweden "Neutron scattering studies of co-aggregation of amyloid proteins and lipids","Investments > €500k","Parkinson's disease & PD-related disorders",Sweden "NEW APPROACH FOR THE STUDY OF ALZHEIMER: CONECTOMIC AND IMAGING IMAGE BY MRI IN RAT TGF344-AD.","Investments < €500k",,Spain "New biomarkers in early diagnosis and treatment of AD","Investments > €500k","Alzheimer's disease & other dementias",Sweden "New biomarkers for Alzheimer’s & Parkinson’s diseases – key tools for early diagnosis and drug development","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders","European Commission" "New biomarkers for early detection of Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias",Norway "New biomarkers of premotor Parkinson","Investments < €500k",,Slovakia "New concept for the treatment of neuroinflammatory and neurodegenerative diseases","Investments > €500k","Neurodegenerative disease in general",Germany "New diagnostic approaches to Creutzfeldt-Jakob disease","Investments < €500k",,"Czech Republic" "New Directions in Bayesian Statistics: formulation, computation and application to exemplar challenges","Investments < €500k",,Australia "New experimental model development to test procognitive and neuroprotective compounds","Investments < €500k",,Hungary "New experimental therapeutic approaches for Parkinson’s disease by direct DA neuronal reprogramming","Investments > €500k","Parkinson's disease & PD-related disorders","European Commission" "New humanised delta-14 mouse model for dissecting the pathobiology of FUS-ALS","Investments < €500k",,"United Kingdom" "New humanised mouse models for dissecting the pathobiology of disease, using FUS-ALS as a paradigm","Investments > €500k","Motor neurone diseases","United Kingdom" "New ideas on plaque can provide a functioning dementia medicine",Fellowships,"Alzheimer's disease & other dementias",Sweden "New imaging techniques in the study of brain perfusion abnormalities and neuronal degeneration processes in people with multiple sclerosis and other degenerative neurological diseases. Associations between radiological markers and genetic polymorphisms of susceptibility and course of neurodegenerative diseases. Nuove tecniche di imaging nello studio delle alterazioni perfusionali cerebrali e dei processi di degenerazione neuronale in soggetti affetti da sclerosi multipla e da altre patologie neurologiche degenerative. Associazioni tra marcatori radiologici e polimorfismi genetici di predisposizione e decorso delle malattie neurodegenerative.","Investments > €500k","Neurodegenerative disease in general|Spinal muscular atrophy (SMA)",Italy "New non-myomaide treatment of cognitive disorders (in vivo)","Investments < €500k",,Poland "New ocular biomarkers for early detection of Alzheimer’s disease","Investments < €500k",,Switzerland "New PET imaging agent for monitoring treatment response in Alzheimers disease","Investments < €500k",,"United States of America" "New piperazines effecting Abeta oligomer displacement from neuronal receptors","Investments < €500k",,"United States of America" "New region-specific targeted MRI to characterize Alzheimers disease pathology",Fellowships,"Alzheimer's disease & other dementias","United States of America" "NEW STRATEGY FOR THE TREATMENT OF EA: VALIDATION OF EPIGENETIC DIANAS, FROM IN-VITRO TO A MURINATE MODEL OF DISEASE. DESIGN AND DEVELOPMENT OF NEW PHARMACOLOGICAL TOOLS","Investments < €500k",,Spain "New therapeutic approaches for multiple system atrophy with starting point alpha-synuclein","Investments < €500k",,Germany "New therapies and diagnostic approaches for Alzheimer’s and Parkinson’s diseases",Fellowships,"Alzheimer's disease & other dementias",Australia "New ways to support family members – e-learning and counseling on dementia","Investments > €500k","Alzheimer's disease & other dementias",Germany "New York City Hispanic Dementia Caregiver Research Program (NHiRP)","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Next Generation Sequencing of Alzheimer’s Disease (AD) Genes in non-familial early-onset AD (EOAD).","Investments < €500k",,"United Kingdom" "NF-kB control of neuronal apoptosis in Alzheimer disease","Investments < €500k",,"United States of America" "NG2 cells in Huntingtons disease","Investments < €500k",,"United States of America" "NG2 cells in Huntingtons disease","Investments < €500k",,"United States of America" "NHMRC National Institute for Dementia Research (NNIDR)","Research Networks",,Australia "Nighttime Agitation and Restless Legs Syndrome in People with Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "NIH Biobank and King College UK",Biobanks,"Alzheimer's disease & other dementias",Canada "NIHR Bioresource (Cambridge University Hospitals NHS Foundation Trust)","Capital Infrastructure",,"United Kingdom" "NIHR Bioresource (Guy’s and St Thomas’ NHS Foundation Trust)","Capital Infrastructure",,"United Kingdom" "NIHR Bioresource (Imperial College Healthcare NHS Trust )","Capital Infrastructure",,"United Kingdom" "NIHR Bioresource (Oxford University Hospitals NHS Foundation Trust)","Capital Infrastructure",,"United Kingdom" "NIHR Bioresource (South London and Maudsley NHS Foundation Trust)","Capital Infrastructure",,"United Kingdom" "NIHR Bioresource (The Newcastle Upon Tyne Hospitals NHS Foundation Trust)","Capital Infrastructure",,"United Kingdom" "NIHR Bioresource (University College London Hospitals NHS Foundation Trust)","Capital Infrastructure",,"United Kingdom" "NIHR Bioresource (University Hospitals of Leicester NHS Trust)","Capital Infrastructure",,"United Kingdom" "NILVAD CBF ADD-on study: The effects of nilvadipine on Cerebral autoregulation, Blood pressure, cerebral blood Flow and -Damage in Alzheimer’s Disease.","Investments < €500k",,Netherlands "NINDS NEXT: Childrens Hospital Boston Clinical Research Site","Investments > €500k","Spinal muscular atrophy (SMA)","United States of America" "NMDA RECEPTOR MODULATORS AS NOOTROPIC THERAPIES IN AGING BRAIN","Investments < €500k",,"United States of America" "NMR Based Studies of Alpha-Synuclein Aggregation and Inhibition","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "NMR imaging 7T /11.7 T magnet – MIRCEN (Bruker)","Capital Infrastructure",,France "NMR Structure of the A-beta Peptide Inside Living Cells","Investments < €500k",,"United States of America" "Nomethiazoles harnessing GABA and NO mimetic activity for Alzheimers therapy","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Non Invasive Identification of Aβ Plaques in Human Retina for the Diagnosis of Alzheimer’s Disease","Investments > €500k","Alzheimer's disease & other dementias",Canada "Non-Alzheimer’s disease degenerative dementias: Identifying prodromal genetic/familial phenotypes, modifying factors, and protein variations involved in progression","Investments > €500k","Alzheimer's disease & other dementias",Australia "Non-amyloid-related hippocampal network dysfunction as an early biomarker of Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias", "Non-classic functions of estrogen","Investments > €500k","Alzheimer's disease & other dementias|Neurodegenerative disease in general",Hungary "Non-conventional target approach for drug discovery against neurodegenerative diseases: Nrf2 upregulation",Fellowships,"Neurodegenerative disease in general", "Non-Human Primate Model of Parkinson’s disease (University of Fribourg)","Experimental Models",,Switzerland "Non-Invasive In-Vivo Histology in Health and Disease Using Magnetic Resonance Imaging (MRI)","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "Non-invasive Markers of Neurodegeneration in Movement Disorders","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Non-invasive Markers of Neurodegeneration in Movement Disorders","Investments > €500k","Neurodegenerative disease in general|Parkinson's disease & PD-related disorders","United States of America" "Non-motor symptoms of people with Parkinson’s in black African/Caribbean and South Asian population in London: case control study and biomarkers and non-motor subtypes evaluation","Investments < €500k",,"United Kingdom" "Noninvasive Antioxidant Quantification in the Human Brain under Oxidative Stress","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Noninvasive Biomarkers to Advance Emerging DBS Electrode Technologies in Parkinsons Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Noninvasive High-resolution Pediatric Surface EMG","Investments < €500k",,"United States of America" "Noninvasive High-resolution Pediatric Surface EMG","Investments < €500k",,"United States of America" "Noninvasive stimulation of the brain dopamine system: A study combining neuromodulation to multimodal neuroimaging",Fellowships,"Neurodegenerative disease in general",Finland "Noninvasive Stimulation to Improve Hippocampal-Dependent Memory in Older Adults","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Nonlinear Models of Cognition Preceding AD and non-AD in a Biracial Population Sample","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Noradrenergic Mechanisms of Depression and L-DOPA-induced Dyskinesia in Parkinson’s Disease","Investments < €500k",,Denmark "Northern Ireland Clinical Research Network (Dementia)","Capital Infrastructure",,"United Kingdom" "Northern Ireland Cohort for Longitudanal Study of Ageing","Population Cohorts","Neurodegenerative disease in general","United Kingdom" "Nortriptyline-mediated attenuation of alpha-synuclein pathology in Parkinsons disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Norwegian Brain Initiative (NORBRAIN): a large-scale infrastructure for 21st century neuroscience","Capital Infrastructure",,Norway "Norwegian Research School of Neuroscience","Capital Infrastructure",,Norway "Novel 3D brain tissue-based screening assay for targeting microglia in CNS neurodegeneration","Investments < €500k",,"United States of America" "Novel 3D brain tissue-based screening assay for targeting microglia in CNS neurodegeneration","Investments < €500k",,"United States of America" "Novel 3D brain tissue-based screening assay for targeting microglia in CNS neurodegeneration","Investments < €500k",,"United States of America" "Novel Aminoadamantane Nitrates for the Treatment of Neurological Diseases","Investments < €500k",,"United States of America" "Novel application of minimally-invasive in vivo Carbon-13 Magnetic Resonance Spectroscopy (MRS) on Brain Metabolism Alterations in Major Progressive Neurodegenerative Diseases",Fellowships,"Neurodegenerative disease in general",Finland "Novel applications of multiphoton absorption for the detection of Alzheimer´s disease-linked amyloid aggregates and biomaterials for blood amyloid fibril capture systems.",Fellowships,"Alzheimer's disease & other dementias",Sweden "Novel approaches to modulate key targets in the pathogenesis of Huntington Disease","Investments > €500k","Huntington's disease",Canada "Novel assays for assessing protein-protein interactions in Alzheimers disease","Investments < €500k",,"United States of America" "NOVEL BIFUNCTIONAL CHEMICAL AGENTS AS THERANOSTIC TOOLS FOR AMYLOID DISEASES","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Novel biomarkers and brain imaging techniques for Alzheimer’s disease to improve early diagnosis and development of novel therapies","Investments < €500k",,Sweden "Novel Biomarkers for Alzheimer’s disease to improve early diagnosis and development of novel therapies","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders",Sweden "Novel biomarkers of ALS subphenotypes using advanced imaging and spectral EEG technology","Investments < €500k",,Ireland "Novel bivalent multifunctional ligands towards Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Novel blood and neuroimaging markers of Alzheimer’s disease and cerebral amyloid angiopathy","Investments > €500k","Alzheimer's disease & other dementias",Canada "Novel control of MT5-MMP on amyloidogenic and inflammatory pathways: validation in human iPSCs from Alzheimer patients and potential therapeutic perspectives","Investments < €500k",,France|Germany "Novel Detection of Early Cognitive and Functional Impairment in the Elderly","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Novel Drug Discovery for AD Targeting Ryanodine Calcium Channels","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Novel drugs for treating Alzheimer’s disease","Investments < €500k",,"United Kingdom" "NOVEL EXPERIMENTAL PLATFORM FOR PRODOMAL PARKINSONS DISEASE","Investments < €500k",,"United States of America" "NOVEL EXPERIMENTAL PLATFORM FOR PRODOMAL PARKINSONS DISEASE","Investments < €500k",,"United States of America" "Novel function of ATXN7 in cilia and impact on the SCA7 pathogenesis","Investments < €500k",,France "Novel genetic determinants of the neuromuscular SMA phenotype","Investments > €500k","Spinal muscular atrophy (SMA)","United States of America" "Novel GLP-1 and GIP dual receptor agonist peptides show neuroprotective effects","Investments < €500k",,"United Kingdom" "Novel hybrid compounds in the cognitive decline caused by neurodegeneration","Investments < €500k",,"Czech Republic" "Novel imaging and endothelial biomarkers of small vessel cerebrovascular disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "NOVEL IMMUNOTHERAPIES IN CHRONIC NEUROLOGICAL DISEASES – REDUCING PATHOGENESIS AND IMPROVING HEALING","Investments < €500k",,Sweden "Novel mechanisms and diagnostic applications for iron in Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias",Australia "Novel mechanisms of actin dynamics underlying cell motility, axon growth, and ALS","Investments > €500k","Motor neurone diseases","United States of America" "Novel Mechanisms of LRRK2-Dependent Neurodegeneration in Parkinsons Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "NOVEL MECHANISMS OF NEURODEGENERATION IN HUMAN BRAIN UNCOVERED BY PATHOGENIC NEUROPEPTIDE MUTATIONS","Investments > €500k","Neurodegenerative disease in general",Sweden "Novel modulators of Aβ42 synthesis and clearance The route towards primary prevention in AD","Investments < €500k",,Sweden "Novel MRI biomarkers for monitoring disease progression in ALS","Investments > €500k","Motor neurone diseases",Canada "Novel MRI Techniques for Brain Banking and Motor Neuron Disease Research","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United Kingdom" "Novel Multiplexing Proteomics to Study the Periphery in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "NOVEL PET IMAGING MARKERS FOR THE EARLY AND PRO-DROMAL PHASE OF PARKINSON’S DISEASE.",Fellowships,"Parkinson's disease & PD-related disorders",Denmark "NOVEL PET TRACERS FOR IMAGING OF ALZHEIMERS DISEASE","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Novel Point-of-Care Diagnostic Techniques for Dementia","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Novel Retinal Biomarkers for Alzheimer’s Disease","Investments > €500k","Alzheimer's disease & other dementias",Canada "Novel risk factor assay for Alzheimer’s disease-Multi-parametric quantification of HPG/HPT- axis dysfunction","Investments < €500k",,Norway "Novel roles by glutamatergic receptors in the synaptic effects of beta amyloid","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Novel Strategies and Mechanisms to Target APOE and Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Novel Strategies for Blood-based Biomarkers for AD: Role of Genetic Variation in a Multivariate Framework","Investments < €500k",,"United States of America" "Novel targeted degradable multifunctional poly(vinyl-co-ester) nanoparticles for Alzheimer’s disease applications",Fellowships,"Alzheimer's disease & other dementias",Australia "Novel Treatment Strategies for Disease Modification and Neuroprotection in Parkinson´s Disease","Investments < €500k",,Sweden "Novel ways for improved cell replacement strategies in Parkinson’s disease: The potential of Nogo-A neutralization.","Investments < €500k",,Switzerland "NOX enzymes as mediators of inflammation-triggered neurodegeneration: modulating NOX enzymes as novel therapies","Investments > €500k","Neurodegenerative disease in general","European Commission" "NS Park","Research Networks",,France NSPark,"Capital Infrastructure",,France "NSTAPS studie – tweede termijn van driejaars en vijfjaars follow-up. NSTAPS study – second term of three-year and five-year follow-up","Investments < €500k",,Netherlands "NSW Brain Tissue Resource Centre",Biobanks,"Neurodegenerative disease in general",Australia "Nucleocytoplasmic transport and nuclear pore disruption in ALS/FTD","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "Nucleocytoplasmic transport and nuclear pore disruption in ALS/FTD","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "NurseSMS – A joint research program on Nurses’ Self-Management Support in people facing progressive incurable diseases","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "Nutrition, the unrecognized determinant in Alzheimer?s disease (NUDAD)","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "Nya PET- och ELISA-baserade biomarkörer för Alzheimers sjukdom","Investments < €500k",,Sweden "O-GlcNAc as a strategy for the treatment of tauopathies","Investments < €500k",,"United Kingdom" "Objective delirium detection with an innovative EEG-based spot monitor","Investments < €500k",,"European Commission" "Objective delirium detection with an innovative EEG-based spot monitor","Investments < €500k",,"European Commission" "OCEAN: One-stop-shop microstructure-sensitive perfusion/diffusion MRI: Application to vascular cognitive impairment","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Of Molecules, Mice and Men: exposing and understanding apolipoprotein E effects across the lifespan","Investments < €500k",,"United Kingdom" "Offpsring Study of Mechanisms for Racial in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Olfactory deficits and donepezil treatment in cognitively impaired elderly","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Oligosaccharides as new therapeutic for CNS repair","Investments < €500k",,"United Kingdom" "Omega 3 pufas for the vascular component of age-related cognitive decline.","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Omega-3 fatty acids and vitamin E complex in prodromal Alzheimer disease: clinical trials in older adults","Investments < €500k",,Sweden "Omega-3, isoflavones & amyloid deposition in cognitively normal elderly Japanese","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Onderzoek naar de (kosten)effectiviteit van DementTalent: een innovatieve vorm van begeleiding van mensen met dementie en hun mantelzorgers. Research on the (cost) effectiveness of DementTalent: an innovative form of guidance for people with dementia and their caregivers","Investments < €500k",,Netherlands "Onderzoek naar het pathologisch mechanisme en naar modificerende genen bij FUS-geïnduceerde amyotrofe laterale sclerose (ALS). Investigation of the pathological mechanism and to modifying genes at FUS-induced amyotrophic lateral sclerosis (ALS)",Fellowships,"Motor neurone diseases",Belgium "Online cognitieve training bij de ziekte van Parkinson. Online cognitive training in Parkinson’s disease","Investments < €500k",,Netherlands "Online Cognitive Behavioural Therapy (CBT) trial","Investments < €500k",,"United Kingdom" "Online Cognitive Behavioural Therapy (CBT) trial – statistics","Investments < €500k",,"United Kingdom" "Online levensalbum: Een onderzoek naar het effect voor mensen met beginnende dementie en hun mantelzorgers. Online Life Album: An investigation into the effect for people with beginner dementia and their caregivers","Investments < €500k",,Netherlands "ONTology-based Web Database for Understanding Amyotrophic Lateral Sclerosis (Sweden)","Case Control Studies","Motor neurone diseases|Prion disease",Sweden "ONWebDUALS: ONTology-based Web Database for Understanding Amyotrophic Lateral Sclerosis","Investments > €500k|JPND Projects","Motor neurone diseases",Germany|JPND|Poland|Portugal|Sweden "ONWebDUALS: ONTology-based Web Database for Understanding Amyotrophic Lateral Sclerosis (Portugal)","Case Control Studies|JPND Projects","Motor neurone diseases",JPND|Portugal "Optical Imaging (bioluminescence & fluorescence) – Institut de Bio-Imaging (IBIO)","Capital Infrastructure",,France "Optical imaging of ocular pathology in Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "Optical imaging of small bio-molecules in living cells and tissues by nonlinear Raman microscopy coupled with vibrational tags","Investments > €500k","Huntington's disease","United States of America" "Optimising acute care for people with dementia: a mixed-methods study","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Optimising exercise prescription for brain health in older adults at risk of dementia",Fellowships,"Alzheimer's disease & other dementias",Australia "Optimising fMRI Detection of Longitudinal Changes in Age-Related Brain Disorders","Investments < €500k",,Canada "Optimising Health of the Ageing Brain","Investments < €500k",,Australia "Optimising medication use to maintain or improve quality of life in aged care facility residents with and without dementia",Fellowships,"Alzheimer's disease & other dementias",Australia "Optimising quality of living throughout the course of Motor Neurone Disease (Opt-Life)","Investments > €500k","Motor neurone diseases","United Kingdom" "Optimising the management of comorbidities in dementia: reducing disparaties and improving clinical outcomes",Fellowships,"Alzheimer's disease & other dementias",Australia "Optimization and preclinical development of soluble gamma-secretase modulators for AD","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Optimization and Validation of an Indicator Cell Assay for Blood-Based Diagnosis of Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Optimization and Validation of Improved Quantitative I-123 Brain SPECT Imaging","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Optimization of a novel series of thiazolopyridines for the treatment of SMA","Investments > €500k","Spinal muscular atrophy (SMA)","United States of America" "Optimization of Bi-Pap and PEG intervention protocols for Amyotrophic Lateral Sclerosis","Investments < €500k",,"United States of America" "Optimization of Bi-Pap and PEG intervention protocols for Amyotrophic Lateral Sclerosis","Investments < €500k",,"United States of America" "Optimization of Compounds that Stabilize the SMN Protein for Treatment of SMA","Investments < €500k",,"United States of America" "Optimization of Compounds that Stabilize the SMN Protein for Treatment of SMA","Investments < €500k",,"United States of America" "Optimization of P2X4 receptor antagonists as therapeutics for neurodegenerative and neuroinflammatory diseases","Investments > €500k","Neurodegenerative disease in general",Germany "Optimized Arterial Spin Labeling MRI in Mild Cognitive Impairment","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Optimizing drug treatment in old age: a novel translational research project","Investments < €500k",,Sweden "Optimizing measures of subjective and objective decline in preclinical AD",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Optimizing Outcome Measures for Clin. Trials in Pre-Clinical Alzheimers Disease","Investments < €500k",,"United States of America" "Optimizing semantic memory measures to detect tau- and amyloid- related cognitive change",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Optogenetic control of amyloid beta protective gene expression in the C. elegans gut microbiota","Investments < €500k",,"United States of America" "Optogenetic dissection of hippocampal circuitry underlying Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Optogenetic Stimulation of Striatal Output Neurons in Mouse Models of Huntingtons Disease",Fellowships,"Huntington's disease","United States of America" "Optogenetically-controlled restoration of muscle function in ALS model mice using engrafted ES-derived motor neurons","Investments < €500k",,"United Kingdom" "Orally-absorbed, small molecule microtubule-stabilizers for tauopathy treatment","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Orb2 a functional amyloid in long-term memory: Its structure and how it forms","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Organellar pH shifts in Alzheimers disease from simulation & experiment",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Organisation anatomique et fonctionnelle du striatum en conditions normale et pathologiques Anatomical and functional organization of the striatum under normal and pathological conditions","Investments < €500k",,Canada "Ostinato – Acceleration of Parkinson pathogenesis by chronic low-dose rate gamma exposure","Investments < €500k",,Norway "OVEREXPRESSION OF APP AND CEREBROVASCULAR REGULATION","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Oxford Parkinson Disease Centre (University of Oxford)","Experimental Models",,"United Kingdom" "Oxidant-producing proteins as novel targets to combat neurodegenerative diseases","Investments > €500k","Neurodegenerative disease in general",Australia "Oxidation of the amyloid beta peptide and implications in the etiology of Alzheimer’s Disease","Investments < €500k",,France "Oxidative DNA Damage And Its Processing","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "OXIDATIVE STRESS AND INFLAMMATION IN THE EVOLUTION OF THE PROCESS OF AGING AND PROGRESSION OF ALZHEIMER’S DISEASE IN DIFFERENT REGIONS OF THE CENTRAL HUMAN NERVOUS SYSTEM","Investments < €500k",,Spain "Oxysteroler och neurodegeneration. Oxysterols and neurodegeneration","Investments < €500k",,Sweden "Oxytocin as a key factor in the behavioral and psychological symptoms of Alzheimer’s disease","Investments < €500k",,Switzerland "PACAP/VIP Glycopeptide Agonists as Neuroprotective Therapies for Parkinsons Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Pacific Northwest Udall Center","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "PaMIR: Parkinson MR imaging repository","Investments > €500k","Parkinson's disease & PD-related disorders","United Kingdom" PAQUID,"Population Cohorts","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders",France "Para-Vascular Basis of Small Vessel Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Paracetamol to enhance quality of life and daily function and to decrease care dependency in advanced dementia: A randomized, double-blind, placebo-controlled crossover trial in long-term care facilities.","Investments < €500k",,Netherlands "Parelsnoer en Biomarkers","Investments < €500k",,Netherlands "Parelsnoer Institute-Parel Neurodegenerative diseases","Research Networks",,Netherlands "Parietal-hippocampal network in the triple transgenic mouse model of Alzheimers","Investments < €500k",,"United States of America" "PARKINSON DISEASE AND COGNITIVE IMPAIRMENT: IDENTIFICATION OF PREDICTIVE GENETIC MARKERS BY MASS SEQUENCING.","Investments < €500k",,Spain "PARKINSON DISEASE MODEL WITH INDUCID PLURIPOTENT CELLS BEARING THE E46K MUTATION IN ALPHA-SINUCLEINE, TO IDENTIFY PATHOGENIC ROUTES","Investments < €500k",,Spain "Parkinson Disease: Predicting the Future","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Parkinson Lab, Dept Clinical Genetics",Biobanks,"Parkinson's disease & PD-related disorders",Netherlands "Parkinson´s disease: evolution and mechanisms of disease progression in a community-based study population","Investments < €500k",,Sweden "Parkinson´s Disease: Genes, Environments and their Interplay","Investments > €500k","Parkinson's disease & PD-related disorders",Sweden "Parkinson’s disease – from genetic risk factors to molecular mechanisms and clinical phenotypes","Investments > €500k","Parkinson's disease & PD-related disorders",Norway "Parkinson’s disease biosamples",Biobanks,"Parkinson's disease & PD-related disorders",Ireland "Parkinson’s disease progression: Prediction, impact and biomarkers.","Investments < €500k",,Norway "Parkinson’s UK Brain Bank","Capital Infrastructure",,"United Kingdom" "Partnership Centre: Dealing with Cognitive and Related Functional Decline in Older People","Investments > €500k","Alzheimer's disease & other dementias",Australia "Partnership for Magnetic Resonance Spectroscopy Biomarker Development","Investments > €500k","Alzheimer's disease & other dementias|Spinocerebellar ataxia (SCA)","United States of America" "Passief bewegen voor een actiever brein bij dementie. Passively move for a more active brain in dementia","Investments < €500k",,Netherlands "Pathobiological Studies of BACE1 and APP in Alzheimers Diseases","Investments < €500k",,"United States of America" "PATHOBIOLOGICAL STUDIES OF VESSEL BACE1 IN CEREBROVASCULAR AMYLOID ANGIOPATHY","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Pathobiology of alpha-1-antitrypsin deficency and the serpinopathies","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Pathobiology of Hypothalamic and Metabolic Dysfunction in Normal Aging and Alzheimers Disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Pathogenesis of autoimmune neurodegeneration: What causes the immune system to destroy healthy neurons?","Investments < €500k",,"European Commission" "Pathogenesis of Postoperative Cognitive Dysfunction","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Pathogenic and adaptive molecular interactions with mutant huntingtin exon 1","Investments < €500k",,Australia "Pathogenic mechanism of the C9orf72 expanded hexanucleotide repeat mutation in neurodegeneration","Investments < €500k",,Slovenia "Pathogenic mechanisms of gene-environment interactions in Parkinsons disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Pathogenic Mechanisms of Reduced Transport Initiation in Perry Syndrome",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Pathogenic role for formin mediated microtubule stabilization pathways in Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "PATHOGENIC ROLE OF AUTOFAGIC / LYSOSOMAL DYSFUNCTION IN PARKINSON DISEASE: DIAGNOSIS AND NEW PRE-CLINICAL THERAPIES","Investments < €500k",,Spain "Pathogenic role of the novel mitochondrial apoptotic protein PSAP in ALS","Investments < €500k",,"United States of America" "Pathogenic role of the novel mitochondrial apoptotic protein PSAP in ALS","Investments < €500k",,"United States of America" "Pathogenicity of neuronally-derived tau in exosomes","Investments < €500k",,"United States of America" "PATHOLOG-OMICS – ESSENTIAL TREMOR IN THE BROADER CONTEXT OF NEURODEGENERATION","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Pathological role of c-Abl in alpha-synucleinoapathy","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Pathological substrate of clinical variability in AD","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "Pathological tau strains and transmission in Alzheimers disease and other tauopathies",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Pathology and treatment of vocal deficits in Parkinson disease",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Pathophysiology of ALS","Investments < €500k",,Australia "Pathophysiology of APP in vivo","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Pathophysiology of Parkinson’s disease","Investments > €500k","Parkinson's disease & PD-related disorders",Canada "Pathophysiology of postoperative delirium and the use of biomimetic sleep as a treatment strategy in the CSICU","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Pathophysiology of REM sleep behaviour disorder in narcolepsy – do narcolepsy patients have increased risk of developing Parkinsonism?","Investments < €500k",,Denmark "Pathophysiology of SNAP in individuals with mild cognitive impairment",Fellowships,"Alzheimer's disease & other dementias",Netherlands "Pathophysiology of Transgenic Mouse Models of Huntingtons Disease","Investments > €500k","Huntington's disease","United States of America" "Pathway complexities of protein misfolding in neurodegenerative diseases: a novel approach to risks evaluation and model development","Investments < €500k",,Sweden "Pathway discovery, validation and compound identification for Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Pathway targeted deep brain stimulation for Parkinsons disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Pathway-driven identification of therapeutic targets for combatting Alzheimer’s disease.","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Pathways of beneficial effects of a physical activity intervention on hippocampal atrophy among older adults",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Pathways through Care – The association between municipal health services and disease course in dementia","Investments > €500k","Alzheimer's disease & other dementias",Norway "Pathways to Alzheimer´s disease","Investments < €500k",,Sweden "Pathways to Alzheimer’s disease","Investments < €500k",,Sweden "Pathways to Brain Health for African Americans: A Community-Based Participatory Research Study","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Patient derived iPS cells for investigating pathogenetic mechanisms of brain diseases that cause movement disorders","Investments < €500k",,Norway "Patient derived iPS cells for investigating pathogenetic mechanisms of brain diseases that cause movement disorders",Fellowships,"Spinocerebellar ataxia (SCA)",Norway "Patient Motor Neuron Assay System for ALS Drug Discovery","Investments < €500k",,"United States of America" "Patient Motor Neuron Assay System for ALS Drug Discovery","Investments < €500k",,"United States of America" "Patient-adjustable MRI technology for high-resolution imaging of deep brain stimulation",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Patient-specific control of movement disorders in Parkinson’s disease by using deep brain stimulation","Investments < €500k",,Luxembourg "Patient-specific induced pluripotent stem cells to study synucleinopathies","Investments < €500k",,Sweden "Patient-specific Segmentation of Cerebral Structures for Deep Brain Stimulation","Investments < €500k",,Luxembourg "Patient-specific stem cell-derived models for Alzheimer’s disease and related neurodegenerative disorders",Fellowships,"Alzheimer's disease & other dementias", "Patient-specific treatment for Parkinson’s disease using reprogrammed skin cells","Investments > €500k","Parkinson's disease & PD-related disorders",Sweden "Patterns and mechanisms of brain atrophy in healthy aging and dementia: Why is the aging brain susceptible to Alzheimers Disease?","Investments > €500k","Alzheimer's disease & other dementias",Norway "Patterns and mechanisms of brain atrophy in healthy aging and dementia: Why is the aging brain susceptible to Alzheimers Disease?",Fellowships,"Alzheimer's disease & other dementias",Norway "Patterns and mechanisms of brain atrophy in healthy aging and dementia: Why is the aging brain susceptible to Alzheimers Disease?",Fellowships,"Alzheimer's disease & other dementias",Norway "Patterns of multimorbidity in primary health care – a prospective observational study","Population Cohorts","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders",Germany "PD-HELP: Development of an intervention to increase help-seeking for non-motor symptoms in people with Parkinson’s","Investments < €500k",,"United Kingdom" "PDE4D Allosteric Modulators for Treating Cognitive Impairment","Investments < €500k",,"United States of America" "People with Stroke and Parkinson’s disease: Home and outdoor shoes","Investments > €500k","Parkinson's disease & PD-related disorders","United Kingdom" "Peptide Biomarkers for Parkinson Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Peptide foldamers/Momentum grant",Fellowships,"Neurodegenerative disease in general",Hungary "Peptide Self-Assembly – Threats and Opportunities",Fellowships,"Alzheimer's disease & other dementias",Sweden "PEPTIDOMIMETIC BACE-1 INHIBITOR PRODRUGS FOR ALZHEIMER’S DISEASE: THE POTENTIAL OF GLUCOSYLATION TO CIRCUMVENT THE BLOOD-BRAIN BARRIER",Fellowships,"Alzheimer's disease & other dementias",Portugal "PERADES: Defining Genetic, Polygenic and Environmental Risk for Alzheimer’s Disease using multiple powerful cohorts, focussed Epigenetics and Stem cell metabolomics","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias","France|JPND|Netherlands|United Kingdom" "Peri-operative Enhanced Recovery hip FracturE Care of paTiEnts with Dementia-“PERFECTED” project","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Pericytes in mechanisms linking type 2 diabetes to increased risk of dementia.","Investments > €500k","Alzheimer's disease & other dementias",Sweden "Perineuronal net treatments for neurodegenerative disease","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "Peripheral & Brain Cholesterol Metabolism in Neurodegenerative Mouse Models",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Peripheral and brain levels of advanced glycation end products AGEs and incident Alzheimers disease and neuropathology","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Peripheral and Central Postural Disorders in the Elderly","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "PERIPHERAL INFLAMMATION AS A RISK FACTOR IN THE PATHOLOGY OF ALZHEIMER’S DISEASE: NEW DIAGNOSTIC TOOLS AND THERAPEUTIC DIALOGS","Investments < €500k",,Spain "Peripheral tissue molecular signatures – providing new insights into Huntingtons Disease pathology","Investments < €500k",,Sweden "PERK as a central mediator of neurotoxicity in tauopathies","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Personal life documentation for people with dementia and caregivers","Investments > €500k","Alzheimer's disease & other dementias",Germany "Personality and Total Health (PATH) Through Life (20s Cohort)","Population Cohorts","Neurodegenerative disease in general",Australia "Personality and Total Health (PATH) Through Life (40s cohort)","Population Cohorts","Neurodegenerative disease in general",Australia "Personality and Total Health (PATH) Through Life (60s cohort)","Population Cohorts","Neurodegenerative disease in general",Australia "Personality Change as an Early Marker of Alzheimers Disease","Investments < €500k",,"United States of America" "Personalized Computer Aided Navigation for Stereotactic Surgery","Investments < €500k",,Luxembourg "Personhood in dementia: A participatory-action research investigation of the value of agency in community","Investments < €500k",,Ireland "PET /µPET/µPET-CT-san/TEP-MRI – Service Hospitalier Frédéric Joliot","Capital Infrastructure",,France "PET Imaging Agents for a4b2 Nicotinic Receptors","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "PET ligands as in vivo diagnostic agents for neuroinflammatory, neurodegenerative and neuro-oncological diseases","Investments > €500k","Neurodegenerative disease in general",Germany "PET- MIRCEN (small and large)","Capital Infrastructure",,France "PGC-1alpha and Pitx3 as individual and combined targets for neuroprotection","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Pharmacogenetics of donepezil in mild cognitively impaired patients",Fellowships,"Alzheimer's disease & other dementias","United States of America" "PHARMACOLOGICAL CHAPERONES FOR GENETIC PRION DISEASES","Investments < €500k",,Spain "Pharmacological modulation of CSF1R activation to control microglial proliferation in Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Pharmacological studies of new benzisoxazolopropylpyrrolidine derivatives as multifunctional ligands with potential prokaryotic and antipsychotic properties (in vivo, animal models)","Investments < €500k",,Poland "Pharmacology of Stimulus Memory and Habit Formation","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Phase 1 clinical studies with the gamma-secretase modulator, NGP 555 to establish safety, pharmacokinetics, and biomarker efficacy","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Phase 1 safety trial for CT1812, a novel small molecule therapeutic targeting a synaptic receptor for Abeta oligomers","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Phase 1b first-in-patient safety trial for CT1812, a novel Alzheimer’s synaptic protection therapeutic","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Phase 3 trial of inosine for Parkinsons disease – DCC","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Phase 3 trial of inosine for Parkinsons disease CCC","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Phase I program with IRL790 for treatment of dyskinesias and psychosis in Parkinson´s disease","Investments > €500k","Parkinson's disease & PD-related disorders",Sweden "PHASE II/III trial for Slowing Progression in Mild Cognitive Impairment","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "PhenotYpe Research for ALS ModIfyer Discovery (PYRAMID)","Investments < €500k",,Netherlands "PHENOTYPES AND HAPLOTIPOSES ASSOCIATED WITH INTERTURED GENEAL ALTERS, HUNTINGTON DISEASE","Investments < €500k",,Spain "Phenotyping the immune response in Alzheimer’s disease by flow cytometry","Investments < €500k",,"United Kingdom" "PHOSPHATASE PROTEIN 2A AS A THERAPEUTIC DIAL FOR THE DEVELOPMENT OF NEW PHARMACIES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES","Investments < €500k",,Spain "Phosphorylation of kinesin light chain and calsyntenin-1/alcadein mediated axonal transport and processing of APP in Alzheimer’s disease","Investments < €500k",,"United Kingdom" "Photoacoustic Microscopy of Metabolic Dysfunction in Alzheimer’s Disease","Investments < €500k",,"United States of America" "Physical Activity and Preservation of Cognitive Function",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Physical activity programmes for community dwelling people with mild to moderate dementia (DAPA – Dementia And Physical Activity)","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Physical and Mental Fatigability in Late Life Clinical Populations","Investments < €500k",,"United States of America" "Physical Frailty and Cognitive Impairment: Intersection, Measurement & Etiologies","Investments < €500k",,"United States of America" "Physiological and pathological interactions of the disordered TPPP/p25: mapping of binding motifs","Investments < €500k",,Hungary "Physiology and Pathophysiology of Apolipoprotein E receptor-2 splicing in Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimers disease (AD)","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "PINK1 regulation of neuronal and mitochondrial homeostasis","Investments < €500k",,"United States of America" "PINK1 regulation of neuronal and mitochondrial homeostasis","Investments < €500k",,"United States of America" "PKR and danger molecules in Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias",France "Plasma Amylin Impact on Cognitive Function and Brain Morphology in the Framingham Heart Study","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Plasma Amylin Impact on Cognitive Function and Brain Morphology in the Framingham Heart Study","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Plasma beta-amyloid in long lived families: genetics and risk of AD","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Plasticity and formation of lasting memories in health and disease. Genetic modeling of key regulators in adult and aging mammals and in neurodegenerative disease","Investments > €500k","Neurodegenerative disease in general","European Commission" "Plasticity circuits in Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Plasticity circuits in Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Plasticity circuits in Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Plasticity of basal ganglia astrocytes in Parkinson´s disease and L-DOPA-induced dyskinesia","Investments < €500k",,Sweden "Plasticity of bridge collaterals in Parkinonian state and treatment","Investments < €500k",,"United States of America" "Plasticity of bridge collaterals in Parkinonian state and treatment","Investments < €500k",,"United States of America" "Plasticity of the Burst-Pause Response in the Tonically Active Cholinergic Interneurons of the Striatum in Normal and Parkinsonian Mice",Fellowships,"Parkinson's disease & PD-related disorders", "‘Pleiotrophic Strategies to Prevent Surgery-induced Cognitive Decline in Normal and Vulnerable Aged Brain’.",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Pleiotropic and Interaction Effects on Alzheimers disease Risk and Progression","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Pleiotropy GWAS of Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Policy Research Unit in Social Care Workforce","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Polymorphism in PrP and its relevance for moose and public health","Investments < €500k",,Sweden "Poor Sleep Altered Circadian Rhythms and Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Population based genotype-phenotype correlation to stratify incident cases of patients with motor neurone disease in Scotland from 2015-2017",Fellowships,"Motor neurone diseases","United Kingdom" "Population based genotype-phenotype correlation to stratify incident cases of patients with motor neurone",Fellowships,"Motor neurone diseases","United Kingdom" "Population based genotype-phenotype correlation to stratify incident cases of patients with motor neurone disease in Scotland from 2015-2017","Investments < €500k",,"United Kingdom" "Portuguese Mass Spectrometry Network","Research Networks",,Portugal "Positive Allosteric Modulators as PET Imaging Ligans for mGluR4","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Post-PT Extension of In-Home Dynamic Standing Table Use in Parkinson Disease","Investments < €500k",,"United States of America" "Post-PT Extension of In-Home Dynamic Standing Table Use in Parkinson Disease","Investments < €500k",,"United States of America" "Post-Stroke Brain Deterioration: Role of Abeta and Neuroinflammation","Investments < €500k",,Canada "Post-transcriptional regulatory networks in neurodegenerative diseases","Investments < €500k",,Slovenia "Postdoc grant: Mental health among older people – with focus on measurements and exercise effects",Fellowships,"Alzheimer's disease & other dementias",Sweden "Postdoctoral Training, Neurobiology of Aging and Alzheimers Disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "POSTMORTEM VALIDATION OF BIOMARKERS FOR IMAGING PARKINSON DISEASE","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Potentiels thérapeutiques de la cystamine pour la maladie de Parkinson. Potential therapeutic cystamine for Parkinson’s disease.","Investments > €500k","Parkinson's disease & PD-related disorders",Canada "Powerful Study of Rare Variants in Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "PPBI – Portuguese Platform of BioImaging","Research Networks",,Portugal "Practical management of cognitive and neuropsychiatric symptoms in MND – development of the MiNDToolkit","Investments < €500k",,"United Kingdom" "Practitoner Fellowship",Fellowships,"Motor neurone diseases",Australia "Pre-Clinical Development of EDN-OL1 for Alzheimers Disease","Investments < €500k",,"United States of America" "Pre-clinical study to fulfill FDA requirements for the completion of AV-1959 IND","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Pre-clinical testing of lenalidomide as pleiotropic therapeutics of Alzheimers disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Pre-MCI Kohort, at-risk for AD kohort – planned- DZNE; University of Bonn",Biobanks,"Alzheimer's disease & other dementias",Germany "Preclincal development of a disease modifying small molecule therapy for Alzheimer diease.","Investments > €500k","Alzheimer's disease & other dementias",Canada "Preclinical AD: Correlates of Amyloid, Tau PET and fcMRI in Framingham Gen 3 Young Adults","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Preclinical Alzheimers Disease Biomarkers: Effects of Midlife Vascular Factors",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Preclinical Alzheimers Disease Drug Development of Novel MAPK Inhibitors","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Preclinical and clinical studies on Parkinson´s disease: Etiology, pathology, and restoration","Investments < €500k",,Sweden "Preclinical and clinical studies with withanolides: Therapeutic effects, molecular signatures and biomarkers","Investments > €500k","Motor neurone diseases",Canada "Preclinical assessment of an ABCA1 agonist as a novel therapeutic for AD","Investments < €500k",,"United States of America" "Preclinical Development of a Selective Suppressor of Neuroinflammation for MCI/AD","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Preclinical Diagnostic Imaging of Amyloid","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Preclinical testing of the splice modulating oligonucleotide LSP-GR1","Investments > €500k","Motor neurone diseases","United States of America" "Predementia neuroimaging TIA (PREVENT) study.","Investments < €500k",,Canada "Predict to prevent frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS)","Investments < €500k",,France PREDICT-PD,"Population Cohorts","Parkinson's disease & PD-related disorders","United Kingdom" PREDICT-PD,Fellowships,"Parkinson's disease & PD-related disorders","United Kingdom" "Predict-PGRN- Caractérisation multimodale prospective de la démence frontotemporale dûe à des mutations du gène PGRN à un stade symptomatique et présymptomatique / PREDICT. Predict-PGRN- Prospective multimodal characterization of frontotemporal dementia due to mutations of the PGRN gene at a symptomatic and presymptomatic stage / PREDICT.","Investments < €500k",,France "Predicting Dementia and Parkinson’s in the Clinic",Fellowships,"Alzheimer's disease & other dementias",Australia "Predicting dementia in Parkinson’s: A genotypic and phenotypic study","Investments < €500k",,"United Kingdom" "Predicting Language Outcome and Recovery After Stroke (PLORAS)","Investments < €500k",,"United Kingdom" "Predicting MRI Abnormalities with Longitudinal Data of the Whitehall II Substudy","Investments > €500k","Neurodegenerative disease in general","United Kingdom" "Predicting outcome in Parkinson’s disease cognitive impairment","Investments < €500k",,Canada "Predicting perioperative cognitive disorders in the elderly based on cardiovascular risk, AD risk and new biomarkers",Fellowships,"Alzheimer's disease & other dementias",Australia "PREdiction de la DEMence PARKinsonienne grâce à la mesure du métabolisme cérébral en TEP. PREdiction of PARKinsonian DEMENCE by Measuring PET Cerebral Metabolism","Investments < €500k",,France "Prediction of Psychosis in Alzheimer Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Predictive model of spread of Parkinsons pathology using network diffusion","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "PREDICTIVE STUDY OF THE DEVELOPMENT OF SMALL BRAIN DISEASE IN HIGH RISK PATIENTS.","Investments < €500k",,Spain "Predictors of Functional Ability in MCI","Investments < €500k",,"United States of America" "Predictors of progression to freezing of gait in Parkinsons disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Prédire pour prévenir les démences frontotemporales (DFT) et la sclérose latérale amyotrophique (SLA). Predict to prevent frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS)","Investments > €500k","Motor neurone diseases",France "Prefrontal AMPA receptors in FTD Pathogenesis","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Prefrontal attention circuitry: Mechanisms of deregulation and restoration in brain disorders","Investments < €500k",,Canada "Prefrontal D1 signaling and cognitive symptoms of Parkinsons disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Prefrontal dopamine and cognitive symptoms of Parkinsons disease",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "PreFrontAls: Searching for therapeutic interventions in frontotemporal dementia with C9ORF72 repeat expansions in the presymptomatic stage","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias|Motor neurone diseases",Germany|Italy|JPND|Netherlands|Spain|Sweden "Preliminary evaluation of the therapeutic potential of lithium in mild cognitive impairment","Investments < €500k",,"United Kingdom" "Prenatal, predictive and presymptomatic diagnosis of neurodegenerative diseases – ethical analysis","Investments > €500k","Neurodegenerative disease in general",Germany "Preoperative Cognitive Screening in Elderly Surgical Patients: Feasibility and Utility for Predicting Morbidity","Investments < €500k",,"United States of America" "Preparation of iPs cells for modeling of neurological disorders","Investments > €500k","Neurodegenerative disease in general",Hungary "Presenilin 2 – a protector against Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias", "Presenilin Variants in the Modulation of Hippocampal Neurogenesis","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Presenilin1/g-secretase regulate miRNAs and neuronal survival","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Presenilins and neuronal calcium dyshomeostasis","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Presenilins in the hippocampal network and Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Preserved non-verbal communication in Alzheimer disease : towards the maintenance of a better quality of life",Fellowships,"Alzheimer's disease & other dementias",France "Presynaptic and astrocytic role of Amyloid precursor protein signaling in the hippocampus",Fellowships,"Alzheimer's disease & other dementias", "Prevalence of Dementia in the Torres Strait and common health issues of later life in the Torres Strait","Investments > €500k","Alzheimer's disease & other dementias",Australia "Prevalence, characteristics and quality of life of nursing home patients with dementia with (very) severe or extreme neuropsychiatric symptoms (the WAALBED-III-study)","Investments < €500k",,Netherlands "PREVENT Research Programme","Investments < €500k",,"United Kingdom" "Preventing cognitive decline and dementia from cerebral microvascular disease","Investments < €500k",,"United Kingdom" "Preventing Experience Dependent Aberrant Plasticity Under Dopamine Deficiency","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Preventing Falls in Older People with Dementia","Investments > €500k","Alzheimer's disease & other dementias",Australia "Prevention of Alzheimer’s Dementia in High Risk Populations: A Randomized Controlled Trial of a Combination of Cognitive Remediation and Brain Stimulation","Investments > €500k","Alzheimer's disease & other dementias",Canada "Prevention of Alzheimer’s Dementia in High Risk Populations: A Randomized Controlled Trial of a Combination of Cognitive Remediation and Brain Stimulation","Case Control Studies","Alzheimer's disease & other dementias",Canada "Prevention of Amyloidogenic Peptide-Induced Network and Cognitive Deficits by Activation of Peptide Degradation Mechanisms – A Drug Discovery and Translational Project Proposal","Investments < €500k",,Sweden "PRIDE – Promoting Independence in Dementia","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Primary Progressive Aphasia: Cognition, Anatomy and Progression","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Prion Detection Through Organized Arrays of Gold Nanorods as SERS Substrates",Fellowships,"Prion disease", "Prion genetic modifiers in the mouse","Investments > €500k","Prion disease","United Kingdom" "Prion kinetics, toxicity and synthesis and its wider relevance","Investments > €500k","Prion disease","United Kingdom" "Prion Protein Proteostasis","Investments < €500k",,Canada "Prion-like behaviour in immunity: super-sized signalling platforms?","Investments < €500k",,Australia "Prion-like transmission of α-synuclein in Parkinson’s disease","Investments > €500k","Parkinson's disease & PD-related disorders","European Commission" "Pro-inflammatory cytokine lowering anti-inflammatory drugs","Investments < €500k",,"United States of America" "Probing Amyloid Plaque Pathology in Alzheimer´s Disease using Advanced Imaging Mass Spectrometry",Fellowships,"Alzheimer's disease & other dementias",Sweden "Probing the role of membrane and cholesterol on APP-C99 structure and dynamics","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Problem Adaptation Therapy for Mild Cognitive Impairment with Depression","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "PROCESSING BY SECRETS OF THE COLINERGIC FORM OF ACETYLCOLINESTERASE, ITS TRANSCRIPTIONAL ACTIVITY AND IMPLICATION IN ALZHEIMER’S DISEASE.","Investments < €500k",,Spain "Processing Of Oxidative Stress In Alzheimer","Investments < €500k",,"United States of America" "Processing Speed Training to Preserve Driving and Functional Competencies in MCI","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Procyanindin A-type dimer: A novel inhibitor of tau aggregation in vivo","Investments < €500k",,"United States of America" PRODIA,"Case Control Studies","Alzheimer's disease & other dementias",Netherlands "PRODIA: Development of biomarkers enabling early and accurate differential diagnosis of dementia","Investments < €500k",,Netherlands "Profiling dementias using complex sound: from symptoms to brain networks.",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Profiling post-translational modifications of histone proteins as a determinant of Parkinson’s susceptibility","Investments < €500k",,"United Kingdom" "Prognosis and Diagnosis of Protein Misfolding Diseases by Seeded Aggregation in Microspheres","Investments < €500k",,"European Commission" "PROGRAM OF PHYSICAL ACTIVITY FOR PATIENTS WITH DEMENTIA AND THEIR FAMILY CAREGIVERS. RANDOM CLINICAL TEST IN PRIMARY CARE","Investments < €500k",,Spain "Programme Grant Ageing and health: Mapping and intervening with the behavioral factors influencing cognitive aging","Investments > €500k","Alzheimer's disease & other dementias",Sweden "Programme Grant Ageing and health: Mental and cognitive health in relation to functional ability and multimorbidity in elderly persons. A life-time and birth cohort perspective","Investments > €500k","Alzheimer's disease & other dementias",Sweden "Programme Grant Care: Living and ageing with cognitive impairments in the technological landscapes of homes and public places","Investments > €500k","Alzheimer's disease & other dementias",Sweden "Programme Grant Elderly: Cognitive aging: From observational studies to intervention","Investments > €500k","Alzheimer's disease & other dementias",Sweden "Programme Grant Elderly: The sensory cognitive communication factor: Preserving social interaction and health in aging","Investments > €500k","Alzheimer's disease & other dementias",Sweden "PROGRESSION OF SMALL CEREBRAL VASCULAR DISEASE: RISK FACTORS, IMPLICATED MECHANISMS AND CLINICAL CONSEQUENCES.","Investments < €500k",,Spain "Progressive functional disruption of inhibitory neurons in tauopathy",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Project ALS Biobank en Database","Investments > €500k","Motor neurone diseases",Netherlands "Project ALS Treatment Institute (TRICALS)","Investments < €500k",,Netherlands "Project Beyond MinE-NL","Investments > €500k","Motor neurone diseases",Netherlands "Project Functionele analyse van het ALS interactoom Project Functional analysis of the ALS interactome","Investments > €500k","Motor neurone diseases",Netherlands "Project Informal Caregivers","Investments > €500k","Motor neurone diseases",Netherlands "Project Inlife. Evaluatie van de bruikbaarheid en effectiviteit van een virtueel sociaal platform voor mantelzorgers en mensen met dementie. Project Inlife. Evaluation of the usefulness and effectiveness of a virtual social platform for caregivers and people with dementia","Investments < €500k",,Netherlands "Project Itwin","Investments < €500k",,Netherlands "Project MinE","Investments > €500k","Motor neurone diseases",Netherlands "Project MinE Ireland: sequencing and analysis of 1,050 Irish genomes to identify the causes of amyotrophic lateral sclerosis","Investments > €500k","Motor neurone diseases",Ireland "Project MRI onderzoek","Investments > €500k","Motor neurone diseases",Netherlands "Project Neuro Imaging Society in ALS (Nisals)","Investments < €500k",,Netherlands "Project of excellence in the field of neuroscience","Investments > €500k","Alzheimer's disease & other dementias","Czech Republic" "Project PSMA","Investments > €500k","Spinal muscular atrophy (SMA)",Netherlands "Project TOTALS","Investments > €500k","Motor neurone diseases",Netherlands "Prokineticin 2 and Neuroinflammatory Mechanisms","Investments < €500k",,"United States of America" "Prokineticin 2 and Neuroinflammatory Mechanisms","Investments < €500k",,"United States of America" "Prolyl isomerases in neural development and aging","Investments < €500k",,"Czech Republic" "Promoting Caregiver Resilience During Medical Crises of Persons Living with Dementia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Promoting Self-Care and Coping for Alzheimers Caregivers","Investments < €500k",,"United States of America" "PROP-AD: Propagation behaviour of peripheral amyloid-β towards brain structures: effects of the blood-brain barrier","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias",Finland|Germany|Israel|JPND|Norway|Sweden "Propagated protein misfolding of SOD1 in ALS: Exemplar for neurodegeneration.","Investments > €500k","Motor neurone diseases",Canada "Propagation of Lewy pathology in Parkinsons disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Propagation of tauopathy: role of degeneration and impact of immunotherapy","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "PROPHETIC:An innovating Personal Healthcare Service for a holistic remote management and treatment of Parkinson patients.",Fellowships,"Parkinson's disease & PD-related disorders","European Commission" "Prosaposin and GPR37 in synucleinopathies","Investments > €500k","Parkinson's disease & PD-related disorders","European Commission" "Prospective Imaging Study of Ageing: Genes, Brain & Behaviour","Investments > €500k","Alzheimer's disease & other dementias",Australia "Prospective Memory in Mild Cognitive Impairment",Fellowships,"Alzheimer's disease & other dementias", "Prospective study of biomarkers and risk factors for ALS incidence and progressio","Investments > €500k","Motor neurone diseases","United States of America" "Prospective study of individuals at risk for spinocerebellar ataxia type 1, type 2, type 3 and type 6","Population Cohorts","Spinocerebellar ataxia (SCA)",Germany "Protease Systems Biology in Tumorigenesis and Neurodegeneration","Investments > €500k","Neurodegenerative disease in general","European Commission" "PROTEASOME AND PARKIN AS DRUG TARGETS AGAINST METHAMPHETAMINE TOXICITY","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Protecting neurons from death: the role of CoREST","Investments < €500k",,Australia "Protecting synaptic connectivity in Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias",Australia "Protection against Abeta toxicity by lithium: investigation of the role of non-canonical, wnt-mediated changes in neurogenesis’.",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Protection against reactive oxygen species in neurodegeneration","Investments > €500k","Motor neurone diseases","European Commission" "Protection of neurons in vitro and in vivo from Synuclein toxicity by molecular tweezers","Investments < €500k",,"France|Spain|United Kingdom" "Protein Aggregation and Inclusion Body Formation","Investments > €500k","Huntington's disease","United States of America" "Protein Aggregation and Inflammasome Signaling in Manganese Neurotoxicity","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Protein Aggregation and Neurotransmitter Deficits in Parkinson Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Protein aggregation and toxicity in human diseases",Fellowships,"Alzheimer's disease & other dementias", "Protein citrullination in cell physiology and disease.",Fellowships,"Neurodegenerative disease in general","United Kingdom" "Protein damage control: regulation of toxic protein aggregation in aging-associated neurodegenerative diseases","Investments > €500k","Neurodegenerative disease in general","European Commission" "Protein homeostasis, protein aggregation and Amyotrophic Lateral Sclerosis",Fellowships,"Motor neurone diseases",Australia "Protein kinase inhibitors for dementia","Investments > €500k","Alzheimer's disease & other dementias",Norway "Protein Misfolding and Disease","Investments < €500k",,Sweden "Protein Misfolding: Prion-like Propagation and Cure. Implications for Neurodegenerative Diseases.","Investments > €500k","Neurodegenerative disease in general","European Commission" "Protein quality control and Disease","Investments > €500k","Parkinson's disease & PD-related disorders",Sweden "Protein Self Assembly into Nanoaggregates","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Protein structure and function by hydrogen exchange mass spectrometry analysis","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Protein variants as blood based biomarkers for diagnosing and staging AD","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Protein variants as blood based biomarkers for diagnosing and staging AD","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Protéine tau plasmatique et biomarqueurs de la dégradation de l’APP (Amyloid precursor protein) pour le diagnostic et le pronostic de la maladie d’Alzheimer. Etude ancillaire à l’étude BALTAZAR (Biomarker of AmyLoïd pepTide and AlZheimer’s diseAse Risk). Plasma tau protein and biomarkers of amyloid precursor protein (APP) for the diagnosis and prognosis of Alzheimer’s disease. Ancillary study under study BALTAZAR (Biomarker of AmyLoïd pepTide and AlZheimer’s diseAse Risk).","Investments < €500k",,France "Proteomic reconstructive microscopy of healthy and diseased dendrites","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Proteomic Studies of Protein Pathways for the Estrogen Therapeutic Window in AD","Investments < €500k",,"United States of America" "Proteostasis and secondary proteinopathy in AD and FTD","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Proteostasis in the aging and Alzheimers disease brain: are the ATases novel targets?","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Proteostasis of aging and stem cells","Investments < €500k",,"European Commission" "PrP N-terminal sequences and biological endpoints in Prion and Alzheimer’s Disease","Investments < €500k",,Canada "PrPC- and NOX-dependent signaling in dementia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "PrPC&PDK1: The PrPC / PDK1 / TACE signaling axis at the cross-road of several aggregate-prone protein-associated neurodegenerative diseases","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias|Prion disease",Belgium|Canada|France|Germany|JPND|Norway "PSK kinases and tau pathology in Alzheimer’s disease","Investments < €500k",,"United Kingdom" "Psychological and nutritional determinants of telomere and genome integrity in dementia carers","Investments < €500k",,Australia "Psychosocial Protective Factors in Cognitive and Brain Aging","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Public dementia care in terms of equal services – family, local and multiethnic perspectives",Fellowships,"Neurodegenerative disease in general",Norway "Public dementia care in terms of equal services – family, local and multiethnic perspectives","Investments > €500k","Alzheimer's disease & other dementias|Neurodegenerative disease in general",Norway "Putting the brakes on Alzheimer’s disease: Exercise and its effects on cognitive decline, neurogenesis and inflammation in the APP/PS-1 mouse","Investments < €500k",,Ireland "Quantification of vascular and neuronal pathology in dementia using PET and MRI","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Quantification of vascular disease burden to stratify dementia for diagnosis and care managemnt","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Quantifying Brain Abnormality by Multimodality Neuroimage Analysis","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Quantitative mapping of substantia nigra iron in Parkinsons Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Quantitative MR Imaging of Vascular Contributions to Aging, Cognitive Decline and Stroke",,"Neurodegenerative disease in general",Canada "Quantitative MR Imaging of Vascular Contributions to Aging, Cognitive Decline and Stroke","Investments > €500k","Neurodegenerative disease in general",Canada "Quantitative MR Microscopy of Phenotypic Biomarkers in Alzheimers Disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Quebec Longitudinal Study on Nutrition and Successful Aging","Population Cohorts","Alzheimer's disease & other dementias",Canada "Quebec Network for Research on Aging","Research Networks",,Canada "QUONDAM: Quantitative analysis of naturally produced speech and language to improve diagnosis and monitoring of dementia","Investments < €500k",,Norway "Racial Differences in Late-Life Cognitive decline and risk of Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Racial Disparities in Alzheimers Disease and Related Dementias: The Role of Blood Pressure Throughout Adulthood","Investments < €500k",,"United States of America" "Racial Disparities in the Health of Caregivers for Persons with Alzheimers Disease","Investments < €500k",,"United States of America" "Radiomarqueur amyloïde cérébral (florbetapir) et démence post Accident Vasculaire Cérébral. Radiomatous cerebral amyloid (florbetapir) and dementia post Cerebral Vascular Accident","Investments < €500k",,France "RAGE and mitochondrial degeneration in diabetes","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Randomized, controlled study on the use of simvastatin in mild cognitive disorders","Investments > €500k","Alzheimer's disease & other dementias",Germany "RANTES and Eotaxin: New players in PD progression","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Rapid progressive Alzheimer’s disease (rpAD): clinical and molecular characterization of a distinct subtype of AD","Disease Registers","Alzheimer's disease & other dementias",Germany "Rational derivation of DA neuron subtypes from iPS cells for improved modelling of Parkinsons disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Rational Design of anti-aggregation aptamers of TDP-43","Investments < €500k",,"United Kingdom" "Rationalisation of antipsychotic drug use in older people, using [18F]-Fallypride PET",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "RBFox proteins as critical determinants for cell toxicity in DRPLA and other Spinocerebellar ataxias","Investments < €500k",,"United Kingdom" "Re-creating the basal ganglia circuitry in a dish: Towards a model for developing therapies for Parkinson’s","Investments < €500k",,"United Kingdom" "Re-Establishing Vascular Integrity in ALS via Endothelial Cell Transplant","Investments > €500k","Motor neurone diseases","United States of America" "Re-visiting Methods for MCI Diagnosis to Improve Biomarker and Trial Findings","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Reach α-synuclein-dependent neurodegeneration: clinical development of therapeutic AFFITOPE vaccines for Parkinson’s disease and multisystem atrophy","Investments > €500k","Parkinson's disease & PD-related disorders","European Commission" "REACT Project: an investigation of the active components of a specialist home treatment intervention to proevent hospital admission of people with dementia in crisis in the community","Investments < €500k",,"United Kingdom" "Rebalancing Innate Immunity in Alzheimers disease by deleting IRAK-M","Investments < €500k",,"United States of America" "Reconstruction and computational modelling of dopaminergic neuronal metabolism","Investments < €500k",,Luxembourg "Redesign Rat Model for ALS Research","Investments > €500k","Motor neurone diseases","United States of America" "Redox-Regulated Inhibitors of the Striatal-Enriched Protein Tyrosine Phosphatase",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Reducing Agitation in Dementia Patients at Home: The Customized Activity Trial","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Reducing pathology in Alzheimer’s Disease through Angiotensin TaRgeting – The RADAR Trial","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Reducing pathology in Alzheimer’s Disease through Angiotensin TaRgeting – The RADAR Trial","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Refining the bioactivity of P42, a hit therapeutic peptide, and developing a combined therapeutic peptide approach for treating Huntington’s Disease.","Investments < €500k",,France "Regenerative Neuroscience Strategies for Healthy Brain Ageing and Dementia",Fellowships,"Alzheimer's disease & other dementias",Australia "Regional Neurotoxicity & Early Biomarkers of Air Pollution Effects on Brain Aging","Investments < €500k",,"United States of America" "Register Competence Network Parkinson’s Disease","Disease Registers","Parkinson's disease & PD-related disorders",Germany "Regulatie van lysosomale enzym-activiteit bij de ziekte van Alzheimer. Regulation of lysosomal enzyme activity in Alzheimer’s disease","Investments < €500k",,Netherlands "Regulation and consequences of LRRK2 phosphorylation,a path to Parkinson’s disease therapy and diagnostics",Fellowships,"Parkinson's disease & PD-related disorders","European Commission" "Regulation of amyloid protein in Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias",Australia "Regulation of BACE1 transcytosis in hippocampal neurons","Investments < €500k",,"United States of America" "Regulation of cellular release of proteins in Parkinson neurodegeneration","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Regulation of cryptic splice sites in neuronal differentiation and disease",Fellowships,"Motor neurone diseases", "Regulation of ephrinB2-dependent angiogenesis by PS1 in normal and AD","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Regulation of Gamma-Secretase by Substrate Inhibitory Domains",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Regulation of glutamate transport in astrocyte subtypes and in ALS","Investments > €500k","Motor neurone diseases","United States of America" "Regulation of hippocampal plasticity and learning and memory by a bloodborne rejuvenation factor","Investments < €500k",,"United States of America" "Regulation of intracellular traffic by TBK1 and its relevance to Amyotrophic Lateral Sclerosis The Kerry Memorial PhD Studentship","Investments < €500k",,"United Kingdom" "Regulation of iron homeostasis by beta-amyloid precursor protein in health and disease.",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Regulation of iron homeostasis through beta-amyloid precursor processing in neuronal health and disease.",Fellowships,"Alzheimer's disease & other dementias", "Regulation of Metabotropic Glutamate Receptor Scaffolded Signaling Complexes","Investments < €500k",,Canada "Regulation of Metabotropic Glutamate Receptor Scaffolded Signaling Complexes","Investments < €500k",,Canada "Regulation of microglial proliferation and its contribution to chronic neurodegeneration","Investments > €500k","Alzheimer's disease & other dementias|Prion disease","United Kingdom" "Regulation of Mitochondrial Autophagy by Parkin","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Regulation of Mitochondrial Function and Motor Neuron Degeneration in SMA","Investments > €500k","Spinal muscular atrophy (SMA)","United States of America" "Regulation of mitochondrial motility and mitophagy by LRRK2.","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Regulation of Mitochondrial Quality Through Mitophagy in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Regulation of neuroinflammation in Alzheimer’s disease by non-coding RNAs","Investments < €500k",,Finland "Regulation of neuroinflammation in Alzheimer’s disease by non-coding RNAs",Fellowships,"Alzheimer's disease & other dementias",Finland "Regulation of neuronal resilience in Alzheimer’s disease by the STI1/Prion protein complex","Investments > €500k","Alzheimer's disease & other dementias",Canada "Regulation of presynaptic activity by β secretase in Alzheimer’s disease","Investments < €500k",,France "Regulation of Protein Trafficking in Neurodegeneration","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Regulation of SNARE-dependent synaptic vesicle fusion","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "REGULATION OF SORLA IN GENERAL AND IN ALZHEIMER´S DISEASE","Investments < €500k",,Denmark "Regulation of striatal acetylcholine transmission by cholinergic interneurons","Investments > €500k","Huntington's disease","United States of America" "Regulation of synaptic function by the Parkinson-related Leucine-rich repeat kinase 2 (LRRK2)",Fellowships,"Parkinson's disease & PD-related disorders",Belgium "Regulation of tau expression in Alzheimer disease and aging","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Regulation of the Heat Shock Response as a Treatment for Niemann-Pick type C disease","Investments < €500k",,"United Kingdom" "Regulation of the oligodendroglial accumulation of alpha-synuclein in Multiple System Atrophy","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "REGULATION OF THE STRESS GRANULE PROTEOME AND TRANSCRIPTOME BY TDP-43 IN ALS: BIOMARKERS AND THERAPEUTIC TARGETS","Investments > €500k","Motor neurone diseases",Canada "Regulatory Approval of the OLFACT Test Battery","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Regulatory mechanisms of dopamine synthesis; towards a therapeutic correction of catecholamine neurotransmiter deficiencies","Investments > €500k","Parkinson's disease & PD-related disorders",Norway "Rehabilitation and dementia – based on user perspective",Fellowships,"Alzheimer's disease & other dementias",Denmark "Rehabilitation of speech and language in primary progressive aphasia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Relation entre hypotension et somnolence post-prandiale chez le parkinsonien : utilisation du modèle d’hyperglycémie provoquée par voie orale HGPO. Relationship between hypotension and post-prandial somnolence in Parkinson’s: use of the model of oral hyperglycemia HGPO.","Investments < €500k",,France "Relationship between serotonergic innervation, dopaminergic deficit and levodopa induced dopamine release patterns in PD treatment-related complications: a longitudinal imaging study","Investments > €500k","Parkinson's disease & PD-related disorders",Canada "REM sleep behavior disorder: predicting the risk of neurodegeneration","Investments < €500k",,"Czech Republic" "Remodeling of cognitive circuits in Parkinson’s disease",Fellowships,"Parkinson's disease & PD-related disorders",Switzerland "Remote Electromagnetic Control of Neural Activity for Treatment of Parkinsons Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Remote ischemic conditioning for neuroprotection in vascular cognitive impairment","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Remote Monitoring of Parkinson’s Patients","Investments < €500k",,Turkey "Replication and Extension of ADSP Discoveries in African-Americans","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Replication and Extension of ADSP Discoveries in African-Americans","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Repositioning Gliptins for Parkinsons Disease Treatment","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Repressor Element 1-Silencing Transcription Factor (REST): A blood-based biomarker for Alzheimer’s disease linking molecular neuropathology with psychological stress","Investments < €500k",,"United Kingdom" "Reprogramming neurons for nervous system repair.",Fellowships,"Neurodegenerative disease in general","United Kingdom" "Repurposed drugs targeting the unfolded protein response to prevent neurodegeneration in dementia","Investments < €500k",,"United Kingdom" "Repurposing Low-Cost Consumer Technology for Motion Correction in Dementia Neuroimaging","Investments < €500k",,"United Kingdom" "Repurposing the PDE5 inhibitor tadalafil for vascular cognitive impairment. A test of concept in older people","Investments < €500k",,"United Kingdom" "Research Fellowship",Fellowships,"Alzheimer's disease & other dementias",Australia "Research Fellowship",Fellowships,"Motor neurone diseases",Australia "Research Fellowship",Fellowships,"Alzheimer's disease & other dementias",Australia "Research into early-onset dementia","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Research Mentoring in Neurology and Translational Research on Alzheimers Disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Researching Patient Safety & Risk enablement","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Reshaping Mitochondrial Efficiency and Integrity to Treat Parkinson’s Disease","Investments > €500k","Parkinson's disease & PD-related disorders",Canada "Reshaping the Path of Mild Cognitive Impairment by Refining Exercise Prescription: Understanding Training Type and Exploring Mechanisms","Investments < €500k",,Canada "Resolving Factors in Alzheimers Disease","Investments < €500k",,"United States of America" "Resolving the Mechanism of Neuroinflammation for the Innovative Therapy of Neurodegenerative Diseases","Investments < €500k",,Slovenia "Resolving ubiquitin-dependent degradation of misfolded proteins using advanced single-molecule techniques.",Fellowships,"Parkinson's disease & PD-related disorders","United Kingdom" "RESTING STATE FUNCTIONAL CONNECTIVITY MRI IN MANGANESE EXPOSED WELDERS",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Resting state functional MRI as a tool to evaluate synaptic transmission deficits possibly elicited by soluble amyloid and inflammation in a mouse model of amyloidosis",Fellowships,"Alzheimer's disease & other dementias",Belgium "Restoration of cognitive deficits induced by diabetes through the modulation of cerebrovascular integrity","Investments < €500k",,Australia "Restoration of olfactory neural circuitry following disruption.","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Restoring brain function: from cortical microcircuits to complex behaviours in neurodegenerative disease.",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Restoring Brain Functions in Alzheimer Models with Interneuron Transplants","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Restoring memory by activating liver x receptors*","Investments < €500k",,Netherlands "Restoring neuroprotective sphingosine 1-phosphate signalling in Alzheimer’s Disease","Investments > €500k","Alzheimer's disease & other dementias",Australia "Restoring Neuroprotective Sphingosine 1-phosphate Signalling in Alzheimer’s Disease","Investments < €500k",,Australia "Retinal neurotoxicity of manganese exposure","Investments < €500k",,"United States of America" "Retinal neurotoxicity of manganese exposure","Investments < €500k",,"United States of America" "Retromer deficiency and Alzheimers disease pathology","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Return of Amyloid Imaging Research Results in MCI","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Reversal of neuronal and cerebrovascular pathology in Alzheimer’s disease","Investments < €500k",,Canada "Reverse apoE4 effects by apoE2 expression in Alzheimers disease","Investments < €500k",,"United States of America" "Reward processing in frontotemporal dementia",Fellowships,"Alzheimer's disease & other dementias","United States of America" "RHAPSODY: Research to assess Polices and Strategies for Dementia in Young","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias","France|Germany|JPND|Netherlands|Portugal|Sweden|United Kingdom" "Rhes-SUMO circuitry in Huntingtons Disease Pathogenesis","Investments > €500k","Huntington's disease","United States of America" "Rhythm and Timing Exercises for Cerebral Vascular Disease in American Indians","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "RiMod-FTD: Risk and Modifying factors in Fronto Temporal Dementia","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias","Belgium|France|Germany|Italy|JPND|Netherlands|United Kingdom" "Risk Communication in Dementia Care","Investments < €500k",,"United Kingdom" "Risk factors and prevention targets for abnormal cognitive aging",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Risk factors and prevention targets for abnormal cognitive aging",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Risk Factors for Stroke and Cognitive Decline in a Tri-Ethnic Region","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Risk factors, early diagnosis, and effective interventions for neurocognitive disorders","Investments > €500k","Alzheimer's disease & other dementias",Australia "Risk for Alzheimers Disease and Cognitive Decline in Project TALENT","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "RNA binding proteins as novel targets in Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "RNA decay in amyotrophic lateral sclerosis and frontotemporal lobar degeneration","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "RNA decay in amyotrophic lateral sclerosis and frontotemporal lobar degeneration","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "RNA dysregulation in neurodegeneration","Investments > €500k","Motor neurone diseases","United States of America" "RNA editing and its functional consequences in the human brain","Investments > €500k","Motor neurone diseases",Sweden "RNA editing for treatment of Huntingtons disease","Investments > €500k","Huntington's disease",Sweden "RNA metabolism in pathology of AOA2/ALS4 neurodegenerative disorders","Investments > €500k","Motor neurone diseases","United Kingdom" "RNA Processing Defects in SMA and Their Contribution to the Disease Phenotype","Investments > €500k","Spinal muscular atrophy (SMA)","United States of America" "RNA signatures of frontotemporal dementia and ALS due to C9ORF72 expansion",Fellowships,"Alzheimer's disease & other dementias","United States of America" "RNA signatures of frontotemporal dementia and ALS due to C9ORF72 expansion",Fellowships,"Motor neurone diseases","United States of America" "RNA splicing dysfunction in Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "RNA-based Expanded Repeat Pathogenic Pathway in Neurodegenerative Diseases","Investments < €500k",,Australia "RNA-demethylase FTO in the regulation of cognitive function and brain energy homeostasis: a novel pharmacological target in Alzheimer’s disease","Investments < €500k",,"Czech Republic" "RNA-Sequencing on Brain Tissue","Bio/Neuroinformatic Resources",,Netherlands "Robotic Assistant for MCI patients at home","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "Robust rare event simulation for protein folding and disease-related aggregation","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Robust rare event simulation for protein folding and disease-related aggregation","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders","United States of America" "Role and mechanisms of alpha-synuclein spreading in Parkinson´s disease",Fellowships,"Parkinson's disease & PD-related disorders",Portugal "Role of ABHD6 in 2-AG Signaling","Investments > €500k","Huntington's disease","United States of America" "ROLE OF ANKK1 in genetics and pathophysiology of the disease PARKINSON’s disease","Investments < €500k",,Spain "Role of Apolipoprotein D in Alzheimer’s Disease and Frontotemporal Dementia",Fellowships,"Alzheimer's disease & other dementias",Australia "Role of apolipoprotein E in age and amyloid beta related neuronal dysfunction","Investments < €500k",,"United States of America" "Role of APP for brain physiology and therapy of Alzheimer ‘s disease – analysis of APP / APLP mediated effects on neuronal morphology and function of the hippocampus","Investments > €500k","Alzheimer's disease & other dementias",Germany "Role of astrocytic 3-phosphoglycerate dehydrogenase in AD","Investments < €500k",,France "Role of astrocytic mitochondria in the early stages of Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias",Switzerland "Role of BACE in the pathogenesis of Alzheimers disease after head trauma","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Role of beta adrenergic receptors in modulation of cognition, pathology and neuroinflammation in Alzheimers Disease","Investments < €500k",,"United States of America" "Role of beta-secretase cleavage of non-amyloid substrates in Alzheimer`s Disease","Investments < €500k",,Switzerland "Role of C9orf72 in Neurodegeneration","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "Role of C9orf72 in Neurodegeneration","Investments > €500k","Motor neurone diseases","United States of America" "Role of caspases in human neuronal cell death and in Alzheimer’s disease.","Investments > €500k","Alzheimer's disease & other dementias",Canada "ROLE OF CHAIN LENGTH AND SEQUENCE CONTEXTS ON POLYGLUTAMINE OLIGOMERIZATION","Investments > €500k","Huntington's disease","United States of America" "Role of Cholinergic-Glutamatergic Co-transmission in Forebrain Circuits","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Role of Circadian Clock Components in Apoptosis and Tauopathy in Drosophila","Investments < €500k",,"United States of America" "Role of CK2 in NMDAR trafficking during development and in Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Role of CRMP2 and Pin1 in the pathogenesis of Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias", "Role of Cyclophilin D in Abeta- induced synaptic injury","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Role of Cyp46 in cholesterol metabolism and neuroprotection in Huntington’s Disease","Investments < €500k",,France "Role of deltaFosB in Neuronal and Cognitive Function",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Role of Elevated Diet-linked TOR Activity and Protein Synthesis in Parkinsons Disease Neurodegeneration",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Role of exosomes in amyloid clearance and plaque formation in AD.",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Role of exosomes in the transmission of Alzheimer phenotype between neurons","Investments < €500k",,France "Role of extracellular vesicle signaling in aging and Alzheimers disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Role of Formylpeptide Receptors in Host Defense","Investments < €500k",,"United States of America" "Role of HLA/MHCII in Parkinsons Disease Pathogenesis","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Role of HO-1 in Aging & Parkinsonian Neural Tissues III","Investments < €500k",,Canada "ROLE OF INTRACELLULAR TRAFFICKINGDYSFUNCTION IN ALZHEIMER’S DISEASE AND AGING",Fellowships,"Alzheimer's disease & other dementias",Portugal "Role of IRAP in Alzheimer’s Disease","Investments < €500k",,Australia "Role of LDLR in regulating metabolism of Apolipoprotein E and Amyloid-beta","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Role of lipid droplets in neurovascular inflammation","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Role of LIPL-4 in lysosomal lipolysis and aging","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Role of LRRK2 in dopaminergic transmission","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Role of LXRs in midbrain dopamine neuron development and Parkinson’s disease","Investments < €500k",,Sweden "Role of microRNA dysregulation in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "Role of microRNA-33 in Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Role of microRNAs as modulators of neuroinflammation in Alzheimer disease","Investments < €500k",,"United States of America" "Role of microtubule acetylation in Parkinson’s disease","Investments > €500k","Parkinson's disease & PD-related disorders","United Kingdom" "Role of midlife cardiovascular disease on Alzheimer’s Pathology and cerebrovascular reactivity in the young-old.","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Role of mitochondria in C9ORF72-related ALS/MND","Investments < €500k",,"United Kingdom" "Role of Mitochondria-Targeted CYP2D6 in Chemical Toxicity","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Role of Mitochondrial CYP2E1 in Chemical Exposure-Driven Neurodegeneration",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Role of Mitophagy in Mitochondrial Protein Quality Control","Investments < €500k",,"United States of America" "Role of Mitophagy in Mitochondrial Protein Quality Control","Investments < €500k",,"United States of America" "Role of MMP-9 in selective motor neuron degeneration in ALS","Investments > €500k","Motor neurone diseases","United States of America" "Role of neuroinflammation in prion-like α-synuclein spreading in the mouse brain","Investments < €500k",,Luxembourg "ROLE OF NEUROMELANIN AND ALPHA-SINUCLEINE IN THE START AND EXTENSION OF PARKINSON DISEASE: DIAGNOSTIC AND THERAPEUTIC POTENTIAL IN NEW PRE-CLINICAL MODELS","Investments < €500k",,Spain "Role of Novel Neurotrophic factors CDNF and MANF in genetic models of amyotrophic lateral sclerosis",Fellowships,"Parkinson's disease & PD-related disorders",Finland "Role of Oligodendroglia in the Pathogenesis of ALS","Investments > €500k","Motor neurone diseases","United States of America" "Role of PAR-1 Kinase in Synaptogenesis","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Role of Parkin in Familial and Idiopathic Parkinsons Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Role of phosphoinositides in neuronal membrane traffic and neurodegeneration","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Role of PINK1 Processing in Mitochondrial Function and Parkinson’s Disease","Investments > €500k","Parkinson's disease & PD-related disorders",Canada "Role of Plks in amyloidogenic APP processing","Investments < €500k",,"United States of America" "Role of PS1 in neurodegeneration","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Role of Systemic Amylin Dyshomeostasis in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Role of Tau Cleavage in Tauopathy","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Role of TFEB in Tauopathy","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Role of the Amyloid Precursor Protein in the cellular phosphoinositide metabolism through its interaction with the PIKfyve complex","Investments < €500k",,"United Kingdom" "Role of the basal ganglia in inhibiting and promoting voluntary movements","Investments < €500k",,Canada "Role of the IL-13 system in dopaminergic cell death","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Role of the Innate Immune System in Aging and Development of Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Role of the microbiome-gut-brain axis in prodromal and established Parkinson’s disease",Fellowships,"Parkinson's disease & PD-related disorders",Finland "Role of the mitochondrial matrix processing protease in mitochondrial biogenesis",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Role of the purinergic receptor P2X7 in Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias",France "Role of the synaptic proteins neuroligin-1 and neurexin-1 in Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias",Denmark "Role of the TOMM40 poly-T variant in the pathogenesis of Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Role of TMEM106B in C9ORF72-related Frontotemporal Lobar Degeneration","Investments < €500k",,"United Kingdom" "Role of translational mechanisms in the retrograde regulation of Synaptic homeostasis","Investments > €500k","Parkinson's disease & PD-related disorders",Canada "Role of TREM2 R47H in Alzheimers disease using novel CRISPR/Cas9 mouse models",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Roles of cardiotrophin-like cytokine partners in the immune response","Investments < €500k",,Canada "Roles of heat shock protein 110 in modulating amyloid neurotoxicity","Investments < €500k",,"United States of America" "Roles of heat shock protein 110 in modulating amyloid neurotoxicity","Investments < €500k",,"United States of America" "Roles of heat shock protein 110 in modulating amyloid neurotoxicity","Investments < €500k",,"United States of America" "Roles of protein SUMOylation in AMPA receptor trafficking, synaptic dysfunction and cognitive impairment in dementia","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Roles of reticulon proteins in neurodegenerative disorders","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Roles of SN27 in regulating glutamate receptors during neurodegeneration","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Rolling it out: Targeted translation intervention to improve driving cessation outcomes for people with dementia across metropolitan and regional areas",Fellowships,"Alzheimer's disease & other dementias",Australia Roodkapje,"Investments < €500k",,Netherlands "ROS driven mitochondrial-telomere dysfunction during environmental stress","Investments < €500k",,"United States of America" "ROS driven mitochondrial-telomere dysfunction during environmental stress","Investments < €500k",,"United States of America" "ROSETTA implementatie","Investments < €500k",,Netherlands "Safe & Easy Environment for Alzheimer’s disease and related disorders","Investments > €500k","Alzheimer's disease & other dementias",France "SAMS – Software Architecture for Mental health Self management","Investments < €500k",,"United Kingdom" "Scaling and Sequencing Motor Output in Humans: fMRI Study","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Scaling the Peaks; Understanding the barriers and drivers to providing and using dementia friendly community services in rural areas: the impact of location, cultures and community in the Peak District National Park on sustaining service innovations",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "School Quality and Racial Disparities in Alzheimers Disease in Project Talent","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Screening a neuroactive drug library to identify new treatments for Parkinson’s","Investments < €500k",,"United Kingdom" "Screening and Immunization: A Novel Approach to Tau Antibody Therapeutics",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Screening for enhancers of sAPPalpha","Investments < €500k",,"United States of America" "Search for new multifunction ligands affecting neurodegenerative processes (behavioral and metabolic tests, in vivo)","Investments < €500k",,Poland "SEARCH FOR NEW THERAPEUTIC DIANES IN PARKINSON’S DISEASE. ANALYSIS OF CELL RECYCLING SYSTEMS AND MITOCHONDRIAL STATUS IN CELLS FROM PATIENTS.","Investments < €500k",,Spain "Search for the Alzheimers Genes","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Search for the Alzheimers Genes","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Search of mechanisms responsible for adverse effects of amyloid beta on muscarinic receptor transmission","Investments < €500k",,"Czech Republic" "Seaweeds from Portuguese coast: Promising therapeutics against neurodegenerative disorders",Fellowships,"Neurodegenerative disease in general",Portugal "Secondary structure determination and protein fold prediction by CD spectroscopy: method development and its application on aberrant protein aggregates and amyloid fibrils","Investments < €500k",,Hungary "Securing intersectoral care through an IT-based service concept for multimorbid patients with dementia","Investments > €500k","Alzheimer's disease & other dementias",Germany "Seeded transmission of SOD1 misfolding","Investments < €500k",,"United States of America" "Seeded transmission of SOD1 misfolding","Investments < €500k",,"United States of America" "Seeing what they see: compensating for cortical visual dysfunction in Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Selecting Futures: The Social and Ethical Implications of Genetic Screening","Investments > €500k","Spinal muscular atrophy (SMA)","United Kingdom" "Selective age-related vulnerability in human perirhinal and lateral entorhinal cortices","Investments < €500k",,"United States of America" "Selective dopaminergic reward signals in the visual cortex of monkeys, humans en Parkinson patients.","Investments < €500k",,Belgium "Selective knockdown of misfolded SOD1 as a therapy for amyotrophic lateral sclerosis","Investments > €500k","Motor neurone diseases",Canada "Selective over expression of TDP-43 in APP/PS1 mice alters APP processing",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Selective vulnerability and somatic mosaicism in the human MND-FTD brain","Investments < €500k",,"United Kingdom" "Selective vulnerability of neuronal degeneration in Parkinson’s disease: the load of routine behaviour",Fellowships,"Parkinson's disease & PD-related disorders","European Commission" "Selective vulnerability to Alzheimer’s disease – understanding changes in white matter connectivity of the visual system in Posterior Cortical Atrophy",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Selectively inhibited transcription of mutant genes in neurodegenerative disease","Investments > €500k","Huntington's disease","United States of America" "Selectively Targeting Oscillations in Parkinson’s disease: Causal effects of the beta-rhythm on motor control",Fellowships,"Parkinson's disease & PD-related disorders","European Commission" "Selectively vulnerable neurons in Alzheimer’s disease: Functional and morphological changes in healthy ageing and early Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias",Australia "Self-assembled hydrogels as a model for neurodegeneration",Fellowships,"Alzheimer's disease & other dementias",Australia "Self-association and membrane binding of alpha-synuclein","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Self-Directed Online Training Intervention for Chinese Dementia Caregivers","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Self-management interventions and mutual assistance community services, helping patients with dementia and caregivers connect with others for evaluation, support and inspiration to improve the care experience","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "Self-propagating protein aggregates in Alzheimer’s disease","Investments < €500k",,Canada "Self-Regulation, Immunological Aging, and Health in Older Adults","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Self-Regulation, Immunological Aging, and Health in Older Adults","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Semantic assessment in aphasia",Fellowships,,"United Kingdom" "Semantic Memory and Language Learning in Alzheimers Disease and Semantic Dementi","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Sensor Enabled Affective Computing for Enhancing Medical Care",Fellowships,"Alzheimer's disease & other dementias","European Commission" "Sensory and Perceptual Measures as Biomarkers of Alzheimers Disease Pathology",Fellowships,"Alzheimer's disease & other dementias","United States of America" "SENSORY MOTOR FUNCTIONS IN THE STRIATAL NETWORK IN HEALTH AND DISEASE.","Investments < €500k",,Sweden "Sensory Processing in the Parkinsonian Striatal Microcircuit.","Investments < €500k",,Sweden "Sequence-based Discovery of AD Risk & Protective Alleles","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Sequence-based Discovery of AD Risk & Protective Alleles","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Sequestrins – New small protein drugs targeting neurodegenerative disorders","Investments < €500k",,Sweden "Serotonergic modulation of Alzheimer-like disease in mice","Investments > €500k","Alzheimer's disease & other dementias",Denmark "Serotonin modulation of neurogenesis-coupled microglial responses in Alzheimer’s-like disease in mice","Investments < €500k",,Denmark "SERVED Memory: Feasibility study of Screening & Enhanced Risk management for Vascular Event related Decline in Memory","Investments < €500k",,"United Kingdom" "Service provision for older people who are homeless and have memory problems","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Service Support Costs for Brain Banking Infrastructure for the South West Dementia Brain Bank (SWDBB)","Capital Infrastructure",,"United Kingdom" "Shared decision making in mild to moderate dementia.","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Short Sleep: Locus Coeruleus Metabolics and the Temporal Progression of Alzheimers","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Short-term memory binding: a sensitive cognitive marker for Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Short-term memory binding: validity as a cognitive biomarker for Alzheimer’s disease across cultures and nations",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Signal Processing for Diagnosis of Parkinson’s Disease from Noisy Speech","Investments > €500k","Parkinson's disease & PD-related disorders",Denmark "Signaling Pathways Regulating Neuronal Survival","Investments > €500k","Huntington's disease","United States of America" "Signalling of DNA single strand breaks and links to neurodegeneration.",Fellowships,"Neurodegenerative disease in general","United Kingdom" "Silencing C9or72 with rAAV Mediated RNAi","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "Silencing C9or72 with rAAV Mediated RNAi","Investments > €500k","Motor neurone diseases","United States of America" "SILENCING MACHADO-JOSEPH DISEASE THROUGH THE SYSTEMIC ROUTE",Fellowships,"Spinocerebellar ataxia (SCA)",Portugal "Silver Memories as Music Therapy","Investments < €500k",,Australia "Simulation of the Kinetics and Inverse Problemfor the Protein PolymERizationin Amyloid Diseases (Prion, Alzheimer’s)","Investments > €500k","Alzheimer's disease & other dementias|Prion disease","European Commission" "Simultaneous PET-MR Modelling and Reconstruction for Imaging Brain Disorders","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Singing and Playing in the Recovering and Degenerating Brain: Efficacy and Neural Mechanisms of Music in Stroke, Brain Injury, and Alzheimer’s Disease",Fellowships,"Neurodegenerative disease in general",Finland "Singing and Playing in the Recovering and Degenerating Brain: Efficacy and Neural Mechanisms of Music in Stroke, Brain Injury, and Alzheimer’s Disease","Investments < €500k",,Finland "Single cell and behavioural studies of entorhinal cortex and hippocampal function in a transgenic mouse model of Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Single cell genomics in the brain in healthy humans and in patients with neurodegenerative diseases","Investments < €500k",,Germany "Single Molecule Studies of Protein Folding Mechanisms","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Single-Cell Imaging of Functional Connectivity as a Window into Cognitive Aging","Investments < €500k",,"United States of America" "Single-centre open label exploratory phase two pilot study of exogenous oral Melatonin for the treatment of nocturia in Parkinson’s","Investments < €500k",,"United Kingdom" "SINUCLEINAS, DEPRESSION AND PARKINSON DISEASE. NEW THERAPEUTIC STRATEGIES BASED ON NUCLEIC ACIDS OF INTERFERENCE","Investments < €500k",,Spain "SIRT1 Limits Microglial Toxicity in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "sirtuin single nucleotide polymorphisms in brain ageing",Fellowships,"Alzheimer's disease & other dementias",Australia "Slaap- en stemmingsstoornissen bij de ziekte van Parkinson; een behandelstudie met lichttherapie. Sleep and mood disorders in Parkinson’s disease; A treatment study with light therapy","Investments < €500k",,Netherlands "SLEEP DEPRIVATION IN PARKINSON’S DISEASE: BRAZIL AND UNITED KINGDOM RESEARCH NETWORK","Investments < €500k",,"United Kingdom" "Sleep Disordered Breathing in normal elderly and risk for Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Sleep disturbance and degeneration in Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias",Australia "Sleep disturbance in people with dementia living in care homes: An audit and crossover trial of a night-time stepped care programme",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Sleep Quality and Human Amlyoid-Beta Kinetics",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Sleep-wake disturbances and cardio-metabolic dysfunction in at risk dementia: a novel pathway in neurocognitive decline’",Fellowships,"Alzheimer's disease & other dementias",Australia "Sleep, plasticity and neurodegeneration: Targeting sleep to improve cognition in Mild Cognitive Impairment (MCI)",Fellowships,"Alzheimer's disease & other dementias",Australia "Smad Signaling in Skeletal Muscle as a Biomarker of Disease Progression in ALS","Investments > €500k","Motor neurone diseases","United States of America" "Small molecule Parkin activators to treat Alzheimers Disease","Investments < €500k",,"United States of America" "Small molecule Parkin activators to treat Alzheimers Disease","Investments < €500k",,"United States of America" "Small molecule Parkin activators to treat Alzheimers Disease","Investments < €500k",,"United States of America" "Small molecule therapeutics for Alzheimers Disease","Investments < €500k",,"United States of America" "SMALL MOLECULE THERAPY FOR ALZHEIMERS DISEASE","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Small molecules activating RET for the treatment of Parkinson’s disease",Fellowships,"Parkinson's disease & PD-related disorders", "Small molecules mimicking GDNF for regeneration of dopaminergic neurons in vivo","Investments < €500k",,"United Kingdom" "Small vessel disease biomarkers in a longitudinally-followed stroke-belt cohort","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Small vessel disease in the brain.Hypotension and hypertension as causes of cognitive decline and dementia. Mechanisms and diagnostics for vascular dysregulation and identification of genetic markers.","Investments > €500k","Alzheimer's disease & other dementias",Sweden "Small vessel disease pathophysiology: human post-mortem brain tissue study with clinical-radiological-pathological correlation",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Small vessel diseases in a mechanistic perspective: Targets for InterventionAffected pathways and mechanistic exploitation for prevention of stroke and dementia","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "Small-Molecule Pharmacological Chaperones to Prevent Synuclein Transmission","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Smart emergency chain in the quarter as a back-up structure for people with dementia","Investments > €500k","Alzheimer's disease & other dementias",Germany "Smart glasses: activity recognition for cognitive aid","Investments > €500k","Alzheimer's disease & other dementias",Australia "SMART: Study of Mental Activity and Resistance Training","Investments > €500k","Alzheimer's disease & other dementias",Australia "SMN dysfunction in FUS-dependent ALS","Investments < €500k",,"United States of America" "SMN dysfunction in FUS-dependent ALS","Investments < €500k",,"United States of America" "SMN immunogene therapy for motor neuron disorders","Investments < €500k",,Australia "Social Regulation of Gene Expression, Supplement","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Social Support Aid for People with Dementia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Socially Assistive Robotic Architecture for Elder Care","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Software Platform for Analyzing Alzheimers and Parkinsons fMRI Connectomes","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Software Platform for Analyzing Alzheimers and Parkinsons fMRI Connectomes","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders","United States of America" "Solid State NMR Structural Analysis of Oligomeric Alzheimers Beta-Amyloid Peptide","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Soluble aSyn is a modulator of AD pathophysiology","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Somatic inactivation of the SNCA locus: a new approach to the understanding and treatment of Parkinsons Disease","Investments < €500k",,"United States of America" "Somatic inactivation of the SNCA locus: a new approach to the understanding and treatment of Parkinsons Disease","Investments < €500k",,"United States of America" "Song and music as a communicative form of intervention in rehabilitation in connection with dementia","Investments < €500k",,Denmark "SOPHIA: Sampling and biomarker optimisation and harmonisation in ALS and other motor neuro diseases","Investments < €500k",,Ireland "SORT1:PGRN blocking antibodies for Frontotemporal dementia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "SPANkracht: een Sociale, Plezierige, Actieve Nuttige daginvulling op eigen kracht voor jonge mensen met dementie. SPANNING Power: A Social, Enjoyable, Active Useful Day-to-Day Infusion for Young People With Dementia","Investments < €500k",,Netherlands "Spatial learning and memory in Huntington’s disease",Fellowships,"Alzheimer's disease & other dementias",Australia "Spatial orientation in patients with cognitive impairment and Alzheimer’s disease","Investments < €500k",,Norway "Spatiotemporal optimization of deep brain stimulation for Parkinsons Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Specific histone modifications in the pathogenesis of Huntington’s disease","Investments < €500k",,Hungary "SPEECH MOVEMENT CLASSIFICATION FOR ASSESSING AND TREATING ALS","Investments > €500k","Motor neurone diseases","United States of America" "Speech, its impairment and cognitive performance in Parkinson’s disease","Investments < €500k",,"Czech Republic" "Sphingolipids and Inflammation in the Development and Progression of Alzheimers","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Sphingolipids: a novel target in the treatment of Alzheimer Disease?","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "Spinal muscular atrophy: inducing SMN expression","Investments > €500k","Spinal muscular atrophy (SMA)","United States of America" "Spinophilin Signaling in the Striatum",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Spreading of Tau assemblies","Investments > €500k","Alzheimer's disease & other dementias|Neurodegenerative disease in general",France "ß-arrestin regulation of G protein-coupled receptor (GPCR) function in Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias",Belgium "STAD: Synapse-to-nucleus communication in Alzheimer’s disease","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias",France|Germany|Italy|JPND "STALLED CAPILLARY FLOW: A NOVEL MECHANISM FOR HYPOPERFUSION IN ALZHEIMER DISEASE","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Stand up to dementia: Reducing prolonged sitting to improve cognitive function in older adults",Fellowships,"Alzheimer's disease & other dementias",Australia "Standardising protocols for the differentiation and integration of human pluripotent stem cell-derived neural transplants in Parkinson’s disease","Investments > €500k","Parkinson's disease & PD-related disorders",Australia "Standardization of a Screening Test for Dementia and Biomarker Research","Investments < €500k",,Turkey "Statins and Dementia in the Oldest-old",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Statistical epidemiology in ageing research","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Statistical Methods for Causal Inference in Observational Studies","Investments < €500k",,"United States of America" "Statistical Methods for Causal Inference in Observational Studies","Investments < €500k",,"United States of America" "Statistical Methods for Neural Mechanisms Mediating Cognitive System in Mental Health Research",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Statistical Models for Alzheimer’s disease and Aging","Investments < €500k",,France "Stem cell therapies: Targeting the non-motor symptoms",Fellowships,"Parkinson's disease & PD-related disorders","United Kingdom" "Stem cell therapy for stroke and other neurodegenerative diseases","Investments > €500k","Parkinson's disease & PD-related disorders",Sweden "Stem-cell research to fight Parkinson’s and depression",Fellowships,"Parkinson's disease & PD-related disorders",Sweden "StemBANCC (FP7-IMI-Seventh Framework Programme/Innovative Medicines Initiative)","Capital Infrastructure",,"European Commission" "STEP REGULATION BY BDNF: THERAPEUTIC IMPLICATIONS IN NEUROLOGICAL DISEASES","Investments < €500k",,Spain "Stimulation cérébrale dans la maladie de Parkinson: mécanismes d’action et implication clinique. Brain stimulation in Parkinson’s disease: mechanisms of action and clinical involvement","Investments < €500k",,Canada "Stimulation of pro-resolving activities in Alzheimer´s disease","Investments > €500k","Alzheimer's disease & other dementias",Sweden "Stimulation of pro-resolving activities in Alzheimer´s disease","Investments > €500k","Alzheimer's disease & other dementias",Sweden "Stimulation of the cerebellum for the treatment of Parkinson’s disease and dyskinesia",Fellowships,"Parkinson's disease & PD-related disorders",France "Stopping the propagation of Alzheimer and other dementias",Fellowships,"Alzheimer's disease & other dementias",Sweden "Strain Typing of vCJD Cases","Investments > €500k","Prion disease","United Kingdom" "Strategies for Managing Persons with Dementia in Assisted Living","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "STRENGTH: Survival, Trigger and Risk, Epigenetic, eNvironmental and Genetic Targets for motor neuron Health","Investments > €500k|JPND Projects","Motor neurone diseases","Belgium|France|Germany|Ireland|Italy|JPND|Netherlands|Sweden|Switzerland|United Kingdom" "Stress and Sexuality Divergent Neuropathy in Alzheimers Disease","Investments < €500k",,"United States of America" "Stress Granules and the Biology of TDP-43","Investments > €500k","Motor neurone diseases","United States of America" "Stress Mental Disorders Accelerated Aging and Dementia a 35 year Cohort Study","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Striatal CaV1.3 Calcium Channels: An Overlooked Antidyskinetic Target for PD","Investments < €500k",,"United States of America" "Striatal CaV1.3 Calcium Channels: An Overlooked Antidyskinetic Target for PD","Investments < €500k",,"United States of America" "Striatal cholinergic cell assemblies in movement disorders","Investments > €500k","Huntington's disease|Parkinson's disease & PD-related disorders","European Commission" "Striatal Nurr1 activity facilitates the dyskinetic state: A novel therapeutic target","Investments < €500k",,"United States of America" "Striatal Nurr1 activity facilitates the dyskinetic state: A novel therapeutic target","Investments < €500k",,"United States of America" "Striatal systems and mechanisms regulating L-dopa-induced dyskinesias in Parkinsons disease","Investments < €500k",,"United States of America" "Striatal systems and mechanisms regulating L-dopa-induced dyskinesias in Parkinsons disease","Investments < €500k",,"United States of America" "Structural analysis of the conformational transitions of the K18 fragment of human tau driven by Hsp70 action",Fellowships,"Neurodegenerative disease in general", "Structural analysis of the Parkinson’s associated kinase PINK1","Investments < €500k",,"United Kingdom" "Structural and biochemical basis of protein amyloid evolution",Fellowships,"Alzheimer's disease & other dementias", "Structural and functional analysis of molecular interactions in neuronal membrane uptake and their malfunctions in neurodegenerative diseases","Investments < €500k",,Sweden "Structural and Functional Connectivity of the Human Basal Ganglia in Health and Disease using High Resolution MRI at 7T",Fellowships,"Parkinson's disease & PD-related disorders","United Kingdom" "Structural and functional neuro-anatomical correlates of memory for context across the adult lifespan.","Investments < €500k",,Canada "Structural and functional roles of exosomal nanovesicles in the formation, release and synaptotoxicity of amyloid proteins","Investments < €500k",,Switzerland "Structural Biology of Amyloid Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Structural biology of the LRP1-Abeta interaction","Investments < €500k",,Denmark "Structural insights into protein forms involved in Huntington’s Disease by Integrative Approaches",Fellowships,"Huntington's disease",France "Structural Markers for Alzheimers Disease and Cerebral Amyloid Angiopathy","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Structural polymorphism in the misfolding and aggregation of expanded polyglutamine proteins","Investments > €500k","Huntington's disease","United States of America" "Structural Studies of Alzheimers beta-Amyloid Fibrils","Investments < €500k",,"United States of America" "Structural Studies of Parkinson’s Disease","Investments > €500k","Parkinson's disease & PD-related disorders",Canada "Structural Studies of Prion Fibrils and Other Protein Fibrils","Investments < €500k",,"United States of America" "Structural studies of prion proteins and their ligand interactions","Investments > €500k","Prion disease","United Kingdom" "Structural study of multiple homologous epitopes present on the molecule of intrinsically disordered protein tau","Investments < €500k",,Slovakia "Structure and activity determination of membrane-active peptides","Investments < €500k",,Australia "Structure and Dynamics of Low-Complexity Regions in Proteins: The Huntingtin Case","Investments > €500k","Huntington's disease","European Commission" "Structure and Dynamics Of Macromolecules In Solution By NMR","Investments < €500k",,"United States of America" "Structure and Function of the Parkinsons disease associated protein LRRK2","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Structure and Inhibition of Amyloid in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Structure and transcriptome analyses in Multiple System Atrophy: from human brain to preclinical models","Investments < €500k",,Denmark "Structure and volume of the olfactory brain: Relationships to olfactory dysfunction, cognitive decline and prospective dementia.","Investments < €500k",,Sweden "Structure determination by vibrational spectroscopy","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Structure of Triplet Repeat mRNA in Neurodegenerative Disease","Investments > €500k","Huntington's disease","United States of America" "Structure-based design and discovery of improved anti-amyloidogenic compounds","Investments < €500k",,Canada "Structure-based Identification and Functional Characterization of SSH1 Inhibitors","Investments < €500k",,"United States of America" "Structure-function studies of faulty proteins and their complexes involved in motor neuron disease","Investments < €500k",,"United Kingdom" "Structure-function studies on ALS associated C9orf72 protein","Investments < €500k",,"United Kingdom" "Structures and mechanisms of nuclear import and export","Investments < €500k",,"United States of America" "Structures and mechanisms of nuclear import and export","Investments < €500k",,"United States of America" "Structures and Propagation of Pathologically Relevant Amyloids in Alzheimers.","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Studies in Dementia and Neurodegenerative Diseases","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Studies of molecular mechanisms in Alzheimer’s disease using imaging mass spectrometry","Investments > €500k","Alzheimer's disease & other dementias",Sweden "Studies on alpha-synuclein degradation and its relevance to Lewy body disease.",Fellowships,"Parkinson's disease & PD-related disorders","United Kingdom" "Studies on amyloid toxicity","Investments < €500k",,Sweden "Studies on benzylic derivatives of xanthines with expected MAO-B inhibitory activity and adenosine A1 and A2A receptors as compounds","Investments < €500k",,Poland "Studies on the plasticity of CNS cholinergic neurons","Investments > €500k","Alzheimer's disease & other dementias",Canada "Studies on the senescent human noradrenergic system with the novel iDISCO 3D immuno-imaging method with special attention on Alzheimer’s disease","Investments < €500k",,Sweden "STUDY BY NEUROIMAGEN OF THE CARRIERS OF THE MUTATION E46K OF THE ALPHA SINUCLEIN GENE AS A MODEL OF DISEASE BY BODIES OF LEWY IDIOPATICA","Investments < €500k",,Spain "Study Of Axially Coordinated Phthalocyanines as Anti-Fibrilogenic Agents and Sers-Probes For Amyloid Aggregates Detection","Investments < €500k",,Turkey "STUDY OF BIOMARKERS IN THE CONTINUOUS PATHOLOGICAL EXISTING BETWEEN LATERAL AMIOTROPHIC SCLEROSIS (ELA) AND FRONTOTEMPORAL LOBULAR DEGENERATION (DLFT) -II","Investments < €500k",,Spain "STUDY OF BIOMARKERS IN THE CONTINUOUS PATHOLOGICAL EXISTING BETWEEN LATERAL AMIOTROPHIC SCLEROSIS (ELA) AND LOBULAR DEVELOPMENT FRONTOTEMPORAL (DLFT) – I","Investments < €500k",,Spain "Study of Health in Pomerania","Population Cohorts","Alzheimer's disease & other dementias|Neurodegenerative disease in general",Germany "Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA)","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Study of the association of microRNA and mitochondria and their role in regulation of neuronal cell death in Fragile X Tremor Ataxia Syndrome (FXTAS)","Investments < €500k",,France "STUDY OF THE EFFECT OF THE DECREASE OF ß-GALACTOSIDASE AND THE CONSEQUENTIAL INCREASE OF GANGLIOSIDE GM1 IN NEURONES ON THE PRODUCTION AND AGGREGATION OF ß-AMYLOID PEPTIDE*","Investments < €500k",,Spain "STUDY OF THE EXOSOMAL MICRORNA EXPRESSION PROFILE IN BIOFLUIDS FOR THE IDENTIFICATION OF DIAGNOSTIC USE BIOMARKERS IN FRONTOTEMPORAL DEMENTIA","Investments < €500k",,Spain "STUDY OF THE GENES INVOLVED IN PARKINSON’S DISEASE BY SEQUENCING THE EXOMA","Investments < €500k",,Spain "STUDY OF THE PATTERN OF DNA MOLTING IN THE HYPOCAMPUS OF PATIENTS WITH ALZHEIMER’S DISEASE","Investments < €500k",,Spain "Study of the relations between global food behaviors and/or specific nutritional factors and ageing on a large population of mature adults","Population Cohorts","Neurodegenerative disease in general",France "STUDY OF THE ROLE OF THE ALPHA-KLOTHO SOLUBLE ISOFORM IN THE START AND PROGRESSION OF COGNITIVE DEFICITS: PRECIOUS DIAGNOSTIC MARKER, AND DIANA MOLECULA WITH THERAPEUTIC POTENTIAL","Investments < €500k",,Spain "Study on Environmental and GenomeWide predictors of early structural brain Alterations in Young students","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "Study on hnRNPA1 Pathobiology in ALS","Investments > €500k","Motor neurone diseases","United States of America" "Study on the analysis of N-glycosylation changes of glycoproteins and the role of glycosylation of protein quality control mechanism in cellular disease model","Investments < €500k",,Poland "Studying the function of c9orf72 in amyotrophic lateral sclerosis","Investments < €500k",,"United Kingdom" "Studying the Physiological Role of Nuak1 in Tau Pathogenesis",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Substitute decision making for elderly people with dementia. Formal and informal representatives and the importance of surrogates for the elderly, relatives and the authorities concerned","Investments > €500k","Alzheimer's disease & other dementias",Sweden "Subtle Change Detection and Quantification in Magnetic Resonance Neuroimaging","Investments < €500k",,Sweden "Super-Resolution Microscopy of Small Quantum Dots to Elucidate the Mechanisms of Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Supporting Activity Engagement in People with Huntingdons Disease: A Phase II Evaluation (Acronym ENGAGE-HD)",Fellowships,"Huntington's disease","United Kingdom" "Supporting Excellence in End of life care in Dementia (SEED programme)","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Surveillance of human spongiform encephalopathies","Disease Registers","Prion disease",Germany "Surveying the physiological changes to cells in Huntington’s disease","Investments < €500k",,Australia "Sustainability for the National Institute of Mental Health","Capital Infrastructure",,"Czech Republic" "SV2C as a novel mediator of transmitter release and neuroprotection in dopamine cells",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Swedish Adoption/Twin Study of Aging","Population Cohorts","Alzheimer's disease & other dementias",Sweden "Swedish Brain Power","Capital Infrastructure",,Sweden "Swedish Brain Power","Research Networks",,Sweden "Swedish National Study on Aging and Care in Kungsholmen","Population Cohorts","Alzheimer's disease & other dementias|Neurodegenerative disease in general",Sweden "Swedish Twin Registry","Population Cohorts","Neurodegenerative disease in general",Sweden "Switching the disease off: Effects of spatial and temporal inactivation of mutant huntingtin in Huntington disease",Fellowships,"Huntington's disease", "Sydney Brain Bank",Biobanks,,Australia "Sydney Memory and Ageing Study","Population Cohorts","Alzheimer's disease & other dementias|Neurodegenerative disease in general|Parkinson's disease & PD-related disorders",Australia "Symptomatic Treatment of Vascular Cognitive Impairment","Investments < €500k",,Netherlands "SYNACTION: Unravelling the pathophysiological role of alpha-synuclein aggregation, transmission and neuroinflammation in neurodegeneration","Investments > €500k|JPND Projects","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders",Belgium|France|Germany|JPND "Synapse formation, synaptic plasticity and neurodegeneration: The role of MEN1 gene","Investments < €500k",,Canada "Synaptic calcium dysregulation in Huntingtons disease",Fellowships,"Huntington's disease","United States of America" "Synaptic circuit protection in AD and HD: BDNF/TrkB and Arc signaling as rescue factors","Investments < €500k",,Finland "Synaptic correlates of learning and memory dysfunction analysed by super-resolution STED microscopy in the hippocampus in vivo","Investments < €500k",,France|Germany "Synaptic Depression: Focus on Cdk5 Signaling","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Synaptic Dysfunction Affecting DNA Integrity in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Synaptic Dysfunction in Alzheimer Disease",Fellowships,"Alzheimer's disease & other dementias","European Commission" "Synaptic dysfunction in Alzheimer Disease: from new in vitro models to identification of new targets.","Investments > €500k","Alzheimer's disease & other dementias",Italy "Synaptic Imbalance in Mild Cognitive Impairment and Alzheimers Disease","Investments < €500k",,"United States of America" "SYNAPTIC MARKERS IN ALZHEIMER’S DISEASE","Investments < €500k",,Spain "Synaptic mechanisms implicated in Alzheimer´s disease","Investments < €500k",,Sweden "SYNAPTIC REGULATION OF ERK-MEDIATED AMYLOID-BETA METABOLISM","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Synaptic substrates of age-dependent memory deficits","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Synaptic toxicity of Huntington disease protein","Investments < €500k",,"United States of America" "Synaptic toxicity of Huntington disease protein","Investments < €500k",,"United States of America" "Synaptic Transmission, Plasticity and Integration in the Subthalamic Nucleus","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Synaptic Transmissions in the Basal Ganglia","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Synaptic vesicle recycling and Parkinson’s disease",Fellowships,"Parkinson's disease & PD-related disorders","European Commission" "Synergistic Neuroprotective Mechanisms of Coffee Components in Parkinsons Diseas","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "SYNJ1 Mediates a Novel Signaling Pathway in Parkinsons Disease","Investments < €500k",,"United States of America" "SYNJ1 Mediates a Novel Signaling Pathway in Parkinsons Disease","Investments < €500k",,"United States of America" "SynSpread: Role and mechanism of alpha-synuclein and ataxin-3 spreading in Parkinson and Machado-Joseph diseases","Investments > €500k|JPND Projects","Parkinson's disease & PD-related disorders|Spinocerebellar ataxia (SCA)",France|JPND|Luxembourg|Portugal "Synthesis and Molecular Modelling of Piperidin Hydrazide as a Potential Anti-Alzheimer Compound","Investments < €500k",,Turkey "Synthetic Heparins as Safe Disease-modifying Drugs for Early-Stage Treatment of AD via Inhibition of Beta-Secretase: Evaluation in a Transgenic Mouse Model","Investments < €500k",,"United Kingdom" "Systematic discovery and functional analysis of the PARKIN modified proteome","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Systematic reviews of interventions which target modifiable risk factors for dementia","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Systemic and central inflammation in Dementia with Lewy Bodies",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "SYSTEMS BIOLOGY OF PATHWAYS INVOLVING BRAIN AGEING","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "Systems Medicine of Mitochondrial Parkinson’s Disease","Investments > €500k","Parkinson's disease & PD-related disorders","European Commission" "T cell-mediated mechanisms of neurodegeneration in models of Parkinsons disease",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Tackling autophagy and apoptosis for the potential therapy of Huntington’s Disease","Investments > €500k","Huntington's disease","United Kingdom" "Tackling key epidemiological and basic scientific research issues in prion diseases.",Fellowships,"Alzheimer's disease & other dementias",Australia "Tackling the complex pathogenesis of non-Alzheimer dementias and motor neurodegenerative disorders",Fellowships,"Alzheimer's disease & other dementias",Australia "Taking the Stress out of Dementia Caregiving","Investments < €500k",,Ireland "Taking the Stress out of Dementia Caregiving","Investments < €500k",,Ireland "TAM receptor control of microglial function and nervous system homeostasis","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Target Engagement Biomarkers for Alzheimers Therapeutics","Investments < €500k",,"United States of America" "Target Identification for Novel Small Molecule Therapeutic for Alzheimers disease","Investments < €500k",,"United States of America" "Target molecules for neurorestoration in Parkinson’s diseas","Investments < €500k",,Sweden "Targeted activation of select neural pathways by deep brain stimulation in patients with Parkinsons disease",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Targeted Brain Delivery of Nrf-2 Gene and α-Synuclein Binding Peptide using Functionalised Gold Nanoparticles for Disease-modifying Therapy of Parkinson’s Disease",Fellowships,"Parkinson's disease & PD-related disorders", "Targeted delivery into brain capillary endothelial cells for the treatment of Alzheimer disease","Investments < €500k",,Canada "Targeted gene transfer across specific synapse types","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Targeting a Novel Regulator of Brain Aging and Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Targeting a SMN lncRNA for the treatment of SMA","Investments > €500k","Spinal muscular atrophy (SMA)","United States of America" "Targeting Alpha-Synuclein for Treating Multiple System Atrophy","Investments < €500k",,France "Targeting Amyloid Propagation in Alzheimer Disease: Structures, Immunology and Extracellular Vesicle Topology","Investments > €500k","Alzheimer's disease & other dementias",Canada "Targeting autophagy to improve protein metabolism in ALS","Investments < €500k",,Australia "Targeting chaperone mediated autophagy to aleviate Aβ accumulation and toxicity in AD","Investments < €500k",,Australia "Targeting glucocerebrosidase for disease-modifying treatments in Parkinson’s disease","Investments < €500k",,"United Kingdom" "Targeting GPCRs to Treat and Prevent Dementia.",Fellowships,"Alzheimer's disease & other dementias",Australia "Targeting huntingtin proteostasis and mitochondria to prevent neuronal dysfunction in Huntington’s disease","Investments < €500k",,Portugal "Targeting Lewy Body Specific Pathology Using Biomarkers","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Targeting Lewy Body Specific Pathology Using Biomarkers","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders","United States of America" "Targeting mitochondrial dysfunction as a potential therapy for the prevention of neurodegenerative disorders including Alzheimer’s Disease (AD)","Investments < €500k",,Australia "TARGETING NATURAL ANTIOXIDANTS TO MITOCHONDRIA: A NEW THERAPEUTIC APPROACH ON NEURODEGENERATIVE DISEASES",Fellowships,"Neurodegenerative disease in general",Portugal "Targeting necroptosis in Alzheimer’s disease: a shift from neuroinflammation to neuroprotection",Fellowships,"Alzheimer's disease & other dementias",Portugal "Targeting neuroinflammatory pathways as novel treatments for dementia",Fellowships,"Alzheimer's disease & other dementias",Australia "Targeting Neurovascular Dysfunction in AD","Investments < €500k",,"United States of America" "Targeting NMDA receptor dysfunctions in Parkinson´s disease","Investments < €500k",,Sweden "Targeting Parkin and Mitochondrial Dynamics in Huntington’s disease","Investments > €500k","Huntington's disease","United Kingdom" "Targeting pathogenic tau with phosphorylated-tau specific intrabodies",Fellowships,"Alzheimer's disease & other dementias",Australia "Targeting perivascular innervation and vascular tone for improved clearance of ß-amyloid from the brain","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Targeting Post-synaptic Tau to Treat Alzheimer’s Disease","Investments > €500k","Alzheimer's disease & other dementias",Australia "Targeting RXRs to enhance autophagy and reduce gliosis in Alzheimers disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "TARGETING SLOW WAVE SLEEP TO CONTROL NEURONAL ACTIVITY AND AMYLOID-BETA DYNAMICS",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Targeting tau to prevent Abeta mediated synapse degeneration in Alzheimer’s","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Targeting the apoE/A-beta Interaction as a Therapeutic Approach for AD","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Targeting the glycation defenses as a protective strategy for Parkinson’s disease","Investments < €500k",,Portugal "Targeting the hematopoietic system: the role of hematopoietic growth factors in restricting A-beta accumulation in Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Targeting the innate immune system in Huntington’s disease","Investments > €500k","Huntington's disease","United Kingdom" "Targeting the kynurenine pathway in Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Targeting the NMDA receptor-mediated disruption of autonomous subthalamic nucleus activity to ameliorate physiological and motor symptoms in a mouse model of Parkinsons Disease",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "Targeting the pathological pathways to Parkinson’s","Investments > €500k","Parkinson's disease & PD-related disorders","United Kingdom" "Targeting the synaptic actin cytoskeleton in Alzheimer’s Disease","Investments > €500k","Alzheimer's disease & other dementias",Australia "Targeting the Ubiquitin Proteasome System to Treat Spinal Muscular Atrophy","Investments > €500k","Spinal muscular atrophy (SMA)","United States of America" "Targeting the Unfolded Protein Response to limit TDP-43 aggregation","Investments < €500k",,"United Kingdom" "Targeting vascular pathology to treat age-related cognitive decline",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Tau and APP interactions in Neurodegeneration",Fellowships,"Alzheimer's disease & other dementias",Australia "Tau conditional knockout mice to elucidate the function of tau in the adult brain","Investments < €500k",,"United States of America" "Tau Conformation in Tauopathies and Neuronal Function","Investments > €500k","Neurodegenerative disease in general","United States of America" "Tau function in pre and postsynaptic plasticity of human cortical neurons","Investments < €500k",,"United States of America" "Tau Imaging in Atypical AD","Investments < €500k",,"United States of America" "TAU IMAGING WITH [18F]T807 PET: THE NEW FRONTIER","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "Tau in Central Nervous System: neurotoxic and autoimmune component","Investments < €500k",,"Czech Republic" "Tau Oligomer Platform Validation Using Lead Series Candidate in htau Mice","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Tau Phosphorylation and Beta Amyloid Production in 1,25 MARRS Gene Silenced Neurons","Investments < €500k",,Turkey "Tau protein and insulin signaling pathways: implication to Alzheimer’s disease and diabetes","Investments < €500k",,Australia "Tau Quantitation in AD with High Resolution MRI and PET",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Tau Structures: From Proteopathic to Protective",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Tau-binding B Cells in Alzheimers Disease","Investments < €500k",,"United States of America" "Tau-directed catalytic antibodies","Investments < €500k",,"United States of America" "Tau-Fyn interaction in normal and diseased states of the brain",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Tau-induced axonal degeneration in Alzheimers disease and tauopathies","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Tau-mediated regulation of axonal transport","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Tau-Spliceosome Interactions in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Tau, amyloid, & white matter burden interact to impact brain networks in preclinical Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Tauopathies and neuronal connectivity: diffusion imaging and CLARITY","Investments < €500k",,"United States of America" "TDP-43 acetylation as a pathogenic modification in ALS & related proteinopathies","Investments > €500k","Motor neurone diseases","United States of America" "TDP-43 acetylation as a pathogenic modification in ALS & related proteinopathies","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "TDP-43 aggregation inhibitors for the treatment of ALS","Investments < €500k",,"United States of America" "TDP-43 aggregation inhibitors for the treatment of ALS","Investments < €500k",,"United States of America" "TDP-43 and Mitochondrial Dysfunction in ALS","Investments > €500k","Motor neurone diseases","United States of America" "TDP-43 Proteinopathy in ALS-FTD: Mechanism, Target Validation and Biomarker","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "TDP-43 Proteinopathy in ALS-FTD: Mechanism, Target Validation and Biomarker","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "TDP-43, RNA Metabolism, and ALS/FTD Pathology","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "TDP-43, RNA Metabolism, and ALS/FTD Pathology","Investments > €500k","Motor neurone diseases","United States of America" "Techniques to include carers’ quality of life in economic evaluation",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Technology enriched supported housing – a study into the lived experience of older people with dementia and their carers","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Technology for the Search of Common Objects in the House","Investments > €500k","Alzheimer's disease & other dementias",France "TEFOR, CNRS","Capital Infrastructure",,France "Telehealth in Motor Neurone Disease","Investments < €500k",,"United Kingdom" "Telehealth in Motor Neurone Disease: the TiM trial. A randomised controlled pilot study of the use of the TiM system to deliver highly specialised care to patients and carers of those living with motor neurone disease.",Fellowships,"Motor neurone diseases","United Kingdom" "Temporal Patterns of Deep Brain Stimulation","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Temporal Trends, Novel Imaging and Molecular Characterization of Preclinical and Clinical Alzheimers Disease in the Framingham Cohorts","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Temporally patterned closed-loop stimulation for therapy of brain disorders","Investments > €500k","Parkinson's disease & PD-related disorders","United Kingdom" "TEP-CT Scan / Nano TEMP-CT Scan /Radiochemistry/US – GAIA","Capital Infrastructure",,France "Testing a combination therapy with Ras-ERK and mTor inhibitors for L-DOPA induced dyskinesia","Investments < €500k",,"United Kingdom" "Testing a new diagnostic tool for Alzheimer’s disease and Dementia with Lewy Bodies","Investments < €500k",,"United Kingdom" "Testing a therapeutic strategy for hippocampal sclerosis of aging, a key AD mimic","Investments < €500k",,"United States of America" "Testing predictions of quantitative models of dopamine signals in different stages of Parkinson’s disease.","Investments < €500k",,Denmark "Testing safe and simple treatments for preventing brain and eye disease",Fellowships,"Alzheimer's disease & other dementias",Australia "Testing Tele-Savvy, an On-line Psychoeducation Program for Informal Alzheimers Caregivers","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Testosterone-Androgen Receptor Genetics: Role in Cognitive and Biological Aging",Fellowships,"Alzheimer's disease & other dementias","United States of America" "TgF344-AD (University College Cork)","Experimental Models",,Ireland "Thalamic interactions with the striatum","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "The 4th World Parkinson Congress is a four-day scientific conference designed to bring the US and global Parkinsons community together for a variety of high level and novel educational symposia.","Investments < €500k",,"United States of America" "The 5-HT4 receptor networks: bodyguards of ADAM10 and APP trafficking","Investments < €500k",,France "The A3 Study: Ante-Amyloid Prevention of Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The Aging Brain and the Cognition-Mobility Interface in Clinically Normal Older Adults",Fellowships,"Alzheimer's disease & other dementias","United States of America" "The aging population: Does the increasing length of life result in more or less ill health?","Investments < €500k",,Sweden "The amyloid and beyond; A molecular answer to forget me not.","Investments < €500k",,Canada "The amyloid beta toxic species","Investments > €500k","Alzheimer's disease & other dementias",Australia "The analysis of mitochondrial dynamics in ageing and neurodegeneration","Investments > €500k","Neurodegenerative disease in general","European Commission" "The ARIC study of midlife sleep and late-life brain amyloid","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The ARIC-PET Amyloid Imaging Study","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The Arts in Dementia – TAnDem","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "The association of FGF-23 and Klotho with cognitive impairment and cerebrovascular disease in chronic kidney disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "The Australian Imaging, Biomarkers & Lifestyle Flagship Study of Ageing","Case Control Studies","Alzheimer's disease & other dementias|Neurodegenerative disease in general",Australia "The Biology of Neuroserpin","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders","United States of America" "The body-mind connection: Exploring the biological mechanisms underlying the effects of somatic health on brain aging","Investments > €500k","Alzheimer's disease & other dementias",Sweden "The calcium binding S100B protein as a modulator of amyloid β aggregation and a potential therapeutic target in Alzheimer’s disease","Investments < €500k",,Portugal "THE CD200-CD200R1 SYSTEM AS A THERAPEUTIC DIANA AND BIOMARKER IN NEUROLOGICAL DISEASES: PARKINSON’S DISEASE","Investments < €500k",,Spain "The Cdk5/35 Kinase","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The cellular basis of neurovascular coupling in the cerebral cortex.","Investments > €500k","Alzheimer's disease & other dementias",Canada "The Clinical Profile of Parkinsons Disease (PD) Pathology","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "The cognitive structure of decisions under risk and uncertainty in Parkinson’s disease","Investments < €500k",,Canada "The connection of MERTK, TSP-1, BDNF, ACE and NOS3 polymorphism with age related macular degeneration and Alzheimer’s disease","Investments < €500k",,Hungary "The Consortium for the Early Identification of Alzheimer’s Disease","Case Control Studies","Alzheimer's disease & other dementias",Canada "The continuum between healthy ageing and idiopathic Parkinson Disease within a propagation perspective of inflammation and damage: the search for new diagnostic, prognostic and therapeutic targets","Investments > €500k","Parkinson's disease & PD-related disorders","European Commission" "The contribution of cytoskeleton disruptions in ALS disease pathology",Fellowships,"Motor neurone diseases","United States of America" "The contribution of epigenetic phenomena to Alzheimer’s disease: an integrated genetic-epigenetic analysis","Investments < €500k",,"United Kingdom" "The contribution of extracellular tau to the propagation of neurodegeneration in Alzheimer disease","Investments < €500k",,Canada "The contribution of extracellular tau to the propagation of neurodegeneration in Alzheimer disease","Investments < €500k",,Canada "The coordination of microtubule-dependent motors during axonal transport.",Fellowships,"Neurodegenerative disease in general","United Kingdom" "The COPA vesicle protein and pathogenesis of spinal muscular atrophy","Investments > €500k","Spinal muscular atrophy (SMA)","United States of America" "The determinants of cross-seeding of protein aggregation: a Multiple TANGO","Investments > €500k","Neurodegenerative disease in general","European Commission" "The development and evaluation of an educational program for the care of older people with dementia in emergency departments","Investments < €500k",,Australia "The development and testing of a communication skills training intervention for healthcare professionals caring for people with dementia in acute hospitals","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "The development and trial of an innovative community based Respite Action intervention for carers of people with Dementia","Investments < €500k",,Australia "The development of a comprehensive medicines management approach for persons with dementia","Investments < €500k",,"United Kingdom" "The development, plasticity and pathology of myelinated CNS axons.",Fellowships,"Neurodegenerative disease in general","United Kingdom" "The disease process of hereditary frontotemporal dementia in the presymptomatic stage: a search for sensitive biomarkers","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "The DOGS+CELLS Trial: A new pathway to treating Alzheimer’s dementia","Investments < €500k",,Australia "The Dutch Flutemetamol in Young Onset Dementia Study","Investments < €500k",,Netherlands "The dynamic role of astrocyte secreted APOε4 in Alzheimer’s disease: investigations using human induced pluripotent stem cells","Investments < €500k",,"United Kingdom" "The effect of chronic intermittent alcohol consumption on the precipitation of dementia.",Fellowships,"Alzheimer's disease & other dementias",Australia "The effect of hypochlorite on the toxicity and clearance of the Alzheimer’s disease-associated amyloid beta peptide","Investments < €500k",,Australia "The Effect of Leucodepletion on Transmission of BSE by Tranfusion of Sheep Blood Components","Investments > €500k","Prion disease","United Kingdom" "The Effect of Low Frequency STN DBS on Sleep and Vigilance in PD Patients",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "The effect of synaptic activity on alpha-synuclein pathogenesis in a model for Parkinson’s Disease",Fellowships,"Parkinson's disease & PD-related disorders",Belgium "The effect of transcranial direct current stimulation on motor learning after stroke","Investments < €500k",,"United Kingdom" "The effects of alpha-synuclein pathology on noradrenergic neurons",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "The effects of amyloid beta on synapses in the brain","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "The effects of noise, socioeconomic status and genetics in the relationship between air pollution and dementia","Investments > €500k","Alzheimer's disease & other dementias",Sweden "The entorhinal cortex and aerobic exercise in aging","Investments < €500k",,"United States of America" "The evaluation of a Healthcare Passport to improve quality of care and communication for people living with dementia (EQulP)","Investments < €500k",,"United Kingdom" "The eyes have it: Dynamic characteristics of retinal blood vessels predict early onset of Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias",Australia "The factor XII-driven contact system as a new therapeutic target in Alzheimer’s disease","Investments < €500k",,Switzerland "The Four Repeat Tauopathy Neuroimaging Initiative","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The functional interplay between alpha synuclein and synaptophysin in synaptic vesicle recycling","Investments < €500k",,Australia "The genetic and environmental determinants of amyloid deposition in older individuals: an amyloid imaging study using the twin design","Investments < €500k",,Australia "The Genetic Regulation and Disease Function of the Frontotemporal Dementia Protei","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The Genetics of ALS and related Neurodegenerative Syndromes: Finding the Genes.","Investments < €500k",,Sweden "The Gut Microbiome in Neurodegenerative Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "The Gut Microbiome in Parkinson Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "The Health Survey in Nord-Trøndelag","Population Cohorts","Alzheimer's disease & other dementias|Neurodegenerative disease in general|Parkinson's disease & PD-related disorders",Norway "The Heart-Brain Connection:the mssing link in the pathophysiology of vascular cognitive impairment","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "The hsp90 Cochaperone FKBP51 Regulates tau Structure and Function","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The impact of beta-amyloid burden on cognition in normal aging","Investments < €500k",,Canada "The impact of drug-induced dyskinesia and its management on the daily life activities of patients with Parkinson’s disease","Investments < €500k",,Canada "The impact of emotional mimicry and oxytocin on frontotemporal dementia","Investments < €500k",,Canada "The impact of endocytic protein Tom1 on Alzheimers disease","Investments < €500k",,"United States of America" "The impact of non-amyloid processes on cognitive aging","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The Impact Of Surgery-Induced Neuroinflammation On Tau Pathology And Function","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The importance of phosphorylation in modulating Hsp70 function; potential for novel therapeutic strategies for cancer and amyloid diseases","Investments < €500k",,Ireland "The importance of precision: a model for movement and movement disorders.","Investments < €500k",,"United Kingdom" "The Incidence and Prognosis of Dementia related to Drug use in out-patients with cognitive impairments (the IPoD-D-Study).","Investments < €500k",,Norway "The inflammatory mediator Lactorferrin induces rapid and pronounced amyloidogenic processing of APP","Investments < €500k",,Australia "The influence of cortical neurodegenerative pathology on white matter integrity","Investments < €500k",,"United Kingdom" "The influence of mild cognitive impairment on falls, gait and rehabilitation",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "The influence of multi-domain cognitive training on large-scale structural and functional brain networks in MCI",Fellowships,"Alzheimer's disease & other dementias","United States of America" "The integration of biomedical research, describing the biological processes relevant to Parkinson’s, into the Gene Ontology database","Investments < €500k",,"United Kingdom" "The INVEST study (Infusion VErsus STimulation), a cost-effectiveness analysis of the treatment of advanced Parkinson’s disease comparing Continuous Levodopa Infusion to the traditional standard treatment Deep Brain Stimulation","Investments > €500k","Parkinson's disease & PD-related disorders",Netherlands "The Irish Longitudinal Study on Ageing","Population Cohorts","Neurodegenerative disease in general",Ireland "The IU/JAX Alzheimers Disease Precision Models Center","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The IU/JAX Alzheimers Disease Precision Models Center","Capital Infrastructure",,"United States of America" "The Kungsholmen Project","Population Cohorts","Alzheimer's disease & other dementias|Neurodegenerative disease in general",Sweden "The Long-Run Impact of Hurricane Katrina on Mortality, Morbidity and Health Care Cost Among the Elderly","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The Longitudinal Course OF Imaging Biomarkers in People At RISK of AD","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The Maastricht Study","Investments > €500k","Alzheimer's disease & other dementias|Neurodegenerative disease in general",Netherlands "The Macrovascular and Microvascular Contributions to Alzheimers Disease: MESA VASCAD","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The MARQUE project: Managing Agitation and Raising QUality of Life. A project to improve quality of life in people with moderate or severe dementia","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "The mechanism of binding of drug candidates to disordered proteins","Investments < €500k",,Hungary "The mechanism of cognitive reserve in bilingualism","Investments < €500k",,"United States of America" "The mechanism of hypertensions protective effect on dementia and slow gait in the oldest-old",Fellowships,"Alzheimer's disease & other dementias","United States of America" "The missing link: mGluR5 as a therapeutic target for cognitive decline in dementia",Fellowships,"Alzheimer's disease & other dementias",Australia "The model of the neuroimmune crosstalk in Alzheimer´s disease","Investments < €500k",,Slovakia "The Molecular Anatomy of Neurons","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders","European Commission" "The molecular basis of the innate response to oligomers of beta amyloid and alpha synuclein","Investments < €500k",,"United Kingdom" "The Molecular Communication Mechanism of Motor Neuron Survival and Synapse Maintenance","Investments > €500k","Motor neurone diseases","European Commission" "The molecular mechanisms of structural conversion and toxicity in amyloid disease.","Investments > €500k","Neurodegenerative disease in general","United Kingdom" "The motor network in Parkinsons disease: mechanisms of therapy","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "The Namaste Care intervention to improve the quality of dying for people with advanced dementia living in care homes: A realist review and feasibility study for a cluster randomised controlled trial","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "The Neighbourhood Team Development Program: Promoting Resident Centeredness in Long-Term Care","Investments > €500k","Alzheimer's disease & other dementias",Canada "THE NERVOUS SYSTEM AUTONOMO ENTERICO AS BIOMARCADOR PRECOZ IN THE DISEASE OF PARKINSON","Investments < €500k",,Spain "The Netherlands Brain Bank (VUMC)",Biobanks,"Alzheimer's disease & other dementias|Motor neurone diseases",Netherlands "The Neural Basis of Apathy in Frontotemporal Degeneration: A Longitudinal Study",Fellowships,"Alzheimer's disease & other dementias","United States of America" "The neural circuitry of executive functions in Parkinson’s disease","Investments < €500k",,Canada "The neural correlates of memory improvement following transcranial direct current stimulation combined with cognitive training","Investments < €500k",,Australia "The NIA Genetics of Alzheimers Disease Data Storage Site","Capital Infrastructure",,"United States of America" "The NIA Genetics of Alzheimers Disease Data Storage Site","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The Norwegian Cognitive impairment After STroke (COAST) study","Investments > €500k","Alzheimer's disease & other dementias",Norway "The Norwegian ParkWest study","Investments < €500k",,Norway "The nuclear receptor TLX as a cell intrinsic regulator underlying inflammation and stress-induced changes in hippocampal neurogenesis: relevance to cognitive disorders","Investments > €500k","Neurodegenerative disease in general",Ireland "The Olfactory Bulb-Entorhinal Cortex Axis as an Early Biomarker for Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The PARADE study: Pathegenic Antibodies and (Rapidly Progressive) Dementia Syndromes",Fellowships,"Alzheimer's disease & other dementias",Netherlands "The Parkinson’s disease associated Pink1-Parkin-RhoT1 pathway in pathology and development","Investments < €500k",,Luxembourg "The PARL-PGAM5-PINK1 axis on mitochondrial homeostasis: implications for Parkinson´s disease.",Fellowships,"Parkinson's disease & PD-related disorders",Portugal "The Pathogenesis of Spinal and Bulbar Muscular Atrophy",Fellowships,"Spinal muscular atrophy (SMA)","United Kingdom" "The pathophysiological role of TDP-43 in amyotrophic lateral sclerosis due to C9orf72 mutations",Fellowships,"Motor neurone diseases","United Kingdom" "The pathophysiological role of TDP-43 in amyotrophic lateral sclerosis due to C9orf72 mutations","Investments < €500k",,"United Kingdom" "The pathophysiological role of TDP43 in amyotrophic lateral sclerosis due to C9orf72 mutations",Fellowships,"Motor neurone diseases","United Kingdom" "The Pathophysiology of Network Synchrony in Parkinsons Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "The Perceptions and Experiences of Children and Young People with a Parent with Dementia","Investments < €500k",,"United Kingdom" "The PERKplexity of the integrated stress response in motor neurons and myelinatin",Fellowships,"Motor neurone diseases","United States of America" "The Pharmacological Enhancement of Sleep for Memory Improvement","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The pilot clinical validation study of a novel pain scale for Parkinson’s","Investments < €500k",,"United Kingdom" "The potential involvement of astrocytes in Parkinson’s: Investigation using human pluripotent stem cells","Investments < €500k",,"United Kingdom" "The PPAR-delta pathway in neural function and Huntingtons disease neuropathology","Investments > €500k","Huntington's disease","United States of America" "The PREVENT Project","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "The preventive potential of nutrition on brain changes underlying deterioration of cognitive behaviour with ageing using advances neuro-imaging techniques","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "The protective role of PACAP in peripheral organs/Momentum grant",Fellowships,"Parkinson's disease & PD-related disorders",Hungary "The regulation of beta-amyloid sensitivity and Alzheimers related impairments by PP2A","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The regulation of iron transport in Parkinson’s disease","Investments < €500k",,Australia "The Regulation of Synaptic Connectivity and Homeostasis by Huntingtin","Investments > €500k","Huntington's disease","United States of America" "The relation between epilepsy and Alzheimer’s disease","Investments < €500k",,Hungary "The relationship between PAF acetylhydrolase, paraoxonase and serum amyloid A in preeclempsia","Investments < €500k",,Turkey "The Relationship Between Tau Pathology and Sleep in Tauopathies",Fellowships,"Alzheimer's disease & other dementias","United States of America" "The Residential Care Transition Module","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The role of 3′ UTR variation in the molecular pathogenesis of motor neuron disease.",Fellowships,"Neurodegenerative disease in general","United Kingdom" "The role of 3′ UTR variation in the molecular pathogenesis of motor neuron disease.",Fellowships,"Neurodegenerative disease in general","United Kingdom" "The role of a novel atypical monoamine transporter in Alzheimers disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "The role of a presenilin 2 truncation (PS2V) in Alzheimer’s Disease","Investments < €500k",,Australia "The role of a Synuclein transcript variants in neuronal pathology and function","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "The role of a-synuclein accumulation in lysosomal hydrolase trafficking and function","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "The role of acetylation in regulating pathophysiology of tau","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The role of aging in LRRK2-associated Parkinsons disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "The role of aging-associated microRNAs in Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The role of alpha-synuclein misfolding in Parkinson’s disease.",Fellowships,"Parkinson's disease & PD-related disorders","United Kingdom" "The Role of Apigenin in Cytokine Answer in Parkinson’s Rat Model","Investments < €500k",,Turkey "The role of apoE and APOE genotype in amyloid-beta clearance after TBI","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The role of apoE in mild traumatic brain injury","Investments > €500k","Alzheimer's disease & other dementias",Canada "The Role of Appoptosin in Alzheimers Disease and Other Tauopathies","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The role of astrocytes in development and progression of Alzheimer’s disease","Investments < €500k",,Sweden "THE ROLE OF ASTROCYTES IN TAU-RELATED NEURONAL CELL DEATH","Investments < €500k",,"United Kingdom" "The role of ATP13A2/PARK9 in secretion of exosomes and alpha synuclein","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "The role of basal forebrain cholinergic and GABAergic projection systems in learning/Momentum grant",Fellowships,"Neurodegenerative disease in general",Hungary "The Role of Brain Beta-Amyloid and Tau Protein in POD and POCD","Investments < €500k",,"United States of America" "The Role of Brain Extracellular Matrix in Neurodegeneration in Alzheimer’s Disease","Investments < €500k",,Turkey "The Role of C9ORF72 Protein Function in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "The Role of C9ORF72 Protein Function in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia","Investments > €500k","Motor neurone diseases","United States of America" "The role of cerebral small vessel disease in cognitive aging","Investments < €500k",,Sweden "The role of Clusterin in cerebral amyloid angiopathy","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The Role of Copper in Cerebral Amyloid Angiopathy","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The role of copper in Ubiquitin-dependent protein degradation in Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias",Australia "The role of Dkk1 in Amyloid-beta mediated effects on dendritic spines and long-term depression","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "The Role of DLG5 in Alzheimers Disease","Investments < €500k",,"United States of America" "The Role of Dopamine in the Regulation of Sleep and Circadian Rhythms",Fellowships,"Neurodegenerative disease in general","European Commission" "The role of dopamine on cortical plasticity and striatal structure in Dopamine-responsive Dystonia",Fellowships,"Parkinson's disease & PD-related disorders",Switzerland "The Role of Drosha in the Pathogenesis of Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The role of endogenous transposable elements in the pathogenesis of MND","Investments < €500k",,"United Kingdom" "The role of epigenetic factors and non-coding RNA in Parkinson’s disease","Investments < €500k",,Hungary "The role of G3BP1 in mutant SOD1-mediated familial ALS","Investments < €500k",,"United States of America" "The role of G3BP1 in mutant SOD1-mediated familial ALS","Investments < €500k",,"United States of America" "The role of G4C2 hexanucleotide repeat expansion and TDP-43 in ALS","Investments < €500k",,"United Kingdom" "The role of glucocerebrosidase and chaperone_mediated autophagy in Parkinsons dis",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "The role of glucocerebrosidase in Parkinsons disease",Fellowships,"Parkinson's disease & PD-related disorders","United States of America" "The role of gut endocrine cells in Parkinsons Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "The role of Hsp27 in neurodegenerative diseases from the aspects of membranes and lipids","Investments < €500k",,Hungary "The role of inflammasome signaling in tauopathies","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The role of intense physical activity in protecting the ageing brain",Fellowships,"Alzheimer's disease & other dementias",Australia "The role of intracellular trafficking in Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias",Portugal "The role of intracellular trafficking in Alzheimer’s disease","Investments < €500k",,Portugal "The Role of Intracranial Atherosclerosis in the Development of Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The Role of KCa3.1 in Neuroinflammation in Alzheimer Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The Role of Kisspeptin GPR54+ in Patagonesis of Alzheimer’s Disease","Investments < €500k",,Turkey "The role of long noncoding RNAs in Parkinson’s Disease","Investments < €500k",,Australia "The role of low complexity domain mutations in RNA-binding proteins associated with Motor Neuron Disease pathogenesis",Fellowships,"Motor neurone diseases","United Kingdom" "The role of low complexity domain mutations in RNA-binding proteins associated with Motor Neuron Disease pathogenesis","Investments > €500k","Motor neurone diseases","United Kingdom" "The role of mental health for the onset of somatic disorders in the elderly. The influence of age, sex, birth cohort, genetic, geographical, social and neurobiological factors","Investments > €500k","Alzheimer's disease & other dementias",Sweden "The role of miRNAs in ALS and their use as a biomarker of disease progression","Investments < €500k",,"United Kingdom" "The role of Miro and PKC signalling in axonal transport defects in amyotrophic lateral sclerosis.","Investments > €500k","Motor neurone diseases","United Kingdom" "The role of mitochondrial DNA variation in Parkinson’s",Fellowships,"Parkinson's disease & PD-related disorders","United Kingdom" "The role of mutant cyclin F in amyotrophic lateral sclerosis","Investments > €500k","Motor neurone diseases",Australia "The role of neuronal intracellular traffic in Alzheimer´s disease",Fellowships,"Alzheimer's disease & other dementias", "The role of NMNAT2 in axon degeneration: relevance to Parkinson’s disease.",Fellowships,"Parkinson's disease & PD-related disorders",Portugal "The Role of Non-coding RNA in Protein Networks and Neurodegenerative Diseases","Investments > €500k","Neurodegenerative disease in general","European Commission" "The Role of Oligodendrocytes in Frontotemporal Dementia",Fellowships,"Alzheimer's disease & other dementias",Australia "The role of PACAP in Parkinson’s disease","Investments < €500k",,Hungary "The Role of Palliative Care Interventions to Reduce Circadian Rhythm Disorders in Persons with Dementia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The Role of Perlecan Domain V in Vascular Dementia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The role of Prolyl oligopeptidase (POP) and its inhibition on α-synuclein aggregation and Parkinson’s disease models","Investments < €500k",,Finland "The role of Prolyl oligopeptidase (POP) and its inhibition on α-synuclein aggregation and Parkinson’s disease models","Investments < €500k",,Finland "The role of Prolyl oligopeptidase (POP) and its inhibition on α-synuclein aggregation and Parkinson’s disease models",Fellowships,"Parkinson's disease & PD-related disorders",Finland "The role of proteinase-activated receptors in pathogenesis of prion diseases","Investments < €500k",,"Czech Republic" "The role of proteoglycans in neurodegeneration",Fellowships,"Alzheimer's disease & other dementias",Australia "The role of RBM3 in Huntingtons disease: pathogenesis and protection",Fellowships,"Huntington's disease","United States of America" "The role of RCAN1 in Alzheimer pathogenesis",,"Alzheimer's disease & other dementias",Canada "The role of RCAN1 in Alzheimer pathogenesis","Investments > €500k","Alzheimer's disease & other dementias",Canada "The Role of Sirtuin 1 Deacetylase in Amyotrophic Lateral Sclerosis",Fellowships,"Motor neurone diseases","United States of America" "The role of somatic mutation in neurodegenerative disease",Fellowships,"Alzheimer's disease & other dementias","United States of America" "The role of striatal cholinergic interneurons in Parkinson’s disease","Investments < €500k",,"United States of America" "The role of striatal cholinergic interneurons in Parkinson’s disease","Investments < €500k",,"United States of America" "The role of TDP-43 dysfunction in C9orf72 iPSC-derived motor and cortical neurons","Investments < €500k",,"United Kingdom" "The role of the blood-brain barrier in Alzheimers disease function","Investments > €500k","Alzheimer's disease & other dementias",Norway "The role of the complement system in the brain","Investments > €500k","Neurodegenerative disease in general|Parkinson's disease & PD-related disorders",Hungary "The role of the neuronal epigenome in natural brain ageing and the progression of Alzheimer’s disease",Fellowships,"Alzheimer's disease & other dementias",Australia "The role of the NLRP3 inflammasome in aging-associated cognitive impairments",Fellowships,"Alzheimer's disease & other dementias","United States of America" "The role of the nuclear transport system in frontotemporal dementia.",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "The role of TMEM106B and CHMP2B in neuronal lysosomal trafficking in frontotemporal dementia","Investments < €500k",,"United Kingdom" "The role of TREM1 signaling in the development of Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The role of TREM2 in Alzheimers disease pathogenesis",Fellowships,"Alzheimer's disease & other dementias","United States of America" "The role of TREM2 in neurodegeneration","Investments < €500k",,"United Kingdom" "The role of ubiquitin in the protein quality control of Huntington’s disease",Fellowships,"Huntington's disease",Netherlands "The role of variant (v)U1 snRNAs in development and disease.","Investments > €500k","Neurodegenerative disease in general|Spinal muscular atrophy (SMA)","United Kingdom" "The Sattaripour Charitable Foundation Fellowship Sequential surface EMG recordings in motor neuron disease: fasciculations as a biomarker of motor neuron disease","Investments < €500k",,"United Kingdom" "The Significance of Perioperative Changes in CSF tau levels in the Elderly","Investments < €500k",,"United States of America" "The START (STrAtegies for RelaTives) study: a pragmatic randomised controlled trial to determine the effectiveness of a manual based coping strategy programme in promoting the mental health of carers of people with dementia – cohort follow-up","Investments < €500k",,"United Kingdom" "The structural and functional connectome across Alzheimers disease subtypes","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The Structure of Prionoid Tau Strains","Investments < €500k",,Switzerland "The subthalamic nucleus and motor control: understanding function and dysfunction in Parkinson’s disease",Fellowships,"Parkinson's disease & PD-related disorders",France "The Swedish BioFINDER study","Case Control Studies","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders",Sweden "The Swedish National March Cohort","Population Cohorts","Neurodegenerative disease in general",Sweden "The TAR DNA-Binding Protein (TDP-43) and Amyotrophic Lateral Sclerosis","Investments > €500k","Motor neurone diseases",Canada "The Tasmanian Healthy Brain Project: a longitudinal intervention study to reduce the risk of ageing-related cognitive decline and dementia","Investments > €500k","Alzheimer's disease & other dementias",Australia "The therapeutic potential for RVG9RÐp137 in a disease relevant model of Parkinson’s dementia","Investments < €500k",,"United Kingdom" "The therapeutic potential of adult neurogenesis in Alzheimer’s disease, studied in a transgenic mouse model",Fellowships,"Alzheimer's disease & other dementias",Belgium "The Toronto Dementia Research Alliance (TDRA) Dementia Clinical Research Database: A Platform in Neurodegenerative Diseases","Investments > €500k","Neurodegenerative disease in general",Canada "The TRPA1 receptor, as potential target in neurodegenerative and inflammatory diseases, and cognitive disorders","Investments < €500k",,Hungary "The tVTA: a new member of basal ganglia with therapeutic potential","Investments > €500k","Parkinson's disease & PD-related disorders",France "The Two Horizons of Research. Cultural Analysis of How Patients and Scientists Face Each Other in Clinical Trials within the Research on Parkinson´s Disease","Investments > €500k","Parkinson's disease & PD-related disorders",Sweden "The UK National Motor Neurone Disease Registry","Investments > €500k","Motor neurone diseases","United Kingdom" "The UK7T Network: developing the ultra-high field MRI platform for biomedical research.","Capital Infrastructure",,"United Kingdom" "The Unfolded Protein Response in Neurodegeneration","Investments > €500k","Neurodegenerative disease in general","European Commission" "The UPR in the cell-to-cell spreading of tau pathology in dementia.","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "The use of a histology slide scanner to aid in the understanding of disease progression and mechanisms in dementia","Investments < €500k",,"United Kingdom" "The usefulness of CSF YKL-40 measurements in the diagnosis of patients with neurodegenerative diaseases.","Investments < €500k",,Poland "The utility of VILIP-1 in the diagnosis of neurodegenerative diseases.","Investments < €500k",,Poland "The validation of new pharmacological strategies in schizophrenia and dementia models","Investments < €500k",,Hungary "The Vallecas Project","Population Cohorts","Alzheimer's disease & other dementias",Spain "The VETSA Longitudinal MRI Twin Study of Aging","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "The VETSA Longitudinal Twin Study of Cognition and Aging (VETSA 3)","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Theoretical and computational modeling of amyloid aggregation","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Theoretical and empirical aspects of aging and rejuvenation","Investments > €500k","Alzheimer's disease & other dementias",Sweden "TherALS-1 : Characterisation of novel small molecule regenerative compounds for the treatment of amyotrophic lateral sclerosis","Investments > €500k","Motor neurone diseases",Belgium "Therapeutic genome editing for amyotrophic lateral sclerosis",Fellowships,"Motor neurone diseases","United States of America" "Therapeutic Intervention in Alzheimer’s Disease; Intranasal Oxytocin Administration to Enhance Emotion Processing and Reduce Caregiver Burden","Investments < €500k",,Australia "Therapeutic potential of boosting astrocytic Nrf2-mediated antioxidant signalling in combating white matter damage, amyloid pathology and cognitive deficits caused by chronic cerebral hypoperfusion",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Therapeutic potential of GMF suppresssion in inflammation and neurodegeneration","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Therapeutic Potential of Small Molecule Activators of the PINK1-Parkin Pathway","Investments < €500k",,"United States of America" "Therapeutic Potential of Small Molecule Activators of the PINK1-Parkin Pathway","Investments < €500k",,"United States of America" "THERAPEUTIC STRATEGIES AGAINST THE TOXICITY PRODUCED BY PEPTIDES AND RNA CODED BY THE ALTERATION OF HTT MUTANT IN HUNTINGTON DISEASE","Investments < €500k",,Spain "Therapeutic target identification for FTD/ALS using human induced pluripotent stem cell models (iPSC)","Investments > €500k","Motor neurone diseases",Belgium "Therapeutic Targeting of Abnormal Conformation in Neurodegenerative Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Therapeutic targeting of impaired lysosomal flux in Alzheimer’s disease","Investments < €500k",,"Ireland|United Kingdom" "Therapeutic targeting of neuroinflammation to slow the progression of neurodegenerative disease",Fellowships,"Motor neurone diseases",Australia "THERAPEUTIC USE OF EPIGENETIC MODULATORS IN ONCOLOGICAL AND NEURODEGENERATIVE DISEASE","Investments > €500k","Alzheimer's disease & other dementias",Spain "Therapeutic use of epigenetic modulators in oncological and neurodegenerative diseases","Investments < €500k",,Germany "Therapy and biomarker development for patients with amyotrophic lateral sclerosis","Investments > €500k","Motor neurone diseases",Germany "Through the D’mentia Lens: an easy accessible dementia simulation for family caregivers using the innovative Oculus Rift VR headset, combined with e-learning;","Investments < €500k",,Netherlands "THYROSAINE KINASE ACK1 IN NEURODEGENERATION AND NEURONAL DEATH","Investments < €500k",,Spain "Time course of early pathophysiological changes and biomarkers in Alzheimer´s disease and related disorders- implications for preventive therapy.","Investments < €500k",,Sweden "Title: Alpha-Synuclein and Cellular Iron Reduction","Investments < €500k",,"United Kingdom" "TNT: Tracking Network dynamics with Tensor factorisations. Application to the human Chronnectome in Alzheimer’s disease","Investments < €500k",,"United Kingdom" "To live with amyotrophic lateral sclerosis (ALS): health-related quality of life, and use and satisfaction with care during the course of the disease","Investments > €500k","Motor neurone diseases",Sweden "To Undertake Prospective Multisource Surveillance for all Cases of Progressive Intellectual and Neurological Deterioration Occurring in Children in the UK","Investments > €500k","Prion disease","United Kingdom" "Tolerability of SRX246 in Huntingtons Disease Patients","Investments > €500k","Huntington's disease","United States of America" "TOMM40-mediated mitochondrial dysfunction and Alzheimers disease","Investments < €500k",,"United States of America" "Tongue- and Jaw-Specific Contributions to Vowel Acoustic Changes: Towards a Mechanistic Model of Intelligibility Loss and Recovery in Dysarthria","Investments < €500k",,"United States of America" "Tongue- and Jaw-Specific Contributions to Vowel Acoustic Changes: Towards a Mechanistic Model of Intelligibility Loss and Recovery in Dysarthria","Investments < €500k",,"United States of America" "Tools for Coordination Among Caregivers of Patients with Alzheimers Disease and Other Dementias","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "TOPIC: Targeting Cytotoxic Protein Oligomers",Fellowships,"Huntington's disease", "Towards a better understanding of the language impairment and neural basis of primary progressive aphasia: A longitudinal study","Investments > €500k","Alzheimer's disease & other dementias",Canada "Towards a unified, computationally-implemented neural network for understanding semantic cognition and its disorders.","Investments > €500k","Neurodegenerative disease in general","United Kingdom" "Towards a unifying theory of Parkinson’s disease: Investigation of the biochemical and genetic role of Rab GTPases","Investments > €500k","Parkinson's disease & PD-related disorders","Germany|United Kingdom" "Towards Alzheimer’s disease pre-dementia intervention: Meeting-point of diagnostics, genetics, and individual risk estimates","Investments > €500k","Alzheimer's disease & other dementias",Norway "Towards an evidence-based clinical management of visual hallucinations: prevalence, prognosis, impact and pathophysiology","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders","United Kingdom" "Towards an understanding of aging and neurodegenerative disease using novel stem cell, reprogramming and genome editing technologies","Investments > €500k","Alzheimer's disease & other dementias",Sweden "Towards deciphering the role of N-terminal post-translational modifications in regulating the function of Huntingtin (Htt) in health and disease","Investments < €500k",,Switzerland "Towards improvement in care delivery in Huntington’s Disease",Fellowships,"Huntington's disease","United Kingdom" "Towards in vivo molecular imaging of α synuclein protein","Investments < €500k",,France "Towards Neurotrophic therapes in Alzheimer’s disease","Investments < €500k",,Sweden "Towards prediction and therapeutic targets of Alzheimer’s disease through directed analysis of genetic risk loci",Fellowships,"Alzheimer's disease & other dementias",Belgium "Towards resilience in family caregiving for people with dementia","Investments > €500k","Alzheimer's disease & other dementias",Ireland "Towards Targeting The Endosome In Neurodegenerative Disease",Fellowships,"Alzheimer's disease & other dementias",Australia "Towards the understanding of pathological protein processing and toxicity in Machado-Joseph disease.","Investments < €500k",,Netherlands "Toxic protein aggregation in neurodegeneration","Investments > €500k","Neurodegenerative disease in general","European Commission" "Toxicant-induced synaptic dysfunction and neurotoxicity in Parkinson disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Traces towards dementia: Identifying neuronal subpopulations and pathogenic mechanisms at presymptomatic stages of Alzheimer´s disease in a new mouse model","Investments < €500k",,Switzerland "Tracking disease progression in Parkinson’s Disease using new postural and brain imaging measures","Investments < €500k",,Australia "Tracking Parkinson’s with proteomic biomarkers","Investments > €500k","Parkinson's disease & PD-related disorders","United Kingdom" "Tracking Parkinson’s: Parkinson’s repository of biomarkers and networked datasets (PROBAND)","Investments > €500k","Parkinson's disease & PD-related disorders","United Kingdom" "Tractography and magnetic resonance spectroscopy in animal models looking for new biomarkers of early stages of Alzheimer-type dementia","Investments < €500k",,Slovakia "Trafficking and endosomal sorting of APP and BACE-1","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Trafficking and Endosomal Sorting of APP and BACE-1","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Train the sedentary brain: move smart to reduce the risk of dementia","Investments > €500k","Alzheimer's disease & other dementias",Netherlands "Training in neurodegeneration, therapeutics intervention and neurorepair",Fellowships,"Neurodegenerative disease in general", "Training Long-Term Memory for Events",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Training program in the neurology of language and neurodegenerative aphasias",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Transcriptional profiling of iPSC-derived motor neurons from patients with the C9orf72 hexanucleotide repeat expansion and correction using antisense oligonucleotides as a potential therapeutic strategy for Amyotrophic Lateral Sclerosis","Investments < €500k",,"United Kingdom" "Transdisciplinary training for dementia research in CFAS","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Transferring NOn autonomous cell degeneration models between EU and USA for development of effective therapies for Motor Neuron Diseases (MND).",Fellowships,"Motor neurone diseases", "Transgenic HD Minipig (TgHD, PIGMOD Center)","Experimental Models",,"Czech Republic" "Transgenic Huntingtons disease monkey resource","Investments > €500k","Huntington's disease","United States of America" "Transgenic marmosets for translational stem cell research","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Transgenic mice with elevated basal level of calcium ions in neurons as a model of agedinduced neurodegeneration of sporadic Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias",Poland "Transgenic modelling of human prion diseases, intermammalian transmission barriers & assessing candidate therapeutics","Investments > €500k","Prion disease","United Kingdom" "Transgenic Rat Model of Cerebral Amyloid Angiopathy","Investments < €500k",,"United States of America" "Transitions to Family Caregiving and Its Impact on Health Indicators","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Translating CD33 genetic mechanism into a novel Alzheimers therapeutic","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Translation of COPE for Publicly-Funded Home Care Clients and their Families","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Translational regulation by DJ-1","Investments < €500k",,"United States of America" "Translational regulation by DJ-1","Investments < €500k",,"United States of America" "TRANSLATIONAL STUDIES OF SAPOSIN C AND GPR37 IN PARKINSON´S DISEASE","Investments < €500k",,Sweden "Translational studies on APP and β-amyloid for Alzheimer’s disease pathogenesis","Investments > €500k","Alzheimer's disease & other dementias",Sweden "Transmissible disease epidemiology & statistical science in public health, criminal justice & performance monitoring","Investments > €500k","Prion disease","United Kingdom" "Transmitophagy: the key to aging and neurodegeneration?",Fellowships,"Alzheimer's disease & other dementias",Finland "Transmitophagy: the key to aging and neurodegeneration?","Investments < €500k",,Finland "Transposable Elements in Frontotemporal Lobar Degeneration","Investments < €500k",,"United States of America" "Transposable Elements in Frontotemporal Lobar Degeneration","Investments < €500k",,"United States of America" "Tranthyretins Regulatory Role in Beta-Amyloid Aggregation and Toxicity","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "TRAP1 and FOXO1 as modifiers of progranulin and FTLD","Investments < €500k",,"United States of America" "TRE-11CGG-GFP (Erasmus MC)","Experimental Models",,Netherlands "Treatment of ALS based on transplantation of glial restricted progenitors","Investments > €500k","Motor neurone diseases","United States of America" "Treatment of late stages of Parkinson´s disease with a highly concentrated DOPA solution administered subcutaneously or intravenously – a national, multicenter, academia-based trial","Investments > €500k","Parkinson's disease & PD-related disorders",Sweden "Treatment of Parkinson´s disease by recreating the endogenous L-Dopa/Dopamine production in midbrain","Investments < €500k",,Sweden "Treatment of psychosis and agitation in Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Treatment of randomly censored covariates in Alzheimers disease studies","Investments < €500k",,"United States of America" "TRIAD : From pictures to numbers: adding throughput and readout to imaging in AD diagnostics","Investments > €500k","Alzheimer's disease & other dementias",Belgium "Triggered Palliative Care for Advanced Dementia: A Pilot Study","Investments < €500k",,"United States of America" "Trinity College GBHI Facility","Capital Infrastructure",,Hungary|Ireland "Triplet repeat polymorphisms as modifiers of health and disease",Fellowships,"Huntington's disease",Netherlands "Triplication alpha-synuclein iPSCs (MRC Centre for Regenerative Medicine)","Experimental Models",,"United Kingdom" "TrkB Receptor PET Tracer Development","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Troubles cognitifs légers et dépression gériatrique : comparaison de caractéristiques cliniques et analyse de l’évolution des patients vers la démence. Mild cognitive disorders and geriatric depression: comparison of clinical characteristics and analysis of the evolution of patients towards dementia","Investments < €500k",,Canada "TRP channels, calcium and AD","Investments < €500k",,Australia "TRPML1 in intracellular Fe2+ and Ca2+ homeostasis/signaling","Investments < €500k",,Canada "Tryptophan metabolites and kynurenic acid analogs in cognitive decline","Investments < €500k",,Hungary "TTR and C9ORF72 in ALS and related disorders","Investments < €500k",,"United States of America" "TTR and C9ORF72 in ALS and related disorders","Investments < €500k",,"United States of America" "TTR and C9ORF72 in ALS and related disorders","Investments < €500k",,"United States of America" "Turku PET Centre","Capital Infrastructure",,Finland "Two Diseases or one? The early pathogenesis of vascular mediated cognitive decline and Alzheimers Disease.",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Type 2 Diabetes Mellitus and Vascular Brain Ageing","Investments > €500k","Alzheimer's disease & other dementias",Australia "Typical and atypical Alzheimer Disease: salivary tau biomarkers, therapy with neuromodulation, and disease subtypes.","Investments > €500k","Alzheimer's disease & other dementias",Canada "Tyrosine phosphorylation in Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Tyrosine phosphorylation in Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "UBIQUITIN-DEPENDENT PROTEOLYSIS IN NEUROGENERATIVE DISORDERS","Investments > €500k","Huntington's disease|Spinal muscular atrophy (SMA)|Spinocerebellar ataxia (SCA)",Sweden "Ubiquitinomic Profiling of synaptic proteins in Alzheimer’s Disease","Investments < €500k",,Australia "UK Biobank Imaging Enhancement Main phase","Investments > €500k","Neurodegenerative disease in general","United Kingdom" "UK Dementias Platform","Investments > €500k","Alzheimer's disease & other dementias|Neurodegenerative disease in general|Parkinson's disease & PD-related disorders","United Kingdom" "UKDP: Integrated DEmentiA research environment (IDEA)","Capital Infrastructure",,"United Kingdom" "Ultra-high field MRI 7T scanner (Cambridge University)","Capital Infrastructure",,"United Kingdom" "Ultra-high field MRI in early Alzheimer’s disease: characterising iron deposition","Investments < €500k",,"United Kingdom" "Unbiased Approaches to Novel Biomarker Discovery in Parkinsons Disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Uncertainty monitoring versus inhibition control: The role of subclude nuclues and effects of deep brain stimulation on oscillatory neuronal networks in Parkinson’s disease compared to compulsive disorder","Investments < €500k",,Germany "Uncovering genetic predisposition to early onset dementia in patients with Parkinson’s disease","Investments < €500k",,Norway "Uncovering the Function of Susceptibility Variants in Alzheimer’s Disease: From GWAS to Cell-Type Specific eQTLs and mQTLs",Fellowships,"Alzheimer's disease & other dementias",Australia "Underlying Mechanisms of Vascular Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Understanding acetylcholine drive of striatal dopamine transmission in an animal model of Parkinson’s","Investments < €500k",,"United Kingdom" "Understanding Alzheimer’s disease using Down syndrome as a model","Investments > €500k","Alzheimer's disease & other dementias",Australia "Understanding Alzheimer’s disease using mouse models of Down syndrome","Investments < €500k",,"United Kingdom" "Understanding Alzheimers Disease in the Context of the Aging Brain","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Understanding Amygdala Neurodegenerative Mechanisms in Alzheimer’s Disease",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Understanding and preventing physical and cognitive decline and falls in older people with dementia",Fellowships,"Alzheimer's disease & other dementias",Australia "Understanding C9ORF72: a novel player in the pathology of ALS/ FTLD","Investments < €500k",,Switzerland "Understanding challenging behavior – the individual-situative technical support for dementia","Investments > €500k","Alzheimer's disease & other dementias",Germany "Understanding death-receptor signaling and physiology in the nervous system: A roadmap for the development of new treatments to neurodegenerative diseases and neurotrauma","Investments > €500k","Neurodegenerative disease in general","European Commission" "Understanding Effective Dementia Workforce Education and Training: A Formative Evaluation (DeWET Evaluation)","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Understanding how genes, environment and experience-dependent brain plasticity influence susceptibility to neurological and psychiatric disorders.",Fellowships,"Huntington's disease",Australia "Understanding how vessel fragility contributes to Alzheimer’s disease","Investments < €500k",,Australia "Understanding Infection in People with Dementia: Incidence, Impact and Prevention.",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Understanding mechanisms and seeking novel biomarkers in Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Understanding memory changes and brain plasticity in mild cognitive impairment","Investments < €500k",,Canada "Understanding molecular control of functional amyloidogenesis.",Fellowships,"Neurodegenerative disease in general","United Kingdom" "Understanding PDI-related neurotoxicity and advancing preventative approaches","Investments < €500k",,"United States of America" "Understanding PDI-related neurotoxicity and advancing preventative approaches","Investments < €500k",,"United States of America" "Understanding PDI-related neurotoxicity and advancing preventative approaches","Investments < €500k",,"United States of America" "Understanding Society: UK Household Longitudinal Study","Population Cohorts","Neurodegenerative disease in general","United Kingdom" "Understanding SOD1 Kinetics in Amyotrophic Lateral Sclerosis","Investments > €500k","Motor neurone diseases","United States of America" "Understanding stroke, vascular dementia and cognitive aging through new techniques and models for assessment of cerebral blood flow and cerebrospinal fluid dynamics","Investments < €500k",,Sweden "Understanding the Basis and Interaction of Non-cognitive and Cognitive Symptoms in Dementia with Lewy Bodies","Investments < €500k",,"United Kingdom" "Understanding the cause of ataxia in the DNA repair deficiency syndrome Ataxia Telangiectasia: a possible link between DNA damage and proteostasis.",Fellowships,,Netherlands "UNDERSTANDING THE CAUSES OF THE RNA GAIN OF FUNCTION DISEASES","Investments > €500k","Neurodegenerative disease in general","European Commission" "Understanding the effects of deep brain stimulation on cortical processing","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Understanding the experience of eating and drinking difficulties from the perspective of people living with dementia in residential care homes",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Understanding the Genetic Basis of Dementia with Lewy Bodies",Fellowships,"Alzheimer's disease & other dementias","United Kingdom" "Understanding the genome-wide gene expression landscape in Dementia with Lewy Bodies","Investments < €500k",,"United Kingdom" "Understanding the inattentive and impulsive brain.",Fellowships,"Neurodegenerative disease in general","United Kingdom" "Understanding the mechanism of SPl1 dependent Alzheimer disease risk","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Understanding the molecular functions of progranulin and granulin in FTLD","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Understanding the Molecular Origins of the Toxicity of Alpha-synuclein in Parkinson’s Disease","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders","United Kingdom" "Understanding the Origins of Amyloid Deposition in Cerebral Amyloid Angiopathy","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Understanding the outcomes of people with cognitive impairment and/or dementia admitted to the general hospital","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Understanding the pathological pathways to Parkinson’s","Investments > €500k","Parkinson's disease & PD-related disorders","United Kingdom" "Understanding the role of altered ubiquitin homeostasis in motor neuron diseases.",Fellowships,"Motor neurone diseases","United Kingdom" "Understanding the role of MAPT in Parkinsonian disorders","Investments > €500k","Neurodegenerative disease in general|Parkinson's disease & PD-related disorders","United States of America" "Understanding the role of MAPT in Parkinsonian disorders","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Understanding the role of TDP-43 in Alzheimers disease and FTLD","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Understanding the role of TDP-43 in motor neuron disease.","Investments < €500k",,Australia "Understanding the roles of slow and fast gamma rhythms in memory processing","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Understanding the Voice Control System in Parkinsons Disease","Investments < €500k",,"United States of America" "Understanding the Voice Control System in Parkinsons Disease","Investments < €500k",,"United States of America" "Unfolded protein response activation protects neurons against pathological tau","Investments < €500k",,"United States of America" "Unfolded Protein Response in Alpha-synucleinopathies","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Unfolding the role of UPR in Parkinson´s Disease",Fellowships,"Parkinson's disease & PD-related disorders",Sweden "Unified high performance analysis of imaging biomarkers for Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "University of Debrecen Faculty of Medicine Brain Bank",Biobanks,"Neurodegenerative disease in general",Hungary "University of Oxford Confidence in Concept Scheme – Round 4","Investments > €500k","Neurodegenerative disease in general","United Kingdom" "University of Oxford Confidence in Concept Scheme – Round 4","Investments < €500k",,"United Kingdom" "Unraveling molecular pathways underlying synergistic cellular toxicity of Aß peptides and protein Tau, the two key players involved in Alzheimer’s disease.","Investments < €500k",,Belgium "Unravelling the molecular basis of amyotrophic lateral sclerosis",Fellowships,"Motor neurone diseases",Australia "Uppsala Longitudinal Study of Adult Men","Population Cohorts","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders",Sweden "Use of Nanopattern Polycarbonate Surfaces in Alzheimer’s Disease Diagnosis","Investments < €500k",,Turkey "Use of Phenoxazine Compounds in Alzheimer’s Disease Treatment","Investments < €500k",,Turkey "User participation for elderly persons with dementia living at home","Investments < €500k",,Norway "Using a rapid diagnostic test for Parkinson’s disease to determine underlying mechanisms, develop new regenerative therapies and test the efficacy of existing regenerative therapies","Investments < €500k",,"United Kingdom" "Using C. elegans to understand seeding and spreading of tau aggregation","Investments < €500k",,"Germany|United Kingdom" "Using computer based cognitive training to provide a personalised therapeutic intervention for people with Huntingdons disease",Fellowships,"Huntington's disease","United Kingdom" "Using computer simulations for predicting interventions restoring healthy patterns of neural activity","Investments > €500k","Parkinson's disease & PD-related disorders","United Kingdom" "Using Consumer Credit Data to Identify Precursors and Consequences of Cognitive Impairment","Investments < €500k",,"United States of America" "Using genetic markers of vascular risk factors as a tool to better understand their relationship with cognitive decline and dementia in the community","Investments < €500k",,France "Using genetic variability in whole transcriptome expression in cells and tissues to understand the pathogenesis of Parkinson’s and Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders","United Kingdom" "Using genetic variability in whole transcriptome expression in the hippocampus and temporal cortex to understand the pathogenesis of Alzheimer’s disease","Investments < €500k",,"United Kingdom" "Using Global Positioning System (GPS) Technologies for Safer Walking: A participative inquiry project","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Using naturally-occurring fungal prions as models of neurodegenerative protein misfolding","Investments > €500k","Neurodegenerative disease in general|Prion disease","United States of America" "Using novel 3’UTR targeting based approaches to study gene function and treat neurodegenerative disease","Investments < €500k",,Finland "Using Patient Reported Outcome Measures to Assess Quality of Life in Dementia","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "USING QUANTITATIVE TRAITS TO IDENTIFY NOVEL GENES FOR ALZHEIMERS DISEASE AND OTHER COMPLEX TRAITS","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Using reporter human iPS cells to study fate, function and Parkinsons disease","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Using RNA signatures for therapy development in neurodegeneration due to C9orf72 expansions","Investments > €500k","Motor neurone diseases","United States of America" "Using RNA signatures for therapy development in neurodegeneration due to C9orf72 expansions","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases","United States of America" "Using shape memory scaffolds to increase transplant survival and prepare a nigro/striatal bridge","Investments < €500k",,"United Kingdom" "Using transcranial Direct Current Stimulation to alleviate anomia in chronic stroke aphasia",Fellowships,,"United Kingdom" "Using uncoupling in mitochondria of astrocytes to promote neuroprotection in Alzheimer’s disease","Investments < €500k",,Switzerland "Using zebrafish to study myelinated axons in vivo.",Fellowships,"Neurodegenerative disease in general","United Kingdom" "Utilisation de la protéomique quantitative ciblée et du marquage aux isotopes stables pour le diagnostic et l’étude des affections neurologiques et en particulier de la maladie d’Alzheimer. Use of targeted quantitative proteomics and stable isotope labeling for the diagnosis and study of neurological disorders and in particular of Alzheimer’s disease.","Investments > €500k","Alzheimer's disease & other dementias",France "Utilization and costs of health and nursing services for elderly patients with multimorbidity in the German Statutory Health Insurance System – a observational cohort study","Population Cohorts","Alzheimer's disease & other dementias|Parkinson's disease & PD-related disorders",Germany "Utilization of human Parkinson’s disease specific neuroepithelial stem cells to define disease associated cellular phenotypes in a co-culture of oligodendrocytes and dopaminergic neurons – CORE","Investments > €500k","Parkinson's disease & PD-related disorders",Luxembourg "Utilization of TALEN technology to investigate the microRNA dependence of PD-associated defects in neural stem cell activity.","Investments < €500k",,Luxembourg "Validating novel ryanodine receptor-targeted compounds for AD therapeutics","Investments < €500k",,"United States of America" "Validating the New Criteria for Preclinical Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Validation and Clinical Implementation of Parkinson’s Disease and Breast Cancer Biomarkers for Diagnosis and Treatment Response Monitoring","Investments > €500k","Parkinson's disease & PD-related disorders",Finland "Validation de biomarqueurs moléculaires d’imagerie cérébrale pour la maladie de Huntington en vue d’un essai thérapeutique ciblant le cycle de Krebs. Validation of Molecular Brain Imaging Biomarkers for Huntington’s Disease for Therapeutic Trials Targeting the Krebs Cycle","Investments < €500k",,France "Validation of a fast and simple peripheral blood diagnostic biomarker kit for Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "Validation of a fast and simple peripheral blood diagnostic biomarker kit for Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "Validation of an O-GlcNAcase inhibitor as a novel therapeutic agent against Alzheimer pathology","Investments < €500k",,"United Kingdom" "Validation of Connexins and Pannexins as a target for Alzheimer’s Disease","Investments > €500k","Alzheimer's disease & other dementias",Canada "Validation of diagnostic and prognostic biomarkers for Parkinson disease","Investments < €500k",,"European Commission" "Validation of diagnostic and prognostic biomarkers for Parkinson disease","Investments < €500k",,"European Commission" "Validation of mild cognitive impairment in Parkinson’s disease","Investments < €500k",,Netherlands "Validation of molecular neuroimaging biomarkers in Huntington’s disease in view of therapeutic trials targeting the Krebs cycle","Investments < €500k",,France "Validation of MT5-MMP as a new therapeutic target in Alzheimer’s disease and mechanisms of action","Investments < €500k",,France "VALIDATION OF NEUROIMAGING BIOMARKERS FOR NIGROSTRAITAL NEURONS","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Validation of Novel Pathogenic Htt Post-Translational Modifications (PTMs)","Investments > €500k","Huntington's disease","United States of America" "Validation of ocular measures as potential biomarkers for early detection of brain amyloid and neurodegeneration.","Investments > €500k","Alzheimer's disease & other dementias",Canada "Validation of the HD-HRQOL (Huntington disease quality of life measure)","Investments > €500k","Huntington's disease","United States of America" "Validation of the human farnesyl pyrophosphate synthase (hFPPS) as a therapeutic target and design of pre-clinical candidates for the treatment of multiple myeloma and neurodegenerative diseases.","Investments < €500k",,Canada "Validation of the Profile for Communication Abilities in Dementia (P-CAD)","Investments < €500k",,Ireland "Valmuska – Intelligent lighting and thermal comfort technologies for care services of home-dwelling elderly people with memory disorder","Investments < €500k",,Finland "Valuing Active Life In Dementia (VALID)","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "Varenicline, a nicotinic receptor agonist for the treatment of Excessive Daytime Sleepiness in Parkinson’s Disease: a placebo-controlled cross-over pilot study.","Investments < €500k",,Netherlands "Variabilité cérébrale comme marqueur de conversion vers une maladie neurodégénérative dans le trouble comportemental en sommeil paradoxale idiopathique. Cerebral variability as a marker of conversion to a neurodegenerative disease in idiopathic paradoxical sleep disorder",Fellowships,"Parkinson's disease & PD-related disorders",Canada "Variability in human axon survival","Investments > €500k","Motor neurone diseases|Neurodegenerative disease in general","United Kingdom" "Variatie in mRNA bij de ziekten van Alzheimer en Parkinson. Variation in mRNA in Alzheimer’s and Parkinson’s Diseases","Investments < €500k",,Netherlands "Vascular Ageing, Decline in Brain and Cognitive Functions","Population Cohorts","Neurodegenerative disease in general",France "Vascular and Aymloid Predictors of Neurodegeneration and Cognitive Decline in Nondemented Subjects.",Fellowships,"Alzheimer's disease & other dementias", "Vascular breakdown in Alzheimers Disease with cerebrovascular disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Vascular Cognitive Risk Score: quantifying the vascular burden in Alzheimer’s Disease",Fellowships,"Alzheimer's disease & other dementias",Australia "Vascular Dementia: revealing the detrimental synergy between hypertension, micro-strokes and Neuro-Vascular Decoupling",Fellowships,"Alzheimer's disease & other dementias","European Commission" "VASCULAR DYSFUNCTION AND FRAGILITY A CAUSAL RELATIONSHIP OF IDA AND RETURN WITH END OF TRIP IN THE DEMENTIA?","Investments < €500k",,Spain "Vascular Dysfunction in Cerebral Amyloid Angiopathy","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Vascular Engineering on chip using differentiated Stem Cells","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "VASCULAR FACTORS IN PREDICTION OF ALZHEIMER’S DISEASE","Investments < €500k",,"Czech Republic" "Vascular mechanisms for the effects of ovarian suppression on cognitive function",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Vascular mechanisms of neurodegeneration: drivers and determinants of dementia","Investments > €500k","Alzheimer's disease & other dementias",Australia "Vascular Pathology in Early and Asymptomatic Cerebral Amyloid Angiopathy","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Vascular risk factors for incident dementia and brain ageing",Fellowships,"Alzheimer's disease & other dementias",Australia "VCID Biomarkers Coordinating Center","Capital Infrastructure",,"United States of America" "VCID Biomarkers Coordinating Center","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "VCP Interacting Drugs as a novel strategy for the treatment of Alzheimer’s disease","Investments > €500k","Alzheimer's disease & other dementias",France "Vesicular modulation of dopamine neuron toxicity","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "Victorian Brain Bank",Biobanks,"Neurodegenerative disease in general",Australia "Vieillissement pathologique et non-pathologique, Activité physique, Génotype et Cognition / ViAGeCo. Pathological and non-pathological aging, Physical activity, Genotype and Cognition / ViAGeCo","Investments < €500k",,France "VIND : Flemish Impulse Funding for Networks for Dementia Research","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases",Belgium "Virtual assistant to support people with MCI based on Smart Glasses","Investments > €500k","Neurodegenerative disease in general",Germany "Virtual Reality based Spatial Memory Intervention for patients with Mild Cognitive Impairment","Investments > €500k","Alzheimer's disease & other dementias",Canada "Virtual Reality based Spatial Memory Intervention for patients with Mild Cognitive Impairment",,"Alzheimer's disease & other dementias",Canada "Virtual, Physiological and Computational Neuromuscular Models for the Predictive Treatment of Parkinson’s Disease","Investments > €500k","Parkinson's disease & PD-related disorders","European Commission" "Visualizing cell maintenance: Chemical tools to investigate the microenvironments of misfolded proteins","Investments < €500k",,"European Commission" "VitaminK2 as a mitochondrial electron carrier to improve Parkinson related deficiency","Investments < €500k",,Belgium "Vitamins D and K and Neuropathologically-Defined Alzheimer and Other Dementias in Older Persons","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Voltage gated sodium channel modulation of microglia activity in Alzheimer’s disease (NCmicroAD)","Investments < €500k",,Romania "Voltage-Dependent Anion Channel and Neurodegeneration in Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Voorspellende factoren voor het beloop van de ziekte van Parkinson over zeer lange termijn. Forecasting factors for the course of Parkinson’s disease in a very long term","Investments < €500k",,Netherlands "VPH Dementia Research Enabled by IT","Investments > €500k","Alzheimer's disease & other dementias","European Commission" "Vrijwillige inzet in het mantelzorgsysteem rond thuiswonende mensen met dementie: diversiteit en randvoorwaarden. Voluntary involvement in the wrist care system around home-living people with dementia: diversity and preconditions","Investments < €500k",,Netherlands "VUmc DNA biobank",Biobanks,"Alzheimer's disease & other dementias|Neurodegenerative disease in general",Netherlands "Wallenberg Clinical Scholars – On the aetiology of neurodegenerative diseases: Is ALS caused by self-propagating distinct strains of SOD1 prions? Studying SOD1 in ALS as a model of understanding neurodegenerative diseases.",Fellowships,"Motor neurone diseases",Sweden "Water-soluble Abeta and its role in Alzheimers disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Wearable sensors in smart textiles","Investments > €500k","Parkinson's disease & PD-related disorders",Sweden "Web-based Behavioral Activation for Alzheimers Caregivers","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "WEB-BASED TOOLS FOR NEUROIMAGING AND RADIOTHERAPY FUNCTIONAL ANALYSIS & QUANTIFICATION (SUBPROYECTO IQ-BRAIN)","Investments < €500k",,Spain "Web-enabled social interaction to delay cognitive decline among seniors with MCI: Phase I","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "What can tau deposition tell us about the appearance of subjective and objective cognitive decline in older adults?",Fellowships,"Alzheimer's disease & other dementias",Australia "What is the relationship between BOLD fMRI and functional MRS in aging and MCI?","Investments < €500k",,"United States of America" "What you get is what you see: How Reward Determines Perception","Investments > €500k","Parkinson's disease & PD-related disorders","European Commission" "What’s going on! Sports and dementia","Investments < €500k",,Germany "White Matter Connectivity and PD Cognitive Phenotypes","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "White Matter Connectivity and PD Cognitive Phenotypes","Investments > €500k","Parkinson's disease & PD-related disorders","United States of America" "White matter damage in age-related cognitive decline","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "White matter degeneration: biomarkers in preclinical Alzheimers Disease","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "White Matter Hyperintentisities in Aging and Dementia","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "White matter hypoxia in a novel model of MMP-mediated inflammation in SHR/SP","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "White Matter Tract Integrity biomarkers of neurodegeneration in aging and MCI",Fellowships,"Alzheimer's disease & other dementias","United States of America" "Whole exome sequencing in familial Alzheimer’s disease without APP/PSEN gene mutations","Investments < €500k",,Netherlands "Whole genome methylomic profiling in Parkinson’s: An integrated genetic-epigenetic approach","Investments < €500k",,"United Kingdom" "Whole genome sequencing in patients and families with dementia: building an open access UK resource","Investments < €500k",,"United Kingdom" "Whole genome sequencing of DNA samples – Birmingham","Investments < €500k",,"United Kingdom" "Whole genome sequencing of DNA samples – King’s, London","Investments < €500k",,"United Kingdom" "Whole genome sequencing of DNA samples – Sheffield","Investments < €500k",,"United Kingdom" "Whole Genome Sequencing; 100plus Study","Investments < €500k",,Netherlands "Whole-exome sequencing of discordant and concordant affected sib pairs in spinocerebellar ataxia type 3 (SCA3): a tool to identify novel modifier genes and highlight disrupted molecular pathways.","Investments < €500k",,Portugal "Whole-genome sequencing of 1000 Irish ALS patients and controls to identify novel ALS genes and pathways","Investments < €500k",,"United Kingdom" "Whole-genome sequencing of 1000 Irish ALS patients and controls to identify novel ALS genes and pathways",Fellowships,"Motor neurone diseases","United Kingdom" "Why Parkinson’s tremor has a variable dopaminergic response – cerebral differences between dopa-responsive and dopa-resistant tremor.",Fellowships,"Parkinson's disease & PD-related disorders",Netherlands "Wisconsin Registry for Alzheimers Prevention: Biomarkers for Preclinical AD","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Wisconsin Registry for Alzheimers Prevention: Sex Differences in DNA Methylation","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "WNT SIGNALING IN DOPAMINE DIFFERENCIATION OF STEM CELLS AND CELL REPLACEMENT THERAPY FOR PARKINSON’S DISEASE.",Fellowships,"Parkinson's disease & PD-related disorders",Denmark "Wnt signaling in dopamine neuron development and Parkinson´s disease cell therapy","Investments > €500k","Parkinson's disease & PD-related disorders",Sweden "WNT signaling: biomarker and target evaluation in Alzheimer’s disease","Investments < €500k",,"United Kingdom" "Womens Health Initiative Memory Study Suite of Studies – Extension Study","Investments < €500k",,"United States of America" "WONDER : interventions for wandering and other behavioral disturbances of persons with dementia in residential care by personalized robot interactions","Investments > €500k","Alzheimer's disease & other dementias|Motor neurone diseases",Belgium "Work4Dementia: Development of an evidence-based intervention to build capacity and resilience for the Australian dementia care workforce",Fellowships,"Alzheimer's disease & other dementias",Australia "YASHIN Admin Supp: Time Trends in Alzheimers Disease: Addressing the Changing Role of Risk Factors and Instrument Validity","Investments > €500k","Alzheimer's disease & other dementias","United States of America" "Young Onset Dementia","Disease Registers","Alzheimer's disease & other dementias",France "Young Onset Dementia – the difficult diagnosis and the stressful life for the whole family","Investments > €500k","Alzheimer's disease & other dementias",Norway "Young Onset Dementia – the difficult diagnosis and the stressful life for the whole family",Fellowships,"Alzheimer's disease & other dementias",Norway "Young Onset Dementia – the difficult diagnosis and the stressful life for the whole family",Fellowships,"Alzheimer's disease & other dementias",Norway "Zebrafish C9orf72 loss of function models of ALS","Investments < €500k",,"United Kingdom" "Zero-Field MRI to Enhance Diagnosis of Neurodegeneration","Investments > €500k","Alzheimer's disease & other dementias","United Kingdom" "ZINC AND COPPER SITES IN ALZHEIMER’S DISEASE","Investments < €500k",,Denmark "Zinc deficiency drives inflammation-dependent cognitive decline in Alzheimer’s disease","Investments < €500k",,"United Kingdom" "Zinc finger gene therapy in the brain for treating Huntington’s disease","Investments < €500k",,"European Commission" "ZnDTSM for Huntington’s disease","Investments < €500k",,Australia "ZonMw – Sphingolipids: A new target in the treatment of Alzheimer’s disease","Investments < €500k",,Slovakia